1	By	_	O	O	_	_	_	_	_
2	using	_	O	O	_	_	_	_	_
3	transient	_	O	O	_	_	_	_	_
4	transfection	_	O	O	_	_	_	_	_
5	assays	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	we	_	O	O	_	_	_	_	_
8	found	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	cross	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	linking	_	O	O	_	_	_	_	_
13	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	supports	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	dependent	_	O	O	_	_	_	_	_
22	gene	_	O	O	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	define	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	system	_	O	O	_	_	_	_	_
10	as	_	O	O	_	_	_	_	_
11	an	_	O	O	_	_	_	_	_
12	intermediate	_	O	O	_	_	_	_	_
13	event	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	signaling	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	suggest	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	pathway	_	O	O	_	_	_	_	_
25	can	_	O	O	_	_	_	_	_
26	influence	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	expression	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	B	_	O	O	_	_	_	_	_
31	cell	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	associated	_	O	O	_	_	_	_	_
34	genes	_	O	O	_	_	_	_	_
35	with	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	kappa	_	O	O	_	_	_	_	_
39	B	_	O	O	_	_	_	_	_
40	consensus	_	O	O	_	_	_	_	_
41	sites	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Targeted	_	O	O	_	_	_	_	_
2	remodeling	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	human	_	O	O	_	_	_	_	_
5	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	promoter	_	O	O	_	_	_	_	_
9	chromatin	_	O	O	_	_	_	_	_
10	structure	_	O	O	_	_	_	_	_
11	produces	_	O	O	_	_	_	_	_
12	increased	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	decreased	_	O	O	_	_	_	_	_
16	silencing	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	183	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	bp	_	O	O	_	_	_	_	_
5	region	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	both	_	O	O	_	_	_	_	_
8	cell	_	O	O	_	_	_	_	_
9	type	_	O	O	_	_	_	_	_
10	specific	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	responsive	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	two	_	O	O	_	_	_	_	_
15	distinct	_	O	O	_	_	_	_	_
16	stimuli	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	lipopolysaccharide	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	dibutyryl	_	O	O	_	_	_	_	_
21	cAMP	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	known	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	regulate	_	O	O	_	_	_	_	_
26	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	expression	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	positive	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	this	_	O	O	_	_	_	_	_
12	element	_	O	O	_	_	_	_	_
13	bound	_	O	O	_	_	_	_	_
14	several	_	O	O	_	_	_	_	_
15	members	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	NF	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	kappaB	_	O	O	_	_	_	_	_
21	family	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	factors	_	O	O	_	_	_	_	_
25	already	_	O	O	_	_	_	_	_
26	implicated	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	signal	_	O	O	_	_	_	_	_
29	transduction	_	O	O	_	_	_	_	_
30	pathways	_	O	O	_	_	_	_	_
31	relevant	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	expression	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	Mutation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	either	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	putative	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappaB	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	binding	_	O	O	_	_	_	_	_
12	sites	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	enhancer	_	O	O	_	_	_	_	_
16	element	_	O	O	_	_	_	_	_
17	decreased	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	LPS	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	stimulated	_	O	O	_	_	_	_	_
22	transcriptional	_	O	O	_	_	_	_	_
23	activity	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Induction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factors	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	human	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	lymphocytes	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	aspirin	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	like	_	O	O	_	_	_	_	_
13	drugs	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	binding	_	O	O	_	_	_	_	_
3	activities	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	expressed	_	O	O	_	_	_	_	_
6	only	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	activated	_	O	O	_	_	_	_	_
9	T	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	reported	_	O	O	_	_	_	_	_
4	here	_	O	O	_	_	_	_	_
5	demonstrate	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	critical	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	gene	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	bona	_	O	O	_	_	_	_	_
22	fide	_	O	O	_	_	_	_	_
23	Th	_	O	O	_	_	_	_	_
24	2	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Whereas	_	O	O	_	_	_	_	_
2	mutations	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	site	_	O	O	_	_	_	_	_
9	abolished	_	O	O	_	_	_	_	_
10	antigen	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	or	_	O	O	_	_	_	_	_
13	cAMP	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	stimulated	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	activation	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	Th	_	O	O	_	_	_	_	_
23	2	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	ectopic	_	O	O	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	Th	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	cells	_	O	O	_	_	_	_	_
36	or	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	a	_	O	O	_	_	_	_	_
39	non	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	lymphoid	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	non	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	producing	_	O	O	_	_	_	_	_
50	cell	_	O	O	_	_	_	_	_
51	line	_	O	O	_	_	_	_	_
52	activated	_	O	O	_	_	_	_	_
53	the	_	O	O	_	_	_	_	_
54	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
55	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	promoter	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	primers	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	1	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	forward	_	O	O	_	_	_	_	_
7	:	_	O	O	_	_	_	_	_
8	5	_	O	O	_	_	_	_	_
9	'	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	TTGAGATGGAGTCTTGCTCTGT	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	3	_	O	O	_	_	_	_	_
14	',	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	reverse	_	O	O	_	_	_	_	_
18	:	_	O	O	_	_	_	_	_
19	5	_	O	O	_	_	_	_	_
20	'	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	CCAGGACCTCAGGAGGCCAGTCA	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	3	_	O	O	_	_	_	_	_
25	';	_	O	O	_	_	_	_	_
26	2	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	forward	_	O	O	_	_	_	_	_
29	:	_	O	O	_	_	_	_	_
30	5	_	O	O	_	_	_	_	_
31	'	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	AGCGGTGAAACTGAGAGTGCGAGGT	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	3	_	O	O	_	_	_	_	_
36	',	_	O	O	_	_	_	_	_
37	2	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	reverse	_	O	O	_	_	_	_	_
40	:	_	O	O	_	_	_	_	_
41	5	_	O	O	_	_	_	_	_
42	'	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	GCCACATCGCTGCAGTTTAG	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	3	_	O	O	_	_	_	_	_
47	'.	_	O	O	_	_	_	_	_

1	Using	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	wild	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	type	_	O	O	_	_	_	_	_
6	or	_	O	O	_	_	_	_	_
7	mutated	_	O	O	_	_	_	_	_
8	human	_	O	O	_	_	_	_	_
9	retinoic	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	acid	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	model	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	kDa	_	O	O	_	_	_	_	_
18	values	_	O	O	_	_	_	_	_
19	determined	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	classical	_	O	O	_	_	_	_	_
22	competition	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	assays	_	O	O	_	_	_	_	_
25	using	_	O	O	_	_	_	_	_
26	tritiated	_	O	O	_	_	_	_	_
27	ligands	_	O	O	_	_	_	_	_
28	are	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	agreement	_	O	O	_	_	_	_	_
31	with	_	O	O	_	_	_	_	_
32	those	_	O	O	_	_	_	_	_
33	measured	_	O	O	_	_	_	_	_
34	by	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	proteolytic	_	O	O	_	_	_	_	_
37	assay	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Transient	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	HIV	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	five	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	eightfold	_	O	O	_	_	_	_	_
14	increase	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	activity	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	Jurkat	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	stimulated	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	phytohemagglutinin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	phorbol	_	O	O	_	_	_	_	_
30	myristate	_	O	O	_	_	_	_	_
31	acetate	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	observed	_	O	O	_	_	_	_	_
3	increase	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	levels	_	O	O	_	_	_	_	_
9	might	_	O	O	_	_	_	_	_
10	facilitate	_	O	O	_	_	_	_	_
11	virus	_	O	O	_	_	_	_	_
12	spread	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	or	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_


1	Similarly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	pGL	_	O	O	_	_	_	_	_
4	3	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	APOprom	_	O	O	_	_	_	_	_
7	502	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	containing	_	O	O	_	_	_	_	_
10	sequence	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	436	_	O	O	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	+	_	O	O	_	_	_	_	_
15	66	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	pGL	_	O	O	_	_	_	_	_
19	3	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	APOprom	_	O	O	_	_	_	_	_
22	225	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	containing	_	O	O	_	_	_	_	_
25	sequence	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	159	_	O	O	_	_	_	_	_
28	/	_	O	O	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	66	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	further	_	O	O	_	_	_	_	_
34	5	_	O	O	_	_	_	_	_
35	'	_	O	O	_	_	_	_	_
36	deletion	_	O	O	_	_	_	_	_
37	reporter	_	O	O	_	_	_	_	_
38	constructs	_	O	O	_	_	_	_	_
39	containing	_	O	O	_	_	_	_	_
40	180	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	150	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	120	_	O	O	_	_	_	_	_
45	or	_	O	O	_	_	_	_	_
46	60	_	O	O	_	_	_	_	_
47	bp	_	O	O	_	_	_	_	_
48	upstream	_	O	O	_	_	_	_	_
49	of	_	O	O	_	_	_	_	_
50	position	_	O	O	_	_	_	_	_
51	+	_	O	O	_	_	_	_	_
52	65	_	O	O	_	_	_	_	_
53	were	_	O	O	_	_	_	_	_
54	generated	_	O	O	_	_	_	_	_
55	(	_	O	O	_	_	_	_	_
56	Figure	_	O	O	_	_	_	_	_
57	3	_	O	O	_	_	_	_	_
58	A	_	O	O	_	_	_	_	_
59	)	_	O	O	_	_	_	_	_
60	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	order	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	analyze	_	O	O	_	_	_	_	_
5	transcriptional	_	O	O	_	_	_	_	_
6	activity	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	reporter	_	O	O	_	_	_	_	_
11	plasmids	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	transiently	_	O	O	_	_	_	_	_
14	transfected	_	O	O	_	_	_	_	_
15	into	_	O	O	_	_	_	_	_
16	A	_	O	O	_	_	_	_	_
17	3	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_
19	01	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	rate	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	not	_	O	O	_	_	_	_	_
6	significantly	_	O	O	_	_	_	_	_
7	altered	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	5	_	O	O	_	_	_	_	_
11	'	_	O	O	_	_	_	_	_
12	deletions	_	O	O	_	_	_	_	_
13	leading	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	502	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	225	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	180	_	O	O	_	_	_	_	_
21	bp	_	O	O	_	_	_	_	_
22	fragments	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	Figure	_	O	O	_	_	_	_	_
25	3	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	regulatory	_	O	O	_	_	_	_	_
3	elements	_	O	O	_	_	_	_	_
4	situated	_	O	O	_	_	_	_	_
5	downstream	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	interact	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	constitutive	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	inducible	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factors	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	mediate	_	O	O	_	_	_	_	_
17	transmission	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	cellular	_	O	O	_	_	_	_	_
20	activation	_	O	O	_	_	_	_	_
21	signals	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	are	_	O	O	_	_	_	_	_
25	important	_	O	O	_	_	_	_	_
26	for	_	O	O	_	_	_	_	_
27	efficient	_	O	O	_	_	_	_	_
28	HIV	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	transcription	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	replication	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	treatment	_	O	O	_	_	_	_	_
3	with	_	O	O	_	_	_	_	_
4	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	nuclear	_	O	O	_	_	_	_	_
9	localization	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	NFkappaB	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	both	_	O	O	_	_	_	_	_
14	memory	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	naive	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	subsets	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	irrespective	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	age	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	donor	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	levels	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	induced	_	O	O	_	_	_	_	_
33	NFkappaB	_	O	O	_	_	_	_	_
34	were	_	O	O	_	_	_	_	_
35	significantly	_	O	O	_	_	_	_	_
36	lower	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	both	_	O	O	_	_	_	_	_
39	subsets	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	T	_	O	O	_	_	_	_	_
42	cells	_	O	O	_	_	_	_	_
43	obtained	_	O	O	_	_	_	_	_
44	from	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	elderly	_	O	O	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	when	_	O	O	_	_	_	_	_
49	compared	_	O	O	_	_	_	_	_
50	to	_	O	O	_	_	_	_	_
51	those	_	O	O	_	_	_	_	_
52	in	_	O	O	_	_	_	_	_
53	young	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	age	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	related	_	O	O	_	_	_	_	_
8	decrease	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	induction	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	nuclear	_	O	O	_	_	_	_	_
13	NFkappaB	_	O	O	_	_	_	_	_
14	correlated	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	decrease	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	intracellular	_	O	O	_	_	_	_	_
19	IL	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	2	_	O	O	_	_	_	_	_
22	receptor	_	O	O	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	anti	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	CD	_	O	O	_	_	_	_	_
28	3	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	induced	_	O	O	_	_	_	_	_
31	proliferation	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	both	_	O	O	_	_	_	_	_
34	memory	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	naive	_	O	O	_	_	_	_	_
37	T	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	subsets	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	our	_	O	O	_	_	_	_	_
4	studies	_	O	O	_	_	_	_	_
5	showed	_	O	O	_	_	_	_	_
6	association	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	IKK	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	alpha	_	O	O	_	_	_	_	_
12	/	_	O	O	_	_	_	_	_
13	beta	_	O	O	_	_	_	_	_
14	heterodimer	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	NIK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	unstimulated	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	understanding	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	LPS	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	TNF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	induced	_	O	O	_	_	_	_	_
10	signaling	_	O	O	_	_	_	_	_
11	may	_	O	O	_	_	_	_	_
12	allow	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	development	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	specific	_	O	O	_	_	_	_	_
17	strategies	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	treat	_	O	O	_	_	_	_	_
20	sepsis	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	associated	_	O	O	_	_	_	_	_
23	disease	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	genes	_	O	O	_	_	_	_	_
4	play	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	positive	_	O	O	_	_	_	_	_
7	role	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	proliferation	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	we	_	O	O	_	_	_	_	_
13	suggest	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	this	_	O	O	_	_	_	_	_
16	regulatory	_	O	O	_	_	_	_	_
17	switch	_	O	O	_	_	_	_	_
18	contributes	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	controlling	_	O	O	_	_	_	_	_
21	entry	_	O	O	_	_	_	_	_
22	into	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	cycle	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Forty	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	eight	_	O	O	_	_	_	_	_
4	hour	_	O	O	_	_	_	_	_
5	after	_	O	O	_	_	_	_	_
6	transfection	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	assay	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	performed	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_


1	Elucidation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	mechanism	_	O	O	_	_	_	_	_
5	involved	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	this	_	O	O	_	_	_	_	_
8	inhibition	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	IgE	_	O	O	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	shows	_	O	O	_	_	_	_	_
13	that	_	O	O	_	_	_	_	_
14	epsilon	_	O	O	_	_	_	_	_
15	germline	_	O	O	_	_	_	_	_
16	transcription	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	decreased	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	RA	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	whereas	_	O	O	_	_	_	_	_
23	production	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	was	_	O	O	_	_	_	_	_
34	not	_	O	O	_	_	_	_	_
35	enhanced	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	presence	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	RA	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	study	_	O	O	_	_	_	_	_
6	shows	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	RA	_	O	O	_	_	_	_	_
9	inhibits	_	O	O	_	_	_	_	_
10	IgE	_	O	O	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	anti	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	+	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	stimulated	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	vitro	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	showed	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	U	_	O	O	_	_	_	_	_
9	2	_	O	O	_	_	_	_	_
10	snRNA	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	also	_	O	O	_	_	_	_	_
17	requires	_	O	O	_	_	_	_	_
18	an	_	O	O	_	_	_	_	_
19	enhancer	_	O	O	_	_	_	_	_
20	comprising	_	O	O	_	_	_	_	_
21	both	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	Oct	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	at	_	O	O	_	_	_	_	_
26	least	_	O	O	_	_	_	_	_
27	one	_	O	O	_	_	_	_	_
28	Sp	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	binding	_	O	O	_	_	_	_	_
32	site	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	also	_	O	O	_	_	_	_	_
4	revealed	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	similar	_	O	O	_	_	_	_	_
7	functional	_	O	O	_	_	_	_	_
8	cooperation	_	O	O	_	_	_	_	_
9	between	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	factors	_	O	O	_	_	_	_	_
13	which	_	O	O	_	_	_	_	_
14	bind	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	Oct	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	adjacent	_	O	O	_	_	_	_	_
21	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	binding	_	O	O	_	_	_	_	_
25	site	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	BJA	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	as	_	O	O	_	_	_	_	_
33	has	_	O	O	_	_	_	_	_
34	been	_	O	O	_	_	_	_	_
35	observed	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	HeLa	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	since	_	O	O	_	_	_	_	_
41	a	_	O	O	_	_	_	_	_
42	template	_	O	O	_	_	_	_	_
43	which	_	O	O	_	_	_	_	_
44	contains	_	O	O	_	_	_	_	_
45	a	_	O	O	_	_	_	_	_
46	weak	_	O	O	_	_	_	_	_
47	binding	_	O	O	_	_	_	_	_
48	site	_	O	O	_	_	_	_	_
49	for	_	O	O	_	_	_	_	_
50	OTFs	_	O	O	_	_	_	_	_
51	expresses	_	O	O	_	_	_	_	_
52	wild	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	type	_	O	O	_	_	_	_	_
55	levels	_	O	O	_	_	_	_	_
56	of	_	O	O	_	_	_	_	_
57	U	_	O	O	_	_	_	_	_
58	2	_	O	O	_	_	_	_	_
59	snRNA	_	O	O	_	_	_	_	_
60	in	_	O	O	_	_	_	_	_
61	both	_	O	O	_	_	_	_	_
62	cell	_	O	O	_	_	_	_	_
63	types	_	O	O	_	_	_	_	_
64	when	_	O	O	_	_	_	_	_
65	the	_	O	O	_	_	_	_	_
66	weak	_	O	O	_	_	_	_	_
67	octamer	_	O	O	_	_	_	_	_
68	-	_	O	O	_	_	_	_	_
69	binding	_	O	O	_	_	_	_	_
70	site	_	O	O	_	_	_	_	_
71	is	_	O	O	_	_	_	_	_
72	combined	_	O	O	_	_	_	_	_
73	with	_	O	O	_	_	_	_	_
74	a	_	O	O	_	_	_	_	_
75	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
76	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
77	-	_	O	O	_	_	_	_	_
78	binding	_	O	O	_	_	_	_	_
79	site	_	O	O	_	_	_	_	_
80	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	functionality	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	both	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	C	_	O	O	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	EBP	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	GATA	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	sites	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	we	_	O	O	_	_	_	_	_
19	analyzed	_	O	O	_	_	_	_	_
20	whether	_	O	O	_	_	_	_	_
21	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	EBPbeta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	can	_	O	O	_	_	_	_	_
29	stimulate	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	MBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	promoter	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	EBPbeta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	negative	_	O	O	_	_	_	_	_
43	Jurkat	_	O	O	_	_	_	_	_
44	T	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	cell	_	O	O	_	_	_	_	_
47	line	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	responsive	_	O	O	_	_	_	_	_
5	elements	_	O	O	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	characteristically	_	O	O	_	_	_	_	_
8	present	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	promoters	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	inducible	_	O	O	_	_	_	_	_
18	genes	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	direct	_	O	O	_	_	_	_	_
3	effect	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	down	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	regulating	_	O	O	_	_	_	_	_
10	HIV	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	gene	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	correlates	_	O	O	_	_	_	_	_
16	well	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	recently	_	O	O	_	_	_	_	_
19	reported	_	O	O	_	_	_	_	_
20	evidence	_	O	O	_	_	_	_	_
21	indicating	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	higher	_	O	O	_	_	_	_	_
24	regulatory	_	O	O	_	_	_	_	_
25	activity	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	+	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	from	_	O	O	_	_	_	_	_
36	HIV	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	1	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	infected	_	O	O	_	_	_	_	_
41	patients	_	O	O	_	_	_	_	_
42	was	_	O	O	_	_	_	_	_
43	associated	_	O	O	_	_	_	_	_
44	with	_	O	O	_	_	_	_	_
45	lower	_	O	O	_	_	_	_	_
46	HIV	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	1	_	O	O	_	_	_	_	_
49	viral	_	O	O	_	_	_	_	_
50	loads	_	O	O	_	_	_	_	_
51	in	_	O	O	_	_	_	_	_
52	these	_	O	O	_	_	_	_	_
53	patients	_	O	O	_	_	_	_	_
54	[	_	O	O	_	_	_	_	_
55	46	_	O	O	_	_	_	_	_
56	]	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	demonstrate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	interferes	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	latter	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	these	_	O	O	_	_	_	_	_
13	two	_	O	O	_	_	_	_	_
14	processes	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	recruitment	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	coactivator	_	O	O	_	_	_	_	_
22	protein	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	300	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	resulting	_	O	O	_	_	_	_	_
28	transcriptional	_	O	O	_	_	_	_	_
29	activation	_	O	O	_	_	_	_	_
30	are	_	O	O	_	_	_	_	_
31	blocked	_	O	O	_	_	_	_	_
32	by	_	O	O	_	_	_	_	_
33	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	observed	_	O	O	_	_	_	_	_
3	with	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappaB	_	O	O	_	_	_	_	_
7	activation	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	mutant	_	O	O	_	_	_	_	_
13	lacking	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	FKH	_	O	O	_	_	_	_	_
16	domain	_	O	O	_	_	_	_	_
17	was	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	stronger	_	O	O	_	_	_	_	_
20	inhibitor	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	CREB	_	O	O	_	_	_	_	_
23	activation	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	+	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	than	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	HEK	_	O	O	_	_	_	_	_
33	293	_	O	O	_	_	_	_	_
34	T	_	O	O	_	_	_	_	_
35	epithelial	_	O	O	_	_	_	_	_
36	cells	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	we	_	O	O	_	_	_	_	_
5	identify	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	CREB	_	O	O	_	_	_	_	_
8	pathway	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	molecular	_	O	O	_	_	_	_	_
12	target	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Antibodies	_	O	O	_	_	_	_	_
2	used	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	flow	_	O	O	_	_	_	_	_
5	cytometric	_	O	O	_	_	_	_	_
6	analysis	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	immunoblot	_	O	O	_	_	_	_	_
9	analysis	_	O	O	_	_	_	_	_

1	Detection	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	protein	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	tried	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	following	_	O	O	_	_	_	_	_
15	antibodies	_	O	O	_	_	_	_	_
16	:	_	O	O	_	_	_	_	_
17	goat	_	O	O	_	_	_	_	_
18	polyclonal	_	O	O	_	_	_	_	_
19	anti	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	Santa	_	O	O	_	_	_	_	_
26	Cruz	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	San	_	O	O	_	_	_	_	_
29	Diego	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	CA	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	USA	_	O	O	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	monoclonal	_	O	O	_	_	_	_	_
37	mouse	_	O	O	_	_	_	_	_
38	anti	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	polyclonal	_	O	O	_	_	_	_	_
45	goat	_	O	O	_	_	_	_	_
46	anti	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	from	_	O	O	_	_	_	_	_
52	R	_	O	O	_	_	_	_	_
53	&	_	O	O	_	_	_	_	_
54	D	_	O	O	_	_	_	_	_
55	Systems	_	O	O	_	_	_	_	_
56	(	_	O	O	_	_	_	_	_
57	Abingdon	_	O	O	_	_	_	_	_
58	,	_	O	O	_	_	_	_	_
59	UK	_	O	O	_	_	_	_	_
60	)	_	O	O	_	_	_	_	_
61	,	_	O	O	_	_	_	_	_
62	and	_	O	O	_	_	_	_	_
63	mouse	_	O	O	_	_	_	_	_
64	monoclonal	_	O	O	_	_	_	_	_
65	anti	_	O	O	_	_	_	_	_
66	-	_	O	O	_	_	_	_	_
67	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
68	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
69	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
70	(	_	O	O	_	_	_	_	_
71	Chemicon	_	O	O	_	_	_	_	_
72	International	_	O	O	_	_	_	_	_
73	Inc	_	O	O	_	_	_	_	_
74	,	_	O	O	_	_	_	_	_
75	Temecula	_	O	O	_	_	_	_	_
76	,	_	O	O	_	_	_	_	_
77	CA	_	O	O	_	_	_	_	_
78	,	_	O	O	_	_	_	_	_
79	USA	_	O	O	_	_	_	_	_
80	)	_	O	O	_	_	_	_	_
81	.	_	O	O	_	_	_	_	_

1	Differential	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	confirmed	_	O	O	_	_	_	_	_
5	subsequently	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	Northern	_	O	O	_	_	_	_	_
8	blot	_	O	O	_	_	_	_	_
9	analysis	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_

1	Uncoupling	_	O	O	_	_	_	_	_
2	activation	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	dependent	_	O	O	_	_	_	_	_
5	HS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	nuclear	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	activated	_	O	O	_	_	_	_	_
13	T	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	transcriptional	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	Jurkat	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	:	_	O	O	_	_	_	_	_
22	differential	_	O	O	_	_	_	_	_
23	signaling	_	O	O	_	_	_	_	_
24	through	_	O	O	_	_	_	_	_
25	CD	_	O	O	_	_	_	_	_
26	3	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	costimulatory	_	O	O	_	_	_	_	_
30	receptors	_	O	O	_	_	_	_	_
31	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	Nuclear	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappaB	_	O	O	_	_	_	_	_
7	correlate	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	syncytium	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	forming	_	O	O	_	_	_	_	_
12	capacity	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	8	_	O	O	_	_	_	_	_
15	e	_	O	O	_	_	_	_	_
16	51	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	expressing	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	defective	_	O	O	_	_	_	_	_
22	HIV	_	O	O	_	_	_	_	_
23	virus	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	gave	_	O	O	_	_	_	_	_
7	per	_	O	O	_	_	_	_	_
8	se	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	low	_	O	O	_	_	_	_	_
12	affinity	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	protein	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	DNA	_	O	O	_	_	_	_	_
18	complex	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	migrated	_	O	O	_	_	_	_	_
21	more	_	O	O	_	_	_	_	_
22	slowly	_	O	O	_	_	_	_	_
23	than	_	O	O	_	_	_	_	_
24	native	_	O	O	_	_	_	_	_
25	NF	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	GM	_	O	O	_	_	_	_	_
28	2	_	O	O	_	_	_	_	_
29	complex	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	support	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	model	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	we	_	O	O	_	_	_	_	_
8	report	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	human	_	O	O	_	_	_	_	_
12	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	promoter	_	O	O	_	_	_	_	_
16	exists	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	multiple	_	O	O	_	_	_	_	_
19	allelic	_	O	O	_	_	_	_	_
20	forms	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	exhibit	_	O	O	_	_	_	_	_
23	distinct	_	O	O	_	_	_	_	_
24	transcriptional	_	O	O	_	_	_	_	_
25	activities	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	positive	_	O	O	_	_	_	_	_
32	T	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	nucleotide	_	O	O	_	_	_	_	_
3	substitution	_	O	O	_	_	_	_	_
4	within	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	recently	_	O	O	_	_	_	_	_
7	described	_	O	O	_	_	_	_	_
8	OAP	_	O	O	_	_	_	_	_
9	40	_	O	O	_	_	_	_	_
10	element	_	O	O	_	_	_	_	_
11	located	_	O	O	_	_	_	_	_
12	just	_	O	O	_	_	_	_	_
13	upstream	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	AT	_	O	O	_	_	_	_	_
19	site	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	P	_	O	O	_	_	_	_	_
22	sequence	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	appears	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	be	_	O	O	_	_	_	_	_
27	largely	_	O	O	_	_	_	_	_
28	responsible	_	O	O	_	_	_	_	_
29	for	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	increased	_	O	O	_	_	_	_	_
32	promotor	_	O	O	_	_	_	_	_
33	strength	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	this	_	O	O	_	_	_	_	_
36	particular	_	O	O	_	_	_	_	_
37	allelic	_	O	O	_	_	_	_	_
38	form	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	promoter	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	EMSAs	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	substitution	_	O	O	_	_	_	_	_
6	results	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	markedly	_	O	O	_	_	_	_	_
10	enhanced	_	O	O	_	_	_	_	_
11	affinity	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	sequence	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	specific	_	O	O	_	_	_	_	_
16	complexes	_	O	O	_	_	_	_	_
17	exhibiting	_	O	O	_	_	_	_	_
18	an	_	O	O	_	_	_	_	_
19	AP	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	1	_	O	O	_	_	_	_	_
22	specificity	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	Here	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	analyzed	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	mechanisms	_	O	O	_	_	_	_	_
8	involved	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	CTLA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	mediated	_	O	O	_	_	_	_	_
15	inhibition	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	activation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	naive	_	O	O	_	_	_	_	_
22	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	+	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	using	_	O	O	_	_	_	_	_
28	Ab	_	O	O	_	_	_	_	_
29	cross	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	linking	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	CTLA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	ligation	_	O	O	_	_	_	_	_
5	inhibited	_	O	O	_	_	_	_	_
6	CD	_	O	O	_	_	_	_	_
7	3	_	O	O	_	_	_	_	_
8	/	_	O	O	_	_	_	_	_
9	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	induced	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mRNA	_	O	O	_	_	_	_	_
17	accumulation	_	O	O	_	_	_	_	_
18	by	_	O	O	_	_	_	_	_
19	inhibiting	_	O	O	_	_	_	_	_
20	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	which	_	O	O	_	_	_	_	_
26	appears	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	be	_	O	O	_	_	_	_	_
29	mediated	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	part	_	O	O	_	_	_	_	_
32	through	_	O	O	_	_	_	_	_
33	decreasing	_	O	O	_	_	_	_	_
34	NF	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	AT	_	O	O	_	_	_	_	_
37	accumulation	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	nuclei	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	CTLA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	engagement	_	O	O	_	_	_	_	_
7	inhibited	_	O	O	_	_	_	_	_
8	progression	_	O	O	_	_	_	_	_
9	through	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	cell	_	O	O	_	_	_	_	_
12	cycle	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	inhibiting	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	production	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	cyclin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	D	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	cyclin	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	dependent	_	O	O	_	_	_	_	_
25	kinase	_	O	O	_	_	_	_	_
26	(	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	cdk	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	cdk	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	when	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	T	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	were	_	O	O	_	_	_	_	_
39	stimulated	_	O	O	_	_	_	_	_
40	with	_	O	O	_	_	_	_	_
41	anti	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	CD	_	O	O	_	_	_	_	_
44	3	_	O	O	_	_	_	_	_
45	/	_	O	O	_	_	_	_	_
46	CD	_	O	O	_	_	_	_	_
47	28	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	with	_	O	O	_	_	_	_	_
50	anti	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	CD	_	O	O	_	_	_	_	_
53	3	_	O	O	_	_	_	_	_
54	alone	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	putative	_	O	O	_	_	_	_	_
3	factors	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	couple	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	signal	_	O	O	_	_	_	_	_
8	transduction	_	O	O	_	_	_	_	_
9	from	_	O	O	_	_	_	_	_
10	surface	_	O	O	_	_	_	_	_
11	receptors	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	cytokine	_	O	O	_	_	_	_	_
17	synthesis	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	natural	_	O	O	_	_	_	_	_
20	killer	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	NK	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	have	_	O	O	_	_	_	_	_
26	not	_	O	O	_	_	_	_	_
27	been	_	O	O	_	_	_	_	_
28	elucidated	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	23	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	induced	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappaB	_	O	O	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	heterodimer	_	O	O	_	_	_	_	_
11	composed	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	/	_	O	O	_	_	_	_	_
16	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	subunits	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Renal	_	O	O	_	_	_	_	_
2	cell	_	O	O	_	_	_	_	_
3	carcinoma	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	derived	_	O	O	_	_	_	_	_
6	gangliosides	_	O	O	_	_	_	_	_
7	suppress	_	O	O	_	_	_	_	_
8	nuclear	_	O	O	_	_	_	_	_
9	factor	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Tumor	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	derived	_	O	O	_	_	_	_	_
4	soluble	_	O	O	_	_	_	_	_
5	products	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	cultured	_	O	O	_	_	_	_	_
8	RCC	_	O	O	_	_	_	_	_
9	explants	_	O	O	_	_	_	_	_
10	inhibit	_	O	O	_	_	_	_	_
11	NFkappaB	_	O	O	_	_	_	_	_
12	activity	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	from	_	O	O	_	_	_	_	_
17	healthy	_	O	O	_	_	_	_	_
18	volunteers	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	despite	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	normal	_	O	O	_	_	_	_	_
23	level	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	stimulus	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	induced	_	O	O	_	_	_	_	_
28	IkappaBalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	degradation	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	these	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Indeed	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	detected	_	O	O	_	_	_	_	_
5	gangliosides	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	supernatants	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	RCC	_	O	O	_	_	_	_	_
10	explants	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	not	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	adjacent	_	O	O	_	_	_	_	_
15	normal	_	O	O	_	_	_	_	_
16	kidney	_	O	O	_	_	_	_	_
17	tissue	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	our	_	O	O	_	_	_	_	_
5	findings	_	O	O	_	_	_	_	_
6	suggest	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	tumor	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	derived	_	O	O	_	_	_	_	_
11	gangliosides	_	O	O	_	_	_	_	_
12	may	_	O	O	_	_	_	_	_
13	blunt	_	O	O	_	_	_	_	_
14	antitumor	_	O	O	_	_	_	_	_
15	immune	_	O	O	_	_	_	_	_
16	responses	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	patients	_	O	O	_	_	_	_	_
19	with	_	O	O	_	_	_	_	_
20	RCCs	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	At	_	O	O	_	_	_	_	_
2	low	_	O	O	_	_	_	_	_
3	GSSG	_	O	O	_	_	_	_	_
4	levels	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	T	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	cannot	_	O	O	_	_	_	_	_
9	optimally	_	O	O	_	_	_	_	_
10	activate	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	immunologically	_	O	O	_	_	_	_	_
13	important	_	O	O	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	factor	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	kappa	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	whereas	_	O	O	_	_	_	_	_
21	high	_	O	O	_	_	_	_	_
22	GSSG	_	O	O	_	_	_	_	_
23	levels	_	O	O	_	_	_	_	_
24	inhibit	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	DNA	_	O	O	_	_	_	_	_
27	binding	_	O	O	_	_	_	_	_
28	activity	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	NF	_	O	O	_	_	_	_	_
31	kappa	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	protein	_	O	O	_	_	_	_	_
4	tyrosine	_	O	O	_	_	_	_	_
5	kinase	_	O	O	_	_	_	_	_
6	activities	_	O	O	_	_	_	_	_
7	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	56	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	lck	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	59	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	fyn	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	are	_	O	O	_	_	_	_	_
15	activated	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	intact	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	hydrogen	_	O	O	_	_	_	_	_
21	peroxide	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	they	_	O	O	_	_	_	_	_
24	are	_	O	O	_	_	_	_	_
25	likely	_	O	O	_	_	_	_	_
26	targets	_	O	O	_	_	_	_	_
27	for	_	O	O	_	_	_	_	_
28	GSSG	_	O	O	_	_	_	_	_
29	action	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	signal	_	O	O	_	_	_	_	_
3	transduction	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	facilitated	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	prooxidant	_	O	O	_	_	_	_	_
8	conditions	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	we	_	O	O	_	_	_	_	_
11	propose	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	well	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	known	_	O	O	_	_	_	_	_
17	immunological	_	O	O	_	_	_	_	_
18	consequences	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	GSH	_	O	O	_	_	_	_	_
21	depletion	_	O	O	_	_	_	_	_
22	ultimately	_	O	O	_	_	_	_	_
23	may	_	O	O	_	_	_	_	_
24	be	_	O	O	_	_	_	_	_
25	results	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	accompanying	_	O	O	_	_	_	_	_
29	GSSG	_	O	O	_	_	_	_	_
30	deficiency	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	HIV	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	infected	_	O	O	_	_	_	_	_
5	patients	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	SIV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	infected	_	O	O	_	_	_	_	_
10	rhesus	_	O	O	_	_	_	_	_
11	macaques	_	O	O	_	_	_	_	_
12	have	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	average	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	significantly	_	O	O	_	_	_	_	_
19	decreased	_	O	O	_	_	_	_	_
20	plasma	_	O	O	_	_	_	_	_
21	cyst	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	e	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	ine	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	intracellular	_	O	O	_	_	_	_	_
28	GSH	_	O	O	_	_	_	_	_
29	levels	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	we	_	O	O	_	_	_	_	_
32	also	_	O	O	_	_	_	_	_
33	hypothesize	_	O	O	_	_	_	_	_
34	that	_	O	O	_	_	_	_	_
35	AIDS	_	O	O	_	_	_	_	_
36	may	_	O	O	_	_	_	_	_
37	be	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	consequence	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	a	_	O	O	_	_	_	_	_
42	GSSG	_	O	O	_	_	_	_	_
43	deficiency	_	O	O	_	_	_	_	_
44	as	_	O	O	_	_	_	_	_
45	well	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	understand	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	action	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	FGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	studies	_	O	O	_	_	_	_	_
14	were	_	O	O	_	_	_	_	_
15	initiated	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	Jurkat	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	express	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	signaling	_	O	O	_	_	_	_	_
24	isoform	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	FGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	membrane	_	O	O	_	_	_	_	_
6	glycoprotein	_	O	O	_	_	_	_	_
7	expressed	_	O	O	_	_	_	_	_
8	specifically	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	monocytes	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	macrophages	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	its	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	markedly	_	O	O	_	_	_	_	_
19	increased	_	O	O	_	_	_	_	_
20	during	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	process	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	monocyte	_	O	O	_	_	_	_	_
25	differentiation	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	shortened	_	O	O	_	_	_	_	_
3	life	_	O	O	_	_	_	_	_
4	span	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	EKLF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	/	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	adult	_	O	O	_	_	_	_	_
11	erythrocytes	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	due	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	deficiency	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	chains	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	is	_	O	O	_	_	_	_	_
24	ameliorated	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	human	_	O	O	_	_	_	_	_
27	gamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	chains	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	ratio	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	adult	_	O	O	_	_	_	_	_
5	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	/	_	O	O	_	_	_	_	_
9	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	mRNA	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	mutant	_	O	O	_	_	_	_	_
16	ES	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	1	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	15	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	wild	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	type	_	O	O	_	_	_	_	_
28	ES	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	transfected	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	primary	_	O	O	_	_	_	_	_
5	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	+	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	vitro	_	O	O	_	_	_	_	_
13	differentiated	_	O	O	_	_	_	_	_
14	Th	_	O	O	_	_	_	_	_
15	2	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	Jurkat	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	Jurkat	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	are	_	O	O	_	_	_	_	_
25	known	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	constitutively	_	O	O	_	_	_	_	_
28	express	_	O	O	_	_	_	_	_
29	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	[	_	O	O	_	_	_	_	_
32	25	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	26	_	O	O	_	_	_	_	_
35	])	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	we	_	O	O	_	_	_	_	_
39	measured	_	O	O	_	_	_	_	_
40	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	promoter	_	O	O	_	_	_	_	_
43	activity	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Overexpression	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	naive	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	diminished	_	O	O	_	_	_	_	_
10	luciferase	_	O	O	_	_	_	_	_
11	activity	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	compared	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	control	_	O	O	_	_	_	_	_
21	vector	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	Figure	_	O	O	_	_	_	_	_
24	8	_	O	O	_	_	_	_	_
25	B	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Only	_	O	O	_	_	_	_	_
2	HEK	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	overexpressing	_	O	O	_	_	_	_	_
5	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	Th	_	O	O	_	_	_	_	_
9	2	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	showed	_	O	O	_	_	_	_	_
12	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	activity	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	Figure	_	O	O	_	_	_	_	_
19	8	_	O	O	_	_	_	_	_
20	D	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	8	_	O	O	_	_	_	_	_
23	E	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Cdk	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	dependent	_	O	O	_	_	_	_	_
5	phosphorylation	_	O	O	_	_	_	_	_
6	therefore	_	O	O	_	_	_	_	_
7	provides	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	switch	_	O	O	_	_	_	_	_
10	during	_	O	O	_	_	_	_	_
11	late	_	O	O	_	_	_	_	_
12	G	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	S	_	O	O	_	_	_	_	_
18	phase	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	both	_	O	O	_	_	_	_	_
21	nullifies	_	O	O	_	_	_	_	_
22	an	_	O	O	_	_	_	_	_
23	early	_	O	O	_	_	_	_	_
24	G	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	cycle	_	O	O	_	_	_	_	_
28	regulatory	_	O	O	_	_	_	_	_
29	function	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	Id	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	modulates	_	O	O	_	_	_	_	_
35	its	_	O	O	_	_	_	_	_
36	target	_	O	O	_	_	_	_	_
37	bHLH	_	O	O	_	_	_	_	_
38	specificity	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Thrombin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	stimulated	_	O	O	_	_	_	_	_
3	tyrosine	_	O	O	_	_	_	_	_
4	phosphorylation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	several	_	O	O	_	_	_	_	_
7	proteins	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	molecular	_	O	O	_	_	_	_	_
10	mass	_	O	O	_	_	_	_	_
11	40	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	42	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	70	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	120	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	130	_	O	O	_	_	_	_	_
21	kDa	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Several	_	O	O	_	_	_	_	_
2	cell	_	O	O	_	_	_	_	_
3	lines	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	hematopoietic	_	O	O	_	_	_	_	_
6	origin	_	O	O	_	_	_	_	_
7	including	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	leukemic	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cell	_	O	O	_	_	_	_	_
12	line	_	O	O	_	_	_	_	_
13	HPB	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_
15	ALL	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	erythroleukemic	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	line	_	O	O	_	_	_	_	_
21	K	_	O	O	_	_	_	_	_
22	562	_	O	O	_	_	_	_	_
23	were	_	O	O	_	_	_	_	_
24	responsive	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	thrombin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	whereas	_	O	O	_	_	_	_	_
29	others	_	O	O	_	_	_	_	_
30	such	_	O	O	_	_	_	_	_
31	as	_	O	O	_	_	_	_	_
32	THP	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	a	_	O	O	_	_	_	_	_
36	myelomonocytic	_	O	O	_	_	_	_	_
37	cell	_	O	O	_	_	_	_	_
38	line	_	O	O	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	BL	_	O	O	_	_	_	_	_
42	2	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	a	_	O	O	_	_	_	_	_
45	Burkitt	_	O	O	_	_	_	_	_
46	lymphoma	_	O	O	_	_	_	_	_
47	were	_	O	O	_	_	_	_	_
48	refractory	_	O	O	_	_	_	_	_
49	to	_	O	O	_	_	_	_	_
50	thrombin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
51	or	_	O	O	_	_	_	_	_
52	TRP	_	O	O	_	_	_	_	_
53	stimulation	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Inflammation	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	constantly	_	O	O	_	_	_	_	_
4	observed	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	allergic	_	O	O	_	_	_	_	_
7	reactions	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_

1	I	_	O	O	_	_	_	_	_
2	kappa	_	O	O	_	_	_	_	_
3	B	_	O	O	_	_	_	_	_
4	/	_	O	O	_	_	_	_	_
5	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	masks	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	nuclear	_	O	O	_	_	_	_	_
11	localization	_	O	O	_	_	_	_	_
12	signal	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	requires	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	transactivation	_	O	O	_	_	_	_	_
24	domain	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	inhibit	_	O	O	_	_	_	_	_
27	NF	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	kappa	_	O	O	_	_	_	_	_
30	B	_	O	O	_	_	_	_	_
31	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	DNA	_	O	O	_	_	_	_	_
34	binding	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Results	_	O	O	_	_	_	_	_
2	from	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	vivo	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	studies	_	O	O	_	_	_	_	_
7	performed	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	these	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mutants	_	O	O	_	_	_	_	_
17	revealed	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	following	_	O	O	_	_	_	_	_
20	:	_	O	O	_	_	_	_	_
21	1	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	I	_	O	O	_	_	_	_	_
24	kappa	_	O	O	_	_	_	_	_
25	B	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	completely	_	O	O	_	_	_	_	_
31	inhibits	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	kappa	_	O	O	_	_	_	_	_
35	B	_	O	O	_	_	_	_	_
36	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	dependent	_	O	O	_	_	_	_	_
40	transcriptional	_	O	O	_	_	_	_	_
41	activation	_	O	O	_	_	_	_	_
42	mediated	_	O	O	_	_	_	_	_
43	through	_	O	O	_	_	_	_	_
44	the	_	O	O	_	_	_	_	_
45	human	_	O	O	_	_	_	_	_
46	immunodeficiency	_	O	O	_	_	_	_	_
47	virus	_	O	O	_	_	_	_	_
48	type	_	O	O	_	_	_	_	_
49	1	_	O	O	_	_	_	_	_
50	kappa	_	O	O	_	_	_	_	_
51	B	_	O	O	_	_	_	_	_
52	enhancer	_	O	O	_	_	_	_	_
53	in	_	O	O	_	_	_	_	_
54	human	_	O	O	_	_	_	_	_
55	T	_	O	O	_	_	_	_	_
56	lymphocytes	_	O	O	_	_	_	_	_
57	,	_	O	O	_	_	_	_	_
58	2	_	O	O	_	_	_	_	_
59	)	_	O	O	_	_	_	_	_
60	the	_	O	O	_	_	_	_	_
61	binding	_	O	O	_	_	_	_	_
62	of	_	O	O	_	_	_	_	_
63	I	_	O	O	_	_	_	_	_
64	kappa	_	O	O	_	_	_	_	_
65	B	_	O	O	_	_	_	_	_
66	/	_	O	O	_	_	_	_	_
67	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
68	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
69	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
70	to	_	O	O	_	_	_	_	_
71	NF	_	O	O	_	_	_	_	_
72	-	_	O	O	_	_	_	_	_
73	kappa	_	O	O	_	_	_	_	_
74	B	_	O	O	_	_	_	_	_
75	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
76	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
77	is	_	O	O	_	_	_	_	_
78	sufficient	_	O	O	_	_	_	_	_
79	to	_	O	O	_	_	_	_	_
80	retarget	_	O	O	_	_	_	_	_
81	NF	_	O	O	_	_	_	_	_
82	-	_	O	O	_	_	_	_	_
83	kappa	_	O	O	_	_	_	_	_
84	B	_	O	O	_	_	_	_	_
85	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
86	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
87	from	_	O	O	_	_	_	_	_
88	the	_	O	O	_	_	_	_	_
89	nucleus	_	O	O	_	_	_	_	_
90	to	_	O	O	_	_	_	_	_
91	the	_	O	O	_	_	_	_	_
92	cytoplasm	_	O	O	_	_	_	_	_
93	,	_	O	O	_	_	_	_	_
94	3	_	O	O	_	_	_	_	_
95	)	_	O	O	_	_	_	_	_
96	selective	_	O	O	_	_	_	_	_
97	deletion	_	O	O	_	_	_	_	_
98	of	_	O	O	_	_	_	_	_
99	the	_	O	O	_	_	_	_	_
100	functional	_	O	O	_	_	_	_	_
101	nuclear	_	O	O	_	_	_	_	_
102	localization	_	O	O	_	_	_	_	_
103	signal	_	O	O	_	_	_	_	_
104	present	_	O	O	_	_	_	_	_
105	in	_	O	O	_	_	_	_	_
106	the	_	O	O	_	_	_	_	_
107	Rel	_	O	O	_	_	_	_	_
108	homology	_	O	O	_	_	_	_	_
109	domain	_	O	O	_	_	_	_	_
110	of	_	O	O	_	_	_	_	_
111	NF	_	O	O	_	_	_	_	_
112	-	_	O	O	_	_	_	_	_
113	kappa	_	O	O	_	_	_	_	_
114	B	_	O	O	_	_	_	_	_
115	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
116	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
117	disrupts	_	O	O	_	_	_	_	_
118	its	_	O	O	_	_	_	_	_
119	ability	_	O	O	_	_	_	_	_
120	to	_	O	O	_	_	_	_	_
121	engage	_	O	O	_	_	_	_	_
122	I	_	O	O	_	_	_	_	_
123	kappa	_	O	O	_	_	_	_	_
124	B	_	O	O	_	_	_	_	_
125	/	_	O	O	_	_	_	_	_
126	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
127	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
128	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
129	,	_	O	O	_	_	_	_	_
130	and	_	O	O	_	_	_	_	_
131	4	_	O	O	_	_	_	_	_
132	)	_	O	O	_	_	_	_	_
133	the	_	O	O	_	_	_	_	_
134	unique	_	O	O	_	_	_	_	_
135	C	_	O	O	_	_	_	_	_
136	-	_	O	O	_	_	_	_	_
137	terminus	_	O	O	_	_	_	_	_
138	of	_	O	O	_	_	_	_	_
139	NF	_	O	O	_	_	_	_	_
140	-	_	O	O	_	_	_	_	_
141	kappa	_	O	O	_	_	_	_	_
142	B	_	O	O	_	_	_	_	_
143	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
144	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
145	attenuates	_	O	O	_	_	_	_	_
146	its	_	O	O	_	_	_	_	_
147	own	_	O	O	_	_	_	_	_
148	nuclear	_	O	O	_	_	_	_	_
149	localization	_	O	O	_	_	_	_	_
150	and	_	O	O	_	_	_	_	_
151	contains	_	O	O	_	_	_	_	_
152	sequences	_	O	O	_	_	_	_	_
153	that	_	O	O	_	_	_	_	_
154	are	_	O	O	_	_	_	_	_
155	required	_	O	O	_	_	_	_	_
156	for	_	O	O	_	_	_	_	_
157	I	_	O	O	_	_	_	_	_
158	kappa	_	O	O	_	_	_	_	_
159	B	_	O	O	_	_	_	_	_
160	-	_	O	O	_	_	_	_	_
161	mediated	_	O	O	_	_	_	_	_
162	inhibition	_	O	O	_	_	_	_	_
163	of	_	O	O	_	_	_	_	_
164	NF	_	O	O	_	_	_	_	_
165	-	_	O	O	_	_	_	_	_
166	kappa	_	O	O	_	_	_	_	_
167	B	_	O	O	_	_	_	_	_
168	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
169	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
170	DNA	_	O	O	_	_	_	_	_
171	binding	_	O	O	_	_	_	_	_
172	activity	_	O	O	_	_	_	_	_
173	.	_	O	O	_	_	_	_	_

1	Therefore	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	investigated	_	O	O	_	_	_	_	_
4	CTCF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	during	_	O	O	_	_	_	_	_
9	induced	_	O	O	_	_	_	_	_
10	differentiation	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	myeloid	_	O	O	_	_	_	_	_
14	leukemia	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	PDBu	_	O	O	_	_	_	_	_
2	+	_	O	O	_	_	_	_	_
3	iono	_	O	O	_	_	_	_	_
4	induced	_	O	O	_	_	_	_	_
5	equally	_	O	O	_	_	_	_	_
6	high	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	levels	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	groups	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	when	_	O	O	_	_	_	_	_
17	stimulated	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	plate	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	bound	_	O	O	_	_	_	_	_
22	anti	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	CD	_	O	O	_	_	_	_	_
25	3	_	O	O	_	_	_	_	_
26	monoclonal	_	O	O	_	_	_	_	_
27	antibody	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	mAb	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	secretion	_	O	O	_	_	_	_	_
37	by	_	O	O	_	_	_	_	_
38	neonatal	_	O	O	_	_	_	_	_
39	cells	_	O	O	_	_	_	_	_
40	was	_	O	O	_	_	_	_	_
41	undetectable	_	O	O	_	_	_	_	_
42	and	_	O	O	_	_	_	_	_
43	adult	_	O	O	_	_	_	_	_
44	cells	_	O	O	_	_	_	_	_
45	produced	_	O	O	_	_	_	_	_
46	low	_	O	O	_	_	_	_	_
47	amounts	_	O	O	_	_	_	_	_
48	of	_	O	O	_	_	_	_	_
49	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	(	_	O	O	_	_	_	_	_
53	mean	_	O	O	_	_	_	_	_
54	331	_	O	O	_	_	_	_	_
55	+	_	O	O	_	_	_	_	_
56	/	_	O	O	_	_	_	_	_
57	-	_	O	O	_	_	_	_	_
58	86	_	O	O	_	_	_	_	_
59	pg	_	O	O	_	_	_	_	_
60	/	_	O	O	_	_	_	_	_
61	ml	_	O	O	_	_	_	_	_
62	)	_	O	O	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_

1	Protein	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	DNA	_	O	O	_	_	_	_	_
4	complexes	_	O	O	_	_	_	_	_
5	were	_	O	O	_	_	_	_	_
6	separated	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	polyacrylamide	_	O	O	_	_	_	_	_
9	electrophoresis	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	detected	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	autoradiography	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	C	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	ChIP	_	O	O	_	_	_	_	_
5	assay	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	performed	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	DNA	_	O	O	_	_	_	_	_
10	from	_	O	O	_	_	_	_	_
11	A	_	O	O	_	_	_	_	_
12	3	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_
14	01	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Immunoprecipitation	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	performed	_	O	O	_	_	_	_	_
4	with	_	O	O	_	_	_	_	_
5	antibodies	_	O	O	_	_	_	_	_
6	against	_	O	O	_	_	_	_	_
7	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	or	_	O	O	_	_	_	_	_
13	actin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	immediate	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	early	_	O	O	_	_	_	_	_
5	gene	_	O	O	_	_	_	_	_
6	product	_	O	O	_	_	_	_	_
7	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	regulates	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	chain	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	promoter	_	O	O	_	_	_	_	_
21	through	_	O	O	_	_	_	_	_
22	noncanonical	_	O	O	_	_	_	_	_
23	Egr	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	Sp	_	O	O	_	_	_	_	_
26	1	_	O	O	_	_	_	_	_
27	binding	_	O	O	_	_	_	_	_
28	sites	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	paper	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	demonstrate	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	PIF	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	based	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	its	_	O	O	_	_	_	_	_
16	recognition	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	anti	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	antisera	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	gel	_	O	O	_	_	_	_	_
26	mobility	_	O	O	_	_	_	_	_
27	shift	_	O	O	_	_	_	_	_
28	assays	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	even	_	O	O	_	_	_	_	_
31	though	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	Rbeta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	DNA	_	O	O	_	_	_	_	_
38	binding	_	O	O	_	_	_	_	_
39	motif	_	O	O	_	_	_	_	_
40	differed	_	O	O	_	_	_	_	_
41	substantially	_	O	O	_	_	_	_	_
42	from	_	O	O	_	_	_	_	_
43	the	_	O	O	_	_	_	_	_
44	canonical	_	O	O	_	_	_	_	_
45	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	binding	_	O	O	_	_	_	_	_
49	site	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	level	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	jun	_	O	O	_	_	_	_	_
8	protein	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	elevated	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	2	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	5	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	fold	_	O	O	_	_	_	_	_
17	within	_	O	O	_	_	_	_	_
18	4	_	O	O	_	_	_	_	_
19	h	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	HU	_	O	O	_	_	_	_	_
22	treated	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	interesting	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	humans	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	rats	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	cortical	_	O	O	_	_	_	_	_
11	thymocytes	_	O	O	_	_	_	_	_
12	undergoing	_	O	O	_	_	_	_	_
13	negative	_	O	O	_	_	_	_	_
14	selection	_	O	O	_	_	_	_	_
15	can	_	O	O	_	_	_	_	_
16	still	_	O	O	_	_	_	_	_
17	induce	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	even	_	O	O	_	_	_	_	_
26	be	_	O	O	_	_	_	_	_
27	rescued	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	vitro	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	if	_	O	O	_	_	_	_	_
32	exogenous	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	is	_	O	O	_	_	_	_	_
37	provided	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	Regulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	glucocorticoid	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	its	_	O	O	_	_	_	_	_
11	cognate	_	O	O	_	_	_	_	_
12	ligand	_	O	O	_	_	_	_	_
13	was	_	O	O	_	_	_	_	_
14	examined	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	glucocorticoid	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	sensitive	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	leukemic	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	line	_	O	O	_	_	_	_	_
26	6	_	O	O	_	_	_	_	_
27	TG	_	O	O	_	_	_	_	_
28	1	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	human	_	O	O	_	_	_	_	_
35	B	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	cell	_	O	O	_	_	_	_	_
38	line	_	O	O	_	_	_	_	_
39	IM	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	9	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_



1	The	_	O	O	_	_	_	_	_
2	lymphotoxin	_	O	O	_	_	_	_	_
3	promoter	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	stimulated	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	HTLV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	I	_	O	O	_	_	_	_	_
10	tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	cell	_	O	O	_	_	_	_	_
22	lines	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	LT	_	O	O	_	_	_	_	_
3	promoter	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	LT	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	293	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	construct	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	contained	_	O	O	_	_	_	_	_
13	an	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	site	_	O	O	_	_	_	_	_
19	was	_	O	O	_	_	_	_	_
20	active	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	LT	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	producing	_	O	O	_	_	_	_	_
26	C	_	O	O	_	_	_	_	_
27	81	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	66	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	45	_	O	O	_	_	_	_	_
32	cell	_	O	O	_	_	_	_	_
33	line	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	which	_	O	O	_	_	_	_	_
36	contains	_	O	O	_	_	_	_	_
37	defective	_	O	O	_	_	_	_	_
38	HTLV	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	I	_	O	O	_	_	_	_	_
41	but	_	O	O	_	_	_	_	_
42	expresses	_	O	O	_	_	_	_	_
43	tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	minimal	_	O	O	_	_	_	_	_
5	promoter	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	regulated	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	CREB	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	ATF	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	SP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	proteins	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	U	_	O	O	_	_	_	_	_
25	937	_	O	O	_	_	_	_	_
26	promonocytic	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	requirement	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	further	_	O	O	_	_	_	_	_
7	confirmed	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	observation	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	inability	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	intermediate	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	+	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	CD	_	O	O	_	_	_	_	_
23	8	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	CD	_	O	O	_	_	_	_	_
28	3	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	thymocytes	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	replicate	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	virus	_	O	O	_	_	_	_	_
37	is	_	O	O	_	_	_	_	_
38	associated	_	O	O	_	_	_	_	_
39	with	_	O	O	_	_	_	_	_
40	a	_	O	O	_	_	_	_	_
41	defect	_	O	O	_	_	_	_	_
42	in	_	O	O	_	_	_	_	_
43	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	production	_	O	O	_	_	_	_	_
45	during	_	O	O	_	_	_	_	_
46	their	_	O	O	_	_	_	_	_
47	interaction	_	O	O	_	_	_	_	_
48	with	_	O	O	_	_	_	_	_
49	TEC	_	O	O	_	_	_	_	_
50	and	_	O	O	_	_	_	_	_
51	correlates	_	O	O	_	_	_	_	_
52	with	_	O	O	_	_	_	_	_
53	the	_	O	O	_	_	_	_	_
54	absence	_	O	O	_	_	_	_	_
55	of	_	O	O	_	_	_	_	_
56	nuclear	_	O	O	_	_	_	_	_
57	NF	_	O	O	_	_	_	_	_
58	-	_	O	O	_	_	_	_	_
59	kappaB	_	O	O	_	_	_	_	_
60	activity	_	O	O	_	_	_	_	_
61	in	_	O	O	_	_	_	_	_
62	these	_	O	O	_	_	_	_	_
63	freshly	_	O	O	_	_	_	_	_
64	isolated	_	O	O	_	_	_	_	_
65	thymocytes	_	O	O	_	_	_	_	_
66	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	expressed	_	O	O	_	_	_	_	_
14	almost	_	O	O	_	_	_	_	_
15	exclusively	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	activated	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	promoter	_	O	O	_	_	_	_	_
3	region	_	O	O	_	_	_	_	_
4	between	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	173	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	60	_	O	O	_	_	_	_	_
10	contained	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	strongest	_	O	O	_	_	_	_	_
13	activating	_	O	O	_	_	_	_	_
14	elements	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Recent	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	poor	_	O	O	_	_	_	_	_
7	induction	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	cell	_	O	O	_	_	_	_	_
13	response	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	human	_	O	O	_	_	_	_	_
16	renal	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	carcinoma	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	RCC	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	may	_	O	O	_	_	_	_	_
23	be	_	O	O	_	_	_	_	_
24	related	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	alterations	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	signal	_	O	O	_	_	_	_	_
29	transduction	_	O	O	_	_	_	_	_
30	pathways	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	report	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	RCC	_	O	O	_	_	_	_	_
8	patients	_	O	O	_	_	_	_	_
9	have	_	O	O	_	_	_	_	_
10	two	_	O	O	_	_	_	_	_
11	alterations	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	kappa	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	motif	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	specific	_	O	O	_	_	_	_	_
18	DNA	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	binding	_	O	O	_	_	_	_	_
21	activity	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	immunodeficiency	_	O	O	_	_	_	_	_
5	virus	_	O	O	_	_	_	_	_
6	type	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	replication	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	vitro	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	novel	_	O	O	_	_	_	_	_
14	combination	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	anti	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	single	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	chain	_	O	O	_	_	_	_	_
22	intrabodies	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	NF	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	kappa	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	antagonists	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	superactivates	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	HIV	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	promoter	_	O	O	_	_	_	_	_
9	through	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	TAR	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	independent	_	O	O	_	_	_	_	_
14	mechanism	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	including	_	O	O	_	_	_	_	_
17	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	induced	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	protein	_	O	O	_	_	_	_	_
25	kinase	_	O	O	_	_	_	_	_
26	C	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	PKC	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	dependent	_	O	O	_	_	_	_	_
32	activation	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	NF	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	kappa	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	inhibitors	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	NF	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	kappa	_	O	O	_	_	_	_	_
47	B	_	O	O	_	_	_	_	_
48	cooperatively	_	O	O	_	_	_	_	_
49	down	_	O	O	_	_	_	_	_
50	-	_	O	O	_	_	_	_	_
51	regulate	_	O	O	_	_	_	_	_
52	this	_	O	O	_	_	_	_	_
53	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	mediated	_	O	O	_	_	_	_	_
56	LTR	_	O	O	_	_	_	_	_
57	superactivation	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	J	_	O	O	_	_	_	_	_
3	delta	_	O	O	_	_	_	_	_
4	1	_	O	O	_	_	_	_	_
5	segment	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	correctly	_	O	O	_	_	_	_	_
8	spliced	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	C	_	O	O	_	_	_	_	_
11	delta	_	O	O	_	_	_	_	_
12	;	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	addition	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	four	_	O	O	_	_	_	_	_
17	C	_	O	O	_	_	_	_	_
18	delta	_	O	O	_	_	_	_	_
19	exons	_	O	O	_	_	_	_	_
20	were	_	O	O	_	_	_	_	_
21	found	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	be	_	O	O	_	_	_	_	_
24	already	_	O	O	_	_	_	_	_
25	assembled	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	LPS	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	also	_	O	O	_	_	_	_	_
4	shown	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	dramatically	_	O	O	_	_	_	_	_
7	increase	_	O	O	_	_	_	_	_
8	HIV	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	from	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	chronically	_	O	O	_	_	_	_	_
15	infected	_	O	O	_	_	_	_	_
16	monocyte	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	macrophage	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	like	_	O	O	_	_	_	_	_
21	cloned	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	line	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	U	_	O	O	_	_	_	_	_
26	1	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	which	_	O	O	_	_	_	_	_
29	produces	_	O	O	_	_	_	_	_
30	very	_	O	O	_	_	_	_	_
31	low	_	O	O	_	_	_	_	_
32	levels	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	HIV	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	1	_	O	O	_	_	_	_	_
37	at	_	O	O	_	_	_	_	_
38	baseline	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Transcripts	_	O	O	_	_	_	_	_
2	from	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	BamHI	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	A	_	O	O	_	_	_	_	_
7	region	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	viral	_	O	O	_	_	_	_	_
11	genome	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	detectable	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	all	_	O	O	_	_	_	_	_
16	cases	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_




1	Efficient	_	O	O	_	_	_	_	_
2	rescue	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	defect	_	O	O	_	_	_	_	_
6	requires	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	intact	_	O	O	_	_	_	_	_
9	GATA	_	O	O	_	_	_	_	_
10	element	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	distal	_	O	O	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	suggesting	_	O	O	_	_	_	_	_
17	autoregulatory	_	O	O	_	_	_	_	_
18	control	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	sequence	_	O	O	_	_	_	_	_
3	contains	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	promoter	_	O	O	_	_	_	_	_
6	specific	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	hematopoietic	_	O	O	_	_	_	_	_
11	lineage	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	first	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	445	_	O	O	_	_	_	_	_
6	/	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	366	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	positive	_	O	O	_	_	_	_	_
13	element	_	O	O	_	_	_	_	_
14	active	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	both	_	O	O	_	_	_	_	_
17	basophils	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_


1	Bars	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	5	_	O	O	_	_	_	_	_
4	microm	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	support	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	feasibility	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	usefulness	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	this	_	O	O	_	_	_	_	_
10	systematic	_	O	O	_	_	_	_	_
11	approach	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	studying	_	O	O	_	_	_	_	_
14	variation	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	gene	_	O	O	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	patterns	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	cancers	_	O	O	_	_	_	_	_
22	as	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	means	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	dissect	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	classify	_	O	O	_	_	_	_	_
29	solid	_	O	O	_	_	_	_	_
30	tumors	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Retinoic	_	O	O	_	_	_	_	_
2	acid	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	RA	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	vitamin	_	O	O	_	_	_	_	_
9	A	_	O	O	_	_	_	_	_
10	derivative	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	exerts	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	wide	_	O	O	_	_	_	_	_
15	range	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	biological	_	O	O	_	_	_	_	_
18	effects	_	O	O	_	_	_	_	_
19	related	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	cell	_	O	O	_	_	_	_	_
22	proliferation	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	differentiation	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	pleiotropic	_	O	O	_	_	_	_	_
3	effects	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	RA	_	O	O	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	thought	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	be	_	O	O	_	_	_	_	_
10	mediated	_	O	O	_	_	_	_	_
11	through	_	O	O	_	_	_	_	_
12	specific	_	O	O	_	_	_	_	_
13	nuclear	_	O	O	_	_	_	_	_
14	RA	_	O	O	_	_	_	_	_
15	receptors	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	RARs	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Stimulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	highly	_	O	O	_	_	_	_	_
4	purified	_	O	O	_	_	_	_	_
5	human	_	O	O	_	_	_	_	_
6	T	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	via	_	O	O	_	_	_	_	_
10	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	adhesion	_	O	O	_	_	_	_	_
16	molecules	_	O	O	_	_	_	_	_
17	induces	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	maintains	_	O	O	_	_	_	_	_
20	proliferation	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	more	_	O	O	_	_	_	_	_
23	than	_	O	O	_	_	_	_	_
24	3	_	O	O	_	_	_	_	_
25	weeks	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Together	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	suggest	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappa	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	plays	_	O	O	_	_	_	_	_
12	an	_	O	O	_	_	_	_	_
13	important	_	O	O	_	_	_	_	_
14	role	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	long	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	term	_	O	O	_	_	_	_	_
19	activation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	primary	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	lymphocytes	_	O	O	_	_	_	_	_
26	via	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	Yet	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	little	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	known	_	O	O	_	_	_	_	_
6	as	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	how	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	RA	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	VitD	_	O	O	_	_	_	_	_
13	3	_	O	O	_	_	_	_	_
14	receptor	_	O	O	_	_	_	_	_
15	network	_	O	O	_	_	_	_	_
16	operates	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	hematopoietic	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	whether	_	O	O	_	_	_	_	_
23	receptor	_	O	O	_	_	_	_	_
24	interactions	_	O	O	_	_	_	_	_
25	can	_	O	O	_	_	_	_	_
26	explain	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	interplay	_	O	O	_	_	_	_	_
29	between	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	RA	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	VitD	_	O	O	_	_	_	_	_
35	3	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	signaling	_	O	O	_	_	_	_	_
38	pathways	_	O	O	_	_	_	_	_
39	during	_	O	O	_	_	_	_	_
40	differentiation	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	subunit	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	E	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	contains	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	basic	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	leucine	_	O	O	_	_	_	_	_
14	zipper	_	O	O	_	_	_	_	_
15	domain	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	dimerizes	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	small	_	O	O	_	_	_	_	_
21	Maf	_	O	O	_	_	_	_	_
22	family	_	O	O	_	_	_	_	_
23	protein	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	form	_	O	O	_	_	_	_	_
26	functional	_	O	O	_	_	_	_	_
27	NF	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	E	_	O	O	_	_	_	_	_
30	2	_	O	O	_	_	_	_	_
31	complex	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	megakaryocytic	_	O	O	_	_	_	_	_
7	lineage	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	mRNA	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	transcribed	_	O	O	_	_	_	_	_
15	only	_	O	O	_	_	_	_	_
16	from	_	O	O	_	_	_	_	_
17	aNF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	E	_	O	O	_	_	_	_	_
20	2	_	O	O	_	_	_	_	_
21	promoter	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	effects	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	GDSP	_	O	O	_	_	_	_	_
5	on	_	O	O	_	_	_	_	_
6	pancreatic	_	O	O	_	_	_	_	_
7	weight	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	serum	_	O	O	_	_	_	_	_
10	amylase	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	lipase	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	morphologic	_	O	O	_	_	_	_	_
15	changes	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	pancreas	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	neutrophil	_	O	O	_	_	_	_	_
21	infiltration	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	nuclear	_	O	O	_	_	_	_	_
25	factor	_	O	O	_	_	_	_	_
26	KB	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	NF	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	KB	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	activation	_	O	O	_	_	_	_	_
33	were	_	O	O	_	_	_	_	_
34	measured	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	rats	_	O	O	_	_	_	_	_
37	infused	_	O	O	_	_	_	_	_
38	with	_	O	O	_	_	_	_	_
39	supramaximal	_	O	O	_	_	_	_	_
40	dose	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	cerulein	_	O	O	_	_	_	_	_
43	(	_	O	O	_	_	_	_	_
44	5	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	g	_	O	O	_	_	_	_	_
47	/	_	O	O	_	_	_	_	_
48	kg	_	O	O	_	_	_	_	_
49	/	_	O	O	_	_	_	_	_
50	h	_	O	O	_	_	_	_	_
51	)	_	O	O	_	_	_	_	_
52	for	_	O	O	_	_	_	_	_
53	6	_	O	O	_	_	_	_	_
54	h	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	DNA	_	O	O	_	_	_	_	_
3	binding	_	O	O	_	_	_	_	_
4	domain	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	MYB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	factor	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	responsible	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	its	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	activity	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	binds	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	B	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	110	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	kDa	_	O	O	_	_	_	_	_
30	nuclear	_	O	O	_	_	_	_	_
31	protein	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Normal	_	O	O	_	_	_	_	_
2	T	_	O	O	_	_	_	_	_
3	lymphocytes	_	O	O	_	_	_	_	_
4	whose	_	O	O	_	_	_	_	_
5	surface	_	O	O	_	_	_	_	_
6	expression	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	CD	_	O	O	_	_	_	_	_
9	3	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	depleted	_	O	O	_	_	_	_	_
12	showed	_	O	O	_	_	_	_	_
13	impaired	_	O	O	_	_	_	_	_
14	UV	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	induced	_	O	O	_	_	_	_	_
17	tyrosine	_	O	O	_	_	_	_	_
18	phosphorylation	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	Ca	_	O	O	_	_	_	_	_
21	2	_	O	O	_	_	_	_	_
22	+	_	O	O	_	_	_	_	_
23	signals	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	neither	_	O	O	_	_	_	_	_
5	E	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	gre	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	nor	_	O	O	_	_	_	_	_
10	EA	_	O	O	_	_	_	_	_
11	/	_	O	O	_	_	_	_	_
12	S	_	O	O	_	_	_	_	_
13	motifs	_	O	O	_	_	_	_	_
14	contributed	_	O	O	_	_	_	_	_
15	pronouncedly	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	Akv	_	O	O	_	_	_	_	_
18	MLV	_	O	O	_	_	_	_	_
19	transcription	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	NIH	_	O	O	_	_	_	_	_
22	3	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	3	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	lacking	_	O	O	_	_	_	_	_
27	DNA	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	binding	_	O	O	_	_	_	_	_
30	ALF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	or	_	O	O	_	_	_	_	_
33	HEB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	E	_	O	O	_	_	_	_	_
36	2	_	O	O	_	_	_	_	_
37	A	_	O	O	_	_	_	_	_
38	proteins	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	show	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	exogenous	_	O	O	_	_	_	_	_
7	PGE	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	mimics	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	NF	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	kappaB	_	O	O	_	_	_	_	_
14	inhibitory	_	O	O	_	_	_	_	_
15	effect	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	FCM	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	subunits	_	O	O	_	_	_	_	_
8	bind	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	an	_	O	O	_	_	_	_	_
11	upstream	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappaB	_	O	O	_	_	_	_	_
15	site	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	human	_	O	O	_	_	_	_	_
18	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	colony	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	stimulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	promoter	_	O	O	_	_	_	_	_
25	involved	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	phorbol	_	O	O	_	_	_	_	_
28	ester	_	O	O	_	_	_	_	_
29	response	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	5637	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	Production	_	O	O	_	_	_	_	_
5	Is	_	O	O	_	_	_	_	_
6	Maintained	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	High	_	O	O	_	_	_	_	_
9	TCR	_	O	O	_	_	_	_	_
10	Signal	_	O	O	_	_	_	_	_
11	Strength	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	next	_	O	O	_	_	_	_	_
3	investigated	_	O	O	_	_	_	_	_
4	whether	_	O	O	_	_	_	_	_
5	repeated	_	O	O	_	_	_	_	_
6	strong	_	O	O	_	_	_	_	_
7	TCR	_	O	O	_	_	_	_	_
8	activation	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	compensatory	_	O	O	_	_	_	_	_
12	signal	_	O	O	_	_	_	_	_
13	for	_	O	O	_	_	_	_	_
14	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	signaling	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	induction	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	Th	_	O	O	_	_	_	_	_
31	1	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	essential	_	O	O	_	_	_	_	_
8	during	_	O	O	_	_	_	_	_
9	both	_	O	O	_	_	_	_	_
10	primary	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	secondary	_	O	O	_	_	_	_	_
13	antigenic	_	O	O	_	_	_	_	_
14	stimulation	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	production	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	Th	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	high	_	O	O	_	_	_	_	_
4	antigen	_	O	O	_	_	_	_	_
5	dose	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	are	_	O	O	_	_	_	_	_
11	required	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	sustaining	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	induction	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	production	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	Th	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Peripheral	_	O	O	_	_	_	_	_
2	blood	_	O	O	_	_	_	_	_
3	mononuclear	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	isolated	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	patients	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	diabetic	_	O	O	_	_	_	_	_
10	nephropathy	_	O	O	_	_	_	_	_
11	show	_	O	O	_	_	_	_	_
12	increased	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	oxidative	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	stress	_	O	O	_	_	_	_	_
19	sensitive	_	O	O	_	_	_	_	_
20	transcription	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	NF	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	kappaB	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappaB	_	O	O	_	_	_	_	_
4	binding	_	O	O	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	correlated	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	degree	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	albuminuria	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	r	_	O	O	_	_	_	_	_
14	=	_	O	O	_	_	_	_	_
15	0	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_
17	316	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	thrombomodulin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	plasma	_	O	O	_	_	_	_	_
23	concentrations	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	r	_	O	O	_	_	_	_	_
26	=	_	O	O	_	_	_	_	_
27	0	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_
29	33	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	indicative	_	O	O	_	_	_	_	_
33	for	_	O	O	_	_	_	_	_
34	albuminuria	_	O	O	_	_	_	_	_
35	associated	_	O	O	_	_	_	_	_
36	endothelial	_	O	O	_	_	_	_	_
37	dysfunction	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappaB	_	O	O	_	_	_	_	_
4	functions	_	O	O	_	_	_	_	_
5	as	_	O	O	_	_	_	_	_
6	both	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	proapoptotic	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	antiapoptotic	_	O	O	_	_	_	_	_
11	regulatory	_	O	O	_	_	_	_	_
12	factor	_	O	O	_	_	_	_	_
13	within	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	single	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	type	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	5	_	O	O	_	_	_	_	_
3	'	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	region	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	R	_	O	O	_	_	_	_	_
8	1	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	13	_	O	O	_	_	_	_	_
12	hypermethylated	_	O	O	_	_	_	_	_
13	CpG	_	O	O	_	_	_	_	_
14	sites	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	mean	_	O	O	_	_	_	_	_
17	number	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	methylated	_	O	O	_	_	_	_	_
20	clones	_	O	O	_	_	_	_	_
21	5	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_
23	5	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	8	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	77	_	O	O	_	_	_	_	_
28	%	_	O	O	_	_	_	_	_
29	methylated	_	O	O	_	_	_	_	_
30	CpGs	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	was	_	O	O	_	_	_	_	_
33	found	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	most	_	O	O	_	_	_	_	_
36	cells	_	O	O	_	_	_	_	_
37	(	_	O	O	_	_	_	_	_
38	except	_	O	O	_	_	_	_	_
39	SD	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	1	_	O	O	_	_	_	_	_
42	and	_	O	O	_	_	_	_	_
43	RPMI	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	8226	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	a	_	O	O	_	_	_	_	_
49	3	_	O	O	_	_	_	_	_
50	'	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	region	_	O	O	_	_	_	_	_
53	(	_	O	O	_	_	_	_	_
54	R	_	O	O	_	_	_	_	_
55	3	_	O	O	_	_	_	_	_
56	)	_	O	O	_	_	_	_	_
57	of	_	O	O	_	_	_	_	_
58	6	_	O	O	_	_	_	_	_
59	hypomethylated	_	O	O	_	_	_	_	_
60	CpG	_	O	O	_	_	_	_	_
61	sites	_	O	O	_	_	_	_	_
62	(	_	O	O	_	_	_	_	_
63	mean	_	O	O	_	_	_	_	_
64	number	_	O	O	_	_	_	_	_
65	of	_	O	O	_	_	_	_	_
66	methylated	_	O	O	_	_	_	_	_
67	clones	_	O	O	_	_	_	_	_
68	1	_	O	O	_	_	_	_	_
69	.	_	O	O	_	_	_	_	_
70	7	_	O	O	_	_	_	_	_
71	of	_	O	O	_	_	_	_	_
72	8	_	O	O	_	_	_	_	_
73	with	_	O	O	_	_	_	_	_
74	33	_	O	O	_	_	_	_	_
75	%	_	O	O	_	_	_	_	_
76	methylated	_	O	O	_	_	_	_	_
77	CpGs	_	O	O	_	_	_	_	_
78	)	_	O	O	_	_	_	_	_
79	was	_	O	O	_	_	_	_	_
80	found	_	O	O	_	_	_	_	_
81	in	_	O	O	_	_	_	_	_
82	most	_	O	O	_	_	_	_	_
83	cells	_	O	O	_	_	_	_	_
84	(	_	O	O	_	_	_	_	_
85	except	_	O	O	_	_	_	_	_
86	CML	_	O	O	_	_	_	_	_
87	-	_	O	O	_	_	_	_	_
88	T	_	O	O	_	_	_	_	_
89	1	_	O	O	_	_	_	_	_
90	and	_	O	O	_	_	_	_	_
91	U	_	O	O	_	_	_	_	_
92	-	_	O	O	_	_	_	_	_
93	937	_	O	O	_	_	_	_	_
94	)	_	O	O	_	_	_	_	_
95	(	_	O	O	_	_	_	_	_
96	Figure	_	O	O	_	_	_	_	_
97	4	_	O	O	_	_	_	_	_
98	A	_	O	O	_	_	_	_	_
99	and	_	O	O	_	_	_	_	_
100	Table	_	O	O	_	_	_	_	_
101	1	_	O	O	_	_	_	_	_
102	)	_	O	O	_	_	_	_	_
103	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	maximum	_	O	O	_	_	_	_	_
3	levels	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	these	_	O	O	_	_	_	_	_
6	markers	_	O	O	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	ML	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	9	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	comparable	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	those	_	O	O	_	_	_	_	_
16	induced	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	VD	_	O	O	_	_	_	_	_
19	3	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	but	_	O	O	_	_	_	_	_
22	after	_	O	O	_	_	_	_	_
23	removal	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	ML	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	9	_	O	O	_	_	_	_	_
28	from	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	medium	_	O	O	_	_	_	_	_
31	by	_	O	O	_	_	_	_	_
32	washing	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	expressions	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	theses	_	O	O	_	_	_	_	_
40	markers	_	O	O	_	_	_	_	_
41	decreased	_	O	O	_	_	_	_	_
42	within	_	O	O	_	_	_	_	_
43	4	_	O	O	_	_	_	_	_
44	hours	_	O	O	_	_	_	_	_
45	and	_	O	O	_	_	_	_	_
46	reached	_	O	O	_	_	_	_	_
47	basal	_	O	O	_	_	_	_	_
48	levels	_	O	O	_	_	_	_	_
49	in	_	O	O	_	_	_	_	_
50	1	_	O	O	_	_	_	_	_
51	day	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	indicating	_	O	O	_	_	_	_	_
54	that	_	O	O	_	_	_	_	_
55	ML	_	O	O	_	_	_	_	_
56	-	_	O	O	_	_	_	_	_
57	9	_	O	O	_	_	_	_	_
58	'	_	O	O	_	_	_	_	_
59	s	_	O	O	_	_	_	_	_
60	induction	_	O	O	_	_	_	_	_
61	of	_	O	O	_	_	_	_	_
62	expression	_	O	O	_	_	_	_	_
63	of	_	O	O	_	_	_	_	_
64	differentiation	_	O	O	_	_	_	_	_
65	-	_	O	O	_	_	_	_	_
66	associated	_	O	O	_	_	_	_	_
67	phenotypes	_	O	O	_	_	_	_	_
68	was	_	O	O	_	_	_	_	_
69	reversible	_	O	O	_	_	_	_	_
70	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	ML	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	9	_	O	O	_	_	_	_	_
8	should	_	O	O	_	_	_	_	_
9	be	_	O	O	_	_	_	_	_
10	useful	_	O	O	_	_	_	_	_
11	for	_	O	O	_	_	_	_	_
12	studying	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	mechanisms	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	monocytic	_	O	O	_	_	_	_	_
17	differentiation	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Secreted	_	O	O	_	_	_	_	_
2	from	_	O	O	_	_	_	_	_
3	activated	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	macrophages	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	bone	_	O	O	_	_	_	_	_
10	marrow	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	derived	_	O	O	_	_	_	_	_
13	MIP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	GOS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	inhibits	_	O	O	_	_	_	_	_
21	primitive	_	O	O	_	_	_	_	_
22	hematopoietic	_	O	O	_	_	_	_	_
23	stem	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	appears	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	be	_	O	O	_	_	_	_	_
29	involved	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	homeostatic	_	O	O	_	_	_	_	_
33	control	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	stem	_	O	O	_	_	_	_	_
36	cell	_	O	O	_	_	_	_	_
37	proliferation	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	PG	_	O	O	_	_	_	_	_
2	490	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	triptolide	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	diterpene	_	O	O	_	_	_	_	_
9	triepoxide	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	potent	_	O	O	_	_	_	_	_
12	immunosuppressive	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	antiinflammatory	_	O	O	_	_	_	_	_
15	properties	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	mechanism	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	PG	_	O	O	_	_	_	_	_
5	490	_	O	O	_	_	_	_	_
6	inhibition	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	cytokine	_	O	O	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	differs	_	O	O	_	_	_	_	_
12	from	_	O	O	_	_	_	_	_
13	cyclosporin	_	O	O	_	_	_	_	_
14	A	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	involves	_	O	O	_	_	_	_	_
17	nuclear	_	O	O	_	_	_	_	_
18	inhibition	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	transcriptional	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappaB	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	purine	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	box	_	O	O	_	_	_	_	_
31	regulator	_	O	O	_	_	_	_	_
32	operating	_	O	O	_	_	_	_	_
33	at	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	ARRE	_	O	O	_	_	_	_	_
36	/	_	O	O	_	_	_	_	_
37	NF	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	AT	_	O	O	_	_	_	_	_
40	site	_	O	O	_	_	_	_	_
41	at	_	O	O	_	_	_	_	_
42	a	_	O	O	_	_	_	_	_
43	step	_	O	O	_	_	_	_	_
44	after	_	O	O	_	_	_	_	_
45	specific	_	O	O	_	_	_	_	_
46	DNA	_	O	O	_	_	_	_	_
47	binding	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_


1	(	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	C	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	Immunoblot	_	O	O	_	_	_	_	_
7	analysis	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	WT	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	transgenic	_	O	O	_	_	_	_	_
14	mice	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	activated	_	O	O	_	_	_	_	_
17	pStat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	purified	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	at	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	time	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	harvest	_	O	O	_	_	_	_	_
36	or	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	C	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	whole	_	O	O	_	_	_	_	_
42	splenocytes	_	O	O	_	_	_	_	_
43	cultured	_	O	O	_	_	_	_	_
44	with	_	O	O	_	_	_	_	_
45	or	_	O	O	_	_	_	_	_
46	without	_	O	O	_	_	_	_	_
47	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_


1	Involvement	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	second	_	O	O	_	_	_	_	_
5	lymphoid	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	specific	_	O	O	_	_	_	_	_
8	enhancer	_	O	O	_	_	_	_	_
9	element	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	regulation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	immunoglobulin	_	O	O	_	_	_	_	_
15	heavy	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	chain	_	O	O	_	_	_	_	_
18	gene	_	O	O	_	_	_	_	_
19	expression	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	microB	_	O	O	_	_	_	_	_
7	element	_	O	O	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	new	_	O	O	_	_	_	_	_
11	crucial	_	O	O	_	_	_	_	_
12	element	_	O	O	_	_	_	_	_
13	important	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	lymphoid	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	specific	_	O	O	_	_	_	_	_
18	expression	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	IgH	_	O	O	_	_	_	_	_
22	gene	_	O	O	_	_	_	_	_
23	but	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	interaction	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	another	_	O	O	_	_	_	_	_
28	enhancer	_	O	O	_	_	_	_	_
29	element	_	O	O	_	_	_	_	_
30	is	_	O	O	_	_	_	_	_
31	essential	_	O	O	_	_	_	_	_
32	for	_	O	O	_	_	_	_	_
33	its	_	O	O	_	_	_	_	_
34	activity	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	ascertain	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	molecular	_	O	O	_	_	_	_	_
5	mechanisms	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	which	_	O	O	_	_	_	_	_
8	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	functions	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	promote	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	regulatory	_	O	O	_	_	_	_	_
15	function	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	+	_	O	O	_	_	_	_	_
20	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	hi	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	we	_	O	O	_	_	_	_	_
27	first	_	O	O	_	_	_	_	_
28	confirmed	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	function	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	as	_	O	O	_	_	_	_	_
35	a	_	O	O	_	_	_	_	_
36	repressor	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	activation	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	NF	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	kappaB	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	previously	_	O	O	_	_	_	_	_
45	implicated	_	O	O	_	_	_	_	_
46	as	_	O	O	_	_	_	_	_
47	a	_	O	O	_	_	_	_	_
48	target	_	O	O	_	_	_	_	_
49	of	_	O	O	_	_	_	_	_
50	other	_	O	O	_	_	_	_	_
51	forkhead	_	O	O	_	_	_	_	_
52	/	_	O	O	_	_	_	_	_
53	winged	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	helix	_	O	O	_	_	_	_	_
56	family	_	O	O	_	_	_	_	_
57	transcription	_	O	O	_	_	_	_	_
58	factors	_	O	O	_	_	_	_	_
59	(	_	O	O	_	_	_	_	_
60	e	_	O	O	_	_	_	_	_
61	.	_	O	O	_	_	_	_	_
62	g	_	O	O	_	_	_	_	_
63	.,	_	O	O	_	_	_	_	_
64	Foxj	_	BPROTEIN	BPROTEIN	_	_	_	_	_
65	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
66	and	_	O	O	_	_	_	_	_
67	Foxo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
68	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
69	a	_	IPROTEIN	IPROTEIN	_	_	_	_	_
70	)	_	O	O	_	_	_	_	_
71	[	_	O	O	_	_	_	_	_
72	19	_	O	O	_	_	_	_	_
73	,	_	O	O	_	_	_	_	_
74	20	_	O	O	_	_	_	_	_
75	]	_	O	O	_	_	_	_	_
76	.	_	O	O	_	_	_	_	_



1	Gliotoxin	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	augmented	_	O	O	_	_	_	_	_
4	dramatically	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	early	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	6	_	O	O	_	_	_	_	_
11	h	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	pro	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	apoptotic	_	O	O	_	_	_	_	_
16	effects	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	neutrophils	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	unmasked	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	ability	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	to	_	O	O	_	_	_	_	_
39	induce	_	O	O	_	_	_	_	_
40	eosinophil	_	O	O	_	_	_	_	_
41	apoptosis	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	H	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	7	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	10	_	O	O	_	_	_	_	_
9	microM	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	specific	_	O	O	_	_	_	_	_
14	inhibitor	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	serine	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	threonine	_	O	O	_	_	_	_	_
19	kinases	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	significantly	_	O	O	_	_	_	_	_
22	blocked	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	mediated	_	O	O	_	_	_	_	_
27	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	expression	_	O	O	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	p	_	O	O	_	_	_	_	_
33	<	_	O	O	_	_	_	_	_
34	0	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_
36	05	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappaB	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	pathogenesis	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	rheumatoid	_	O	O	_	_	_	_	_
15	arthritis	_	O	O	_	_	_	_	_
16	has	_	O	O	_	_	_	_	_
17	long	_	O	O	_	_	_	_	_
18	been	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	subject	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	controversy	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	MKK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	MKK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	MKK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	all	_	O	O	_	_	_	_	_
12	activated	_	O	O	_	_	_	_	_
13	p	_	O	O	_	_	_	_	_
14	38	_	O	O	_	_	_	_	_
15	MAPk	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	experimental	_	O	O	_	_	_	_	_
18	models	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	only	_	O	O	_	_	_	_	_
21	MKK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	found	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	activate	_	O	O	_	_	_	_	_
27	recombinant	_	O	O	_	_	_	_	_
28	p	_	O	O	_	_	_	_	_
29	38	_	O	O	_	_	_	_	_
30	MAPk	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	LPS	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	treated	_	O	O	_	_	_	_	_
35	neutrophils	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	Of	_	O	O	_	_	_	_	_
2	p	_	O	O	_	_	_	_	_
3	38	_	O	O	_	_	_	_	_
4	MAPk	_	O	O	_	_	_	_	_
5	isoforms	_	O	O	_	_	_	_	_
6	studied	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	only	_	O	O	_	_	_	_	_
9	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	38	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	38	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	delta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	were	_	O	O	_	_	_	_	_
17	detected	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	neutrophils	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	38	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	MAPk	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	resulted	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	transient	_	O	O	_	_	_	_	_
11	decrease	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mRNA	_	O	O	_	_	_	_	_
17	accumulation	_	O	O	_	_	_	_	_
18	but	_	O	O	_	_	_	_	_
19	persistent	_	O	O	_	_	_	_	_
20	loss	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	synthesis	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	support	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	pathway	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	which	_	O	O	_	_	_	_	_
8	LPS	_	O	O	_	_	_	_	_
9	stimulation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	neutrophils	_	O	O	_	_	_	_	_
12	results	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	MKK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	which	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	turn	_	O	O	_	_	_	_	_
22	activates	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	38	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	MAPk	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	ultimately	_	O	O	_	_	_	_	_
29	regulating	_	O	O	_	_	_	_	_
30	adhesion	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	kappaB	_	O	O	_	_	_	_	_
35	activation	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	enhanced	_	O	O	_	_	_	_	_
38	gene	_	O	O	_	_	_	_	_
39	expression	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	and	_	O	O	_	_	_	_	_
46	regulation	_	O	O	_	_	_	_	_
47	of	_	O	O	_	_	_	_	_
48	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	synthesis	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_


1	Host	_	O	O	_	_	_	_	_
2	defense	_	O	O	_	_	_	_	_
3	mechanisms	_	O	O	_	_	_	_	_
4	triggered	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	microbial	_	O	O	_	_	_	_	_
7	lipoproteins	_	O	O	_	_	_	_	_
8	through	_	O	O	_	_	_	_	_
9	toll	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	like	_	O	O	_	_	_	_	_
12	receptors	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_



1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	pp	_	O	O	_	_	_	_	_
4	90	_	O	O	_	_	_	_	_
5	rsk	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	early	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	growth	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	response	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	pokeweed	_	O	O	_	_	_	_	_
16	mitogen	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Inhibitory	_	O	O	_	_	_	_	_
2	effect	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	growth	_	O	O	_	_	_	_	_
5	hormone	_	O	O	_	_	_	_	_
6	on	_	O	O	_	_	_	_	_
7	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	secretion	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	nuclear	_	O	O	_	_	_	_	_
13	factor	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappaB	_	O	O	_	_	_	_	_
16	translocation	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	lipopolysaccharide	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	stimulated	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	monocytes	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	From	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	other	_	O	O	_	_	_	_	_
5	findings	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	picture	_	O	O	_	_	_	_	_
8	emerges	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	there	_	O	O	_	_	_	_	_
11	are	_	O	O	_	_	_	_	_
12	at	_	O	O	_	_	_	_	_
13	least	_	O	O	_	_	_	_	_
14	three	_	O	O	_	_	_	_	_
15	categories	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	factors	_	O	O	_	_	_	_	_
18	which	_	O	O	_	_	_	_	_
19	mediate	_	O	O	_	_	_	_	_
20	cell	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	type	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	specific	_	O	O	_	_	_	_	_
25	transcription	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	lymphocytes	_	O	O	_	_	_	_	_
29	:	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	specific	_	O	O	_	_	_	_	_
36	factors	_	O	O	_	_	_	_	_
37	such	_	O	O	_	_	_	_	_
38	as	_	O	O	_	_	_	_	_
39	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	that	_	O	O	_	_	_	_	_
49	are	_	O	O	_	_	_	_	_
50	not	_	O	O	_	_	_	_	_
51	expressed	_	O	O	_	_	_	_	_
52	in	_	O	O	_	_	_	_	_
53	most	_	O	O	_	_	_	_	_
54	other	_	O	O	_	_	_	_	_
55	cell	_	O	O	_	_	_	_	_
56	types	_	O	O	_	_	_	_	_
57	:	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	b	_	O	O	_	_	_	_	_
60	)	_	O	O	_	_	_	_	_
61	ubiquitous	_	O	O	_	_	_	_	_
62	factors	_	O	O	_	_	_	_	_
63	such	_	O	O	_	_	_	_	_
64	as	_	O	O	_	_	_	_	_
65	NF	_	O	O	_	_	_	_	_
66	-	_	O	O	_	_	_	_	_
67	kappa	_	O	O	_	_	_	_	_
68	B	_	O	O	_	_	_	_	_
69	that	_	O	O	_	_	_	_	_
70	are	_	O	O	_	_	_	_	_
71	constitutively	_	O	O	_	_	_	_	_
72	active	_	O	O	_	_	_	_	_
73	in	_	O	O	_	_	_	_	_
74	B	_	O	O	_	_	_	_	_
75	cells	_	O	O	_	_	_	_	_
76	but	_	O	O	_	_	_	_	_
77	are	_	O	O	_	_	_	_	_
78	sequestered	_	O	O	_	_	_	_	_
79	in	_	O	O	_	_	_	_	_
80	an	_	O	O	_	_	_	_	_
81	inactive	_	O	O	_	_	_	_	_
82	form	_	O	O	_	_	_	_	_
83	in	_	O	O	_	_	_	_	_
84	other	_	O	O	_	_	_	_	_
85	cells	_	O	O	_	_	_	_	_
86	;	_	O	O	_	_	_	_	_
87	(	_	O	O	_	_	_	_	_
88	c	_	O	O	_	_	_	_	_
89	)	_	O	O	_	_	_	_	_
90	ubiquitously	_	O	O	_	_	_	_	_
91	active	_	O	O	_	_	_	_	_
92	factors	_	O	O	_	_	_	_	_
93	,	_	O	O	_	_	_	_	_
94	exemplified	_	O	O	_	_	_	_	_
95	by	_	O	O	_	_	_	_	_
96	the	_	O	O	_	_	_	_	_
97	one	_	O	O	_	_	_	_	_
98	binding	_	O	O	_	_	_	_	_
99	to	_	O	O	_	_	_	_	_
100	the	_	O	O	_	_	_	_	_
101	E	_	O	O	_	_	_	_	_
102	3	_	O	O	_	_	_	_	_
103	sequence	_	O	O	_	_	_	_	_
104	motif	_	O	O	_	_	_	_	_
105	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	using	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	DNA	_	O	O	_	_	_	_	_
5	sequence	_	O	O	_	_	_	_	_
6	selected	_	O	O	_	_	_	_	_
7	for	_	O	O	_	_	_	_	_
8	its	_	O	O	_	_	_	_	_
9	ability	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	bind	_	O	O	_	_	_	_	_
12	recombinant	_	O	O	_	_	_	_	_
13	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	vitro	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	we	_	O	O	_	_	_	_	_
20	show	_	O	O	_	_	_	_	_
21	here	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	is	_	O	O	_	_	_	_	_
27	present	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	DNA	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	binding	_	O	O	_	_	_	_	_
32	complexes	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	nuclear	_	O	O	_	_	_	_	_
35	extracts	_	O	O	_	_	_	_	_
36	from	_	O	O	_	_	_	_	_
37	various	_	O	O	_	_	_	_	_
38	B	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	cell	_	O	O	_	_	_	_	_
41	lines	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Circular	_	O	O	_	_	_	_	_
2	dichroism	_	O	O	_	_	_	_	_
3	analysis	_	O	O	_	_	_	_	_
4	reveals	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	NO	_	O	O	_	_	_	_	_
7	induces	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	profound	_	O	O	_	_	_	_	_
10	conformational	_	O	O	_	_	_	_	_
11	change	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	21	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	ras	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	association	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	GDP	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	GTP	_	O	O	_	_	_	_	_
22	exchange	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Western	_	O	O	_	_	_	_	_
2	blotting	_	O	O	_	_	_	_	_
3	analysis	_	O	O	_	_	_	_	_
4	with	_	O	O	_	_	_	_	_
5	anti	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	antibody	_	O	O	_	_	_	_	_
13	indicated	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	E	_	O	O	_	_	_	_	_
16	3330	_	O	O	_	_	_	_	_
17	inhibited	_	O	O	_	_	_	_	_
18	degradation	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	which	_	O	O	_	_	_	_	_
27	is	_	O	O	_	_	_	_	_
28	an	_	O	O	_	_	_	_	_
29	inhibitory	_	O	O	_	_	_	_	_
30	protein	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	kappa	_	O	O	_	_	_	_	_
35	B	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	LPS	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	stimulated	_	O	O	_	_	_	_	_
41	monocytes	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Discussion	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	common	_	O	O	_	_	_	_	_
13	pathway	_	O	O	_	_	_	_	_
14	required	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	production	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	Th	_	O	O	_	_	_	_	_
24	1	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	Th	_	O	O	_	_	_	_	_
27	2	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	Th	_	O	O	_	_	_	_	_
31	17	_	O	O	_	_	_	_	_
32	cell	_	O	O	_	_	_	_	_
33	subsets	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	which	_	O	O	_	_	_	_	_
36	differentiate	_	O	O	_	_	_	_	_
37	along	_	O	O	_	_	_	_	_
38	distinct	_	O	O	_	_	_	_	_
39	pathways	_	O	O	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	such	_	O	O	_	_	_	_	_
42	that	_	O	O	_	_	_	_	_
43	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	provides	_	O	O	_	_	_	_	_
47	a	_	O	O	_	_	_	_	_
48	highly	_	O	O	_	_	_	_	_
49	regulated	_	O	O	_	_	_	_	_
50	feedback	_	O	O	_	_	_	_	_
51	loop	_	O	O	_	_	_	_	_
52	to	_	O	O	_	_	_	_	_
53	avoid	_	O	O	_	_	_	_	_
54	the	_	O	O	_	_	_	_	_
55	extremes	_	O	O	_	_	_	_	_
56	of	_	O	O	_	_	_	_	_
57	excessive	_	O	O	_	_	_	_	_
58	inflammation	_	O	O	_	_	_	_	_
59	or	_	O	O	_	_	_	_	_
60	chronic	_	O	O	_	_	_	_	_
61	infections	_	O	O	_	_	_	_	_
62	and	_	O	O	_	_	_	_	_
63	also	_	O	O	_	_	_	_	_
64	allow	_	O	O	_	_	_	_	_
65	a	_	O	O	_	_	_	_	_
66	protective	_	O	O	_	_	_	_	_
67	response	_	O	O	_	_	_	_	_
68	to	_	O	O	_	_	_	_	_
69	diverse	_	O	O	_	_	_	_	_
70	pathogens	_	O	O	_	_	_	_	_
71	.	_	O	O	_	_	_	_	_

1	Using	_	O	O	_	_	_	_	_
2	an	_	O	O	_	_	_	_	_
3	invivo	_	O	O	_	_	_	_	_
4	transfer	_	O	O	_	_	_	_	_
5	model	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	DO	_	O	O	_	_	_	_	_
8	11	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_
10	10	_	O	O	_	_	_	_	_
11	TCR	_	O	O	_	_	_	_	_
12	transgenic	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	Castro	_	O	O	_	_	_	_	_
16	etal	_	O	O	_	_	_	_	_
17	.,	_	O	O	_	_	_	_	_
18	2000	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	we	_	O	O	_	_	_	_	_
22	showed	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	producing	_	O	O	_	_	_	_	_
29	Th	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	were	_	O	O	_	_	_	_	_
33	differentiated	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	presence	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	high	_	O	O	_	_	_	_	_
39	doses	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	OVA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	protein	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	LPS	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	showed	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	this	_	O	O	_	_	_	_	_
6	induction	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	inTh	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	invivo	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	markedly	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	but	_	O	O	_	_	_	_	_
19	not	_	O	O	_	_	_	_	_
20	totally	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	reduced	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	deficient	_	O	O	_	_	_	_	_
28	Tcells	_	O	O	_	_	_	_	_
29	as	_	O	O	_	_	_	_	_
30	observed	_	O	O	_	_	_	_	_
31	during	_	O	O	_	_	_	_	_
32	T	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	gondii	_	O	O	_	_	_	_	_
2	has	_	O	O	_	_	_	_	_
3	been	_	O	O	_	_	_	_	_
4	suggested	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	Shaw	_	O	O	_	_	_	_	_
7	etal	_	O	O	_	_	_	_	_
8	.,	_	O	O	_	_	_	_	_
9	2006	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	found	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	+	_	O	O	_	_	_	_	_
8	Tcells	_	O	O	_	_	_	_	_
9	exposed	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	high	_	O	O	_	_	_	_	_
13	dose	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	antigen	_	O	O	_	_	_	_	_
16	do	_	O	O	_	_	_	_	_
17	not	_	O	O	_	_	_	_	_
18	express	_	O	O	_	_	_	_	_
19	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	upon	_	O	O	_	_	_	_	_
23	restimulation	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	but	_	O	O	_	_	_	_	_
26	can	_	O	O	_	_	_	_	_
27	be	_	O	O	_	_	_	_	_
28	induced	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	produce	_	O	O	_	_	_	_	_
31	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	upon	_	O	O	_	_	_	_	_
35	re	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	exposure	_	O	O	_	_	_	_	_
38	to	_	O	O	_	_	_	_	_
39	a	_	O	O	_	_	_	_	_
40	high	_	O	O	_	_	_	_	_
41	dose	_	O	O	_	_	_	_	_
42	of	_	O	O	_	_	_	_	_
43	antigen	_	O	O	_	_	_	_	_
44	in	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	recall	_	O	O	_	_	_	_	_
47	phase	_	O	O	_	_	_	_	_
48	in	_	O	O	_	_	_	_	_
49	the	_	O	O	_	_	_	_	_
50	absence	_	O	O	_	_	_	_	_
51	of	_	O	O	_	_	_	_	_
52	added	_	O	O	_	_	_	_	_
53	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
54	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
55	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	increased	_	O	O	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	observed	_	O	O	_	_	_	_	_
9	during	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	secondary	_	O	O	_	_	_	_	_
12	phase	_	O	O	_	_	_	_	_
13	will	_	O	O	_	_	_	_	_
14	induce	_	O	O	_	_	_	_	_
15	increased	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	production	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	DCs	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	suggests	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	repeated	_	O	O	_	_	_	_	_
26	high	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	level	_	O	O	_	_	_	_	_
29	TCR	_	O	O	_	_	_	_	_
30	activation	_	O	O	_	_	_	_	_
31	feeds	_	O	O	_	_	_	_	_
32	back	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	upregulate	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	production	_	O	O	_	_	_	_	_
39	by	_	O	O	_	_	_	_	_
40	DC	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	HIV	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	TF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	involved	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	transcriptional	_	O	O	_	_	_	_	_
13	regulation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	HIV	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	role	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	AP	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	regulation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	HTLV	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	I	_	O	O	_	_	_	_	_
17	LTR	_	O	O	_	_	_	_	_
18	gene	_	O	O	_	_	_	_	_
19	expression	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	we	_	O	O	_	_	_	_	_
22	used	_	O	O	_	_	_	_	_
23	an	_	O	O	_	_	_	_	_
24	AP	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	2	_	O	O	_	_	_	_	_
27	cDNA	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	DNA	_	O	O	_	_	_	_	_
30	binding	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	transient	_	O	O	_	_	_	_	_
33	expression	_	O	O	_	_	_	_	_
34	assays	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	unstimulated	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	which	_	O	O	_	_	_	_	_
5	do	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	secrete	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	only	_	O	O	_	_	_	_	_
13	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	binds	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	this	_	O	O	_	_	_	_	_
18	region	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	while	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	stimulated	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	secreting	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	inducible	_	O	O	_	_	_	_	_
30	EGR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	protein	_	O	O	_	_	_	_	_
34	recognizes	_	O	O	_	_	_	_	_
35	this	_	O	O	_	_	_	_	_
36	element	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	critical	_	O	O	_	_	_	_	_
6	role	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	ZIP	_	O	O	_	_	_	_	_
10	site	_	O	O	_	_	_	_	_
11	for	_	O	O	_	_	_	_	_
12	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	promoter	_	O	O	_	_	_	_	_
16	activity	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	factor	_	O	O	_	_	_	_	_
4	nuclear	_	O	O	_	_	_	_	_
5	factor	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	critical	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	inducible	_	O	O	_	_	_	_	_
20	expression	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	multiple	_	O	O	_	_	_	_	_
23	cellular	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	viral	_	O	O	_	_	_	_	_
26	genes	_	O	O	_	_	_	_	_
27	involved	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	inflammation	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	infection	_	O	O	_	_	_	_	_
32	including	_	O	O	_	_	_	_	_
33	interleukin	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	1	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	IL	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	and	_	O	O	_	_	_	_	_
47	adhesion	_	O	O	_	_	_	_	_
48	molecules	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	Sodium	_	O	O	_	_	_	_	_
2	salicylate	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	aspirin	_	O	O	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	inhibited	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappa	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	from	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	Ig	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	enhancer	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	immunodeficiency	_	O	O	_	_	_	_	_
23	virus	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	HIV	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	long	_	O	O	_	_	_	_	_
28	terminal	_	O	O	_	_	_	_	_
29	repeat	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	LTR	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	transfected	_	O	O	_	_	_	_	_
35	T	_	O	O	_	_	_	_	_
36	cells	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Early	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	EBF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	identified	_	O	O	_	_	_	_	_
11	previously	_	O	O	_	_	_	_	_
12	as	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	tissue	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	specific	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	differentiation	_	O	O	_	_	_	_	_
19	stage	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	specific	_	O	O	_	_	_	_	_
22	DNA	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	binding	_	O	O	_	_	_	_	_
25	protein	_	O	O	_	_	_	_	_
26	that	_	O	O	_	_	_	_	_
27	participates	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	regulation	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	pre	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	B	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	lymphocyte	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	specific	_	O	O	_	_	_	_	_
41	mb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	gene	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Pentoxifylline	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	trisubstituted	_	O	O	_	_	_	_	_
5	xanthine	_	O	O	_	_	_	_	_
6	derivative	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	has	_	O	O	_	_	_	_	_
9	been	_	O	O	_	_	_	_	_
10	used	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	decrease	_	O	O	_	_	_	_	_
13	blood	_	O	O	_	_	_	_	_
14	viscosity	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	reasonably	_	O	O	_	_	_	_	_
18	well	_	O	O	_	_	_	_	_
19	tolerated	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	most	_	O	O	_	_	_	_	_
22	recipients	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	drug	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Suppression	_	O	O	_	_	_	_	_
2	by	_	O	O	_	_	_	_	_
3	azelastine	_	O	O	_	_	_	_	_
4	hydrochloride	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	involved	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	generation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	cytokines	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	nitric	_	O	O	_	_	_	_	_
18	oxide	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	transcription	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	at	_	O	O	_	_	_	_	_
9	least	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	part	_	O	O	_	_	_	_	_
12	controlled	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	two	_	O	O	_	_	_	_	_
15	positive	_	O	O	_	_	_	_	_
16	regulatory	_	O	O	_	_	_	_	_
17	regions	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	PRRI	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	PRRII	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	PRRI	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	an	_	O	O	_	_	_	_	_
4	inducible	_	O	O	_	_	_	_	_
5	proximal	_	O	O	_	_	_	_	_
6	enhancer	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	located	_	O	O	_	_	_	_	_
9	between	_	O	O	_	_	_	_	_
10	nucleotides	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	276	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	244	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	which	_	O	O	_	_	_	_	_
18	contains	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	kappaB	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	SRE	_	O	O	_	_	_	_	_
24	/	_	O	O	_	_	_	_	_
25	CArG	_	O	O	_	_	_	_	_
26	motifs	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	PRRII	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	cell	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	specific	_	O	O	_	_	_	_	_
9	enhancer	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	located	_	O	O	_	_	_	_	_
12	between	_	O	O	_	_	_	_	_
13	nucleotides	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	137	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	64	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	which	_	O	O	_	_	_	_	_
21	binds	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	cell	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	specific	_	O	O	_	_	_	_	_
28	Ets	_	O	O	_	_	_	_	_
29	protein	_	O	O	_	_	_	_	_
30	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	HMG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	I	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	Y	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	proteins	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	induced	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	Stat	_	O	O	_	_	_	_	_
9	5	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	b	_	O	O	_	_	_	_	_
13	proteins	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	GASd	_	O	O	_	_	_	_	_
18	element	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	confirm	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	physiological	_	O	O	_	_	_	_	_
5	relevance	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	these	_	O	O	_	_	_	_	_
8	findings	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	we	_	O	O	_	_	_	_	_
11	carried	_	O	O	_	_	_	_	_
12	out	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	vivo	_	O	O	_	_	_	_	_
15	footprinting	_	O	O	_	_	_	_	_
16	experiments	_	O	O	_	_	_	_	_
17	which	_	O	O	_	_	_	_	_
18	showed	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	stimulation	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	correlated	_	O	O	_	_	_	_	_
29	with	_	O	O	_	_	_	_	_
30	occupancy	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	GASd	_	O	O	_	_	_	_	_
34	element	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	demonstrate	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	major	_	O	O	_	_	_	_	_
6	role	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	GASd	_	O	O	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	EBSd	_	O	O	_	_	_	_	_
12	element	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	regulation	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	suggest	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	T	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	specific	_	O	O	_	_	_	_	_
29	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	factor	_	O	O	_	_	_	_	_
33	can	_	O	O	_	_	_	_	_
34	serve	_	O	O	_	_	_	_	_
35	as	_	O	O	_	_	_	_	_
36	a	_	O	O	_	_	_	_	_
37	transcriptional	_	O	O	_	_	_	_	_
38	repressor	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	indicated	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	U	_	O	O	_	_	_	_	_
5	0126	_	O	O	_	_	_	_	_
6	or	_	O	O	_	_	_	_	_
7	PD	_	O	O	_	_	_	_	_
8	184352	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	MEK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	inhibitors	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	SB	_	O	O	_	_	_	_	_
15	203580	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	38	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	inhibitor	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	CT	_	O	O	_	_	_	_	_
23	99021	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	GSK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	inhibitor	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	or	_	O	O	_	_	_	_	_
32	a	_	O	O	_	_	_	_	_
33	similar	_	O	O	_	_	_	_	_
34	amount	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	DMSO	_	O	O	_	_	_	_	_
37	were	_	O	O	_	_	_	_	_
38	present	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	culture	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_



1	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	treatment	_	O	O	_	_	_	_	_
3	induces	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	rapid	_	O	O	_	_	_	_	_
6	translocation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	65	_	O	O	_	_	_	_	_
10	kD	_	O	O	_	_	_	_	_
11	transcriptional	_	O	O	_	_	_	_	_
12	activator	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappaB	_	O	O	_	_	_	_	_
16	subunit	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	Rel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	whose	_	O	O	_	_	_	_	_
22	binding	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	nucleus	_	O	O	_	_	_	_	_
26	occurs	_	O	O	_	_	_	_	_
27	before	_	O	O	_	_	_	_	_
28	changes	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	intracellular	_	O	O	_	_	_	_	_
31	ROS	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	definition	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	pathway	_	O	O	_	_	_	_	_
6	will	_	O	O	_	_	_	_	_
7	yield	_	O	O	_	_	_	_	_
8	new	_	O	O	_	_	_	_	_
9	insights	_	O	O	_	_	_	_	_
10	into	_	O	O	_	_	_	_	_
11	inflammation	_	O	O	_	_	_	_	_
12	initiated	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	signalling	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Each	_	O	O	_	_	_	_	_
2	experiment	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	carried	_	O	O	_	_	_	_	_
5	out	_	O	O	_	_	_	_	_
6	at	_	O	O	_	_	_	_	_
7	least	_	O	O	_	_	_	_	_
8	three	_	O	O	_	_	_	_	_
9	times	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_



1	Bars	_	O	O	_	_	_	_	_
2	show	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	mean	_	O	O	_	_	_	_	_
5	+	_	O	O	_	_	_	_	_
6	/	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	SD	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	three	_	O	O	_	_	_	_	_
11	independent	_	O	O	_	_	_	_	_
12	experiments	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	amounts	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	precipitates	_	O	O	_	_	_	_	_
10	were	_	O	O	_	_	_	_	_
11	assessed	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	immunoblotting	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	anti	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	mAb	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Additionally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	this	_	O	O	_	_	_	_	_
4	signaling	_	O	O	_	_	_	_	_
5	pathway	_	O	O	_	_	_	_	_
6	also	_	O	O	_	_	_	_	_
7	leads	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	induced	_	O	O	_	_	_	_	_
12	apoptosis	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	lymphocytes	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	dependent	_	O	O	_	_	_	_	_
19	on	_	O	O	_	_	_	_	_
20	FasL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	transcription	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Co	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	Rel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	FasL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	enhanced	_	O	O	_	_	_	_	_
16	its	_	O	O	_	_	_	_	_
17	activity	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	co	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	expression	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	IkappaB	_	O	O	_	_	_	_	_
25	dramatically	_	O	O	_	_	_	_	_
26	inhibited	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	inducible	_	O	O	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	activity	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	AP	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	not	_	O	O	_	_	_	_	_
12	required	_	O	O	_	_	_	_	_
13	for	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	induced	_	O	O	_	_	_	_	_
17	FasL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Quantitative	_	O	O	_	_	_	_	_
2	real	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	time	_	O	O	_	_	_	_	_
5	PCR	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_

1	Primer	_	O	O	_	_	_	_	_
2	pairs	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	evaluated	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	integrity	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	analysis	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	amplification	_	O	O	_	_	_	_	_
12	plot	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	dissociation	_	O	O	_	_	_	_	_
15	curves	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	efficiency	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	PCR	_	O	O	_	_	_	_	_
21	amplification	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Progesterone	_	O	O	_	_	_	_	_
2	effectively	_	O	O	_	_	_	_	_
3	blocked	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	broad	_	O	O	_	_	_	_	_
6	spectrum	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	K	_	O	O	_	_	_	_	_
9	+	_	O	O	_	_	_	_	_
10	channels	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	reducing	_	O	O	_	_	_	_	_
13	both	_	O	O	_	_	_	_	_
14	Kv	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	charybdotoxin	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	resistant	_	O	O	_	_	_	_	_
22	components	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	KV	_	O	O	_	_	_	_	_
25	current	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	KCa	_	O	O	_	_	_	_	_
28	current	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	T	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	as	_	O	O	_	_	_	_	_
34	well	_	O	O	_	_	_	_	_
35	as	_	O	O	_	_	_	_	_
36	blocking	_	O	O	_	_	_	_	_
37	several	_	O	O	_	_	_	_	_
38	cloned	_	O	O	_	_	_	_	_
39	KV	_	O	O	_	_	_	_	_
40	channels	_	O	O	_	_	_	_	_
41	expressed	_	O	O	_	_	_	_	_
42	in	_	O	O	_	_	_	_	_
43	cell	_	O	O	_	_	_	_	_
44	lines	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Progesterone	_	O	O	_	_	_	_	_
2	had	_	O	O	_	_	_	_	_
3	little	_	O	O	_	_	_	_	_
4	or	_	O	O	_	_	_	_	_
5	no	_	O	O	_	_	_	_	_
6	effect	_	O	O	_	_	_	_	_
7	on	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	cloned	_	O	O	_	_	_	_	_
10	voltage	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	gated	_	O	O	_	_	_	_	_
13	Na	_	O	O	_	_	_	_	_
14	+	_	O	O	_	_	_	_	_
15	channel	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	an	_	O	O	_	_	_	_	_
18	inward	_	O	O	_	_	_	_	_
19	rectifier	_	O	O	_	_	_	_	_
20	K	_	O	O	_	_	_	_	_
21	+	_	O	O	_	_	_	_	_
22	channel	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	or	_	O	O	_	_	_	_	_
25	on	_	O	O	_	_	_	_	_
26	lymphocyte	_	O	O	_	_	_	_	_
27	Ca	_	O	O	_	_	_	_	_
28	2	_	O	O	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	Cl	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	channels	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	propose	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	direct	_	O	O	_	_	_	_	_
5	inhibition	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	K	_	O	O	_	_	_	_	_
8	+	_	O	O	_	_	_	_	_
9	channels	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	progesterone	_	O	O	_	_	_	_	_
15	contributes	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	progesterone	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	induced	_	O	O	_	_	_	_	_
20	immunosuppression	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	0	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	0	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_
10	5	_	O	O	_	_	_	_	_
11	microM	_	O	O	_	_	_	_	_
12	DMDTC	_	O	O	_	_	_	_	_
13	inhibits	_	O	O	_	_	_	_	_
14	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	activation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	NF	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	kappaB	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	primary	_	O	O	_	_	_	_	_
26	human	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	T	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	alterations	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	MTS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	tumor	_	O	O	_	_	_	_	_
10	suppressor	_	O	O	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	chromosome	_	O	O	_	_	_	_	_
14	9	_	O	O	_	_	_	_	_
15	p	_	O	O	_	_	_	_	_
16	21	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	which	_	O	O	_	_	_	_	_
19	encodes	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	16	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	inhibitor	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	cyclin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	dependent	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	6	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	tumorigenesis	_	O	O	_	_	_	_	_
38	is	_	O	O	_	_	_	_	_
39	not	_	O	O	_	_	_	_	_
40	yet	_	O	O	_	_	_	_	_
41	clear	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	investigated	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	regulation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	thymidine	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	phytohemagglutinin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	stimulated	_	O	O	_	_	_	_	_
12	normal	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	lymphocytes	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	16	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	negative	_	O	O	_	_	_	_	_
22	human	_	O	O	_	_	_	_	_
23	acute	_	O	O	_	_	_	_	_
24	lymphoblastic	_	O	O	_	_	_	_	_
25	leukemia	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	lines	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	MOLT	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	4	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	CEM	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_



1	To	_	O	O	_	_	_	_	_
2	investigate	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	effect	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	NAC	_	O	O	_	_	_	_	_
7	on	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	induction	_	O	O	_	_	_	_	_
10	phase	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	responses	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	we	_	O	O	_	_	_	_	_
17	analyzed	_	O	O	_	_	_	_	_
18	its	_	O	O	_	_	_	_	_
19	action	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	dendritic	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	DC	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	derived	_	O	O	_	_	_	_	_
28	from	_	O	O	_	_	_	_	_
29	adherent	_	O	O	_	_	_	_	_
30	PBMC	_	O	O	_	_	_	_	_
31	cultured	_	O	O	_	_	_	_	_
32	with	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	NAC	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	inhibited	_	O	O	_	_	_	_	_
4	DC	_	O	O	_	_	_	_	_
5	responses	_	O	O	_	_	_	_	_
6	induced	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	engagement	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	activated	_	O	O	_	_	_	_	_
6	signal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	transducers	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	activators	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	of	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	transcription	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	STAT	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	addition	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	kappaB	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	NAC	_	O	O	_	_	_	_	_
24	treatment	_	O	O	_	_	_	_	_
25	or	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	transfection	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	decoy	_	O	O	_	_	_	_	_
30	oligodeoxynucleotides	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	kappaB	_	O	O	_	_	_	_	_
35	or	_	O	O	_	_	_	_	_
36	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	only	_	O	O	_	_	_	_	_
39	partly	_	O	O	_	_	_	_	_
40	blocked	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	induced	_	O	O	_	_	_	_	_
46	germline	_	O	O	_	_	_	_	_
47	Cepsilon	_	O	O	_	_	_	_	_
48	transcription	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	abolished	_	O	O	_	_	_	_	_
4	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	upregulation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	but	_	O	O	_	_	_	_	_
14	promoted	_	O	O	_	_	_	_	_
15	upregulation	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	23	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_


1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	naive	_	O	O	_	_	_	_	_
4	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	+	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	antigen	_	O	O	_	_	_	_	_
11	induces	_	O	O	_	_	_	_	_
12	their	_	O	O	_	_	_	_	_
13	differentiation	_	O	O	_	_	_	_	_
14	into	_	O	O	_	_	_	_	_
15	effector	_	O	O	_	_	_	_	_
16	cytolytic	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	lymphocytes	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	CTLs	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	CTLs	_	O	O	_	_	_	_	_
2	lyse	_	O	O	_	_	_	_	_
3	infected	_	O	O	_	_	_	_	_
4	or	_	O	O	_	_	_	_	_
5	aberrant	_	O	O	_	_	_	_	_
6	target	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	exocytosis	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	lytic	_	O	O	_	_	_	_	_
12	granules	_	O	O	_	_	_	_	_
13	containing	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	pore	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	forming	_	O	O	_	_	_	_	_
18	protein	_	O	O	_	_	_	_	_
19	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	family	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	proteases	_	O	O	_	_	_	_	_
25	termed	_	O	O	_	_	_	_	_
26	granzymes	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	confirmation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	specificity	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	these	_	O	O	_	_	_	_	_
8	DNA	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	complexes	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	demonstrated	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	inability	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	unlabeled	_	O	O	_	_	_	_	_
20	APO	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	Sp	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	/	_	O	O	_	_	_	_	_
25	3	_	O	O	_	_	_	_	_
26	mut	_	O	O	_	_	_	_	_
27	probe	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	abolish	_	O	O	_	_	_	_	_
30	binding	_	O	O	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	Figure	_	O	O	_	_	_	_	_
33	6	_	O	O	_	_	_	_	_
34	A	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	lanes	_	O	O	_	_	_	_	_
37	12	_	O	O	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	13	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Only	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	positive	_	O	O	_	_	_	_	_
4	controls	_	O	O	_	_	_	_	_
5	showed	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	DNA	_	O	O	_	_	_	_	_
8	band	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	an	_	O	O	_	_	_	_	_
12	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	plasmid	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	sheared	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	cross	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	linked	_	O	O	_	_	_	_	_
24	input	_	O	O	_	_	_	_	_
25	DNA	_	O	O	_	_	_	_	_
26	used	_	O	O	_	_	_	_	_
27	as	_	O	O	_	_	_	_	_
28	template	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	we	_	O	O	_	_	_	_	_
5	demonstrate	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	subfragment	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	C	_	O	O	_	_	_	_	_
11	26	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	region	_	O	O	_	_	_	_	_
16	between	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	21	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	bp	_	O	O	_	_	_	_	_
21	elements	_	O	O	_	_	_	_	_
22	is	_	O	O	_	_	_	_	_
23	involved	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	trans	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	activation	_	O	O	_	_	_	_	_
28	by	_	O	O	_	_	_	_	_
29	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	tax	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	possibly	_	O	O	_	_	_	_	_
34	through	_	O	O	_	_	_	_	_
35	binding	_	O	O	_	_	_	_	_
36	to	_	O	O	_	_	_	_	_
37	an	_	O	O	_	_	_	_	_
38	NF	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	kappa	_	O	O	_	_	_	_	_
41	B	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	like	_	O	O	_	_	_	_	_
44	nuclear	_	O	O	_	_	_	_	_
45	factor	_	O	O	_	_	_	_	_
46	or	_	O	O	_	_	_	_	_
47	factors	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	report	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	cloning	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	Kip	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	from	_	O	O	_	_	_	_	_
13	murine	_	O	O	_	_	_	_	_
14	genomic	_	O	O	_	_	_	_	_
15	DNA	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	functional	_	O	O	_	_	_	_	_
19	analysis	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	promoter	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	Kip	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	gene	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	analyze	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	regulatory	_	O	O	_	_	_	_	_
5	mechanisms	_	O	O	_	_	_	_	_
6	controlling	_	O	O	_	_	_	_	_
7	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	Kip	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	we	_	O	O	_	_	_	_	_
15	characterized	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	5	_	O	O	_	_	_	_	_
18	'	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	flanking	_	O	O	_	_	_	_	_
21	region	_	O	O	_	_	_	_	_
22	from	_	O	O	_	_	_	_	_
23	nt	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1609	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	+	_	O	O	_	_	_	_	_
28	178	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	confirm	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	role	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	regulation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	promoter	_	O	O	_	_	_	_	_
18	activity	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	we	_	O	O	_	_	_	_	_
21	silenced	_	O	O	_	_	_	_	_
22	their	_	O	O	_	_	_	_	_
23	translation	_	O	O	_	_	_	_	_
24	via	_	O	O	_	_	_	_	_
25	RNA	_	O	O	_	_	_	_	_
26	interference	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	unspecific	_	O	O	_	_	_	_	_
3	control	_	O	O	_	_	_	_	_
4	siRNA	_	O	O	_	_	_	_	_
5	had	_	O	O	_	_	_	_	_
6	no	_	O	O	_	_	_	_	_
7	influence	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	Figure	_	O	O	_	_	_	_	_
10	7	_	O	O	_	_	_	_	_
11	A	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	both	_	O	O	_	_	_	_	_
4	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	factors	_	O	O	_	_	_	_	_
10	are	_	O	O	_	_	_	_	_
11	mediating	_	O	O	_	_	_	_	_
12	transcriptional	_	O	O	_	_	_	_	_
13	activity	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	host	_	O	O	_	_	_	_	_
3	response	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	Mycobacterium	_	O	O	_	_	_	_	_
6	tuberculosis	_	O	O	_	_	_	_	_
7	includes	_	O	O	_	_	_	_	_
8	granuloma	_	O	O	_	_	_	_	_
9	formation	_	O	O	_	_	_	_	_
10	at	_	O	O	_	_	_	_	_
11	sites	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	infection	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	systemic	_	O	O	_	_	_	_	_
16	symptoms	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	bound	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	cyclophilin	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	cyclosporin	_	O	O	_	_	_	_	_
7	A	_	O	O	_	_	_	_	_
8	binds	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	inactivates	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	key	_	O	O	_	_	_	_	_
13	signalling	_	O	O	_	_	_	_	_
14	intermediate	_	O	O	_	_	_	_	_
15	calcineurin	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	gene	_	O	O	_	_	_	_	_
3	product	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	when	_	O	O	_	_	_	_	_
6	overexpressed	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	Jurkat	_	O	O	_	_	_	_	_
9	T	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	specifically	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	from	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	enhancer	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	activating	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	specific	_	O	O	_	_	_	_	_
30	transcription	_	O	O	_	_	_	_	_
31	factors	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	AT	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	IL	_	O	O	_	_	_	_	_
39	2	_	O	O	_	_	_	_	_
40	A	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	protein	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	termed	_	O	O	_	_	_	_	_
5	calcium	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	signal	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	modulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	cyclophilin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	CAML	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	acts	_	O	O	_	_	_	_	_
16	downstream	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	TCR	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	upstream	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	calcineurin	_	O	O	_	_	_	_	_
24	by	_	O	O	_	_	_	_	_
25	causing	_	O	O	_	_	_	_	_
26	an	_	O	O	_	_	_	_	_
27	influx	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	calcium	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_


1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	partially	_	O	O	_	_	_	_	_
5	blocked	_	O	O	_	_	_	_	_
6	for	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappaB	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	TRADD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	mutant	_	O	O	_	_	_	_	_
15	consisting	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	residues	_	O	O	_	_	_	_	_
18	122	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	293	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	cells	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	then	_	O	O	_	_	_	_	_
5	incubated	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	inactivated	_	O	O	_	_	_	_	_
8	splenocytes	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	stimulated	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	anti	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mAb	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	four	_	O	O	_	_	_	_	_
19	more	_	O	O	_	_	_	_	_
20	days	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	+	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	were	_	O	O	_	_	_	_	_
8	analyzed	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	CFSE	_	O	O	_	_	_	_	_
11	dilution	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	Fig	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	suppression	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	significantly	_	O	O	_	_	_	_	_
5	reduced	_	O	O	_	_	_	_	_
6	when	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	CbfbF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	F	_	O	O	_	_	_	_	_
12	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	cre	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mice	_	O	O	_	_	_	_	_
17	were	_	O	O	_	_	_	_	_
18	used	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	demonstrating	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	induced	_	O	O	_	_	_	_	_
27	Runx	_	O	O	_	_	_	_	_
28	complexes	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	important	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	suppressive	_	O	O	_	_	_	_	_
34	activity	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	+	_	O	O	_	_	_	_	_
39	T	_	O	O	_	_	_	_	_
40	reg	_	O	O	_	_	_	_	_
41	cells	_	O	O	_	_	_	_	_
42	(	_	O	O	_	_	_	_	_
43	Fig	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	No	_	O	O	_	_	_	_	_
2	suppression	_	O	O	_	_	_	_	_
3	could	_	O	O	_	_	_	_	_
4	be	_	O	O	_	_	_	_	_
5	observed	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	all	_	O	O	_	_	_	_	_
8	control	_	O	O	_	_	_	_	_
9	groups	_	O	O	_	_	_	_	_
10	without	_	O	O	_	_	_	_	_
11	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	at	_	O	O	_	_	_	_	_
15	all	_	O	O	_	_	_	_	_
16	tested	_	O	O	_	_	_	_	_
17	ratios	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	Fig	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	suppression	_	O	O	_	_	_	_	_
4	experiment	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	human	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	reduced	_	O	O	_	_	_	_	_
10	suppressive	_	O	O	_	_	_	_	_
11	activity	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	caused	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	reduced	_	O	O	_	_	_	_	_
16	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	expression	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	siRNA	_	O	O	_	_	_	_	_
24	inhibition	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	BSAP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	found	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	be	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	only	_	O	O	_	_	_	_	_
11	abundant	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	binding	_	O	O	_	_	_	_	_
15	activity	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	nuclear	_	O	O	_	_	_	_	_
21	extracts	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	interacts	_	O	O	_	_	_	_	_
24	with	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	promoter	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	Transcriptional	_	O	O	_	_	_	_	_
2	control	_	O	O	_	_	_	_	_
3	by	_	O	O	_	_	_	_	_
4	META	_	O	O	_	_	_	_	_
5	parallels	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	several	_	O	O	_	_	_	_	_
9	lymphokine	_	O	O	_	_	_	_	_
10	genes	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	being	_	O	O	_	_	_	_	_
13	specific	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	dependent	_	O	O	_	_	_	_	_
19	on	_	O	O	_	_	_	_	_
20	their	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	inhibited	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	immunosuppressive	_	O	O	_	_	_	_	_
28	drug	_	O	O	_	_	_	_	_
29	cyclosporine	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	CsA	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Preassociation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	separate	_	O	O	_	_	_	_	_
13	signalling	_	O	O	_	_	_	_	_
14	complexes	_	O	O	_	_	_	_	_
15	prior	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	cytokine	_	O	O	_	_	_	_	_
18	stimulation	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	STAT	_	O	O	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	heterocomplexes	_	O	O	_	_	_	_	_
8	exist	_	O	O	_	_	_	_	_
9	prior	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	cytokine	_	O	O	_	_	_	_	_
12	treatment	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	examine	_	O	O	_	_	_	_	_
4	molecular	_	O	O	_	_	_	_	_
5	mechanisms	_	O	O	_	_	_	_	_
6	controlling	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	pattern	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	monocytic	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	treatment	_	O	O	_	_	_	_	_
10	led	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	production	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	ROIs	_	O	O	_	_	_	_	_
16	which	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	independent	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	5	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	LOX	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	enzyme	_	O	O	_	_	_	_	_
25	but	_	O	O	_	_	_	_	_
26	requires	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	NADPH	_	O	O	_	_	_	_	_
29	oxidase	_	O	O	_	_	_	_	_
30	activity	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	inhibition	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	HIV	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	replication	_	O	O	_	_	_	_	_
9	appears	_	O	O	_	_	_	_	_
10	not	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	be	_	O	O	_	_	_	_	_
13	directly	_	O	O	_	_	_	_	_
14	correlated	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	GSH	_	O	O	_	_	_	_	_
17	levels	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	factors	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	NFAT	_	O	O	_	_	_	_	_
6	family	_	O	O	_	_	_	_	_
7	play	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	key	_	O	O	_	_	_	_	_
10	role	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	cytokine	_	O	O	_	_	_	_	_
16	genes	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	other	_	O	O	_	_	_	_	_
19	genes	_	O	O	_	_	_	_	_
20	during	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	immune	_	O	O	_	_	_	_	_
23	response	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Recombinant	_	O	O	_	_	_	_	_
2	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	can	_	O	O	_	_	_	_	_
5	mediate	_	O	O	_	_	_	_	_
6	transcription	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	colony	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	stimulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	promoters	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	T	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	suggesting	_	O	O	_	_	_	_	_
36	that	_	O	O	_	_	_	_	_
37	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	contributes	_	O	O	_	_	_	_	_
40	to	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	CsA	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	sensitive	_	O	O	_	_	_	_	_
45	transcription	_	O	O	_	_	_	_	_
46	of	_	O	O	_	_	_	_	_
47	these	_	O	O	_	_	_	_	_
48	genes	_	O	O	_	_	_	_	_
49	during	_	O	O	_	_	_	_	_
50	the	_	O	O	_	_	_	_	_
51	immune	_	O	O	_	_	_	_	_
52	response	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	Transient	_	O	O	_	_	_	_	_
2	overexpression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	hTAFII	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	selectively	_	O	O	_	_	_	_	_
7	squelches	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	some	_	O	O	_	_	_	_	_
12	genes	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Rat	_	O	O	_	_	_	_	_
2	IgG	_	O	O	_	_	_	_	_
3	anti	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	clones	_	O	O	_	_	_	_	_
9	8	_	O	O	_	_	_	_	_
10	G	_	O	O	_	_	_	_	_
11	3	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	G	_	O	O	_	_	_	_	_
15	6	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	Ascenion	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	were	_	O	O	_	_	_	_	_
20	used	_	O	O	_	_	_	_	_
21	at	_	O	O	_	_	_	_	_
22	1	_	O	O	_	_	_	_	_
23	:	_	O	O	_	_	_	_	_
24	10	_	O	O	_	_	_	_	_
25	dilution	_	O	O	_	_	_	_	_
26	from	_	O	O	_	_	_	_	_
27	tissue	_	O	O	_	_	_	_	_
28	culture	_	O	O	_	_	_	_	_
29	supernatants	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	followed	_	O	O	_	_	_	_	_
32	with	_	O	O	_	_	_	_	_
33	8	_	O	O	_	_	_	_	_
34	mug	_	O	O	_	_	_	_	_
35	/	_	O	O	_	_	_	_	_
36	ml	_	O	O	_	_	_	_	_
37	biotinylated	_	O	O	_	_	_	_	_
38	mouse	_	O	O	_	_	_	_	_
39	F	_	O	O	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	ab	_	O	O	_	_	_	_	_
42	'	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	anti	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	rat	_	O	O	_	_	_	_	_
47	IgG	_	O	O	_	_	_	_	_
48	(	_	O	O	_	_	_	_	_
49	H	_	O	O	_	_	_	_	_
50	+	_	O	O	_	_	_	_	_
51	L	_	O	O	_	_	_	_	_
52	)	_	O	O	_	_	_	_	_
53	pre	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	adsorbed	_	O	O	_	_	_	_	_
56	to	_	O	O	_	_	_	_	_
57	mouse	_	O	O	_	_	_	_	_
58	serum	_	O	O	_	_	_	_	_
59	(	_	O	O	_	_	_	_	_
60	Jackson	_	O	O	_	_	_	_	_
61	ImmunoResearch	_	O	O	_	_	_	_	_
62	)	_	O	O	_	_	_	_	_
63	and	_	O	O	_	_	_	_	_
64	2	_	O	O	_	_	_	_	_
65	mug	_	O	O	_	_	_	_	_
66	/	_	O	O	_	_	_	_	_
67	ml	_	O	O	_	_	_	_	_
68	streptavidin	_	O	O	_	_	_	_	_
69	-	_	O	O	_	_	_	_	_
70	alkaline	_	O	O	_	_	_	_	_
71	phosphatase	_	O	O	_	_	_	_	_
72	conjugate	_	O	O	_	_	_	_	_
73	(	_	O	O	_	_	_	_	_
74	Jackson	_	O	O	_	_	_	_	_
75	ImmunoResearch	_	O	O	_	_	_	_	_
76	)	_	O	O	_	_	_	_	_
77	.	_	O	O	_	_	_	_	_

1	Stains	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	developed	_	O	O	_	_	_	_	_
4	with	_	O	O	_	_	_	_	_
5	BCIP	_	O	O	_	_	_	_	_
6	/	_	O	O	_	_	_	_	_
7	NBT	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	counterstained	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	Nuclear	_	O	O	_	_	_	_	_
12	Fast	_	O	O	_	_	_	_	_
13	Red	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	Dako	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	markedly	_	O	O	_	_	_	_	_
5	reduces	_	O	O	_	_	_	_	_
6	nuclear	_	O	O	_	_	_	_	_
7	factor	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	/	_	O	O	_	_	_	_	_
15	Rel	_	O	O	_	_	_	_	_
16	nuclear	_	O	O	_	_	_	_	_
17	activity	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	PBMC	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	stimulation	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	anti	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	CD	_	O	O	_	_	_	_	_
28	3	_	O	O	_	_	_	_	_
29	mAb	_	O	O	_	_	_	_	_
30	OKT	_	O	O	_	_	_	_	_
31	3	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Indeed	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	monocytes	_	O	O	_	_	_	_	_
4	pretreated	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	able	_	O	O	_	_	_	_	_
11	so	_	O	O	_	_	_	_	_
12	inhibit	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	nuclear	_	O	O	_	_	_	_	_
18	activity	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	purified	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	lymphocytes	_	O	O	_	_	_	_	_
23	stimulated	_	O	O	_	_	_	_	_
24	with	_	O	O	_	_	_	_	_
25	OKT	_	O	O	_	_	_	_	_
26	3	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IFN	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	alpha	_	O	O	_	_	_	_	_
6	)	_	O	O	_	_	_	_	_
7	does	_	O	O	_	_	_	_	_
8	not	_	O	O	_	_	_	_	_
9	have	_	O	O	_	_	_	_	_
10	any	_	O	O	_	_	_	_	_
11	effects	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	retinoid	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	dependent	_	O	O	_	_	_	_	_
17	regulation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	myeloid	_	O	O	_	_	_	_	_
21	surface	_	O	O	_	_	_	_	_
22	markers	_	O	O	_	_	_	_	_
23	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	11	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	b	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	33	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Thrombin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	peptide	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	14	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	amino	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	acid	_	O	O	_	_	_	_	_
12	peptide	_	O	O	_	_	_	_	_
13	representing	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	new	_	O	O	_	_	_	_	_
16	NH	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	terminus	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	proteolytically	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	activated	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	mimicked	_	O	O	_	_	_	_	_
27	thrombin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	'	_	O	O	_	_	_	_	_
29	s	_	O	O	_	_	_	_	_
30	action	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	inducing	_	O	O	_	_	_	_	_
33	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	expression	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	regulation	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	phorbol	_	O	O	_	_	_	_	_
10	ester	_	O	O	_	_	_	_	_
11	stimulated	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	lines	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	cytomegalovirus	_	O	O	_	_	_	_	_
3	binding	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	human	_	O	O	_	_	_	_	_
6	monocytes	_	O	O	_	_	_	_	_
7	induces	_	O	O	_	_	_	_	_
8	immunoregulatory	_	O	O	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	showed	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	HCMV	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	monocytes	_	O	O	_	_	_	_	_
9	resulted	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	production	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	release	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	protein	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	induced	_	O	O	_	_	_	_	_
4	gene	_	O	O	_	_	_	_	_
5	products	_	O	O	_	_	_	_	_
6	have	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappaB	_	O	O	_	_	_	_	_
10	sites	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	their	_	O	O	_	_	_	_	_
13	promoter	_	O	O	_	_	_	_	_
14	regions	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	we	_	O	O	_	_	_	_	_
17	next	_	O	O	_	_	_	_	_
18	examined	_	O	O	_	_	_	_	_
19	whether	_	O	O	_	_	_	_	_
20	there	_	O	O	_	_	_	_	_
21	was	_	O	O	_	_	_	_	_
22	an	_	O	O	_	_	_	_	_
23	up	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	regulation	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	nuclear	_	O	O	_	_	_	_	_
28	NF	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	kappaB	_	O	O	_	_	_	_	_
31	levels	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	While	_	O	O	_	_	_	_	_
2	a	_	O	O	_	_	_	_	_
3	nuclear	_	O	O	_	_	_	_	_
4	factor	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	s	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	both	_	O	O	_	_	_	_	_
10	peripheral	_	O	O	_	_	_	_	_
11	blood	_	O	O	_	_	_	_	_
12	monocytes	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	binds	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	peri	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	kappa	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	site	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	electrophoretic	_	O	O	_	_	_	_	_
25	mobility	_	O	O	_	_	_	_	_
26	shift	_	O	O	_	_	_	_	_
27	assays	_	O	O	_	_	_	_	_
28	suggest	_	O	O	_	_	_	_	_
29	that	_	O	O	_	_	_	_	_
30	either	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	different	_	O	O	_	_	_	_	_
33	protein	_	O	O	_	_	_	_	_
34	binds	_	O	O	_	_	_	_	_
35	to	_	O	O	_	_	_	_	_
36	this	_	O	O	_	_	_	_	_
37	site	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	monocytes	_	O	O	_	_	_	_	_
40	versus	_	O	O	_	_	_	_	_
41	T	_	O	O	_	_	_	_	_
42	cells	_	O	O	_	_	_	_	_
43	or	_	O	O	_	_	_	_	_
44	that	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	protein	_	O	O	_	_	_	_	_
47	recognizing	_	O	O	_	_	_	_	_
48	this	_	O	O	_	_	_	_	_
49	enhancer	_	O	O	_	_	_	_	_
50	element	_	O	O	_	_	_	_	_
51	undergoes	_	O	O	_	_	_	_	_
52	differential	_	O	O	_	_	_	_	_
53	modification	_	O	O	_	_	_	_	_
54	in	_	O	O	_	_	_	_	_
55	monocytes	_	O	O	_	_	_	_	_
56	and	_	O	O	_	_	_	_	_
57	T	_	O	O	_	_	_	_	_
58	cells	_	O	O	_	_	_	_	_
59	,	_	O	O	_	_	_	_	_
60	thus	_	O	O	_	_	_	_	_
61	supporting	_	O	O	_	_	_	_	_
62	the	_	O	O	_	_	_	_	_
63	transfection	_	O	O	_	_	_	_	_
64	data	_	O	O	_	_	_	_	_
65	.	_	O	O	_	_	_	_	_

1	Lipopolysaccharide	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	induced	_	O	O	_	_	_	_	_
4	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	requires	_	O	O	_	_	_	_	_
9	continuous	_	O	O	_	_	_	_	_
10	presence	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	LPS	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	inhibited	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	bactericidal	_	O	O	_	_	_	_	_
18	/	_	O	O	_	_	_	_	_
19	permeability	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	increasing	_	O	O	_	_	_	_	_
22	protein	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	Tissue	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	specific	_	O	O	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	mediated	_	O	O	_	_	_	_	_
16	via	_	O	O	_	_	_	_	_
17	cis	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	acting	_	O	O	_	_	_	_	_
20	elements	_	O	O	_	_	_	_	_
21	located	_	O	O	_	_	_	_	_
22	within	_	O	O	_	_	_	_	_
23	315	_	O	O	_	_	_	_	_
24	base	_	O	O	_	_	_	_	_
25	pairs	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	transcription	_	O	O	_	_	_	_	_
29	start	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	later	_	O	O	_	_	_	_	_
3	result	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	inhibition	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	this	_	O	O	_	_	_	_	_
8	activation	_	O	O	_	_	_	_	_
9	pathway	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	21	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	ras	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	was	_	O	O	_	_	_	_	_
17	down	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	regulation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	activity	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	transcription	_	O	O	_	_	_	_	_
26	factor	_	O	O	_	_	_	_	_
27	AP	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	subsequent	_	O	O	_	_	_	_	_
32	coordinate	_	O	O	_	_	_	_	_
33	reductions	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	gene	_	O	O	_	_	_	_	_
39	expression	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	protein	_	O	O	_	_	_	_	_
42	production	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Mononuclear	_	O	O	_	_	_	_	_
2	phagocytes	_	O	O	_	_	_	_	_
3	play	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	major	_	O	O	_	_	_	_	_
6	role	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	immune	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	inflammatory	_	O	O	_	_	_	_	_
11	responses	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	characterize	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	protein	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	DNA	_	O	O	_	_	_	_	_
7	interactions	_	O	O	_	_	_	_	_
8	important	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	developmental	_	O	O	_	_	_	_	_
12	control	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	human	_	O	O	_	_	_	_	_
16	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	locus	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	we	_	O	O	_	_	_	_	_
22	analyzed	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	vivo	_	O	O	_	_	_	_	_
26	dimethyl	_	O	O	_	_	_	_	_
27	sulfate	_	O	O	_	_	_	_	_
28	footprinting	_	O	O	_	_	_	_	_
29	erythroid	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	expressing	_	O	O	_	_	_	_	_
32	either	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	fetal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	or	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	adult	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	developmental	_	O	O	_	_	_	_	_
40	program	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	promoter	_	O	O	_	_	_	_	_
3	regions	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	actively	_	O	O	_	_	_	_	_
7	transcribed	_	O	O	_	_	_	_	_
8	genes	_	O	O	_	_	_	_	_
9	demonstrated	_	O	O	_	_	_	_	_
10	extensive	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	consistent	_	O	O	_	_	_	_	_
13	footprints	_	O	O	_	_	_	_	_
14	over	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	canonical	_	O	O	_	_	_	_	_
17	elements	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	such	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	CACCC	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	CCAAT	_	O	O	_	_	_	_	_
24	motifs	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	RNA	_	O	O	_	_	_	_	_
2	isolation	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	cDNA	_	O	O	_	_	_	_	_
5	synthesis	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_


1	An	_	O	O	_	_	_	_	_
2	isotype	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	specific	_	O	O	_	_	_	_	_
5	activator	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	major	_	O	O	_	_	_	_	_
8	histocompatibility	_	O	O	_	_	_	_	_
9	complex	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	MHC	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	class	_	O	O	_	_	_	_	_
14	II	_	O	O	_	_	_	_	_
15	genes	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	independent	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	class	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	II	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	transactivator	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	demonstrate	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	existence	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	an	_	O	O	_	_	_	_	_
11	HLA	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	DQ	_	O	O	_	_	_	_	_
14	isotype	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	specific	_	O	O	_	_	_	_	_
17	trans	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	acting	_	O	O	_	_	_	_	_
20	factor	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	which	_	O	O	_	_	_	_	_
23	functions	_	O	O	_	_	_	_	_
24	independently	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	NLSs	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappa	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	AP	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	NFAT	_	O	O	_	_	_	_	_
15	differ	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	NLS	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	STAT	_	O	O	_	_	_	_	_
21	1	_	O	O	_	_	_	_	_
22	has	_	O	O	_	_	_	_	_
23	not	_	O	O	_	_	_	_	_
24	yet	_	O	O	_	_	_	_	_
25	been	_	O	O	_	_	_	_	_
26	identified	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	After	_	O	O	_	_	_	_	_
2	initiation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	differentiation	_	O	O	_	_	_	_	_
6	process	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	showed	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	similar	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	kinetic	_	O	O	_	_	_	_	_
18	within	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	first	_	O	O	_	_	_	_	_
21	3	_	O	O	_	_	_	_	_
22	d	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	which	_	O	O	_	_	_	_	_
25	are	_	O	O	_	_	_	_	_
26	considered	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	be	_	O	O	_	_	_	_	_
29	critical	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	T	_	O	O	_	_	_	_	_
32	cell	_	O	O	_	_	_	_	_
33	commitment	_	O	O	_	_	_	_	_
34	[	_	O	O	_	_	_	_	_
35	18	_	O	O	_	_	_	_	_
36	]	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	critical	_	O	O	_	_	_	_	_
3	issue	_	O	O	_	_	_	_	_
4	concerns	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	mechanism	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	which	_	O	O	_	_	_	_	_
9	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	which	_	O	O	_	_	_	_	_
13	has	_	O	O	_	_	_	_	_
14	no	_	O	O	_	_	_	_	_
15	transmembrane	_	O	O	_	_	_	_	_
16	domain	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	transduces	_	O	O	_	_	_	_	_
19	its	_	O	O	_	_	_	_	_
20	signal	_	O	O	_	_	_	_	_
21	following	_	O	O	_	_	_	_	_
22	LPS	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	previously	_	O	O	_	_	_	_	_
4	found	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	high	_	O	O	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	human	_	O	O	_	_	_	_	_
10	Ah	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	TCDD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	mRNA	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	peripheral	_	O	O	_	_	_	_	_
19	blood	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	individuals	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Expression	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	thyrotropin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	autoimmune	_	O	O	_	_	_	_	_
10	thyroid	_	O	O	_	_	_	_	_
11	disease	_	O	O	_	_	_	_	_
12	:	_	O	O	_	_	_	_	_
13	coregulation	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	parameters	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	thyroid	_	O	O	_	_	_	_	_
18	function	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	inverse	_	O	O	_	_	_	_	_
21	relation	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	major	_	O	O	_	_	_	_	_
24	histocompatibility	_	O	O	_	_	_	_	_
25	complex	_	O	O	_	_	_	_	_
26	classes	_	O	O	_	_	_	_	_
27	I	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	II	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	toll	_	O	O	_	_	_	_	_
4	signaling	_	O	O	_	_	_	_	_
5	pathway	_	O	O	_	_	_	_	_
6	:	_	O	O	_	_	_	_	_
7	divergence	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	nuclear	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	JNK	_	O	O	_	_	_	_	_
14	/	_	O	O	_	_	_	_	_
15	SAPK	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	upstream	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	associated	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	TRAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	activated	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	TRAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	nuclear	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	NF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	inducing	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	NIK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	both	_	O	O	_	_	_	_	_
31	involved	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	subsequent	_	O	O	_	_	_	_	_
34	steps	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	kappaB	_	O	O	_	_	_	_	_
39	activation	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	tested	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	effect	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	three	_	O	O	_	_	_	_	_
7	linear	_	O	O	_	_	_	_	_
8	or	_	O	O	_	_	_	_	_
9	two	_	O	O	_	_	_	_	_
10	loop	_	O	O	_	_	_	_	_
11	peptides	_	O	O	_	_	_	_	_
12	derived	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	V	_	O	O	_	_	_	_	_
16	3	_	O	O	_	_	_	_	_
17	region	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	HTLV	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	III	_	O	O	_	_	_	_	_
23	BH	_	O	O	_	_	_	_	_
24	10	_	O	O	_	_	_	_	_
25	clone	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	SF	_	O	O	_	_	_	_	_
29	2	_	O	O	_	_	_	_	_
30	strain	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	human	_	O	O	_	_	_	_	_
33	immunodeficiency	_	O	O	_	_	_	_	_
34	virus	_	O	O	_	_	_	_	_
35	type	_	O	O	_	_	_	_	_
36	1	_	O	O	_	_	_	_	_
37	on	_	O	O	_	_	_	_	_
38	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	driven	_	O	O	_	_	_	_	_
43	T	_	O	O	_	_	_	_	_
44	cell	_	O	O	_	_	_	_	_
45	proliferation	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	Formation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	transcriptional	_	O	O	_	_	_	_	_
8	complex	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	essential	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	transcription	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	WIN	_	O	O	_	_	_	_	_
2	53071	_	O	O	_	_	_	_	_
3	inhibited	_	O	O	_	_	_	_	_
4	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	production	_	O	O	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	calcium	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	dependent	_	O	O	_	_	_	_	_
14	PMA	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	ionomycin	_	O	O	_	_	_	_	_
17	pathway	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	examined	_	O	O	_	_	_	_	_
3	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	alpha	_	O	O	_	_	_	_	_
9	A	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	product	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	two	_	O	O	_	_	_	_	_
24	alpha	_	O	O	_	_	_	_	_
25	B	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	encoded	_	O	O	_	_	_	_	_
28	isomers	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	for	_	O	O	_	_	_	_	_
31	their	_	O	O	_	_	_	_	_
32	effects	_	O	O	_	_	_	_	_
33	on	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	promoter	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Jurkat	_	O	O	_	_	_	_	_
2	cell	_	O	O	_	_	_	_	_
3	extract	_	O	O	_	_	_	_	_
4	contained	_	O	O	_	_	_	_	_
5	PEBP	_	O	O	_	_	_	_	_
6	2	_	O	O	_	_	_	_	_
7	site	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	binding	_	O	O	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	s	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	cross	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	reacted	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	antimouse	_	O	O	_	_	_	_	_
20	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	antibodies	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	hydrophobic	_	O	O	_	_	_	_	_
3	domain	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	Ca	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	+	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	modulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	cyclophilin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	modulates	_	O	O	_	_	_	_	_
13	calcium	_	O	O	_	_	_	_	_
14	influx	_	O	O	_	_	_	_	_
15	signaling	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	lymphocytes	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	monocytes	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	inhibitors	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	phosphatases	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	okadaic	_	O	O	_	_	_	_	_
12	acid	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	calyculin	_	O	O	_	_	_	_	_
15	A	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	were	_	O	O	_	_	_	_	_
18	found	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	increase	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	mRNA	_	O	O	_	_	_	_	_
23	accumulation	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	cytokine	_	O	O	_	_	_	_	_
26	production	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	show	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	protein	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	phosphatase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	2	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	inhibitors	_	O	O	_	_	_	_	_
12	exert	_	O	O	_	_	_	_	_
13	multiple	_	O	O	_	_	_	_	_
14	effects	_	O	O	_	_	_	_	_
15	on	_	O	O	_	_	_	_	_
16	cytokine	_	O	O	_	_	_	_	_
17	production	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	human	_	O	O	_	_	_	_	_
20	monocytes	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	suggest	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	these	_	O	O	_	_	_	_	_
25	two	_	O	O	_	_	_	_	_
26	phosphatases	_	O	O	_	_	_	_	_
27	play	_	O	O	_	_	_	_	_
28	important	_	O	O	_	_	_	_	_
29	roles	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	regulating	_	O	O	_	_	_	_	_
32	interleukin	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	production	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	Challenges	_	O	O	_	_	_	_	_
2	in	_	O	O	_	_	_	_	_
3	developing	_	O	O	_	_	_	_	_
4	new	_	O	O	_	_	_	_	_
5	therapeutic	_	O	O	_	_	_	_	_
6	strategies	_	O	O	_	_	_	_	_
7	include	_	O	O	_	_	_	_	_
8	not	_	O	O	_	_	_	_	_
9	only	_	O	O	_	_	_	_	_
10	identifying	_	O	O	_	_	_	_	_
11	novel	_	O	O	_	_	_	_	_
12	agents	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	but	_	O	O	_	_	_	_	_
15	also	_	O	O	_	_	_	_	_
16	improving	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	definitions	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	clinical	_	O	O	_	_	_	_	_
21	endpoints	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	defining	_	O	O	_	_	_	_	_
24	efficacy	_	O	O	_	_	_	_	_
25	at	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	biologic	_	O	O	_	_	_	_	_
28	level	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Costimulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	through	_	O	O	_	_	_	_	_
6	both	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	Ag	_	O	O	_	_	_	_	_
9	receptor	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	leads	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	high	_	O	O	_	_	_	_	_
16	level	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	production	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	which	_	O	O	_	_	_	_	_
23	is	_	O	O	_	_	_	_	_
24	vital	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	development	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	an	_	O	O	_	_	_	_	_
30	immune	_	O	O	_	_	_	_	_
31	response	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	vivo	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	identified	_	O	O	_	_	_	_	_
4	as	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	mRNA	_	O	O	_	_	_	_	_
7	encoding	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	which	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	expressed	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	fast	_	O	O	_	_	_	_	_
20	kinetics	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	NK	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	upon	_	O	O	_	_	_	_	_
27	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	but	_	O	O	_	_	_	_	_
32	not	_	O	O	_	_	_	_	_
33	IL	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	12	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	stimulation	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Accordingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	increased	_	O	O	_	_	_	_	_
4	AP	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	DNA	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	binding	_	O	O	_	_	_	_	_
10	activity	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	AP	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	dependent	_	O	O	_	_	_	_	_
17	transcriptional	_	O	O	_	_	_	_	_
18	activity	_	O	O	_	_	_	_	_
19	were	_	O	O	_	_	_	_	_
20	detected	_	O	O	_	_	_	_	_
21	exclusively	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	stimulated	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	alternative	_	O	O	_	_	_	_	_
3	pathway	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	mediated	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	viral	_	O	O	_	_	_	_	_
12	enhancer	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	domain	_	O	O	_	_	_	_	_
18	capable	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	binding	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	prototypical	_	O	O	_	_	_	_	_
23	form	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	transcription	_	O	O	_	_	_	_	_
27	factor	_	O	O	_	_	_	_	_
28	nuclear	_	O	O	_	_	_	_	_
29	factor	_	O	O	_	_	_	_	_
30	kappa	_	O	O	_	_	_	_	_
31	B	_	O	O	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	NF	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	kappa	_	O	O	_	_	_	_	_
36	B	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	present	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	many	_	O	O	_	_	_	_	_
41	cell	_	O	O	_	_	_	_	_
42	types	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	including	_	O	O	_	_	_	_	_
45	T	_	O	O	_	_	_	_	_
46	lymphocytes	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_


1	Because	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	elevated	_	O	O	_	_	_	_	_
4	Myb	_	O	O	_	_	_	_	_
5	:	_	O	O	_	_	_	_	_
6	Maf	_	O	O	_	_	_	_	_
7	status	_	O	O	_	_	_	_	_
8	seen	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	differentiating	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	can	_	O	O	_	_	_	_	_
13	be	_	O	O	_	_	_	_	_
14	recapitulated	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	overexpression	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	Maf	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	myeloid	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	lines	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	we	_	O	O	_	_	_	_	_
27	inducibly	_	O	O	_	_	_	_	_
28	expressed	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	Maf	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	cDNA	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	2	_	O	O	_	_	_	_	_
36	bipotent	_	O	O	_	_	_	_	_
37	human	_	O	O	_	_	_	_	_
38	myeloid	_	O	O	_	_	_	_	_
39	progenitor	_	O	O	_	_	_	_	_
40	cells	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Induction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	NF	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	kappa	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	during	_	O	O	_	_	_	_	_
8	monocyte	_	O	O	_	_	_	_	_
9	differentiation	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	associated	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	HIV	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	expression	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Cells	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	monocyte	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	macrophage	_	O	O	_	_	_	_	_
7	lineage	_	O	O	_	_	_	_	_
8	are	_	O	O	_	_	_	_	_
9	important	_	O	O	_	_	_	_	_
10	targets	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	HIV	_	O	O	_	_	_	_	_
13	infection	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	Also	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	promonocyte	_	O	O	_	_	_	_	_
6	cell	_	O	O	_	_	_	_	_
7	line	_	O	O	_	_	_	_	_
8	chronically	_	O	O	_	_	_	_	_
9	infected	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	HIV	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	HIV	_	O	O	_	_	_	_	_
20	transcription	_	O	O	_	_	_	_	_
21	were	_	O	O	_	_	_	_	_
22	enhanced	_	O	O	_	_	_	_	_
23	on	_	O	O	_	_	_	_	_
24	stimulation	_	O	O	_	_	_	_	_
25	with	_	O	O	_	_	_	_	_
26	phorbol	_	O	O	_	_	_	_	_
27	ester	_	O	O	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	On	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	basis	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	these	_	O	O	_	_	_	_	_
6	assays	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	all	_	O	O	_	_	_	_	_
9	N	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	Oct	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	factors	_	O	O	_	_	_	_	_
14	were	_	O	O	_	_	_	_	_
15	found	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	be	_	O	O	_	_	_	_	_
18	distinct	_	O	O	_	_	_	_	_
19	from	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	ubiquitous	_	O	O	_	_	_	_	_
22	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	lymphoid	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	specific	_	O	O	_	_	_	_	_
30	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	proteins	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	therefore	_	O	O	_	_	_	_	_
3	speculate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	N	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	Oct	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	other	_	O	O	_	_	_	_	_
12	N	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	Oct	_	O	O	_	_	_	_	_
15	factors	_	O	O	_	_	_	_	_
16	have	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	specific	_	O	O	_	_	_	_	_
19	role	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	gene	_	O	O	_	_	_	_	_
22	expression	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	nervous	_	O	O	_	_	_	_	_
28	system	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	order	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	investigate	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	nature	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	A	_	O	O	_	_	_	_	_
10	6	_	O	O	_	_	_	_	_
11	H	_	O	O	_	_	_	_	_
12	mAb	_	O	O	_	_	_	_	_
13	costimulus	_	O	O	_	_	_	_	_
14	at	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	transcriptional	_	O	O	_	_	_	_	_
17	level	_	O	O	_	_	_	_	_
18	we	_	O	O	_	_	_	_	_
19	have	_	O	O	_	_	_	_	_
20	examined	_	O	O	_	_	_	_	_
21	induction	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	transcription	_	O	O	_	_	_	_	_
25	factors	_	O	O	_	_	_	_	_
26	OCT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	AP	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	NF	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	kappa	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	which	_	O	O	_	_	_	_	_
39	are	_	O	O	_	_	_	_	_
40	known	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	be	_	O	O	_	_	_	_	_
43	transcriptional	_	O	O	_	_	_	_	_
44	regulators	_	O	O	_	_	_	_	_
45	of	_	O	O	_	_	_	_	_
46	several	_	O	O	_	_	_	_	_
47	cytokine	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	cytokine	_	O	O	_	_	_	_	_
50	receptor	_	O	O	_	_	_	_	_
51	genes	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	including	_	O	O	_	_	_	_	_
54	the	_	O	O	_	_	_	_	_
55	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
56	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	and	_	O	O	_	_	_	_	_
59	IL	_	O	O	_	_	_	_	_
60	-	_	O	O	_	_	_	_	_
61	2	_	O	O	_	_	_	_	_
62	R	_	O	O	_	_	_	_	_
63	genes	_	O	O	_	_	_	_	_
64	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	NF	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	kappaB	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	thought	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	be	_	O	O	_	_	_	_	_
10	required	_	O	O	_	_	_	_	_
11	for	_	O	O	_	_	_	_	_
12	cytokine	_	O	O	_	_	_	_	_
13	release	_	O	O	_	_	_	_	_
14	from	_	O	O	_	_	_	_	_
15	LPS	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	responsive	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	critical	_	O	O	_	_	_	_	_
22	step	_	O	O	_	_	_	_	_
23	for	_	O	O	_	_	_	_	_
24	endotoxic	_	O	O	_	_	_	_	_
25	effects	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	transient	_	O	O	_	_	_	_	_
3	cotransfection	_	O	O	_	_	_	_	_
4	experiments	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	dominant	_	O	O	_	_	_	_	_
7	negative	_	O	O	_	_	_	_	_
8	mutants	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	IL	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	signaling	_	O	O	_	_	_	_	_
15	pathway	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	including	_	O	O	_	_	_	_	_
18	MyD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	88	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	IRAK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	IRAK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	TRAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	inhibited	_	O	O	_	_	_	_	_
30	both	_	O	O	_	_	_	_	_
31	IL	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	LPS	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	induced	_	O	O	_	_	_	_	_
39	NF	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	kappaB	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	luciferase	_	O	O	_	_	_	_	_
44	activity	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	LTR	_	O	O	_	_	_	_	_
6	sequence	_	O	O	_	_	_	_	_
7	changes	_	O	O	_	_	_	_	_
8	can	_	O	O	_	_	_	_	_
9	significantly	_	O	O	_	_	_	_	_
10	affect	_	O	O	_	_	_	_	_
11	basal	_	O	O	_	_	_	_	_
12	LTR	_	O	O	_	_	_	_	_
13	function	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	transcription	_	O	O	_	_	_	_	_
16	factor	_	O	O	_	_	_	_	_
17	recruitment	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	which	_	O	O	_	_	_	_	_
20	may	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	turn	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	alter	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	course	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	viral	_	O	O	_	_	_	_	_
30	replication	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	CNS	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	immune	_	O	O	_	_	_	_	_
37	system	_	O	O	_	_	_	_	_
38	origin	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	+	_	O	O	_	_	_	_	_
4	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	+	_	O	O	_	_	_	_	_
7	nTreg	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	were	_	O	O	_	_	_	_	_
10	preactivated	_	O	O	_	_	_	_	_
11	during	_	O	O	_	_	_	_	_
12	2	_	O	O	_	_	_	_	_
13	d	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	presence	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	absence	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	an	_	O	O	_	_	_	_	_
21	increasing	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	concentration	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	representative	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	three	_	O	O	_	_	_	_	_
7	independent	_	O	O	_	_	_	_	_
8	experiments	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_

1	Overproduction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	NFKB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	lyt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	Rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	:	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	mechanism	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	HTLV	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	I	_	O	O	_	_	_	_	_
21	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	mediated	_	O	O	_	_	_	_	_
24	trans	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	via	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	NF	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	kappa	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	signalling	_	O	O	_	_	_	_	_
34	pathway	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	NFKB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	precursor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	physically	_	O	O	_	_	_	_	_
9	associated	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	Rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	HTLV	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	I	_	O	O	_	_	_	_	_
21	infected	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_



1	The	_	O	O	_	_	_	_	_
2	activity	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	promoter	_	O	O	_	_	_	_	_
6	regulating	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	synthesis	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	precursor	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	subunit	_	O	O	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	enhanced	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	these	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	observations	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	during	_	O	O	_	_	_	_	_
6	chronic	_	O	O	_	_	_	_	_
7	HIV	_	O	O	_	_	_	_	_
8	infection	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	U	_	O	O	_	_	_	_	_
11	937	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	continuous	_	O	O	_	_	_	_	_
15	NF	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	kappa	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	translocation	_	O	O	_	_	_	_	_
27	results	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	promoter	_	O	O	_	_	_	_	_
32	upregulation	_	O	O	_	_	_	_	_
33	with	_	O	O	_	_	_	_	_
34	subsequent	_	O	O	_	_	_	_	_
35	cytosolic	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	kappa	_	O	O	_	_	_	_	_
39	B	_	O	O	_	_	_	_	_
40	accumulation	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	ready	_	O	O	_	_	_	_	_
43	for	_	O	O	_	_	_	_	_
44	further	_	O	O	_	_	_	_	_
45	translocation	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	Accordingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	immunoblot	_	O	O	_	_	_	_	_
4	experiments	_	O	O	_	_	_	_	_
5	showed	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	amongst	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	kappa	_	O	O	_	_	_	_	_
11	B	_	O	O	_	_	_	_	_
12	/	_	O	O	_	_	_	_	_
13	Rel	_	O	O	_	_	_	_	_
14	proteins	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	RelA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	are	_	O	O	_	_	_	_	_
21	mobilized	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	nucleus	_	O	O	_	_	_	_	_
25	following	_	O	O	_	_	_	_	_
26	microglial	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	stimulation	_	O	O	_	_	_	_	_
29	with	_	O	O	_	_	_	_	_
30	A	_	O	O	_	_	_	_	_
31	beta	_	O	O	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	25	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	35	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	plus	_	O	O	_	_	_	_	_
38	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Rowe	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	C	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_
5	Gregory	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	F	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_
9	Wang	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	E	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_
13	Kieff	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	A	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_
18	Rickinson	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	Cell	_	O	O	_	_	_	_	_
21	65	_	O	O	_	_	_	_	_
22	:	_	O	O	_	_	_	_	_
23	1107	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1115	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	1991	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Additionally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	inhibits	_	O	O	_	_	_	_	_
7	thymocyte	_	O	O	_	_	_	_	_
8	proliferation	_	O	O	_	_	_	_	_
9	[	_	O	O	_	_	_	_	_
10	6	_	O	O	_	_	_	_	_
11	]	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	major	_	O	O	_	_	_	_	_
3	signalling	_	O	O	_	_	_	_	_
4	pathway	_	O	O	_	_	_	_	_
5	known	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	date	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	R	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	Smads	_	O	O	_	_	_	_	_
15	[	_	O	O	_	_	_	_	_
16	13	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	27	_	O	O	_	_	_	_	_
19	]	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	Id	_	O	O	_	_	_	_	_
4	proteins	_	O	O	_	_	_	_	_
5	are	_	O	O	_	_	_	_	_
6	known	_	O	O	_	_	_	_	_
7	as	_	O	O	_	_	_	_	_
8	important	_	O	O	_	_	_	_	_
9	parts	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	signalling	_	O	O	_	_	_	_	_
12	pathways	_	O	O	_	_	_	_	_
13	involved	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	development	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	cycle	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	tumorigenesis	_	O	O	_	_	_	_	_
21	[	_	O	O	_	_	_	_	_
22	32	_	O	O	_	_	_	_	_
23	]	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	High	_	O	O	_	_	_	_	_
2	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	mRNA	_	O	O	_	_	_	_	_
6	expression	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	DLBCL	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	shown	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	correlate	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	unfavourable	_	O	O	_	_	_	_	_
16	outcome	_	O	O	_	_	_	_	_
17	[	_	O	O	_	_	_	_	_
18	12	_	O	O	_	_	_	_	_
19	]	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Oleic	_	O	O	_	_	_	_	_
2	acid	_	O	O	_	_	_	_	_
3	inhibits	_	O	O	_	_	_	_	_
4	endothelial	_	O	O	_	_	_	_	_
5	activation	_	O	O	_	_	_	_	_
6	:	_	O	O	_	_	_	_	_
7	A	_	O	O	_	_	_	_	_
8	direct	_	O	O	_	_	_	_	_
9	vascular	_	O	O	_	_	_	_	_
10	antiatherogenic	_	O	O	_	_	_	_	_
11	mechanism	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	nutritional	_	O	O	_	_	_	_	_
15	component	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	mediterranean	_	O	O	_	_	_	_	_
19	diet	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	oleic	_	O	O	_	_	_	_	_
3	acid	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	implicated	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	antiatherogenic	_	O	O	_	_	_	_	_
9	effects	_	O	O	_	_	_	_	_
10	attributed	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	Mediterranean	_	O	O	_	_	_	_	_
14	diet	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	we	_	O	O	_	_	_	_	_
17	investigated	_	O	O	_	_	_	_	_
18	whether	_	O	O	_	_	_	_	_
19	this	_	O	O	_	_	_	_	_
20	fatty	_	O	O	_	_	_	_	_
21	acid	_	O	O	_	_	_	_	_
22	can	_	O	O	_	_	_	_	_
23	modulate	_	O	O	_	_	_	_	_
24	endothelial	_	O	O	_	_	_	_	_
25	activation	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	ie	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	concerted	_	O	O	_	_	_	_	_
31	expression	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	gene	_	O	O	_	_	_	_	_
34	products	_	O	O	_	_	_	_	_
35	involved	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	leukocyte	_	O	O	_	_	_	_	_
38	recruitment	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	early	_	O	O	_	_	_	_	_
41	atherogenesis	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Interfering	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	either	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappaB	_	O	O	_	_	_	_	_
7	activation	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	proteasome	_	O	O	_	_	_	_	_
10	inhibitor	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	or	_	O	O	_	_	_	_	_
13	translocation	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	double	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	stranded	_	O	O	_	_	_	_	_
18	oligonucleotides	_	O	O	_	_	_	_	_
19	containing	_	O	O	_	_	_	_	_
20	NF	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kappaB	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	sequence	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	prevents	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	development	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	A	_	O	O	_	_	_	_	_
31	/	_	O	O	_	_	_	_	_
32	R	_	O	O	_	_	_	_	_
33	tolerance	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	ie	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	increase	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	A	_	O	O	_	_	_	_	_
41	/	_	O	O	_	_	_	_	_
42	R	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	induced	_	O	O	_	_	_	_	_
45	PMN	_	O	O	_	_	_	_	_
46	adhesion	_	O	O	_	_	_	_	_
47	to	_	O	O	_	_	_	_	_
48	HUVECs	_	O	O	_	_	_	_	_
49	is	_	O	O	_	_	_	_	_
50	the	_	O	O	_	_	_	_	_
51	same	_	O	O	_	_	_	_	_
52	after	_	O	O	_	_	_	_	_
53	the	_	O	O	_	_	_	_	_
54	first	_	O	O	_	_	_	_	_
55	and	_	O	O	_	_	_	_	_
56	second	_	O	O	_	_	_	_	_
57	A	_	O	O	_	_	_	_	_
58	/	_	O	O	_	_	_	_	_
59	R	_	O	O	_	_	_	_	_
60	challenges	_	O	O	_	_	_	_	_
61	)	_	O	O	_	_	_	_	_
62	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	NOS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	during	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	second	_	O	O	_	_	_	_	_
7	A	_	O	O	_	_	_	_	_
8	/	_	O	O	_	_	_	_	_
9	R	_	O	O	_	_	_	_	_
10	insult	_	O	O	_	_	_	_	_
11	results	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	generation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	an	_	O	O	_	_	_	_	_
17	oxidant	_	O	O	_	_	_	_	_
18	stress	_	O	O	_	_	_	_	_
19	similar	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	observed	_	O	O	_	_	_	_	_
23	after	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	first	_	O	O	_	_	_	_	_
26	A	_	O	O	_	_	_	_	_
27	/	_	O	O	_	_	_	_	_
28	R	_	O	O	_	_	_	_	_
29	challenge	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	increased	_	O	O	_	_	_	_	_
3	NO	_	O	O	_	_	_	_	_
4	production	_	O	O	_	_	_	_	_
5	during	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	second	_	O	O	_	_	_	_	_
8	A	_	O	O	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	R	_	O	O	_	_	_	_	_
11	insult	_	O	O	_	_	_	_	_
12	reduces	_	O	O	_	_	_	_	_
13	PMN	_	O	O	_	_	_	_	_
14	adhesion	_	O	O	_	_	_	_	_
15	most	_	O	O	_	_	_	_	_
16	likely	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	reducing	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	intracellular	_	O	O	_	_	_	_	_
21	oxidant	_	O	O	_	_	_	_	_
22	stress	_	O	O	_	_	_	_	_
23	induced	_	O	O	_	_	_	_	_
24	by	_	O	O	_	_	_	_	_
25	A	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	R	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	gene	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	two	_	O	O	_	_	_	_	_
5	transcripts	_	O	O	_	_	_	_	_
6	:	_	O	O	_	_	_	_	_
7	isolation	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	an	_	O	O	_	_	_	_	_
10	alternative	_	O	O	_	_	_	_	_
11	transcript	_	O	O	_	_	_	_	_
12	encoding	_	O	O	_	_	_	_	_
13	for	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	autoantigen	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	La	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	SS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	from	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	cDNA	_	O	O	_	_	_	_	_
24	library	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	patient	_	O	O	_	_	_	_	_
28	with	_	O	O	_	_	_	_	_
29	primary	_	O	O	_	_	_	_	_
30	Sjogrens	_	O	O	_	_	_	_	_
31	'	_	O	O	_	_	_	_	_
32	syndrome	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	T	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	transcriptional	_	O	O	_	_	_	_	_
6	activity	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	this	_	O	O	_	_	_	_	_
9	core	_	O	O	_	_	_	_	_
10	promoter	_	O	O	_	_	_	_	_
11	was	_	O	O	_	_	_	_	_
12	not	_	O	O	_	_	_	_	_
13	inducible	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	mitogenic	_	O	O	_	_	_	_	_
16	stimulation	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	treatment	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	but	_	O	O	_	_	_	_	_
22	was	_	O	O	_	_	_	_	_
23	dependent	_	O	O	_	_	_	_	_
24	on	_	O	O	_	_	_	_	_
25	a	_	O	O	_	_	_	_	_
26	GC	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	box	_	O	O	_	_	_	_	_
29	which	_	O	O	_	_	_	_	_
30	was	_	O	O	_	_	_	_	_
31	recognized	_	O	O	_	_	_	_	_
32	by	_	O	O	_	_	_	_	_
33	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	specificity	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	transcription	_	O	O	_	_	_	_	_
43	factors	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	N	_	O	O	_	_	_	_	_
3	element	_	O	O	_	_	_	_	_
4	could	_	O	O	_	_	_	_	_
5	independently	_	O	O	_	_	_	_	_
6	mediate	_	O	O	_	_	_	_	_
7	low	_	O	O	_	_	_	_	_
8	levels	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	HeLa	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	extracts	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	conjunction	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	octamer	_	O	O	_	_	_	_	_
29	element	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	it	_	O	O	_	_	_	_	_
32	can	_	O	O	_	_	_	_	_
33	promote	_	O	O	_	_	_	_	_
34	high	_	O	O	_	_	_	_	_
35	levels	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	transcription	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	B	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	cell	_	O	O	_	_	_	_	_
42	extracts	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	appearance	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	CMAT	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	complex	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	inhibited	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	both	_	O	O	_	_	_	_	_
12	cyclosporin	_	O	O	_	_	_	_	_
13	A	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	rapamycin	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Role	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	up	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	regulation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	Fas	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	normal	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	aberrant	_	O	O	_	_	_	_	_
19	double	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	negative	_	O	O	_	_	_	_	_
22	lpr	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	gld	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Supershift	_	O	O	_	_	_	_	_
2	analysis	_	O	O	_	_	_	_	_
3	revealed	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	proteins	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	be	_	O	O	_	_	_	_	_
8	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	Krox	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	20	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	;	_	O	O	_	_	_	_	_
21	Egr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	was	_	O	O	_	_	_	_	_
25	not	_	O	O	_	_	_	_	_
26	detected	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	agreement	_	O	O	_	_	_	_	_
3	with	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	decrease	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	insulin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	mRNA	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	insulin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	content	_	O	O	_	_	_	_	_
14	was	_	O	O	_	_	_	_	_
15	observed	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	glycation	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	induced	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	Following	_	O	O	_	_	_	_	_
2	glucocorticoid	_	O	O	_	_	_	_	_
3	treatment	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	6	_	O	O	_	_	_	_	_
6	TG	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	chromatin	_	O	O	_	_	_	_	_
13	fragmentation	_	O	O	_	_	_	_	_
14	was	_	O	O	_	_	_	_	_
15	observed	_	O	O	_	_	_	_	_
16	after	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	delay	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	24	_	O	O	_	_	_	_	_
21	h	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Fragmentation	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	not	_	O	O	_	_	_	_	_
4	observed	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	ICR	_	O	O	_	_	_	_	_
7	27	_	O	O	_	_	_	_	_
8	TK	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_
10	3	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	containing	_	O	O	_	_	_	_	_
13	mutant	_	O	O	_	_	_	_	_
14	glucocorticoid	_	O	O	_	_	_	_	_
15	receptors	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	L	_	O	O	_	_	_	_	_
18	753	_	O	O	_	_	_	_	_
19	F	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	are	_	O	O	_	_	_	_	_
23	activation	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	deficient	_	O	O	_	_	_	_	_
26	but	_	O	O	_	_	_	_	_
27	retain	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	ability	_	O	O	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	repress	_	O	O	_	_	_	_	_
32	AP	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	activity	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	described	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	other	_	O	O	_	_	_	_	_
5	systems	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	fragmentation	_	O	O	_	_	_	_	_
8	required	_	O	O	_	_	_	_	_
9	ongoing	_	O	O	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	synthesis	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	has	_	O	O	_	_	_	_	_
3	been	_	O	O	_	_	_	_	_
4	suggested	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	ubiquitin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	proteasome	_	O	O	_	_	_	_	_
10	system	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	involved	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	process	_	O	O	_	_	_	_	_
16	;	_	O	O	_	_	_	_	_
17	however	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	specific	_	O	O	_	_	_	_	_
21	enzymes	_	O	O	_	_	_	_	_
22	involved	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	mechanism	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	limited	_	O	O	_	_	_	_	_
28	proteolysis	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	which	_	O	O	_	_	_	_	_
32	half	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	molecule	_	O	O	_	_	_	_	_
36	is	_	O	O	_	_	_	_	_
37	spared	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	have	_	O	O	_	_	_	_	_
40	been	_	O	O	_	_	_	_	_
41	obscure	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	novel	_	O	O	_	_	_	_	_
3	enzyme	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	distinct	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	AP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	53	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	conjugating	_	O	O	_	_	_	_	_
17	ligase	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	from	_	O	O	_	_	_	_	_
21	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	""""	_	O	O	_	_	_	_	_
27	N	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	end	_	O	O	_	_	_	_	_
30	rule	_	O	O	_	_	_	_	_
31	""""	_	O	O	_	_	_	_	_
32	ligase	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	DNA	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	activities	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	Jun	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	Fos	_	O	O	_	_	_	_	_
12	heterodimers	_	O	O	_	_	_	_	_
13	were	_	O	O	_	_	_	_	_
14	observed	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	electrophoretic	_	O	O	_	_	_	_	_
17	mobility	_	O	O	_	_	_	_	_
18	shift	_	O	O	_	_	_	_	_
19	assays	_	O	O	_	_	_	_	_
20	during	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	course	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	natural	_	O	O	_	_	_	_	_
25	cytotoxicity	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Interaction	_	O	O	_	_	_	_	_
2	between	_	O	O	_	_	_	_	_
3	immunoglobulin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	like	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	transcript	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	leukocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	Ig	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	like	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	on	_	O	O	_	_	_	_	_
17	NKL	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	HLA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	on	_	O	O	_	_	_	_	_
25	target	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	leads	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	an	_	O	O	_	_	_	_	_
30	impairment	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	NKL	_	O	O	_	_	_	_	_
33	natural	_	O	O	_	_	_	_	_
34	cytotoxicity	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	which	_	O	O	_	_	_	_	_
37	correlates	_	O	O	_	_	_	_	_
38	with	_	O	O	_	_	_	_	_
39	an	_	O	O	_	_	_	_	_
40	absence	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	JunB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	FosB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	and	_	O	O	_	_	_	_	_
47	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	transcription	_	O	O	_	_	_	_	_
51	,	_	O	O	_	_	_	_	_
52	as	_	O	O	_	_	_	_	_
53	well	_	O	O	_	_	_	_	_
54	as	_	O	O	_	_	_	_	_
55	an	_	O	O	_	_	_	_	_
56	absence	_	O	O	_	_	_	_	_
57	of	_	O	O	_	_	_	_	_
58	their	_	O	O	_	_	_	_	_
59	DNA	_	O	O	_	_	_	_	_
60	-	_	O	O	_	_	_	_	_
61	binding	_	O	O	_	_	_	_	_
62	activity	_	O	O	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_

1	Biol	_	O	O	_	_	_	_	_
2	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	30	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	member	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	tumor	_	O	O	_	_	_	_	_
9	necrosis	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	TNF	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	receptor	_	O	O	_	_	_	_	_
15	family	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	expressed	_	O	O	_	_	_	_	_
19	constitutively	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	surface	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	human	_	O	O	_	_	_	_	_
26	T	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	line	_	O	O	_	_	_	_	_
29	ACH	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	2	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	which	_	O	O	_	_	_	_	_
34	is	_	O	O	_	_	_	_	_
35	chronically	_	O	O	_	_	_	_	_
36	infected	_	O	O	_	_	_	_	_
37	with	_	O	O	_	_	_	_	_
38	human	_	O	O	_	_	_	_	_
39	immunodeficiency	_	O	O	_	_	_	_	_
40	virus	_	O	O	_	_	_	_	_
41	type	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	1	_	O	O	_	_	_	_	_
44	(	_	O	O	_	_	_	_	_
45	HIV	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	1	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	Evaluation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	role	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	ligand	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	thermal	_	O	O	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	specific	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	vitro	_	O	O	_	_	_	_	_
17	synthesized	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	glucocorticoid	_	O	O	_	_	_	_	_
20	receptor	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	cell	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	free	_	O	O	_	_	_	_	_
7	synthesized	_	O	O	_	_	_	_	_
8	hGR	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	capable	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	specific	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	glucocorticoid	_	O	O	_	_	_	_	_
16	response	_	O	O	_	_	_	_	_
17	element	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	GRE	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	containing	_	O	O	_	_	_	_	_
23	DNA	_	O	O	_	_	_	_	_
24	fragments	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	addition	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	either	_	O	O	_	_	_	_	_
7	ligand	_	O	O	_	_	_	_	_
8	or	_	O	O	_	_	_	_	_
9	antagonist	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	combination	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	heat	_	O	O	_	_	_	_	_
15	activation	_	O	O	_	_	_	_	_
16	step	_	O	O	_	_	_	_	_
17	promoted	_	O	O	_	_	_	_	_
18	DNA	_	O	O	_	_	_	_	_
19	binding	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	approximately	_	O	O	_	_	_	_	_
22	3	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	fold	_	O	O	_	_	_	_	_
25	over	_	O	O	_	_	_	_	_
26	that	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	heat	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	activated	_	O	O	_	_	_	_	_
31	unliganded	_	O	O	_	_	_	_	_
32	receptors	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Similarities	_	O	O	_	_	_	_	_
2	between	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	effects	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	dexamethasone	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	RU	_	O	O	_	_	_	_	_
9	486	_	O	O	_	_	_	_	_
10	suggest	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	antiglucocorticoid	_	O	O	_	_	_	_	_
14	properties	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	RU	_	O	O	_	_	_	_	_
17	486	_	O	O	_	_	_	_	_
18	do	_	O	O	_	_	_	_	_
19	not	_	O	O	_	_	_	_	_
20	occur	_	O	O	_	_	_	_	_
21	at	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	level	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	specific	_	O	O	_	_	_	_	_
26	DNA	_	O	O	_	_	_	_	_
27	binding	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	rate	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	LTR	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	directed	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	increased	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	response	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	treatment	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	either	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	phorbol	_	O	O	_	_	_	_	_
18	ester	_	O	O	_	_	_	_	_
19	or	_	O	O	_	_	_	_	_
20	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	if	_	O	O	_	_	_	_	_
25	either	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	or	_	O	O	_	_	_	_	_
31	NF	_	O	O	_	_	_	_	_
32	kappa	_	O	O	_	_	_	_	_
33	B	_	O	O	_	_	_	_	_
34	binding	_	O	O	_	_	_	_	_
35	sites	_	O	O	_	_	_	_	_
36	were	_	O	O	_	_	_	_	_
37	deleted	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	but	_	O	O	_	_	_	_	_
40	failed	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	respond	_	O	O	_	_	_	_	_
43	to	_	O	O	_	_	_	_	_
44	these	_	O	O	_	_	_	_	_
45	mitogenic	_	O	O	_	_	_	_	_
46	stimuli	_	O	O	_	_	_	_	_
47	if	_	O	O	_	_	_	_	_
48	both	_	O	O	_	_	_	_	_
49	sequences	_	O	O	_	_	_	_	_
50	were	_	O	O	_	_	_	_	_
51	absent	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_



1	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	ligation	_	O	O	_	_	_	_	_
6	alone	_	O	O	_	_	_	_	_
7	had	_	O	O	_	_	_	_	_
8	no	_	O	O	_	_	_	_	_
9	effect	_	O	O	_	_	_	_	_
10	on	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	factor	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	dose	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	OKT	_	O	O	_	_	_	_	_
7	3	_	O	O	_	_	_	_	_
8	required	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	achieve	_	O	O	_	_	_	_	_
11	half	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	maximal	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	same	_	O	O	_	_	_	_	_
18	using	_	O	O	_	_	_	_	_
19	PMA	_	O	O	_	_	_	_	_
20	or	_	O	O	_	_	_	_	_
21	different	_	O	O	_	_	_	_	_
22	concentrations	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	ligands	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	appropriates	_	O	O	_	_	_	_	_
8	TRADD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	enable	_	O	O	_	_	_	_	_
11	efficient	_	O	O	_	_	_	_	_
12	long	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	term	_	O	O	_	_	_	_	_
15	lymphoblastoid	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	outgrowth	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	report	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	identification	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	importance	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	same	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	non	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	cytokine	_	O	O	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	TCRG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	enhancer	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	elevated	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	HIV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	infected	_	O	O	_	_	_	_	_
12	individuals	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	has	_	O	O	_	_	_	_	_
15	been	_	O	O	_	_	_	_	_
16	implicated	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	disease	_	O	O	_	_	_	_	_
19	progression	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	addition	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	down	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	regulating	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	cellular	_	O	O	_	_	_	_	_
17	immune	_	O	O	_	_	_	_	_
18	response	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	HIV	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	1	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	may	_	O	O	_	_	_	_	_
25	also	_	O	O	_	_	_	_	_
26	play	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	role	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	mediated	_	O	O	_	_	_	_	_
35	activation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	HIV	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	replication	_	O	O	_	_	_	_	_
41	in	_	O	O	_	_	_	_	_
42	the	_	O	O	_	_	_	_	_
43	monocyte	_	O	O	_	_	_	_	_
44	/	_	O	O	_	_	_	_	_
45	macrophage	_	O	O	_	_	_	_	_
46	lineage	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_


1	Lipopolysaccharide	_	O	O	_	_	_	_	_
2	induction	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	promoter	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	monocytic	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	maximal	_	O	O	_	_	_	_	_
6	LPS	_	O	O	_	_	_	_	_
7	induction	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	promoter	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	mediated	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	concerted	_	O	O	_	_	_	_	_
18	participation	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	at	_	O	O	_	_	_	_	_
21	least	_	O	O	_	_	_	_	_
22	two	_	O	O	_	_	_	_	_
23	separate	_	O	O	_	_	_	_	_
24	cis	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	acting	_	O	O	_	_	_	_	_
27	regulatory	_	O	O	_	_	_	_	_
28	elements	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	cAMP	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	dependent	_	O	O	_	_	_	_	_
4	regulation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	proenkephalin	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	JunD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	JunB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	:	_	O	O	_	_	_	_	_
12	positive	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	negative	_	O	O	_	_	_	_	_
15	effects	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	AP	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	1	_	O	O	_	_	_	_	_
20	proteins	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	used	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	NK	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	line	_	O	O	_	_	_	_	_
11	NK	_	O	O	_	_	_	_	_
12	92	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	define	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	molecular	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	cellular	_	O	O	_	_	_	_	_
19	basis	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	NK	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	mediated	_	O	O	_	_	_	_	_
25	EC	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Forty	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	eight	_	O	O	_	_	_	_	_
4	hours	_	O	O	_	_	_	_	_
5	after	_	O	O	_	_	_	_	_
6	transfection	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	EC	_	O	O	_	_	_	_	_
9	were	_	O	O	_	_	_	_	_
10	stimulated	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	NK	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	or	_	O	O	_	_	_	_	_
15	NK	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	membrane	_	O	O	_	_	_	_	_
18	extracts	_	O	O	_	_	_	_	_
19	for	_	O	O	_	_	_	_	_
20	7	_	O	O	_	_	_	_	_
21	hr	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	activation	_	O	O	_	_	_	_	_
24	was	_	O	O	_	_	_	_	_
25	measured	_	O	O	_	_	_	_	_
26	by	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	luciferase	_	O	O	_	_	_	_	_
29	assay	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Anetholdithiolthione	_	O	O	_	_	_	_	_
2	(	_	O	O	_	_	_	_	_
3	ADT	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	5	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	[	_	O	O	_	_	_	_	_
8	p	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	methoxyphenyl	_	O	O	_	_	_	_	_
11	]	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	3	_	O	O	_	_	_	_	_
14	H	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	1	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	dithiol	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	3	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	thione	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	is	_	O	O	_	_	_	_	_
27	an	_	O	O	_	_	_	_	_
28	antioxidant	_	O	O	_	_	_	_	_
29	which	_	O	O	_	_	_	_	_
30	has	_	O	O	_	_	_	_	_
31	been	_	O	O	_	_	_	_	_
32	used	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	protect	_	O	O	_	_	_	_	_
35	against	_	O	O	_	_	_	_	_
36	acetaminophen	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	CCl	_	O	O	_	_	_	_	_
40	4	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	induced	_	O	O	_	_	_	_	_
43	hepatotoxicity	_	O	O	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	lipid	_	O	O	_	_	_	_	_
46	peroxidation	_	O	O	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	radiation	_	O	O	_	_	_	_	_
49	injury	_	O	O	_	_	_	_	_
50	,	_	O	O	_	_	_	_	_
51	and	_	O	O	_	_	_	_	_
52	also	_	O	O	_	_	_	_	_
53	has	_	O	O	_	_	_	_	_
54	been	_	O	O	_	_	_	_	_
55	used	_	O	O	_	_	_	_	_
56	clinically	_	O	O	_	_	_	_	_
57	as	_	O	O	_	_	_	_	_
58	an	_	O	O	_	_	_	_	_
59	anti	_	O	O	_	_	_	_	_
60	-	_	O	O	_	_	_	_	_
61	choleretic	_	O	O	_	_	_	_	_
62	agent	_	O	O	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_

1	Transcriptional	_	O	O	_	_	_	_	_
2	control	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	steroid	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	regulated	_	O	O	_	_	_	_	_
7	apoptosis	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	murine	_	O	O	_	_	_	_	_
10	thymoma	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	TAR	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	independent	_	O	O	_	_	_	_	_
4	transactivation	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	derived	_	O	O	_	_	_	_	_
10	from	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	CNS	_	O	O	_	_	_	_	_
13	:	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	novel	_	O	O	_	_	_	_	_
16	mechanism	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	HIV	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	gene	_	O	O	_	_	_	_	_
22	regulation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	end	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	did	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	detect	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	significant	_	O	O	_	_	_	_	_
11	difference	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	DNMT	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	DNMT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	DNMT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	DNMT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	MBP	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	MBD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	MBD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	MBD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	MeCP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	)	_	O	O	_	_	_	_	_
40	mRNA	_	O	O	_	_	_	_	_
41	expression	_	O	O	_	_	_	_	_
42	between	_	O	O	_	_	_	_	_
43	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	positive	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	negative	_	O	O	_	_	_	_	_
51	cells	_	O	O	_	_	_	_	_
52	(	_	O	O	_	_	_	_	_
53	Figure	_	O	O	_	_	_	_	_
54	5	_	O	O	_	_	_	_	_
55	D	_	O	O	_	_	_	_	_
56	)	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_

1	FACS	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	based	_	O	O	_	_	_	_	_
4	cytotoxicity	_	O	O	_	_	_	_	_
5	assay	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_


1	Besides	_	O	O	_	_	_	_	_
2	in	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	lymphocytes	_	O	O	_	_	_	_	_
6	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	activity	_	O	O	_	_	_	_	_
10	could	_	O	O	_	_	_	_	_
11	also	_	O	O	_	_	_	_	_
12	be	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	lymphocyte	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	depleted	_	O	O	_	_	_	_	_
20	spleen	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	purified	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	lymphocytes	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	requires	_	O	O	_	_	_	_	_
29	agents	_	O	O	_	_	_	_	_
30	that	_	O	O	_	_	_	_	_
31	both	_	O	O	_	_	_	_	_
32	release	_	O	O	_	_	_	_	_
33	intracellular	_	O	O	_	_	_	_	_
34	calcium	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	activate	_	O	O	_	_	_	_	_
37	protein	_	O	O	_	_	_	_	_
38	kinase	_	O	O	_	_	_	_	_
39	C	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	two	_	O	O	_	_	_	_	_
3	different	_	O	O	_	_	_	_	_
4	anti	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	onco	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	genic	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factors	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	53	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	are	_	O	O	_	_	_	_	_
20	required	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	distinct	_	O	O	_	_	_	_	_
23	apoptotic	_	O	O	_	_	_	_	_
24	pathways	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	T	_	O	O	_	_	_	_	_
27	lymphocytes	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	show	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	mitogen	_	O	O	_	_	_	_	_
6	induction	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	converting	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	enzyme	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	ICE	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	)	_	O	O	_	_	_	_	_
18	gene	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	mammalian	_	O	O	_	_	_	_	_
22	homologue	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	Caenorhabditis	_	O	O	_	_	_	_	_
26	elegans	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	death	_	O	O	_	_	_	_	_
29	gene	_	O	O	_	_	_	_	_
30	ced	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	is	_	O	O	_	_	_	_	_
35	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	dependent	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Ectopic	_	O	O	_	_	_	_	_
2	overexpression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	results	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	endogenous	_	O	O	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	ICE	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	enhances	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	sensitivity	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	radiation	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	induced	_	O	O	_	_	_	_	_
27	apoptosis	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	erythropoietin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	cooperate	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	promote	_	O	O	_	_	_	_	_
9	erythroid	_	O	O	_	_	_	_	_
10	cell	_	O	O	_	_	_	_	_
11	survival	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	regulating	_	O	O	_	_	_	_	_
14	bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	xL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	report	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	erythroid	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	strongly	_	O	O	_	_	_	_	_
13	induces	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	anti	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	apoptotic	_	O	O	_	_	_	_	_
21	protein	_	O	O	_	_	_	_	_
22	bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	xL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	but	_	O	O	_	_	_	_	_
27	not	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	related	_	O	O	_	_	_	_	_
30	proteins	_	O	O	_	_	_	_	_
31	bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	mcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	transformation	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	growth	_	O	O	_	_	_	_	_
6	properties	_	O	O	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	EBV	_	O	O	_	_	_	_	_
10	are	_	O	O	_	_	_	_	_
11	associated	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	upregulation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	[	_	O	O	_	_	_	_	_
19	35	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	38	_	O	O	_	_	_	_	_
22	]	_	O	O	_	_	_	_	_
23	;	_	O	O	_	_	_	_	_
24	hence	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	effects	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	upregulation	_	O	O	_	_	_	_	_
32	on	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	growth	_	O	O	_	_	_	_	_
35	properties	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	lymphoma	_	O	O	_	_	_	_	_
39	cells	_	O	O	_	_	_	_	_
40	were	_	O	O	_	_	_	_	_
41	further	_	O	O	_	_	_	_	_
42	examined	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	constitutive	_	O	O	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	pStat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	abundant	_	O	O	_	_	_	_	_
9	nuclear	_	O	O	_	_	_	_	_
10	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	suggests	_	O	O	_	_	_	_	_
13	that	_	O	O	_	_	_	_	_
14	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	signaling	_	O	O	_	_	_	_	_
17	contributes	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	mediated	_	O	O	_	_	_	_	_
23	lymphoma	_	O	O	_	_	_	_	_
24	development	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Cellular	_	O	O	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	molecular	_	O	O	_	_	_	_	_
4	mechanisms	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	synthesis	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	atopic	_	O	O	_	_	_	_	_
12	diseases	_	O	O	_	_	_	_	_
13	:	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	study	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	allergen	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	helper	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Peripheral	_	O	O	_	_	_	_	_
2	blood	_	O	O	_	_	_	_	_
3	mononuclear	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	from	_	O	O	_	_	_	_	_
6	atopic	_	O	O	_	_	_	_	_
7	asthma	_	O	O	_	_	_	_	_
8	patients	_	O	O	_	_	_	_	_
9	both	_	O	O	_	_	_	_	_
10	proliferated	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	produced	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	after	_	O	O	_	_	_	_	_
17	incubation	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	mite	_	O	O	_	_	_	_	_
20	allergen	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	suggesting	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	mite	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	specific	_	O	O	_	_	_	_	_
27	helper	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	were	_	O	O	_	_	_	_	_
31	involved	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	eosinophilic	_	O	O	_	_	_	_	_
35	inflammation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	atopic	_	O	O	_	_	_	_	_
38	asthma	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	same	_	O	O	_	_	_	_	_
3	gene	_	O	O	_	_	_	_	_
4	segment	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	transcribed	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	nonproducing	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	clones	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	suggesting	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	synthesis	_	O	O	_	_	_	_	_
27	is	_	O	O	_	_	_	_	_
28	regulated	_	O	O	_	_	_	_	_
29	at	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	transcriptional	_	O	O	_	_	_	_	_
32	level	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_


1	Second	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	tyrphostin	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	tyrosine	_	O	O	_	_	_	_	_
7	kinase	_	O	O	_	_	_	_	_
8	inhibitor	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	impaired	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	first	_	O	O	_	_	_	_	_
16	but	_	O	O	_	_	_	_	_
17	not	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	second	_	O	O	_	_	_	_	_
20	junB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	mRNA	_	O	O	_	_	_	_	_
22	peak	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Conversely	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	genistein	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	another	_	O	O	_	_	_	_	_
6	tyrosine	_	O	O	_	_	_	_	_
7	kinase	_	O	O	_	_	_	_	_
8	inhibitor	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	totally	_	O	O	_	_	_	_	_
11	abolished	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	second	_	O	O	_	_	_	_	_
17	peak	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	junB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	mRNA	_	O	O	_	_	_	_	_
21	whereas	_	O	O	_	_	_	_	_
22	it	_	O	O	_	_	_	_	_
23	did	_	O	O	_	_	_	_	_
24	not	_	O	O	_	_	_	_	_
25	affect	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	first	_	O	O	_	_	_	_	_
31	peak	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	Nonpituitary	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	prolactin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	gene	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	independent	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	Pit	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	differentially	_	O	O	_	_	_	_	_
14	controlled	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	endometrial	_	O	O	_	_	_	_	_
20	stroma	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	polymorphism	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	affects	_	O	O	_	_	_	_	_
5	OCT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	promoter	_	O	O	_	_	_	_	_
13	region	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	associated	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	severe	_	O	O	_	_	_	_	_
18	malaria	_	O	O	_	_	_	_	_
19	[	_	O	O	_	_	_	_	_
20	see	_	O	O	_	_	_	_	_
21	comments	_	O	O	_	_	_	_	_
22	]	_	O	O	_	_	_	_	_



1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Promotes	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	Lymphomas	_	O	O	_	_	_	_	_
9	That	_	O	O	_	_	_	_	_
10	Can	_	O	O	_	_	_	_	_
11	Escape	_	O	O	_	_	_	_	_
12	Allelic	_	O	O	_	_	_	_	_
13	Exclusion	_	O	O	_	_	_	_	_


1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	promotes	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	development	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	malignancy	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	can	_	O	O	_	_	_	_	_
22	result	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	aberrant	_	O	O	_	_	_	_	_
26	escape	_	O	O	_	_	_	_	_
27	from	_	O	O	_	_	_	_	_
28	allelic	_	O	O	_	_	_	_	_
29	exclusion	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	previously	_	O	O	_	_	_	_	_
4	demonstrated	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	stimulation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	monocytic	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	either	_	O	O	_	_	_	_	_
12	LPS	_	O	O	_	_	_	_	_
13	or	_	O	O	_	_	_	_	_
14	LAMPf	_	O	O	_	_	_	_	_
15	led	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	series	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	common	_	O	O	_	_	_	_	_
21	downstream	_	O	O	_	_	_	_	_
22	signaling	_	O	O	_	_	_	_	_
23	events	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	including	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	activation	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	protein	_	O	O	_	_	_	_	_
30	tyrosine	_	O	O	_	_	_	_	_
31	kinase	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	mitogen	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	activated	_	O	O	_	_	_	_	_
37	protein	_	O	O	_	_	_	_	_
38	kinase	_	O	O	_	_	_	_	_
39	cascades	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	previously	_	O	O	_	_	_	_	_
4	reported	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	presence	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	transcriptional	_	O	O	_	_	_	_	_
10	control	_	O	O	_	_	_	_	_
11	element	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	properties	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	silencer	_	O	O	_	_	_	_	_
18	extending	_	O	O	_	_	_	_	_
19	from	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	392	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	177	_	O	O	_	_	_	_	_
25	bp	_	O	O	_	_	_	_	_
26	relative	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	cap	_	O	O	_	_	_	_	_
30	site	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	human	_	O	O	_	_	_	_	_
34	epsilon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	encoding	_	O	O	_	_	_	_	_
39	gene	_	O	O	_	_	_	_	_
40	[	_	O	O	_	_	_	_	_
41	Cao	_	O	O	_	_	_	_	_
42	et	_	O	O	_	_	_	_	_
43	al	_	O	O	_	_	_	_	_
44	.,	_	O	O	_	_	_	_	_
45	Proc	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_
47	Natl	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_
49	Acad	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_
51	Sci	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_
53	USA	_	O	O	_	_	_	_	_
54	86	_	O	O	_	_	_	_	_
55	(	_	O	O	_	_	_	_	_
56	1989	_	O	O	_	_	_	_	_
57	)	_	O	O	_	_	_	_	_
58	5306	_	O	O	_	_	_	_	_
59	-	_	O	O	_	_	_	_	_
60	5309	_	O	O	_	_	_	_	_
61	]	_	O	O	_	_	_	_	_
62	.	_	O	O	_	_	_	_	_

1	Two	_	O	O	_	_	_	_	_
2	binding	_	O	O	_	_	_	_	_
3	proteins	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	detected	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	K	_	O	O	_	_	_	_	_
8	562	_	O	O	_	_	_	_	_
9	nuclear	_	O	O	_	_	_	_	_
10	extracts	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	while	_	O	O	_	_	_	_	_
13	only	_	O	O	_	_	_	_	_
14	one	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	found	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	extracts	_	O	O	_	_	_	_	_
19	from	_	O	O	_	_	_	_	_
20	HeLa	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	Both	_	O	O	_	_	_	_	_
2	NK	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	subtypes	_	O	O	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	closely	_	O	O	_	_	_	_	_
11	associated	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	Epstein	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	Barr	_	O	O	_	_	_	_	_
16	virus	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	EBV	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	EBV	_	O	O	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	determined	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	23	_	O	O	_	_	_	_	_
12	cases	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	nasal	_	O	O	_	_	_	_	_
15	lymphoma	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	NL	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	situ	_	O	O	_	_	_	_	_
22	hybridisation	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	ISH	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	reverse	_	O	O	_	_	_	_	_
28	transcriptase	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	polymerase	_	O	O	_	_	_	_	_
31	chain	_	O	O	_	_	_	_	_
32	reaction	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	RT	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	PCR	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	immunohistochemistry	_	O	O	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	IH	_	O	O	_	_	_	_	_
42	)	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Of	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	23	_	O	O	_	_	_	_	_
4	cases	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	19	_	O	O	_	_	_	_	_
7	were	_	O	O	_	_	_	_	_
8	classified	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	NK	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	cell	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	4	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	tumours	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Cortivazol	_	O	O	_	_	_	_	_
2	significantly	_	O	O	_	_	_	_	_
3	induced	_	O	O	_	_	_	_	_
4	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	mRNA	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	normal	_	O	O	_	_	_	_	_
9	CEM	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	C	_	O	O	_	_	_	_	_
12	7	_	O	O	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	well	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	two	_	O	O	_	_	_	_	_
18	classes	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	dex	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	resistant	_	O	O	_	_	_	_	_
23	clones	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	although	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	dex	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	resistant	_	O	O	_	_	_	_	_
30	clones	_	O	O	_	_	_	_	_
31	needed	_	O	O	_	_	_	_	_
32	at	_	O	O	_	_	_	_	_
33	least	_	O	O	_	_	_	_	_
34	10	_	O	O	_	_	_	_	_
35	times	_	O	O	_	_	_	_	_
36	more	_	O	O	_	_	_	_	_
37	cortivazol	_	O	O	_	_	_	_	_
38	than	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	normal	_	O	O	_	_	_	_	_
41	cells	_	O	O	_	_	_	_	_
42	for	_	O	O	_	_	_	_	_
43	significant	_	O	O	_	_	_	_	_
44	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	mRNA	_	O	O	_	_	_	_	_
46	induction	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	lysis	_	O	O	_	_	_	_	_
5	pathway	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	dex	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	resistant	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	defective	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	that	_	O	O	_	_	_	_	_
16	dex	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	resistant	_	O	O	_	_	_	_	_
19	clones	_	O	O	_	_	_	_	_
20	needed	_	O	O	_	_	_	_	_
21	significantly	_	O	O	_	_	_	_	_
22	more	_	O	O	_	_	_	_	_
23	cortivazol	_	O	O	_	_	_	_	_
24	than	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	normal	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	for	_	O	O	_	_	_	_	_
29	lysis	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Flow	_	O	O	_	_	_	_	_
2	cytometry	_	O	O	_	_	_	_	_
3	.	_	O	O	_	_	_	_	_


1	NF	_	O	O	_	_	_	_	_
2	kappa	_	O	O	_	_	_	_	_
3	B	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	potent	_	O	O	_	_	_	_	_
7	mediator	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	specific	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	monocytes	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	has	_	O	O	_	_	_	_	_
17	been	_	O	O	_	_	_	_	_
18	shown	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	play	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	role	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	transcription	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	HIV	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	genome	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	promonocytic	_	O	O	_	_	_	_	_
33	leukemias	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	used	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	32	_	O	O	_	_	_	_	_
6	P	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	labeled	_	O	O	_	_	_	_	_
9	oligonucleotide	_	O	O	_	_	_	_	_
10	derived	_	O	O	_	_	_	_	_
11	from	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	immunodeficiency	_	O	O	_	_	_	_	_
14	virus	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	long	_	O	O	_	_	_	_	_
21	terminal	_	O	O	_	_	_	_	_
22	repeat	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	which	_	O	O	_	_	_	_	_
25	contains	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	tandem	_	O	O	_	_	_	_	_
28	repeat	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	NF	_	O	O	_	_	_	_	_
32	kappa	_	O	O	_	_	_	_	_
33	B	_	O	O	_	_	_	_	_
34	binding	_	O	O	_	_	_	_	_
35	sequence	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	as	_	O	O	_	_	_	_	_
38	a	_	O	O	_	_	_	_	_
39	probe	_	O	O	_	_	_	_	_
40	in	_	O	O	_	_	_	_	_
41	a	_	O	O	_	_	_	_	_
42	gel	_	O	O	_	_	_	_	_
43	retardation	_	O	O	_	_	_	_	_
44	assay	_	O	O	_	_	_	_	_
45	to	_	O	O	_	_	_	_	_
46	study	_	O	O	_	_	_	_	_
47	this	_	O	O	_	_	_	_	_
48	transcription	_	O	O	_	_	_	_	_
49	factor	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	constitutive	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factor	_	O	O	_	_	_	_	_
5	SP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	unaffected	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	addition	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	TPA	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	Protein	_	O	O	_	_	_	_	_
2	kinase	_	O	O	_	_	_	_	_
3	C	_	O	O	_	_	_	_	_
4	inhibitor	_	O	O	_	_	_	_	_
5	staurosporine	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	but	_	O	O	_	_	_	_	_
8	not	_	O	O	_	_	_	_	_
9	cyclic	_	O	O	_	_	_	_	_
10	nucleotide	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	kinase	_	O	O	_	_	_	_	_
15	inhibitor	_	O	O	_	_	_	_	_
16	HA	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1004	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	also	_	O	O	_	_	_	_	_
21	dramatically	_	O	O	_	_	_	_	_
22	reduced	_	O	O	_	_	_	_	_
23	constitutive	_	O	O	_	_	_	_	_
24	levels	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	nuclear	_	O	O	_	_	_	_	_
27	NF	_	O	O	_	_	_	_	_
28	kappa	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	used	_	O	O	_	_	_	_	_
3	our	_	O	O	_	_	_	_	_
4	monoclonal	_	O	O	_	_	_	_	_
5	model	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	germinal	_	O	O	_	_	_	_	_
8	center	_	O	O	_	_	_	_	_
9	maturation	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	CL	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	01	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	investigate	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	role	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	30	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	human	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	differentiation	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	like	_	O	O	_	_	_	_	_
4	PMA	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	TG	_	O	O	_	_	_	_	_
7	markedly	_	O	O	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	kappa	_	O	O	_	_	_	_	_
11	B	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	Jurkat	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	toto	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	results	_	O	O	_	_	_	_	_
6	suggest	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	TG	_	O	O	_	_	_	_	_
9	induces	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	through	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	PKC	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	independent	_	O	O	_	_	_	_	_
24	pathway	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	PD	_	O	O	_	_	_	_	_
2	184352	_	O	O	_	_	_	_	_
3	caused	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	similar	_	O	O	_	_	_	_	_
6	inhibition	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	Th	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	dose	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	dependent	_	O	O	_	_	_	_	_
21	fashion	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	Figure	_	O	O	_	_	_	_	_
24	5	_	O	O	_	_	_	_	_
25	D	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	FigureS	_	O	O	_	_	_	_	_
28	5	_	O	O	_	_	_	_	_
29	A	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_


1	Interestingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	CTLA	_	O	O	_	_	_	_	_
4	4	_	O	O	_	_	_	_	_
5	Ig	_	O	O	_	_	_	_	_
6	did	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	significantly	_	O	O	_	_	_	_	_
9	inhibit	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	either	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	activated	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	NFAT	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	or	_	O	O	_	_	_	_	_
23	AP	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	reporters	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	isolated	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	5	_	O	O	_	_	_	_	_
6	'	_	O	O	_	_	_	_	_
7	region	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	ecto	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	'	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	nucleotidase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	low	_	O	O	_	_	_	_	_
18	K	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	m	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	5	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	'	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	NT	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	gene	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	established	_	O	O	_	_	_	_	_
30	that	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	969	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	base	_	O	O	_	_	_	_	_
35	pair	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	bp	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	fragment	_	O	O	_	_	_	_	_
40	confers	_	O	O	_	_	_	_	_
41	cell	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	specific	_	O	O	_	_	_	_	_
44	expression	_	O	O	_	_	_	_	_
45	of	_	O	O	_	_	_	_	_
46	a	_	O	O	_	_	_	_	_
47	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	reporter	_	O	O	_	_	_	_	_
49	gene	_	O	O	_	_	_	_	_
50	that	_	O	O	_	_	_	_	_
51	correlates	_	O	O	_	_	_	_	_
52	with	_	O	O	_	_	_	_	_
53	the	_	O	O	_	_	_	_	_
54	expression	_	O	O	_	_	_	_	_
55	of	_	O	O	_	_	_	_	_
56	endogenous	_	O	O	_	_	_	_	_
57	ecto	_	BPROTEIN	BPROTEIN	_	_	_	_	_
58	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
59	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
60	'	_	IPROTEIN	IPROTEIN	_	_	_	_	_
61	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
62	NT	_	IPROTEIN	IPROTEIN	_	_	_	_	_
63	mRNA	_	O	O	_	_	_	_	_
64	and	_	O	O	_	_	_	_	_
65	enzymatic	_	O	O	_	_	_	_	_
66	activity	_	O	O	_	_	_	_	_
67	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	768	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	bp	_	O	O	_	_	_	_	_
5	upstream	_	O	O	_	_	_	_	_
6	negative	_	O	O	_	_	_	_	_
7	regulatory	_	O	O	_	_	_	_	_
8	region	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	identified	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	conferred	_	O	O	_	_	_	_	_
14	lymphocyte	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	specific	_	O	O	_	_	_	_	_
17	negative	_	O	O	_	_	_	_	_
18	regulation	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	heterologous	_	O	O	_	_	_	_	_
22	system	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	244	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	bp	_	O	O	_	_	_	_	_
28	deoxycytidine	_	O	O	_	_	_	_	_
29	kinase	_	O	O	_	_	_	_	_
30	core	_	O	O	_	_	_	_	_
31	promoter	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	find	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	iNO	_	O	O	_	_	_	_	_
5	produced	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	murine	_	O	O	_	_	_	_	_
8	macrophage	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	like	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	RAW	_	O	O	_	_	_	_	_
14	264	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_
16	7	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	can	_	O	O	_	_	_	_	_
19	inhibit	_	O	O	_	_	_	_	_
20	cytokine	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	induced	_	O	O	_	_	_	_	_
23	endothelial	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	activation	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	separated	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	mixed	_	O	O	_	_	_	_	_
31	endothelial	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	RAW	_	O	O	_	_	_	_	_
34	264	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_
36	7	_	O	O	_	_	_	_	_
37	coculture	_	O	O	_	_	_	_	_
38	system	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	mRNA	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	ATL	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	generally	_	O	O	_	_	_	_	_
14	higher	_	O	O	_	_	_	_	_
15	than	_	O	O	_	_	_	_	_
16	those	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	lymphoid	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	now	_	O	O	_	_	_	_	_
3	report	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	EC	_	O	O	_	_	_	_	_
6	costimulation	_	O	O	_	_	_	_	_
7	causes	_	O	O	_	_	_	_	_
8	increased	_	O	O	_	_	_	_	_
9	levels	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	mRNA	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	result	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	increased	_	O	O	_	_	_	_	_
20	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	PBL	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Levels	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	other	_	O	O	_	_	_	_	_
4	nuclear	_	O	O	_	_	_	_	_
5	factors	_	O	O	_	_	_	_	_
6	involved	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	regulation	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	not	_	O	O	_	_	_	_	_
14	altered	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	EC	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	although	_	O	O	_	_	_	_	_
19	NFAT	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	DNA	_	O	O	_	_	_	_	_
22	complexes	_	O	O	_	_	_	_	_
23	migrated	_	O	O	_	_	_	_	_
24	at	_	O	O	_	_	_	_	_
25	a	_	O	O	_	_	_	_	_
26	slightly	_	O	O	_	_	_	_	_
27	different	_	O	O	_	_	_	_	_
28	mobility	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	summary	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	our	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	suggest	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	changes	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	composition	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factor	_	O	O	_	_	_	_	_
15	AP	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	key	_	O	O	_	_	_	_	_
21	molecular	_	O	O	_	_	_	_	_
22	mechanism	_	O	O	_	_	_	_	_
23	for	_	O	O	_	_	_	_	_
24	increasing	_	O	O	_	_	_	_	_
25	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	transcription	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	may	_	O	O	_	_	_	_	_
31	underlie	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	phenomenon	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	costimulation	_	O	O	_	_	_	_	_
36	by	_	O	O	_	_	_	_	_
37	EC	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	differential	_	O	O	_	_	_	_	_
3	binding	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	specific	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	Rel	_	O	O	_	_	_	_	_
12	subunits	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	likely	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	mediate	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	disparate	_	O	O	_	_	_	_	_
19	functions	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	these	_	O	O	_	_	_	_	_
22	two	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappa	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	/	_	O	O	_	_	_	_	_
28	Rel	_	O	O	_	_	_	_	_
29	binding	_	O	O	_	_	_	_	_
30	sites	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_


1	BMPs	_	O	O	_	_	_	_	_
2	are	_	O	O	_	_	_	_	_
3	30	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	38	_	O	O	_	_	_	_	_
6	kDa	_	O	O	_	_	_	_	_
7	hetero	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	or	_	O	O	_	_	_	_	_
10	homodimeric	_	O	O	_	_	_	_	_
11	proteins	_	O	O	_	_	_	_	_
12	originally	_	O	O	_	_	_	_	_
13	identified	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	their	_	O	O	_	_	_	_	_
16	ability	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	induce	_	O	O	_	_	_	_	_
19	ectopic	_	O	O	_	_	_	_	_
20	cartilage	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	bone	_	O	O	_	_	_	_	_
23	formation	_	O	O	_	_	_	_	_
24	[	_	O	O	_	_	_	_	_
25	2	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	3	_	O	O	_	_	_	_	_
28	]	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	mutant	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	containing	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	serine	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	alanine	_	O	O	_	_	_	_	_
11	substitution	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	DNA	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	binding	_	O	O	_	_	_	_	_
17	domain	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	protein	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	bound	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	several	_	O	O	_	_	_	_	_
25	known	_	O	O	_	_	_	_	_
26	ZEBRA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	binding	_	O	O	_	_	_	_	_
29	sites	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	activated	_	O	O	_	_	_	_	_
32	transcription	_	O	O	_	_	_	_	_
33	from	_	O	O	_	_	_	_	_
34	reporters	_	O	O	_	_	_	_	_
35	bearing	_	O	O	_	_	_	_	_
36	known	_	O	O	_	_	_	_	_
37	ZEBRA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	responsive	_	O	O	_	_	_	_	_
40	promoters	_	O	O	_	_	_	_	_
41	but	_	O	O	_	_	_	_	_
42	did	_	O	O	_	_	_	_	_
43	not	_	O	O	_	_	_	_	_
44	disrupt	_	O	O	_	_	_	_	_
45	latency	_	O	O	_	_	_	_	_
46	in	_	O	O	_	_	_	_	_
47	EBV	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	infected	_	O	O	_	_	_	_	_
50	cell	_	O	O	_	_	_	_	_
51	lines	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	Single	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	stranded	_	O	O	_	_	_	_	_
4	RNA	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	digested	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	mixture	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	Rnase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	precipitated	_	O	O	_	_	_	_	_
19	using	_	O	O	_	_	_	_	_
20	isopropanol	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_


1	It	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	concluded	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	even	_	O	O	_	_	_	_	_
6	when	_	O	O	_	_	_	_	_
7	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	unable	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	activate	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappaB	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	it	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	still	_	O	O	_	_	_	_	_
20	capable	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	inducing	_	O	O	_	_	_	_	_
23	certain	_	O	O	_	_	_	_	_
24	characteristics	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	activated	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	strongly	_	O	O	_	_	_	_	_
31	suggesting	_	O	O	_	_	_	_	_
32	that	_	O	O	_	_	_	_	_
33	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	can	_	O	O	_	_	_	_	_
36	also	_	O	O	_	_	_	_	_
37	activate	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	independently	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	NF	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	kappaB	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	IE	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	gene	_	O	O	_	_	_	_	_
5	product	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	cytomegalovirus	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	HCMV	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	one	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	few	_	O	O	_	_	_	_	_
17	viral	_	O	O	_	_	_	_	_
18	regulatory	_	O	O	_	_	_	_	_
19	proteins	_	O	O	_	_	_	_	_
20	expressed	_	O	O	_	_	_	_	_
21	immediately	_	O	O	_	_	_	_	_
22	upon	_	O	O	_	_	_	_	_
23	infection	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	host	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	found	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	retinoblastoma	_	O	O	_	_	_	_	_
6	susceptibility	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	product	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	Rb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	dramatically	_	O	O	_	_	_	_	_
13	suppressed	_	O	O	_	_	_	_	_
14	this	_	O	O	_	_	_	_	_
15	IE	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	transactivation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	various	_	O	O	_	_	_	_	_
20	promoters	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	imply	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	need	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	maintain	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	certain	_	O	O	_	_	_	_	_
12	level	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappaB	_	O	O	_	_	_	_	_
17	transcriptional	_	O	O	_	_	_	_	_
18	activity	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	order	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	survive	_	O	O	_	_	_	_	_
23	;	_	O	O	_	_	_	_	_
24	up	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	down	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	regulation	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	nuclear	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	kappaB	_	O	O	_	_	_	_	_
34	through	_	O	O	_	_	_	_	_
35	modulation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	IkappaBalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	expression	_	O	O	_	_	_	_	_
39	by	_	O	O	_	_	_	_	_
40	cytokines	_	O	O	_	_	_	_	_
41	or	_	O	O	_	_	_	_	_
42	DEX	_	O	O	_	_	_	_	_
43	may	_	O	O	_	_	_	_	_
44	lead	_	O	O	_	_	_	_	_
45	to	_	O	O	_	_	_	_	_
46	cell	_	O	O	_	_	_	_	_
47	survival	_	O	O	_	_	_	_	_
48	or	_	O	O	_	_	_	_	_
49	cell	_	O	O	_	_	_	_	_
50	death	_	O	O	_	_	_	_	_
51	,	_	O	O	_	_	_	_	_
52	respectively	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	cells	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	washed	_	O	O	_	_	_	_	_
5	twice	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	fluorescent	_	O	O	_	_	_	_	_
8	intensity	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	analysed	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	flow	_	O	O	_	_	_	_	_
13	cytometry	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	All	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	shown	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	representative	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	at	_	O	O	_	_	_	_	_
8	two	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	four	_	O	O	_	_	_	_	_
11	independent	_	O	O	_	_	_	_	_
12	experiments	_	O	O	_	_	_	_	_
13	unless	_	O	O	_	_	_	_	_
14	otherwise	_	O	O	_	_	_	_	_
15	indicated	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Additionally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	region	_	O	O	_	_	_	_	_
5	between	_	O	O	_	_	_	_	_
6	bases	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	107	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	59	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	containing	_	O	O	_	_	_	_	_
18	putative	_	O	O	_	_	_	_	_
19	AP	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	2	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	motifs	_	O	O	_	_	_	_	_
27	appears	_	O	O	_	_	_	_	_
28	necessary	_	O	O	_	_	_	_	_
29	for	_	O	O	_	_	_	_	_
30	basal	_	O	O	_	_	_	_	_
31	level	_	O	O	_	_	_	_	_
32	expression	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	gene	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	+	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	4	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	8	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	wk	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	old	_	O	O	_	_	_	_	_
14	Tcra	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	/	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	x	_	O	O	_	_	_	_	_
19	P	_	O	O	_	_	_	_	_
20	14	_	O	O	_	_	_	_	_
21	TCR	_	O	O	_	_	_	_	_
22	transgenic	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	Taconic	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	C	_	O	O	_	_	_	_	_
28	57	_	O	O	_	_	_	_	_
29	BL	_	O	O	_	_	_	_	_
30	/	_	O	O	_	_	_	_	_
31	6	_	O	O	_	_	_	_	_
32	J	_	O	O	_	_	_	_	_
33	WT	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	or	_	O	O	_	_	_	_	_
36	Tbx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	21	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	/	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	The	_	O	O	_	_	_	_	_
43	Jackson	_	O	O	_	_	_	_	_
44	Laboratory	_	O	O	_	_	_	_	_
45	)	_	O	O	_	_	_	_	_
46	mice	_	O	O	_	_	_	_	_
47	were	_	O	O	_	_	_	_	_
48	purified	_	O	O	_	_	_	_	_
49	(	_	O	O	_	_	_	_	_
50	>	_	O	O	_	_	_	_	_
51	95	_	O	O	_	_	_	_	_
52	%	_	O	O	_	_	_	_	_
53	purity	_	O	O	_	_	_	_	_
54	)	_	O	O	_	_	_	_	_
55	by	_	O	O	_	_	_	_	_
56	negative	_	O	O	_	_	_	_	_
57	selection	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	Invitrogen	_	O	O	_	_	_	_	_
60	)	_	O	O	_	_	_	_	_
61	from	_	O	O	_	_	_	_	_
62	pooled	_	O	O	_	_	_	_	_
63	spleen	_	O	O	_	_	_	_	_
64	and	_	O	O	_	_	_	_	_
65	lymph	_	O	O	_	_	_	_	_
66	node	_	O	O	_	_	_	_	_
67	cells	_	O	O	_	_	_	_	_
68	.	_	O	O	_	_	_	_	_

1	Mutation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	Ser	_	O	O	_	_	_	_	_
4	184	_	O	O	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	diminished	_	O	O	_	_	_	_	_
7	transactivation	_	O	O	_	_	_	_	_
8	function	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	suggesting	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	activating	_	O	O	_	_	_	_	_
17	phosphorylation	_	O	O	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	is	_	O	O	_	_	_	_	_
20	inducible	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	is	_	O	O	_	_	_	_	_
25	constitutively	_	O	O	_	_	_	_	_
26	present	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	B	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	So	_	O	O	_	_	_	_	_
2	far	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	transcriptional	_	O	O	_	_	_	_	_
5	analyses	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	have	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	carried	_	O	O	_	_	_	_	_
12	out	_	O	O	_	_	_	_	_
13	only	_	O	O	_	_	_	_	_
14	using	_	O	O	_	_	_	_	_
15	bacterial	_	O	O	_	_	_	_	_
16	constituents	_	O	O	_	_	_	_	_
17	such	_	O	O	_	_	_	_	_
18	as	_	O	O	_	_	_	_	_
19	LPS	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	stimuli	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assay	_	O	O	_	_	_	_	_
5	revealed	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	potential	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	binding	_	O	O	_	_	_	_	_
13	sequence	_	O	O	_	_	_	_	_
14	which	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	located	_	O	O	_	_	_	_	_
17	around	_	O	O	_	_	_	_	_
18	120	_	O	O	_	_	_	_	_
19	bp	_	O	O	_	_	_	_	_
20	upstream	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	initiation	_	O	O	_	_	_	_	_
25	site	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	murine	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	human	_	O	O	_	_	_	_	_
30	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	genes	_	O	O	_	_	_	_	_
33	formed	_	O	O	_	_	_	_	_
34	an	_	O	O	_	_	_	_	_
35	NF	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	kappaB	_	O	O	_	_	_	_	_
38	complex	_	O	O	_	_	_	_	_
39	with	_	O	O	_	_	_	_	_
40	nuclear	_	O	O	_	_	_	_	_
41	extract	_	O	O	_	_	_	_	_
42	from	_	O	O	_	_	_	_	_
43	Daudi	_	O	O	_	_	_	_	_
44	cells	_	O	O	_	_	_	_	_
45	stimulated	_	O	O	_	_	_	_	_
46	by	_	O	O	_	_	_	_	_
47	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	ligation	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_


1	METHODS	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	A	_	O	O	_	_	_	_	_
4	panel	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	mAECA	_	O	O	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	generated	_	O	O	_	_	_	_	_
9	from	_	O	O	_	_	_	_	_
10	peripheral	_	O	O	_	_	_	_	_
11	blood	_	O	O	_	_	_	_	_
12	lymphocytes	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	patient	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	Takayasu	_	O	O	_	_	_	_	_
18	arteritis	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	using	_	O	O	_	_	_	_	_
21	Epstein	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	Barr	_	O	O	_	_	_	_	_
24	virus	_	O	O	_	_	_	_	_
25	transformation	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	Nef	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	affects	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	binding	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	cellular	_	O	O	_	_	_	_	_
10	factors	_	O	O	_	_	_	_	_
11	implicated	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	regulation	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	32	_	O	O	_	_	_	_	_
19	P	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	labeled	_	O	O	_	_	_	_	_
22	oligonucleotides	_	O	O	_	_	_	_	_
23	corresponding	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	binding	_	O	O	_	_	_	_	_
27	sites	_	O	O	_	_	_	_	_
28	were	_	O	O	_	_	_	_	_
29	incubated	_	O	O	_	_	_	_	_
30	with	_	O	O	_	_	_	_	_
31	nuclear	_	O	O	_	_	_	_	_
32	extracts	_	O	O	_	_	_	_	_
33	prepared	_	O	O	_	_	_	_	_
34	from	_	O	O	_	_	_	_	_
35	Nef	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	expressing	_	O	O	_	_	_	_	_
38	T	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	cell	_	O	O	_	_	_	_	_
41	lines	_	O	O	_	_	_	_	_
42	that	_	O	O	_	_	_	_	_
43	were	_	O	O	_	_	_	_	_
44	not	_	O	O	_	_	_	_	_
45	stimulated	_	O	O	_	_	_	_	_
46	or	_	O	O	_	_	_	_	_
47	were	_	O	O	_	_	_	_	_
48	stimulated	_	O	O	_	_	_	_	_
49	with	_	O	O	_	_	_	_	_
50	T	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	cell	_	O	O	_	_	_	_	_
53	mitogens	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Some	_	O	O	_	_	_	_	_
2	pulmonary	_	O	O	_	_	_	_	_
3	diseases	_	O	O	_	_	_	_	_
4	like	_	O	O	_	_	_	_	_
5	bronchitis	_	O	O	_	_	_	_	_
6	or	_	O	O	_	_	_	_	_
7	asthma	_	O	O	_	_	_	_	_
8	bronchiale	_	O	O	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	mediated	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	inflammatory	_	O	O	_	_	_	_	_
13	mechanisms	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	bronchial	_	O	O	_	_	_	_	_
16	epithelial	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_



1	The	_	O	O	_	_	_	_	_
2	P	_	O	O	_	_	_	_	_
3	sequence	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	located	_	O	O	_	_	_	_	_
6	between	_	O	O	_	_	_	_	_
7	positions	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	79	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	69	_	O	O	_	_	_	_	_
13	relative	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	transcription	_	O	O	_	_	_	_	_
17	start	_	O	O	_	_	_	_	_
18	site	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	gene	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	this	_	O	O	_	_	_	_	_
29	location	_	O	O	_	_	_	_	_
30	was	_	O	O	_	_	_	_	_
31	confirmed	_	O	O	_	_	_	_	_
32	by	_	O	O	_	_	_	_	_
33	base	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	substitution	_	O	O	_	_	_	_	_
36	mutations	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_


1	6	_	O	O	_	_	_	_	_
2	.	_	O	O	_	_	_	_	_

1	Partitioning	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	SMX	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	NHOH	_	O	O	_	_	_	_	_
6	into	_	O	O	_	_	_	_	_
7	red	_	O	O	_	_	_	_	_
8	blood	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	significantly	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	P	_	O	O	_	_	_	_	_
14	<	_	O	O	_	_	_	_	_
15	0	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_
17	05	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	lower	_	O	O	_	_	_	_	_
20	than	_	O	O	_	_	_	_	_
21	with	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	hydroxylamine	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	dapsone	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	balance	_	O	O	_	_	_	_	_
7	between	_	O	O	_	_	_	_	_
8	oxidation	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	SMX	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	its	_	O	O	_	_	_	_	_
13	toxic	_	O	O	_	_	_	_	_
14	metabolites	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	their	_	O	O	_	_	_	_	_
17	reduction	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	an	_	O	O	_	_	_	_	_
20	important	_	O	O	_	_	_	_	_
21	protective	_	O	O	_	_	_	_	_
22	cellular	_	O	O	_	_	_	_	_
23	mechanism	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_



1	De	_	O	O	_	_	_	_	_
2	novo	_	O	O	_	_	_	_	_
3	DNA	_	O	O	_	_	_	_	_
4	methylation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	genes	_	O	O	_	_	_	_	_
7	such	_	O	O	_	_	_	_	_
8	as	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	cycle	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	repair	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	apoptosis	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	tumor	_	O	O	_	_	_	_	_
18	suppressor	_	O	O	_	_	_	_	_
19	genes	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	therefore	_	O	O	_	_	_	_	_
22	thought	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	be	_	O	O	_	_	_	_	_
25	involved	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	tumorigenesis	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	15	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	17	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	B	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	strongly	_	O	O	_	_	_	_	_
9	influenced	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	presence	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	cytokines	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	regulatory	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	transcription	_	O	O	_	_	_	_	_
13	factor	_	O	O	_	_	_	_	_
14	activated	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	either	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	or	_	O	O	_	_	_	_	_
20	cytokines	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	No	_	O	O	_	_	_	_	_
2	NF	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	IL	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	6	_	O	O	_	_	_	_	_
7	binding	_	O	O	_	_	_	_	_
8	activity	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	detected	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	same	_	O	O	_	_	_	_	_
14	nuclear	_	O	O	_	_	_	_	_
15	extracts	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	MBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	selective	_	O	O	_	_	_	_	_
8	among	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	eosinophil	_	O	O	_	_	_	_	_
11	granule	_	O	O	_	_	_	_	_
12	proteins	_	O	O	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	stimulus	_	O	O	_	_	_	_	_
16	for	_	O	O	_	_	_	_	_
17	neutrophil	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	release	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	further	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	that	_	O	O	_	_	_	_	_
27	stimulation	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	neutrophil	_	O	O	_	_	_	_	_
30	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	release	_	O	O	_	_	_	_	_
34	by	_	O	O	_	_	_	_	_
35	MBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	involves	_	O	O	_	_	_	_	_
37	both	_	O	O	_	_	_	_	_
38	transcriptional	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	posttranscriptional	_	O	O	_	_	_	_	_
41	regulation	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_


1	the	_	O	O	_	_	_	_	_
2	cells	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	tolerant	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	LPS	_	O	O	_	_	_	_	_
7	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	isolating	_	O	O	_	_	_	_	_
3	Daudi	_	O	O	_	_	_	_	_
4	x	_	O	O	_	_	_	_	_
5	HeLa	_	O	O	_	_	_	_	_
6	heterokaryons	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	few	_	O	O	_	_	_	_	_
9	hours	_	O	O	_	_	_	_	_
10	after	_	O	O	_	_	_	_	_
11	fusion	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	we	_	O	O	_	_	_	_	_
14	have	_	O	O	_	_	_	_	_
15	studied	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	initial	_	O	O	_	_	_	_	_
18	fate	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	two	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	specific	_	O	O	_	_	_	_	_
25	transcription	_	O	O	_	_	_	_	_
26	factors	_	O	O	_	_	_	_	_
27	involved	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	Ig	_	O	O	_	_	_	_	_
30	gene	_	O	O	_	_	_	_	_
31	transcription	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	NF	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	kappa	_	O	O	_	_	_	_	_
40	B	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	interaction	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappaB	_	O	O	_	_	_	_	_
9	presumably	_	O	O	_	_	_	_	_
10	takes	_	O	O	_	_	_	_	_
11	place	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	nucleus	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	it	_	O	O	_	_	_	_	_
17	may	_	O	O	_	_	_	_	_
18	also	_	O	O	_	_	_	_	_
19	be	_	O	O	_	_	_	_	_
20	possible	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	cytoplasmic	_	O	O	_	_	_	_	_
24	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	protein	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	bind	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	NF	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	kappaB	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	cytoplasm	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	prevent	_	O	O	_	_	_	_	_
38	localization	_	O	O	_	_	_	_	_
39	to	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	nucleus	_	O	O	_	_	_	_	_
42	following	_	O	O	_	_	_	_	_
43	an	_	O	O	_	_	_	_	_
44	activation	_	O	O	_	_	_	_	_
45	stimulus	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	appear	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	suggest	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	carboxyl	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	terminal	_	O	O	_	_	_	_	_
11	FKH	_	O	O	_	_	_	_	_
12	domain	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	critically	_	O	O	_	_	_	_	_
15	important	_	O	O	_	_	_	_	_
16	for	_	O	O	_	_	_	_	_
17	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	down	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	regulate	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappaB	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	dependent	_	O	O	_	_	_	_	_
28	transcription	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	identify	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	cell	_	O	O	_	_	_	_	_
6	cycle	_	O	O	_	_	_	_	_
7	regulator	_	O	O	_	_	_	_	_
8	E	_	O	O	_	_	_	_	_
9	2	_	O	O	_	_	_	_	_
10	F	_	O	O	_	_	_	_	_
11	as	_	O	O	_	_	_	_	_
12	an	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	target	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	lymphocytes	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	PI	_	O	O	_	_	_	_	_
22	3	_	O	O	_	_	_	_	_
23	K	_	O	O	_	_	_	_	_
24	as	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	critical	_	O	O	_	_	_	_	_
27	signaling	_	O	O	_	_	_	_	_
28	pathway	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	PI	_	O	O	_	_	_	_	_
4	3	_	O	O	_	_	_	_	_
5	K	_	O	O	_	_	_	_	_
6	inhibits	_	O	O	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	Rb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	induction	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	cyclin	_	O	O	_	_	_	_	_
14	D	_	O	O	_	_	_	_	_
15	3	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	degradation	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	kip	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Erythropoietin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	dependent	_	O	O	_	_	_	_	_
4	induction	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	hemoglobin	_	O	O	_	_	_	_	_
7	synthesis	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	cytokine	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	line	_	O	O	_	_	_	_	_
15	M	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	TAT	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	supplemented	_	O	O	_	_	_	_	_
4	cytokine	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	switched	_	O	O	_	_	_	_	_
7	from	_	O	O	_	_	_	_	_
8	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	EPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	hemoglobin	_	O	O	_	_	_	_	_
15	synthesis	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	M	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	TAT	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	increased	_	O	O	_	_	_	_	_
26	rapidly	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	within	_	O	O	_	_	_	_	_
29	5	_	O	O	_	_	_	_	_
30	h	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	level	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	mRNA	_	O	O	_	_	_	_	_
41	increased	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_


1	An	_	O	O	_	_	_	_	_
2	in	_	O	O	_	_	_	_	_
3	vitro	_	O	O	_	_	_	_	_
4	surrogate	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	immunotherapy	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	incubation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	fresh	_	O	O	_	_	_	_	_
15	peripheral	_	O	O	_	_	_	_	_
16	blood	_	O	O	_	_	_	_	_
17	mononuclear	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	PBMC	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	from	_	O	O	_	_	_	_	_
23	healthy	_	O	O	_	_	_	_	_
24	individuals	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	for	_	O	O	_	_	_	_	_
30	several	_	O	O	_	_	_	_	_
31	days	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	resulting	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	production	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	lymphokine	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	activated	_	O	O	_	_	_	_	_
41	killer	_	O	O	_	_	_	_	_
42	(	_	O	O	_	_	_	_	_
43	LAK	_	O	O	_	_	_	_	_
44	)	_	O	O	_	_	_	_	_
45	activity	_	O	O	_	_	_	_	_
46	in	_	O	O	_	_	_	_	_
47	these	_	O	O	_	_	_	_	_
48	cultures	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	obtained	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	treated	_	O	O	_	_	_	_	_
12	patients	_	O	O	_	_	_	_	_
13	did	_	O	O	_	_	_	_	_
14	not	_	O	O	_	_	_	_	_
15	have	_	O	O	_	_	_	_	_
16	low	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	level	_	O	O	_	_	_	_	_
19	constitutive	_	O	O	_	_	_	_	_
20	expression	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	STAT	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	factors	_	O	O	_	_	_	_	_
25	as	_	O	O	_	_	_	_	_
26	did	_	O	O	_	_	_	_	_
27	LAK	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	activation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	nuclear	_	O	O	_	_	_	_	_
5	factor	_	O	O	_	_	_	_	_
6	kappa	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	intact	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	mechanistically	_	O	O	_	_	_	_	_
19	not	_	O	O	_	_	_	_	_
20	well	_	O	O	_	_	_	_	_
21	understood	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Phosphorylation	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	accompanied	_	O	O	_	_	_	_	_
4	by	_	O	O	_	_	_	_	_
5	induced	_	O	O	_	_	_	_	_
6	processing	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	precursors	_	O	O	_	_	_	_	_
10	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	100	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	degradation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Surprisingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	even	_	O	O	_	_	_	_	_
4	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	but	_	O	O	_	_	_	_	_
8	not	_	O	O	_	_	_	_	_
9	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	was	_	O	O	_	_	_	_	_
14	phosphorylated	_	O	O	_	_	_	_	_
15	after	_	O	O	_	_	_	_	_
16	induction	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	vivo	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	suggesting	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	selectively	_	O	O	_	_	_	_	_
26	activates	_	O	O	_	_	_	_	_
27	only	_	O	O	_	_	_	_	_
28	specific	_	O	O	_	_	_	_	_
29	NF	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	kappa	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	heteromers	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	that	_	O	O	_	_	_	_	_
36	modifications	_	O	O	_	_	_	_	_
37	regulate	_	O	O	_	_	_	_	_
38	not	_	O	O	_	_	_	_	_
39	only	_	O	O	_	_	_	_	_
40	I	_	O	O	_	_	_	_	_
41	kappa	_	O	O	_	_	_	_	_
42	B	_	O	O	_	_	_	_	_
43	molecules	_	O	O	_	_	_	_	_
44	but	_	O	O	_	_	_	_	_
45	also	_	O	O	_	_	_	_	_
46	NF	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	kappa	_	O	O	_	_	_	_	_
49	B	_	O	O	_	_	_	_	_
50	molecules	_	O	O	_	_	_	_	_
51	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	found	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	induction	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	hydrogen	_	O	O	_	_	_	_	_
10	peroxide	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappa	_	O	O	_	_	_	_	_
15	B	_	O	O	_	_	_	_	_
16	translocation	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	nucleus	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	which	_	O	O	_	_	_	_	_
22	is	_	O	O	_	_	_	_	_
23	assumed	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	be	_	O	O	_	_	_	_	_
26	triggered	_	O	O	_	_	_	_	_
27	by	_	O	O	_	_	_	_	_
28	reactive	_	O	O	_	_	_	_	_
29	oxygen	_	O	O	_	_	_	_	_
30	intermediates	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	also	_	O	O	_	_	_	_	_
33	coincided	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	incorporation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	phosphate	_	O	O	_	_	_	_	_
38	into	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	same	_	O	O	_	_	_	_	_
41	subunits	_	O	O	_	_	_	_	_
42	that	_	O	O	_	_	_	_	_
43	were	_	O	O	_	_	_	_	_
44	modified	_	O	O	_	_	_	_	_
45	after	_	O	O	_	_	_	_	_
46	stimulation	_	O	O	_	_	_	_	_
47	by	_	O	O	_	_	_	_	_
48	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	phosphorylation	_	O	O	_	_	_	_	_
4	appears	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	be	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	general	_	O	O	_	_	_	_	_
9	mechanism	_	O	O	_	_	_	_	_
10	for	_	O	O	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	vivo	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_


1	TPA	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	synergism	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	determined	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	have	_	O	O	_	_	_	_	_
9	occurred	_	O	O	_	_	_	_	_
10	at	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	responsive	_	O	O	_	_	_	_	_
15	element	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	GRE	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	level	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	functional	_	O	O	_	_	_	_	_
22	analysis	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	deletion	_	O	O	_	_	_	_	_
25	mutants	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	synthetic	_	O	O	_	_	_	_	_
28	GRE	_	O	O	_	_	_	_	_
29	oligonucleotides	_	O	O	_	_	_	_	_
30	driving	_	O	O	_	_	_	_	_
31	chloramphenicol	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	acetyl	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	transferase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	expression	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	Synergism	_	O	O	_	_	_	_	_
2	required	_	O	O	_	_	_	_	_
3	an	_	O	O	_	_	_	_	_
4	intact	_	O	O	_	_	_	_	_
5	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	DNA	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	domain	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	whereas	_	O	O	_	_	_	_	_
12	amino	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	or	_	O	O	_	_	_	_	_
15	carboxyl	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	terminal	_	O	O	_	_	_	_	_
18	domains	_	O	O	_	_	_	_	_
19	were	_	O	O	_	_	_	_	_
20	dispensable	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Conversely	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	jun	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	transfection	_	O	O	_	_	_	_	_
11	blunted	_	O	O	_	_	_	_	_
12	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	dependent	_	O	O	_	_	_	_	_
15	transcription	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	HeLa	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	propose	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	Jun	_	O	O	_	_	_	_	_
5	plays	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	bifunctional	_	O	O	_	_	_	_	_
8	role	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	GR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	transcriptional	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	GRE	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	selecting	_	O	O	_	_	_	_	_
19	either	_	O	O	_	_	_	_	_
20	synergistic	_	O	O	_	_	_	_	_
21	or	_	O	O	_	_	_	_	_
22	antagonistic	_	O	O	_	_	_	_	_
23	activity	_	O	O	_	_	_	_	_
24	depending	_	O	O	_	_	_	_	_
25	on	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	specific	_	O	O	_	_	_	_	_
30	microenvironment	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	expressed	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	this	_	O	O	_	_	_	_	_
7	tester	_	O	O	_	_	_	_	_
8	strain	_	O	O	_	_	_	_	_
9	represses	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	reporter	_	O	O	_	_	_	_	_
15	gene	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	changes	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	phenotype	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	from	_	O	O	_	_	_	_	_
24	Lac	_	O	O	_	_	_	_	_
25	+	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	Lac	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Signals	_	O	O	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	nuclear	_	O	O	_	_	_	_	_
4	factors	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	regulate	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	genes	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	helper	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	cAMP	_	O	O	_	_	_	_	_
5	almost	_	O	O	_	_	_	_	_
6	completely	_	O	O	_	_	_	_	_
7	inhibited	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	PMA	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	dependent	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	endogenous	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	gene	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	well	_	O	O	_	_	_	_	_
23	as	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	transfected	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	positively	_	O	O	_	_	_	_	_
12	regulated	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	cAMP	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	manner	_	O	O	_	_	_	_	_
18	opposite	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	gene	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	treatment	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	transiently	_	O	O	_	_	_	_	_
7	transfected	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	lymphocytes	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	anti	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	antibodies	_	O	O	_	_	_	_	_
16	results	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	activation	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	HIV	_	O	O	_	_	_	_	_
22	long	_	O	O	_	_	_	_	_
23	terminal	_	O	O	_	_	_	_	_
24	repeat	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	vitro	_	O	O	_	_	_	_	_
3	translated	_	O	O	_	_	_	_	_
4	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	protein	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	found	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	specifically	_	O	O	_	_	_	_	_
12	inhibit	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	DNA	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	binding	_	O	O	_	_	_	_	_
17	activity	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	NF	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	kappa	_	O	O	_	_	_	_	_
28	B	_	O	O	_	_	_	_	_
29	complex	_	O	O	_	_	_	_	_
30	but	_	O	O	_	_	_	_	_
31	not	_	O	O	_	_	_	_	_
32	that	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	/	_	O	O	_	_	_	_	_
38	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	KBF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	factor	_	O	O	_	_	_	_	_
43	or	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	other	_	O	O	_	_	_	_	_
46	DNA	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	binding	_	O	O	_	_	_	_	_
49	proteins	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	cDNA	_	O	O	_	_	_	_	_
6	encodes	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	I	_	O	O	_	_	_	_	_
9	kappa	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	like	_	O	O	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	likely	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	be	_	O	O	_	_	_	_	_
19	involved	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	regulation	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	transcriptional	_	O	O	_	_	_	_	_
24	responses	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	NF	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	kappa	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	including	_	O	O	_	_	_	_	_
32	adhesion	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	dependent	_	O	O	_	_	_	_	_
35	pathways	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	monocyte	_	O	O	_	_	_	_	_
38	activation	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	identified	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	potent	_	O	O	_	_	_	_	_
6	inhibitory	_	O	O	_	_	_	_	_
7	sequence	_	O	O	_	_	_	_	_
8	within	_	O	O	_	_	_	_	_
9	its	_	O	O	_	_	_	_	_
10	N	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	terminal	_	O	O	_	_	_	_	_
13	domain	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	Previous	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	have	_	O	O	_	_	_	_	_
4	characterized	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	augmentation	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	TCR	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	mediated	_	O	O	_	_	_	_	_
13	signaling	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	peripheral	_	O	O	_	_	_	_	_
16	blood	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	through	_	O	O	_	_	_	_	_
20	transcriptional	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	an	_	O	O	_	_	_	_	_
24	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	promoter	_	O	O	_	_	_	_	_
28	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	response	_	O	O	_	_	_	_	_
31	element	_	O	O	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	CD	_	O	O	_	_	_	_	_
34	28	_	O	O	_	_	_	_	_
35	RE	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	along	_	O	O	_	_	_	_	_
39	with	_	O	O	_	_	_	_	_
40	enhanced	_	O	O	_	_	_	_	_
41	mRNA	_	O	O	_	_	_	_	_
42	stability	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	LPMC	_	O	O	_	_	_	_	_
2	exhibited	_	O	O	_	_	_	_	_
3	increased	_	O	O	_	_	_	_	_
4	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	production	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	response	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	costimulation	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	compared	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	activated	_	O	O	_	_	_	_	_
19	through	_	O	O	_	_	_	_	_
20	CD	_	O	O	_	_	_	_	_
21	2	_	O	O	_	_	_	_	_
22	alone	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	AT	_	O	O	_	_	_	_	_
4	activation	_	O	O	_	_	_	_	_
5	induced	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	CAML	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	interacting	_	O	O	_	_	_	_	_
11	member	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	tumor	_	O	O	_	_	_	_	_
15	necrosis	_	O	O	_	_	_	_	_
16	factor	_	O	O	_	_	_	_	_
17	receptor	_	O	O	_	_	_	_	_
18	superfamily	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_


1	Helenalin	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	an	_	O	O	_	_	_	_	_
4	anti	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	inflammatory	_	O	O	_	_	_	_	_
7	sesquiterpene	_	O	O	_	_	_	_	_
8	lactone	_	O	O	_	_	_	_	_
9	from	_	O	O	_	_	_	_	_
10	Arnica	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	selectively	_	O	O	_	_	_	_	_
13	inhibits	_	O	O	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	factor	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappaB	_	O	O	_	_	_	_	_
19	[	_	O	O	_	_	_	_	_
20	see	_	O	O	_	_	_	_	_
21	comments	_	O	O	_	_	_	_	_
22	]	_	O	O	_	_	_	_	_

1	Alcoholic	_	O	O	_	_	_	_	_
2	extracts	_	O	O	_	_	_	_	_
3	prepared	_	O	O	_	_	_	_	_
4	form	_	O	O	_	_	_	_	_
5	Arnicae	_	O	O	_	_	_	_	_
6	flos	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	collective	_	O	O	_	_	_	_	_
10	name	_	O	O	_	_	_	_	_
11	for	_	O	O	_	_	_	_	_
12	flowerheads	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	Arnica	_	O	O	_	_	_	_	_
15	montana	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	A	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	active	_	O	O	_	_	_	_	_
3	ingredients	_	O	O	_	_	_	_	_
4	mediating	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	pharmacological	_	O	O	_	_	_	_	_
7	effect	_	O	O	_	_	_	_	_
8	are	_	O	O	_	_	_	_	_
9	mainly	_	O	O	_	_	_	_	_
10	sesquiterpene	_	O	O	_	_	_	_	_
11	lactones	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	such	_	O	O	_	_	_	_	_
14	as	_	O	O	_	_	_	_	_
15	helenalin	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	11	_	O	O	_	_	_	_	_
18	alpha	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	13	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	dihydrohelenalin	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	chamissonolid	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	their	_	O	O	_	_	_	_	_
27	ester	_	O	O	_	_	_	_	_
28	derivatives	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappaB	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	which	_	O	O	_	_	_	_	_
6	resides	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	an	_	O	O	_	_	_	_	_
9	inactive	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	cytoplasmic	_	O	O	_	_	_	_	_
12	complex	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	unstimulated	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	activated	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	phosphorylation	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	degradation	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	its	_	O	O	_	_	_	_	_
25	inhibitory	_	O	O	_	_	_	_	_
26	subunit	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	IkappaB	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	effect	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	both	_	O	O	_	_	_	_	_
5	cytokines	_	O	O	_	_	_	_	_
6	on	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	monocyte	_	O	O	_	_	_	_	_
9	maturation	_	O	O	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	differentiation	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	11	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	b	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	13	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	26	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	other	_	O	O	_	_	_	_	_
26	macrophage	_	O	O	_	_	_	_	_
27	markers	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	68	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	was	_	O	O	_	_	_	_	_
36	examined	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_


1	Treatment	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	lymphocytes	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	optimal	_	O	O	_	_	_	_	_
9	concentration	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	okadaic	_	O	O	_	_	_	_	_
12	acid	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	an	_	O	O	_	_	_	_	_
15	inhibitor	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	phosphatases	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	2	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	resulted	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	induction	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	transcription	_	O	O	_	_	_	_	_
30	factor	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	AP	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	a	_	O	O	_	_	_	_	_
37	marked	_	O	O	_	_	_	_	_
38	increase	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	NF	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	kappa	_	O	O	_	_	_	_	_
43	B	_	O	O	_	_	_	_	_
44	levels	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	okadaic	_	O	O	_	_	_	_	_
3	acid	_	O	O	_	_	_	_	_
4	provides	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	potent	_	O	O	_	_	_	_	_
7	inductive	_	O	O	_	_	_	_	_
8	signal	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	AP	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	it	_	O	O	_	_	_	_	_
19	did	_	O	O	_	_	_	_	_
20	not	_	O	O	_	_	_	_	_
21	induce	_	O	O	_	_	_	_	_
22	either	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	proliferation	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	immunoglobulin	_	O	O	_	_	_	_	_
28	secretion	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assays	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	EMSA	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	43	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	mer	_	O	O	_	_	_	_	_
13	oligonucleotide	_	O	O	_	_	_	_	_
14	derived	_	O	O	_	_	_	_	_
15	from	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	functionally	_	O	O	_	_	_	_	_
18	identified	_	O	O	_	_	_	_	_
19	cis	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	acting	_	O	O	_	_	_	_	_
22	element	_	O	O	_	_	_	_	_
23	revealed	_	O	O	_	_	_	_	_
24	specific	_	O	O	_	_	_	_	_
25	complexes	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	closest	_	O	O	_	_	_	_	_
3	match	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	known	_	O	O	_	_	_	_	_
7	SP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	consensus	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	within	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	respective	_	O	O	_	_	_	_	_
15	region	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	TCCCCTCCCCT	_	O	O	_	_	_	_	_
19	motif	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Transactivation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	promoter	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	human	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	leukemia	_	O	O	_	_	_	_	_
15	virus	_	O	O	_	_	_	_	_
16	type	_	O	O	_	_	_	_	_
17	I	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	type	_	O	O	_	_	_	_	_
20	II	_	O	O	_	_	_	_	_
21	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	proteins	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Expression	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	HTLV	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	I	_	O	O	_	_	_	_	_
11	productively	_	O	O	_	_	_	_	_
12	infected	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	may	_	O	O	_	_	_	_	_
15	be	_	O	O	_	_	_	_	_
16	important	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	hypercalcemia	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	osteolytic	_	O	O	_	_	_	_	_
22	bone	_	O	O	_	_	_	_	_
23	lesions	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	neutrophilia	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	elevation	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	C	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	reactive	_	O	O	_	_	_	_	_
32	protein	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	fever	_	O	O	_	_	_	_	_
36	frequently	_	O	O	_	_	_	_	_
37	seen	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	patients	_	O	O	_	_	_	_	_
40	with	_	O	O	_	_	_	_	_
41	HTLV	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	I	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	induced	_	O	O	_	_	_	_	_
46	adult	_	O	O	_	_	_	_	_
47	T	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	cell	_	O	O	_	_	_	_	_
50	leukemia	_	O	O	_	_	_	_	_
51	/	_	O	O	_	_	_	_	_
52	lymphoma	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	Tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	TNF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	controls	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	cell	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	major	_	O	O	_	_	_	_	_
18	inducer	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	human	_	O	O	_	_	_	_	_
21	immunodeficiency	_	O	O	_	_	_	_	_
22	virus	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	HIV	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	1	_	O	O	_	_	_	_	_
28	replication	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	chronically	_	O	O	_	_	_	_	_
31	infected	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	platelets	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	monocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	chemotactic	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	MCP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	secretion	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	surface	_	O	O	_	_	_	_	_
19	expression	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	intercellular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	on	_	O	O	_	_	_	_	_
32	endothelial	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	has	_	O	O	_	_	_	_	_
35	been	_	O	O	_	_	_	_	_
36	assessed	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	ADP	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	activated	_	O	O	_	_	_	_	_
7	platelets	_	O	O	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	MCP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	dependent	_	O	O	_	_	_	_	_
19	transcription	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_


1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	protein	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	which	_	O	O	_	_	_	_	_
8	both	_	O	O	_	_	_	_	_
9	functional	_	O	O	_	_	_	_	_
10	alpha	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	helices	_	O	O	_	_	_	_	_
13	have	_	O	O	_	_	_	_	_
14	been	_	O	O	_	_	_	_	_
15	deleted	_	O	O	_	_	_	_	_
16	displays	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	dominant	_	O	O	_	_	_	_	_
19	negative	_	O	O	_	_	_	_	_
20	phenotype	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	a	_	O	O	_	_	_	_	_
3	series	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	electrophoretic	_	O	O	_	_	_	_	_
6	mobility	_	O	O	_	_	_	_	_
7	shift	_	O	O	_	_	_	_	_
8	assays	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	extracts	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	highly	_	O	O	_	_	_	_	_
14	polarized	_	O	O	_	_	_	_	_
15	Th	_	O	O	_	_	_	_	_
16	2	_	O	O	_	_	_	_	_
17	clones	_	O	O	_	_	_	_	_
18	from	_	O	O	_	_	_	_	_
19	atopics	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	Th	_	O	O	_	_	_	_	_
22	1	_	O	O	_	_	_	_	_
23	clones	_	O	O	_	_	_	_	_
24	from	_	O	O	_	_	_	_	_
25	controls	_	O	O	_	_	_	_	_
26	we	_	O	O	_	_	_	_	_
27	compared	_	O	O	_	_	_	_	_
28	DNA	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	binding	_	O	O	_	_	_	_	_
31	activities	_	O	O	_	_	_	_	_
32	at	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	two	_	O	O	_	_	_	_	_
35	NFAT	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	binding	_	O	O	_	_	_	_	_
38	elements	_	O	O	_	_	_	_	_
39	P	_	O	O	_	_	_	_	_
40	0	_	O	O	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	P	_	O	O	_	_	_	_	_
43	1	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	crucial	_	O	O	_	_	_	_	_
47	proximal	_	O	O	_	_	_	_	_
48	human	_	O	O	_	_	_	_	_
49	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	promoter	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	mean	_	O	O	_	_	_	_	_
6	+	_	O	O	_	_	_	_	_
7	/	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	SEM	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	triplicate	_	O	O	_	_	_	_	_
12	samples	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	case	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	IgE	_	O	O	_	_	_	_	_
6	class	_	O	O	_	_	_	_	_
7	switching	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	activates	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	IgE	_	O	O	_	_	_	_	_
15	germline	_	O	O	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	inducing	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	interaction	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	factor	_	O	O	_	_	_	_	_
25	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	STAT	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	with	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	responsive	_	O	O	_	_	_	_	_
36	DNA	_	O	O	_	_	_	_	_
37	element	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	proximal	_	O	O	_	_	_	_	_
41	region	_	O	O	_	_	_	_	_
42	of	_	O	O	_	_	_	_	_
43	the	_	O	O	_	_	_	_	_
44	promoter	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assays	_	O	O	_	_	_	_	_
5	show	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	nucleoprotein	_	O	O	_	_	_	_	_
9	complex	_	O	O	_	_	_	_	_
10	formed	_	O	O	_	_	_	_	_
11	on	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	upstream	_	O	O	_	_	_	_	_
14	site	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	contains	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	classical	_	O	O	_	_	_	_	_
24	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	heterodimer	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	effect	_	O	O	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	dependent	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	presence	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	binding	_	O	O	_	_	_	_	_
17	site	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	demonstrating	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	motif	_	O	O	_	_	_	_	_
27	is	_	O	O	_	_	_	_	_
28	necessary	_	O	O	_	_	_	_	_
29	but	_	O	O	_	_	_	_	_
30	not	_	O	O	_	_	_	_	_
31	sufficient	_	O	O	_	_	_	_	_
32	for	_	O	O	_	_	_	_	_
33	mediating	_	O	O	_	_	_	_	_
34	cytokine	_	O	O	_	_	_	_	_
35	up	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	regulation	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	combination	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	kappa	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	/	_	O	O	_	_	_	_	_
12	rel	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	site	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	response	_	O	O	_	_	_	_	_
20	element	_	O	O	_	_	_	_	_
21	conferred	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	inducibility	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	heterologous	_	O	O	_	_	_	_	_
29	minimal	_	O	O	_	_	_	_	_
30	promoter	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	while	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	individual	_	O	O	_	_	_	_	_
35	sites	_	O	O	_	_	_	_	_
36	had	_	O	O	_	_	_	_	_
37	no	_	O	O	_	_	_	_	_
38	effect	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	SLP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	76	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	Vav	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	function	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	separate	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	but	_	O	O	_	_	_	_	_
11	overlapping	_	O	O	_	_	_	_	_
12	pathways	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	augment	_	O	O	_	_	_	_	_
15	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Southwestern	_	O	O	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	gel	_	O	O	_	_	_	_	_
4	renaturation	_	O	O	_	_	_	_	_
5	experiments	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	use	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	purified	_	O	O	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	fractions	_	O	O	_	_	_	_	_
13	revealed	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	TCF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	derived	_	O	O	_	_	_	_	_
22	from	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	family	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	57	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	53	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	kD	_	O	O	_	_	_	_	_
32	proteins	_	O	O	_	_	_	_	_
33	that	_	O	O	_	_	_	_	_
34	are	_	O	O	_	_	_	_	_
35	abundantly	_	O	O	_	_	_	_	_
36	expressed	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	mature	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	immature	_	O	O	_	_	_	_	_
41	T	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	cell	_	O	O	_	_	_	_	_
44	lines	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	Jurkat	_	O	O	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	CCRF	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	CEM	_	O	O	_	_	_	_	_
51	)	_	O	O	_	_	_	_	_
52	and	_	O	O	_	_	_	_	_
53	not	_	O	O	_	_	_	_	_
54	in	_	O	O	_	_	_	_	_
55	mature	_	O	O	_	_	_	_	_
56	B	_	O	O	_	_	_	_	_
57	cells	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	JY	_	O	O	_	_	_	_	_
60	,	_	O	O	_	_	_	_	_
61	Namalwa	_	O	O	_	_	_	_	_
62	)	_	O	O	_	_	_	_	_
63	or	_	O	O	_	_	_	_	_
64	nonlymphoid	_	O	O	_	_	_	_	_
65	(	_	O	O	_	_	_	_	_
66	HeLa	_	O	O	_	_	_	_	_
67	)	_	O	O	_	_	_	_	_
68	cell	_	O	O	_	_	_	_	_
69	lines	_	O	O	_	_	_	_	_
70	.	_	O	O	_	_	_	_	_

1	Tandem	_	O	O	_	_	_	_	_
2	copies	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	enhancer	_	O	O	_	_	_	_	_
6	functioned	_	O	O	_	_	_	_	_
7	synergistically	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	mature	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	Jurkat	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	T	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	lines	_	O	O	_	_	_	_	_
17	as	_	O	O	_	_	_	_	_
18	well	_	O	O	_	_	_	_	_
19	as	_	O	O	_	_	_	_	_
20	resting	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	activated	_	O	O	_	_	_	_	_
23	immature	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	CCRF	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	CEM	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	T	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	cell	_	O	O	_	_	_	_	_
32	lines	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Reactive	_	O	O	_	_	_	_	_
2	oxygen	_	O	O	_	_	_	_	_
3	intermediates	_	O	O	_	_	_	_	_
4	as	_	O	O	_	_	_	_	_
5	apparently	_	O	O	_	_	_	_	_
6	widely	_	O	O	_	_	_	_	_
7	used	_	O	O	_	_	_	_	_
8	messengers	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	HIV	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappa	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	/	_	O	O	_	_	_	_	_
6	Rel	_	O	O	_	_	_	_	_
7	family	_	O	O	_	_	_	_	_
8	members	_	O	O	_	_	_	_	_
9	regulating	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	monocytic	_	O	O	_	_	_	_	_
17	THP	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	1	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	functional	_	O	O	_	_	_	_	_
3	analysis	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	revealed	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	AP	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	NF	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	kappaB	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	elements	_	O	O	_	_	_	_	_
25	were	_	O	O	_	_	_	_	_
26	involved	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	conferring	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	responsiveness	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	CMV	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Data	_	O	O	_	_	_	_	_
2	analysis	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	performed	_	O	O	_	_	_	_	_
5	using	_	O	O	_	_	_	_	_
6	FlowJo	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	Tree	_	O	O	_	_	_	_	_
9	Star	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	Ashland	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	Oregon	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	United	_	O	O	_	_	_	_	_
16	States	_	O	O	_	_	_	_	_
17	)	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_



1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	FK	_	O	O	_	_	_	_	_
5	506	_	O	O	_	_	_	_	_
6	or	_	O	O	_	_	_	_	_
7	EGTA	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	Ca	_	O	O	_	_	_	_	_
10	2	_	O	O	_	_	_	_	_
11	+	_	O	O	_	_	_	_	_
12	chelator	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	similarly	_	O	O	_	_	_	_	_
15	affected	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	formation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	like	_	O	O	_	_	_	_	_
23	site	_	O	O	_	_	_	_	_
24	binding	_	O	O	_	_	_	_	_
25	complexes	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	which	_	O	O	_	_	_	_	_
28	were	_	O	O	_	_	_	_	_
29	not	_	O	O	_	_	_	_	_
30	recognized	_	O	O	_	_	_	_	_
31	by	_	O	O	_	_	_	_	_
32	any	_	O	O	_	_	_	_	_
33	antibodies	_	O	O	_	_	_	_	_
34	against	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	human	_	O	O	_	_	_	_	_
37	Rel	_	O	O	_	_	_	_	_
38	family	_	O	O	_	_	_	_	_
39	proteins	_	O	O	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	Rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	,	_	O	O	_	_	_	_	_
51	and	_	O	O	_	_	_	_	_
52	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
53	49	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	)	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	confirmed	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	previous	_	O	O	_	_	_	_	_
7	report	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	FK	_	O	O	_	_	_	_	_
10	506	_	O	O	_	_	_	_	_
11	suppressed	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	PMA	_	O	O	_	_	_	_	_
14	/	_	O	O	_	_	_	_	_
15	ionomycin	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	induced	_	O	O	_	_	_	_	_
18	activation	_	O	O	_	_	_	_	_
19	through	_	O	O	_	_	_	_	_
20	authentic	_	O	O	_	_	_	_	_
21	kappa	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	site	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	immunoglobulin	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	Ig	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	gene	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	which	_	O	O	_	_	_	_	_
33	NF	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	kappa	_	O	O	_	_	_	_	_
36	B	_	O	O	_	_	_	_	_
37	binding	_	O	O	_	_	_	_	_
38	was	_	O	O	_	_	_	_	_
39	also	_	O	O	_	_	_	_	_
40	decreased	_	O	O	_	_	_	_	_
41	by	_	O	O	_	_	_	_	_
42	FK	_	O	O	_	_	_	_	_
43	506	_	O	O	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	indicating	_	O	O	_	_	_	_	_
46	that	_	O	O	_	_	_	_	_
47	both	_	O	O	_	_	_	_	_
48	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	kappa	_	O	O	_	_	_	_	_
52	B	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	like	_	O	O	_	_	_	_	_
55	site	_	O	O	_	_	_	_	_
56	and	_	O	O	_	_	_	_	_
57	Ig	_	BPROTEIN	BPROTEIN	_	_	_	_	_
58	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
59	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
60	site	_	O	O	_	_	_	_	_
61	are	_	O	O	_	_	_	_	_
62	FK	_	O	O	_	_	_	_	_
63	506	_	O	O	_	_	_	_	_
64	-	_	O	O	_	_	_	_	_
65	sensitive	_	O	O	_	_	_	_	_
66	in	_	O	O	_	_	_	_	_
67	spite	_	O	O	_	_	_	_	_
68	of	_	O	O	_	_	_	_	_
69	the	_	O	O	_	_	_	_	_
70	difference	_	O	O	_	_	_	_	_
71	of	_	O	O	_	_	_	_	_
72	binding	_	O	O	_	_	_	_	_
73	factors	_	O	O	_	_	_	_	_
74	.	_	O	O	_	_	_	_	_


1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	like	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	kappa	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	TCF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	activity	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	phorbol	_	O	O	_	_	_	_	_
16	esters	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	other	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	cell	_	O	O	_	_	_	_	_
22	activators	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factor	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	phagocytic	_	O	O	_	_	_	_	_
11	stimuli	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	neutrophils	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Under	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	conditions	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	found	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	be	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	rapid	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	transient	_	O	O	_	_	_	_	_
18	response	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	reaching	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	maximum	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	10	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	15	_	O	O	_	_	_	_	_
27	min	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	returning	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	near	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	basal	_	O	O	_	_	_	_	_
35	levels	_	O	O	_	_	_	_	_
36	by	_	O	O	_	_	_	_	_
37	30	_	O	O	_	_	_	_	_
38	min	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Consistent	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	quantitative	_	O	O	_	_	_	_	_
7	DNase	_	O	O	_	_	_	_	_
8	footprinting	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	using	_	O	O	_	_	_	_	_
16	increasing	_	O	O	_	_	_	_	_
17	amounts	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	recombinant	_	O	O	_	_	_	_	_
20	NFATp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	demonstrated	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	76	_	O	O	_	_	_	_	_
26	site	_	O	O	_	_	_	_	_
27	binds	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	NFATp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	with	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	higher	_	O	O	_	_	_	_	_
33	affinity	_	O	O	_	_	_	_	_
34	than	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	kappa	_	O	O	_	_	_	_	_
37	3	_	O	O	_	_	_	_	_
38	site	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Specific	_	O	O	_	_	_	_	_
2	PCR	_	O	O	_	_	_	_	_
3	products	_	O	O	_	_	_	_	_
4	for	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	four	_	O	O	_	_	_	_	_
7	rearrangements	_	O	O	_	_	_	_	_
8	corresponding	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	calculated	_	O	O	_	_	_	_	_
12	sizes	_	O	O	_	_	_	_	_
13	are	_	O	O	_	_	_	_	_
14	indicated	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	arrows	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Clonality	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	determined	_	O	O	_	_	_	_	_
4	by	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	appearance	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	predominant	_	O	O	_	_	_	_	_
10	band	_	O	O	_	_	_	_	_
11	at	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	correct	_	O	O	_	_	_	_	_
14	size	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	single	_	O	O	_	_	_	_	_
18	V	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	J	_	O	O	_	_	_	_	_
21	rearrangement	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	Molecular	_	O	O	_	_	_	_	_
2	dissection	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	B	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	specific	_	O	O	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	coactivator	_	O	O	_	_	_	_	_
12	OCA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	has	_	O	O	_	_	_	_	_
16	revealed	_	O	O	_	_	_	_	_
17	distinct	_	O	O	_	_	_	_	_
18	regions	_	O	O	_	_	_	_	_
19	important	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	respectively	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	for	_	O	O	_	_	_	_	_
24	recruitment	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	immunoglobulin	_	O	O	_	_	_	_	_
27	promoters	_	O	O	_	_	_	_	_
28	through	_	O	O	_	_	_	_	_
29	interaction	_	O	O	_	_	_	_	_
30	with	_	O	O	_	_	_	_	_
31	octamer	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	bound	_	O	O	_	_	_	_	_
34	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	for	_	O	O	_	_	_	_	_
39	subsequent	_	O	O	_	_	_	_	_
40	coactivator	_	O	O	_	_	_	_	_
41	function	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_


1	Effect	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	on	_	O	O	_	_	_	_	_
7	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	Induction	_	O	O	_	_	_	_	_

1	Cells	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	harvested	_	O	O	_	_	_	_	_
4	for	_	O	O	_	_	_	_	_
5	mRNA	_	O	O	_	_	_	_	_
6	quantification	_	O	O	_	_	_	_	_
7	after	_	O	O	_	_	_	_	_
8	5	_	O	O	_	_	_	_	_
9	d	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	chromatin	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	sheared	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	200	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	1000	_	O	O	_	_	_	_	_
9	bp	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	length	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	sonication	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	five	_	O	O	_	_	_	_	_
16	pulses	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	10	_	O	O	_	_	_	_	_
19	s	_	O	O	_	_	_	_	_
20	at	_	O	O	_	_	_	_	_
21	30	_	O	O	_	_	_	_	_
22	%	_	O	O	_	_	_	_	_
23	power	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	Bandelin	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	messages	_	O	O	_	_	_	_	_
3	rapidly	_	O	O	_	_	_	_	_
4	declined	_	O	O	_	_	_	_	_
5	thereafter	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	activation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	both	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	an	_	O	O	_	_	_	_	_
12	NFAT	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	driven	_	O	O	_	_	_	_	_
15	minimal	_	O	O	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	were	_	O	O	_	_	_	_	_
18	shown	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	depend	_	O	O	_	_	_	_	_
21	on	_	O	O	_	_	_	_	_
22	signals	_	O	O	_	_	_	_	_
23	transduced	_	O	O	_	_	_	_	_
24	by	_	O	O	_	_	_	_	_
25	Raf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Sequence	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	promoter	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	downstream	_	O	O	_	_	_	_	_
11	region	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	primer	_	O	O	_	_	_	_	_
3	binding	_	O	O	_	_	_	_	_
4	sites	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	5	_	O	O	_	_	_	_	_
7	'	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	RACE	_	O	O	_	_	_	_	_
10	analysis	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	cloning	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	reporter	_	O	O	_	_	_	_	_
17	constructs	_	O	O	_	_	_	_	_
18	are	_	O	O	_	_	_	_	_
19	underlined	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	names	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	primers	_	O	O	_	_	_	_	_
26	are	_	O	O	_	_	_	_	_
27	annotated	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Promotes	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	Lymphomas	_	O	O	_	_	_	_	_
9	That	_	O	O	_	_	_	_	_
10	Can	_	O	O	_	_	_	_	_
11	Escape	_	O	O	_	_	_	_	_
12	Allelic	_	O	O	_	_	_	_	_
13	Exclusion	_	O	O	_	_	_	_	_

1	Percentages	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	B	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	1	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	b	_	O	O	_	_	_	_	_
12	or	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	2	_	O	O	_	_	_	_	_
15	subsets	_	O	O	_	_	_	_	_
16	are	_	O	O	_	_	_	_	_
17	shown	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	each	_	O	O	_	_	_	_	_
20	quadrant	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_


1	Actin	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	used	_	O	O	_	_	_	_	_
4	as	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	loading	_	O	O	_	_	_	_	_
7	control	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	biophysical	_	O	O	_	_	_	_	_
5	properties	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	pulmonary	_	O	O	_	_	_	_	_
8	surfactant	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	immunomodulatory	_	O	O	_	_	_	_	_
11	activity	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	Specifically	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	examined	_	O	O	_	_	_	_	_
5	nuclear	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	NF	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	kappa	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	because	_	O	O	_	_	_	_	_
18	it	_	O	O	_	_	_	_	_
19	is	_	O	O	_	_	_	_	_
20	crucial	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	transcriptional	_	O	O	_	_	_	_	_
23	regulation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	many	_	O	O	_	_	_	_	_
26	inflammatory	_	O	O	_	_	_	_	_
27	cytokine	_	O	O	_	_	_	_	_
28	genes	_	O	O	_	_	_	_	_
29	including	_	O	O	_	_	_	_	_
30	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	resting	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	many	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	Rel	_	O	O	_	_	_	_	_
15	factors	_	O	O	_	_	_	_	_
16	are	_	O	O	_	_	_	_	_
17	sequestered	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	cytoplasm	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	various	_	O	O	_	_	_	_	_
23	ankyrin	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	rich	_	O	O	_	_	_	_	_
26	inhibitory	_	O	O	_	_	_	_	_
27	proteins	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	including	_	O	O	_	_	_	_	_
30	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	demonstrate	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	stimulated	_	O	O	_	_	_	_	_
11	nuclear	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	both	_	O	O	_	_	_	_	_
20	HTLV	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	I	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	infected	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	transfected	_	O	O	_	_	_	_	_
29	human	_	O	O	_	_	_	_	_
30	T	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	is	_	O	O	_	_	_	_	_
33	associated	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	phosphorylation	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	rapid	_	O	O	_	_	_	_	_
39	proteolytic	_	O	O	_	_	_	_	_
40	degradation	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	presented	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	Fig	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	gene	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	originally	_	O	O	_	_	_	_	_
5	named	_	O	O	_	_	_	_	_
6	AML	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	human	_	O	O	_	_	_	_	_
12	homologue	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	Drosophila	_	O	O	_	_	_	_	_
16	gene	_	O	O	_	_	_	_	_
17	runt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	controls	_	O	O	_	_	_	_	_
20	early	_	O	O	_	_	_	_	_
21	events	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	fly	_	O	O	_	_	_	_	_
24	embryogenesis	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_


1	Analysis	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	ligand	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	domain	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	human	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	retinoic	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	acid	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	site	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	directed	_	O	O	_	_	_	_	_
18	mutagenesis	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	From	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	results	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	can	_	O	O	_	_	_	_	_
7	conclude	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	electrostatic	_	O	O	_	_	_	_	_
10	interactions	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	retinoids	_	O	O	_	_	_	_	_
13	with	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	RAR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	LBD	_	O	O	_	_	_	_	_
19	play	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	significant	_	O	O	_	_	_	_	_
22	role	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	ligand	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Hypoxic	_	O	O	_	_	_	_	_
2	induction	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	human	_	O	O	_	_	_	_	_
11	endothelial	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	Production	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	hypoxic	_	O	O	_	_	_	_	_
8	ECs	_	O	O	_	_	_	_	_
9	occurred	_	O	O	_	_	_	_	_
10	concomitantly	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	increased	_	O	O	_	_	_	_	_
14	levels	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	mRNA	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	based	_	O	O	_	_	_	_	_
22	on	_	O	O	_	_	_	_	_
23	polymerase	_	O	O	_	_	_	_	_
24	chain	_	O	O	_	_	_	_	_
25	reaction	_	O	O	_	_	_	_	_
26	analysis	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	increased	_	O	O	_	_	_	_	_
30	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	transcription	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	based	_	O	O	_	_	_	_	_
36	on	_	O	O	_	_	_	_	_
37	nuclear	_	O	O	_	_	_	_	_
38	run	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	on	_	O	O	_	_	_	_	_
41	assays	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappaB	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	MNC	_	O	O	_	_	_	_	_
6	nuclear	_	O	O	_	_	_	_	_
7	extracts	_	O	O	_	_	_	_	_
8	decreased	_	O	O	_	_	_	_	_
9	at	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	hr	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	reached	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	nadir	_	O	O	_	_	_	_	_
16	at	_	O	O	_	_	_	_	_
17	4	_	O	O	_	_	_	_	_
18	hr	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	gradually	_	O	O	_	_	_	_	_
21	increased	_	O	O	_	_	_	_	_
22	at	_	O	O	_	_	_	_	_
23	8	_	O	O	_	_	_	_	_
24	hr	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	returned	_	O	O	_	_	_	_	_
27	back	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	baseline	_	O	O	_	_	_	_	_
30	levels	_	O	O	_	_	_	_	_
31	at	_	O	O	_	_	_	_	_
32	24	_	O	O	_	_	_	_	_
33	hr	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	jun	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	fos	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	family	_	O	O	_	_	_	_	_
9	members	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	12	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	O	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	tetradecanoylphorbol	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	13	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	acetate	_	O	O	_	_	_	_	_
20	induced	_	O	O	_	_	_	_	_
21	hemopoietic	_	O	O	_	_	_	_	_
22	differentiation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	CoCl	_	O	O	_	_	_	_	_
4	2	_	O	O	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	caused	_	O	O	_	_	_	_	_
7	time	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	dependent	_	O	O	_	_	_	_	_
10	tyrosine	_	O	O	_	_	_	_	_
11	phosphorylation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	mitogen	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	activated	_	O	O	_	_	_	_	_
16	protein	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	MAP	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	kinase	_	O	O	_	_	_	_	_
21	isoform	_	O	O	_	_	_	_	_
22	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	without	_	O	O	_	_	_	_	_
25	significantly	_	O	O	_	_	_	_	_
26	affecting	_	O	O	_	_	_	_	_
27	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	indicating	_	O	O	_	_	_	_	_
31	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	is	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	preferred	_	O	O	_	_	_	_	_
36	substrate	_	O	O	_	_	_	_	_
37	for	_	O	O	_	_	_	_	_
38	upstream	_	O	O	_	_	_	_	_
39	kinase	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	MAPK	_	O	O	_	_	_	_	_
43	pathway	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	phosphorylation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	PECAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	transendothelial	_	O	O	_	_	_	_	_
9	migration	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	monocytes	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	response	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	CoCl	_	O	O	_	_	_	_	_
16	2	_	O	O	_	_	_	_	_
17	were	_	O	O	_	_	_	_	_
18	inhibited	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	protein	_	O	O	_	_	_	_	_
21	kinase	_	O	O	_	_	_	_	_
22	inhibitor	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	GF	_	O	O	_	_	_	_	_
25	109203	_	O	O	_	_	_	_	_
26	X	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	augmented	_	O	O	_	_	_	_	_
30	by	_	O	O	_	_	_	_	_
31	protein	_	O	O	_	_	_	_	_
32	phosphatase	_	O	O	_	_	_	_	_
33	inhibitor	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	Calyculin	_	O	O	_	_	_	_	_
36	A	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	conclude	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	PAF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	receptor	_	O	O	_	_	_	_	_
7	antagonist	_	O	O	_	_	_	_	_
8	inhibits	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	CoCl	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	or	_	O	O	_	_	_	_	_
14	hypoxia	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	induced	_	O	O	_	_	_	_	_
17	increase	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	adhesion	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	SS	_	O	O	_	_	_	_	_
23	RBC	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	PECAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	phosphorylation	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	concomitant	_	O	O	_	_	_	_	_
33	transendothelial	_	O	O	_	_	_	_	_
34	migration	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	monocytes	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	upregulates	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	activated	_	O	O	_	_	_	_	_
14	human	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	at	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	transcriptional	_	O	O	_	_	_	_	_
20	level	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	enhancing	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	DNA	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	activities	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	both	_	O	O	_	_	_	_	_
29	nuclear	_	O	O	_	_	_	_	_
30	factor	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	activated	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	activator	_	O	O	_	_	_	_	_
37	protein	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	present	_	O	O	_	_	_	_	_
4	report	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	we	_	O	O	_	_	_	_	_
7	studied	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	role	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	stromal	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	derived	_	O	O	_	_	_	_	_
15	cytokine	_	O	O	_	_	_	_	_
16	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	gene	_	O	O	_	_	_	_	_
31	regulation	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	activated	_	O	O	_	_	_	_	_
34	T	_	O	O	_	_	_	_	_
35	lymphocytes	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	mouse	_	O	O	_	_	_	_	_
5	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	units	_	O	O	_	_	_	_	_
9	start	_	O	O	_	_	_	_	_
10	at	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	major	_	O	O	_	_	_	_	_
13	initiation	_	O	O	_	_	_	_	_
14	site	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Nuclear	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	proteins	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	distinctly	_	O	O	_	_	_	_	_
10	biphasic	_	O	O	_	_	_	_	_
11	kinetics	_	O	O	_	_	_	_	_
12	following	_	O	O	_	_	_	_	_
13	phorbol	_	O	O	_	_	_	_	_
14	ester	_	O	O	_	_	_	_	_
15	activation	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	55	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	75	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	early	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	/	_	O	O	_	_	_	_	_
30	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	85	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	late	_	O	O	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	reduced	_	O	O	_	_	_	_	_
6	cysteine	_	O	O	_	_	_	_	_
7	thiols	_	O	O	_	_	_	_	_
8	play	_	O	O	_	_	_	_	_
9	an	_	O	O	_	_	_	_	_
10	important	_	O	O	_	_	_	_	_
11	role	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	DNA	_	O	O	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	activity	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	this	_	O	O	_	_	_	_	_
19	family	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	Rel	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	related	_	O	O	_	_	_	_	_
24	transcription	_	O	O	_	_	_	_	_
25	factors	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	Author	_	O	O	_	_	_	_	_
2	Summary	_	O	O	_	_	_	_	_

1	Latent	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	membrane	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	expressed	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	many	_	O	O	_	_	_	_	_
13	EBV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	associated	_	O	O	_	_	_	_	_
16	cancers	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	responsible	_	O	O	_	_	_	_	_
20	for	_	O	O	_	_	_	_	_
21	most	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	altered	_	O	O	_	_	_	_	_
25	cellular	_	O	O	_	_	_	_	_
26	growth	_	O	O	_	_	_	_	_
27	properties	_	O	O	_	_	_	_	_
28	that	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	induced	_	O	O	_	_	_	_	_
31	by	_	O	O	_	_	_	_	_
32	EBV	_	O	O	_	_	_	_	_
33	infection	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	further	_	O	O	_	_	_	_	_
3	characterize	_	O	O	_	_	_	_	_
4	altered	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	TCRzeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	56	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	lck	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	impaired	_	O	O	_	_	_	_	_
17	activation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	NFkappaB	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	lymphocytes	_	O	O	_	_	_	_	_
23	were	_	O	O	_	_	_	_	_
24	obtained	_	O	O	_	_	_	_	_
25	from	_	O	O	_	_	_	_	_
26	65	_	O	O	_	_	_	_	_
27	patients	_	O	O	_	_	_	_	_
28	with	_	O	O	_	_	_	_	_
29	RCC	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	majority	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	whom	_	O	O	_	_	_	_	_
35	were	_	O	O	_	_	_	_	_
36	receiving	_	O	O	_	_	_	_	_
37	combination	_	O	O	_	_	_	_	_
38	cytokine	_	O	O	_	_	_	_	_
39	therapy	_	O	O	_	_	_	_	_
40	[	_	O	O	_	_	_	_	_
41	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	-	_	O	O	_	_	_	_	_
51	containing	_	O	O	_	_	_	_	_
52	regimens	_	O	O	_	_	_	_	_
53	]	_	O	O	_	_	_	_	_
54	and	_	O	O	_	_	_	_	_
55	37	_	O	O	_	_	_	_	_
56	control	_	O	O	_	_	_	_	_
57	individuals	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	majority	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	patients	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	advanced	_	O	O	_	_	_	_	_
8	RCC	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	peripheral	_	O	O	_	_	_	_	_
11	blood	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	express	_	O	O	_	_	_	_	_
15	TCRzeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	56	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	lck	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	a	_	O	O	_	_	_	_	_
26	subset	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	reduced	_	O	O	_	_	_	_	_
29	levels	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	these	_	O	O	_	_	_	_	_
32	TCRzeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	associated	_	O	O	_	_	_	_	_
34	molecules	_	O	O	_	_	_	_	_
35	are	_	O	O	_	_	_	_	_
36	seen	_	O	O	_	_	_	_	_
37	that	_	O	O	_	_	_	_	_
38	may	_	O	O	_	_	_	_	_
39	increase	_	O	O	_	_	_	_	_
40	during	_	O	O	_	_	_	_	_
41	cytokine	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	based	_	O	O	_	_	_	_	_
44	therapy	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	base	_	O	O	_	_	_	_	_
3	exchange	_	O	O	_	_	_	_	_
4	at	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	509	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	initiation	_	O	O	_	_	_	_	_
12	site	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	TGF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	beta	_	O	O	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	also	_	O	O	_	_	_	_	_
21	linked	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	elevated	_	O	O	_	_	_	_	_
24	total	_	O	O	_	_	_	_	_
25	IgE	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	p	_	O	O	_	_	_	_	_
28	<	_	O	O	_	_	_	_	_
29	0	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_
31	01	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	studied	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	effects	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	TPA	_	O	O	_	_	_	_	_
7	on	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	regulation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	HL	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	60	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	during	_	O	O	_	_	_	_	_
22	monocytic	_	O	O	_	_	_	_	_
23	differentiation	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Low	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	transcripts	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	detectable	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	untreated	_	O	O	_	_	_	_	_
12	HL	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	60	_	O	O	_	_	_	_	_
15	leukemic	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	increased	_	O	O	_	_	_	_	_
19	significantly	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	6	_	O	O	_	_	_	_	_
22	h	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	reached	_	O	O	_	_	_	_	_
26	near	_	O	O	_	_	_	_	_
27	maximal	_	O	O	_	_	_	_	_
28	levels	_	O	O	_	_	_	_	_
29	by	_	O	O	_	_	_	_	_
30	24	_	O	O	_	_	_	_	_
31	h	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	exposure	_	O	O	_	_	_	_	_
34	to	_	O	O	_	_	_	_	_
35	32	_	O	O	_	_	_	_	_
36	nM	_	O	O	_	_	_	_	_
37	TPA	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	defect	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	maturation	_	O	O	_	_	_	_	_
5	resulted	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	transgene	_	O	O	_	_	_	_	_
9	dose	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	dependent	_	O	O	_	_	_	_	_
12	reduction	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	peripheral	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	CD	_	O	O	_	_	_	_	_
21	8	_	O	O	_	_	_	_	_
22	lineage	_	O	O	_	_	_	_	_
23	being	_	O	O	_	_	_	_	_
24	more	_	O	O	_	_	_	_	_
25	severely	_	O	O	_	_	_	_	_
26	affected	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	study	_	O	O	_	_	_	_	_
3	defines	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	oncogenic	_	O	O	_	_	_	_	_
6	properties	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	promoting	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	lymphomagenesis	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Table	_	O	O	_	_	_	_	_
2	1	_	O	O	_	_	_	_	_
3	summarizes	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	biological	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	molecular	_	O	O	_	_	_	_	_
8	properties	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	were	_	O	O	_	_	_	_	_
11	identified	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	wild	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	type	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	transgenic	_	O	O	_	_	_	_	_
20	lymphomas	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	many	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	molecular	_	O	O	_	_	_	_	_
6	properties	_	O	O	_	_	_	_	_
7	studied	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	similar	_	O	O	_	_	_	_	_
10	between	_	O	O	_	_	_	_	_
11	wild	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	type	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	transgenic	_	O	O	_	_	_	_	_
18	lymphomas	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	there	_	O	O	_	_	_	_	_
21	were	_	O	O	_	_	_	_	_
22	distinguishing	_	O	O	_	_	_	_	_
23	biological	_	O	O	_	_	_	_	_
24	properties	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	namely	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	ability	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	transgenic	_	O	O	_	_	_	_	_
33	lymphomas	_	O	O	_	_	_	_	_
34	to	_	O	O	_	_	_	_	_
35	induce	_	O	O	_	_	_	_	_
36	higher	_	O	O	_	_	_	_	_
37	levels	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	survival	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	proliferation	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	B	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	1	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	constitute	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	predominant	_	O	O	_	_	_	_	_
8	lymphocyte	_	O	O	_	_	_	_	_
9	population	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	peritoneal	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	pleuropericardial	_	O	O	_	_	_	_	_
15	cavities	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	while	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	2	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	are	_	O	O	_	_	_	_	_
23	mainly	_	O	O	_	_	_	_	_
24	found	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	spleen	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	lymph	_	O	O	_	_	_	_	_
30	node	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	peripheral	_	O	O	_	_	_	_	_
34	blood	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	previously	_	O	O	_	_	_	_	_
4	shown	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	cRel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	specifically	_	O	O	_	_	_	_	_
9	activated	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	both	_	O	O	_	_	_	_	_
12	wild	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	type	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	transgenic	_	O	O	_	_	_	_	_
19	lymphomas	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	suggesting	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	activation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	cRel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	is	_	O	O	_	_	_	_	_
27	associated	_	O	O	_	_	_	_	_
28	with	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	cell	_	O	O	_	_	_	_	_
31	transformation	_	O	O	_	_	_	_	_
32	[	_	O	O	_	_	_	_	_
33	27	_	O	O	_	_	_	_	_
34	]	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Similarly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	due	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	mimicry	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	signaling	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	transgenic	_	O	O	_	_	_	_	_
12	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	mice	_	O	O	_	_	_	_	_
15	are	_	O	O	_	_	_	_	_
16	also	_	O	O	_	_	_	_	_
17	defective	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	GC	_	O	O	_	_	_	_	_
20	formation	_	O	O	_	_	_	_	_
21	[	_	O	O	_	_	_	_	_
22	23	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	49	_	O	O	_	_	_	_	_
25	]	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Whereas	_	O	O	_	_	_	_	_
2	different	_	O	O	_	_	_	_	_
3	anti	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	mAb	_	O	O	_	_	_	_	_
8	or	_	O	O	_	_	_	_	_
9	HIV	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	gp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	120	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	could	_	O	O	_	_	_	_	_
15	all	_	O	O	_	_	_	_	_
16	trigger	_	O	O	_	_	_	_	_
17	activation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	protein	_	O	O	_	_	_	_	_
21	tyrosine	_	O	O	_	_	_	_	_
22	kinases	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	56	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	lck	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	59	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	fyn	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	phosphorylation	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	Shc	_	O	O	_	_	_	_	_
35	adaptor	_	O	O	_	_	_	_	_
36	protein	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	which	_	O	O	_	_	_	_	_
39	mediates	_	O	O	_	_	_	_	_
40	signals	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	Ras	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	they	_	O	O	_	_	_	_	_
45	differed	_	O	O	_	_	_	_	_
46	significantly	_	O	O	_	_	_	_	_
47	in	_	O	O	_	_	_	_	_
48	their	_	O	O	_	_	_	_	_
49	ability	_	O	O	_	_	_	_	_
50	to	_	O	O	_	_	_	_	_
51	activate	_	O	O	_	_	_	_	_
52	NF	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	AT	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	observations	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	adherence	_	O	O	_	_	_	_	_
6	results	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	increases	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	EGR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	PDGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	mRNA	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Numbers	_	O	O	_	_	_	_	_
2	show	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	percentage	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	+	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_




1	By	_	O	O	_	_	_	_	_
2	using	_	O	O	_	_	_	_	_
3	several	_	O	O	_	_	_	_	_
4	HBD	_	O	O	_	_	_	_	_
5	subfragments	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	mAb	_	O	O	_	_	_	_	_
9	18	_	O	O	_	_	_	_	_
10	C	_	O	O	_	_	_	_	_
11	7	_	O	O	_	_	_	_	_
12	epitope	_	O	O	_	_	_	_	_
13	was	_	O	O	_	_	_	_	_
14	located	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	N	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	terminal	_	O	O	_	_	_	_	_
20	region	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	HBD	_	O	O	_	_	_	_	_
24	from	_	O	O	_	_	_	_	_
25	Thr	_	O	O	_	_	_	_	_
26	729	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	Leu	_	O	O	_	_	_	_	_
29	765	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	18	_	O	O	_	_	_	_	_
3	C	_	O	O	_	_	_	_	_
4	7	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	incubated	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	liganded	_	O	O	_	_	_	_	_
9	MR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	it	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	able	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	partly	_	O	O	_	_	_	_	_
16	displace	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	20	_	O	O	_	_	_	_	_
19	%	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	hormone	_	O	O	_	_	_	_	_
23	from	_	O	O	_	_	_	_	_
24	its	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	site	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	sucrose	_	O	O	_	_	_	_	_
3	gradient	_	O	O	_	_	_	_	_
4	analysis	_	O	O	_	_	_	_	_
5	indicated	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	simultaneous	_	O	O	_	_	_	_	_
8	presence	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	two	_	O	O	_	_	_	_	_
11	kinds	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	receptor	_	O	O	_	_	_	_	_
14	complexes	_	O	O	_	_	_	_	_
15	:	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	steroid	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	MR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	complex	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	antibody	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	MR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	complex	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicated	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	epitope	_	O	O	_	_	_	_	_
7	recognized	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	18	_	O	O	_	_	_	_	_
10	C	_	O	O	_	_	_	_	_
11	7	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	directly	_	O	O	_	_	_	_	_
14	implicated	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	hormone	_	O	O	_	_	_	_	_
17	binding	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Studies	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	also	_	O	O	_	_	_	_	_
4	performed	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	an	_	O	O	_	_	_	_	_
7	HL	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	60	_	O	O	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	vinc	_	O	O	_	_	_	_	_
12	revertant	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	HL	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	60	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	vinc	_	O	O	_	_	_	_	_
19	/	_	O	O	_	_	_	_	_
20	R	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	line	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	has	_	O	O	_	_	_	_	_
25	regained	_	O	O	_	_	_	_	_
26	partial	_	O	O	_	_	_	_	_
27	sensitivity	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	vincristine	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	BACKGROUND	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	fundamentally	_	O	O	_	_	_	_	_
8	involved	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	eosinophilic	_	O	O	_	_	_	_	_
11	inflammation	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	OBJECTIVE	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	We	_	O	O	_	_	_	_	_
4	aimed	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	find	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	transcriptional	_	O	O	_	_	_	_	_
9	mechanisms	_	O	O	_	_	_	_	_
10	that	_	O	O	_	_	_	_	_
11	regulate	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	gene	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	selectively	_	O	O	_	_	_	_	_
19	control	_	O	O	_	_	_	_	_
20	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	synthesis	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	For	_	O	O	_	_	_	_	_
2	real	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	time	_	O	O	_	_	_	_	_
5	PCR	_	O	O	_	_	_	_	_
6	detection	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	immunoprecipitated	_	O	O	_	_	_	_	_
9	targets	_	O	O	_	_	_	_	_
10	using	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	SYBR	_	O	O	_	_	_	_	_
13	Green	_	O	O	_	_	_	_	_
14	PCR	_	O	O	_	_	_	_	_
15	Kit	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	standard	_	O	O	_	_	_	_	_
19	curve	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	obtained	_	O	O	_	_	_	_	_
22	with	_	O	O	_	_	_	_	_
23	serial	_	O	O	_	_	_	_	_
24	dilutions	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	input	_	O	O	_	_	_	_	_
27	DNA	_	O	O	_	_	_	_	_
28	for	_	O	O	_	_	_	_	_
29	each	_	O	O	_	_	_	_	_
30	sample	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	mul	_	O	O	_	_	_	_	_
35	ChIP	_	O	O	_	_	_	_	_
36	DNA	_	O	O	_	_	_	_	_
37	was	_	O	O	_	_	_	_	_
38	used	_	O	O	_	_	_	_	_
39	per	_	O	O	_	_	_	_	_
40	PCR	_	O	O	_	_	_	_	_
41	reaction	_	O	O	_	_	_	_	_
42	(	_	O	O	_	_	_	_	_
43	performed	_	O	O	_	_	_	_	_
44	in	_	O	O	_	_	_	_	_
45	duplicates	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	Refer	_	O	O	_	_	_	_	_
2	to	_	O	O	_	_	_	_	_
3	Table	_	O	O	_	_	_	_	_
4	S	_	O	O	_	_	_	_	_
5	1	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	available	_	O	O	_	_	_	_	_
8	at	_	O	O	_	_	_	_	_
9	http	_	O	O	_	_	_	_	_
10	://	_	O	O	_	_	_	_	_
11	www	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_
13	jem	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_
15	org	_	O	O	_	_	_	_	_
16	/	_	O	O	_	_	_	_	_
17	cgi	_	O	O	_	_	_	_	_
18	/	_	O	O	_	_	_	_	_
19	content	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	full	_	O	O	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	jem	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_
25	20081242	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	DC	_	O	O	_	_	_	_	_
28	1	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	for	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	list	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	primer	_	O	O	_	_	_	_	_
35	sets	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	examined	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	effects	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	N	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	acetyl	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	L	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	cysteine	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	NAC	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	well	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	characterized	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	thiol	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	containing	_	O	O	_	_	_	_	_
26	antioxidant	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	on	_	O	O	_	_	_	_	_
29	agonist	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	induced	_	O	O	_	_	_	_	_
32	monocytic	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	adhesion	_	O	O	_	_	_	_	_
35	to	_	O	O	_	_	_	_	_
36	endothelial	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	EC	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	binding	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	its	_	O	O	_	_	_	_	_
12	consensus	_	O	O	_	_	_	_	_
13	sequences	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	gene	_	O	O	_	_	_	_	_
24	exhibits	_	O	O	_	_	_	_	_
25	marked	_	O	O	_	_	_	_	_
26	differences	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	redox	_	O	O	_	_	_	_	_
29	sensitivity	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	allowing	_	O	O	_	_	_	_	_
32	for	_	O	O	_	_	_	_	_
33	differential	_	O	O	_	_	_	_	_
34	gene	_	O	O	_	_	_	_	_
35	expression	_	O	O	_	_	_	_	_
36	regulated	_	O	O	_	_	_	_	_
37	by	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	same	_	O	O	_	_	_	_	_
40	transcription	_	O	O	_	_	_	_	_
41	factor	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	investigated	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	regulation	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	HIV	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	dopamine	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	Jurkat	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	primary	_	O	O	_	_	_	_	_
22	blood	_	O	O	_	_	_	_	_
23	mononuclear	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	PBMC	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Constitutive	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	kappa	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	mRNA	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	nucleated	_	O	O	_	_	_	_	_
19	fetal	_	O	O	_	_	_	_	_
20	blood	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	up	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	regulation	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	anti	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	CD	_	O	O	_	_	_	_	_
38	3	_	O	O	_	_	_	_	_
39	stimulation	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	secretion	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	anti	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	CD	_	O	O	_	_	_	_	_
12	3	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	stimulated	_	O	O	_	_	_	_	_
15	cord	_	O	O	_	_	_	_	_
16	blood	_	O	O	_	_	_	_	_
17	mononuclear	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	was	_	O	O	_	_	_	_	_
20	still	_	O	O	_	_	_	_	_
21	blunted	_	O	O	_	_	_	_	_
22	compared	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	control	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	from	_	O	O	_	_	_	_	_
27	adults	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_


1	Here	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	demonstrate	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	an	_	O	O	_	_	_	_	_
9	MHC	_	O	O	_	_	_	_	_
10	class	_	O	O	_	_	_	_	_
11	II	_	O	O	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	specific	_	O	O	_	_	_	_	_
15	transcription	_	O	O	_	_	_	_	_
16	activator	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	transactivation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	multiple	_	O	O	_	_	_	_	_
5	cis	_	O	O	_	_	_	_	_
6	elements	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	especially	_	O	O	_	_	_	_	_
9	S	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	X	_	O	O	_	_	_	_	_
12	2	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	DR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	proximal	_	O	O	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	group	_	O	O	_	_	_	_	_
22	II	_	O	O	_	_	_	_	_
23	CID	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	is	_	O	O	_	_	_	_	_
26	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	dependent	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	53	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	paradox	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	pathogenesis	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	tumor	_	O	O	_	_	_	_	_
10	progression	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Recent	_	O	O	_	_	_	_	_
2	evidence	_	O	O	_	_	_	_	_
3	suggests	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	53	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	molecule	_	O	O	_	_	_	_	_
9	appears	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	two	_	O	O	_	_	_	_	_
12	different	_	O	O	_	_	_	_	_
13	forms	_	O	O	_	_	_	_	_
14	:	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	mutant	_	O	O	_	_	_	_	_
17	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	53	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	stimulates	_	O	O	_	_	_	_	_
21	tumor	_	O	O	_	_	_	_	_
22	progression	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	wild	_	O	O	_	_	_	_	_
26	type	_	O	O	_	_	_	_	_
27	p	_	O	O	_	_	_	_	_
28	53	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	that	_	O	O	_	_	_	_	_
30	inhibits	_	O	O	_	_	_	_	_
31	tumor	_	O	O	_	_	_	_	_
32	progression	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	pathway	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	disabled	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	treatment	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	lymphoma	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	phosphorylation	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	Figure	_	O	O	_	_	_	_	_
24	4	_	O	O	_	_	_	_	_
25	C	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_




1	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	.	_	O	O	_	_	_	_	_
4	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	heterodimers	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	also	_	O	O	_	_	_	_	_
10	detected	_	O	O	_	_	_	_	_
11	bound	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	this	_	O	O	_	_	_	_	_
14	sequence	_	O	O	_	_	_	_	_
15	at	_	O	O	_	_	_	_	_
16	early	_	O	O	_	_	_	_	_
17	time	_	O	O	_	_	_	_	_
18	points	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	7	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	16	_	O	O	_	_	_	_	_
23	h	_	O	O	_	_	_	_	_
24	;	_	O	O	_	_	_	_	_
25	early	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	both	_	O	O	_	_	_	_	_
30	remained	_	O	O	_	_	_	_	_
31	active	_	O	O	_	_	_	_	_
32	at	_	O	O	_	_	_	_	_
33	later	_	O	O	_	_	_	_	_
34	time	_	O	O	_	_	_	_	_
35	points	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	40	_	O	O	_	_	_	_	_
38	h	_	O	O	_	_	_	_	_
39	;	_	O	O	_	_	_	_	_
40	late	_	O	O	_	_	_	_	_
41	)	_	O	O	_	_	_	_	_
42	after	_	O	O	_	_	_	_	_
43	activation	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	mediated	_	O	O	_	_	_	_	_
3	by	_	O	O	_	_	_	_	_
4	NFAT	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	highly	_	O	O	_	_	_	_	_
7	inducible	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	effector	_	O	O	_	_	_	_	_
10	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	+	_	O	O	_	_	_	_	_
13	T	_	O	O	_	_	_	_	_
14	helper	_	O	O	_	_	_	_	_
15	2	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	Th	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	but	_	O	O	_	_	_	_	_
22	not	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	Th	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	It	_	O	O	_	_	_	_	_
2	has	_	O	O	_	_	_	_	_
3	previously	_	O	O	_	_	_	_	_
4	been	_	O	O	_	_	_	_	_
5	shown	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	transgenic	_	O	O	_	_	_	_	_
10	mice	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	restricted	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	220	_	O	O	_	_	_	_	_
20	+	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	lymphoma	_	O	O	_	_	_	_	_
25	detected	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	greatly	_	O	O	_	_	_	_	_
28	enlarged	_	O	O	_	_	_	_	_
29	spleens	_	O	O	_	_	_	_	_
30	[	_	O	O	_	_	_	_	_
31	23	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	26	_	O	O	_	_	_	_	_
34	]	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	involvement	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappaB	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	PGE	_	O	O	_	_	_	_	_
10	2	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	activating	_	O	O	_	_	_	_	_
14	effect	_	O	O	_	_	_	_	_
15	on	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	transcription	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	further	_	O	O	_	_	_	_	_
22	confirmed	_	O	O	_	_	_	_	_
23	using	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	kappaB	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	regulated	_	O	O	_	_	_	_	_
28	luciferase	_	O	O	_	_	_	_	_
29	encoding	_	O	O	_	_	_	_	_
30	vector	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	by	_	O	O	_	_	_	_	_
33	electrophoretic	_	O	O	_	_	_	_	_
34	mobility	_	O	O	_	_	_	_	_
35	shift	_	O	O	_	_	_	_	_
36	assays	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	secretion	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	PGE	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	macrophages	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	response	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	infection	_	O	O	_	_	_	_	_
15	or	_	O	O	_	_	_	_	_
16	inflammatory	_	O	O	_	_	_	_	_
17	activators	_	O	O	_	_	_	_	_
18	could	_	O	O	_	_	_	_	_
19	induce	_	O	O	_	_	_	_	_
20	signaling	_	O	O	_	_	_	_	_
21	events	_	O	O	_	_	_	_	_
22	resulting	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	activation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	proviral	_	O	O	_	_	_	_	_
27	DNA	_	O	O	_	_	_	_	_
28	present	_	O	O	_	_	_	_	_
29	into	_	O	O	_	_	_	_	_
30	T	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	latently	_	O	O	_	_	_	_	_
33	infected	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	HIV	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	1	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Antigen	_	O	O	_	_	_	_	_
2	receptor	_	O	O	_	_	_	_	_
3	signals	_	O	O	_	_	_	_	_
4	prolong	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	DNA	_	O	O	_	_	_	_	_
11	interaction	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	probably	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	functionally	_	O	O	_	_	_	_	_
16	antagonizing	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	IL	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	induced	_	O	O	_	_	_	_	_
23	synthesis	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	a	_	O	O	_	_	_	_	_
26	protein	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	s	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	responsible	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	transient	_	O	O	_	_	_	_	_
34	NF	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	kappa	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	DNA	_	O	O	_	_	_	_	_
40	interaction	_	O	O	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	consequently	_	O	O	_	_	_	_	_
43	synergistically	_	O	O	_	_	_	_	_
44	enhance	_	O	O	_	_	_	_	_
45	IL	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	1	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	induced	_	O	O	_	_	_	_	_
50	NF	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	kappa	_	O	O	_	_	_	_	_
53	B	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	dependent	_	O	O	_	_	_	_	_
56	gene	_	O	O	_	_	_	_	_
57	transcription	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	vitro	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	translation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	complementary	_	O	O	_	_	_	_	_
9	DNA	_	O	O	_	_	_	_	_
10	resulted	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	synthesis	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	protein	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	an	_	O	O	_	_	_	_	_
19	apparent	_	O	O	_	_	_	_	_
20	molecular	_	O	O	_	_	_	_	_
21	size	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	65	_	O	O	_	_	_	_	_
24	kilodaltons	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	kD	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	65	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kD	_	O	O	_	_	_	_	_
8	protein	_	O	O	_	_	_	_	_
9	associated	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	subunit	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	kappa	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	probe	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	form	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	complex	_	O	O	_	_	_	_	_
29	with	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	same	_	O	O	_	_	_	_	_
32	electrophoretic	_	O	O	_	_	_	_	_
33	mobility	_	O	O	_	_	_	_	_
34	as	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	kappa	_	O	O	_	_	_	_	_
39	B	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	DNA	_	O	O	_	_	_	_	_
42	complex	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_


1	Originally	_	O	O	_	_	_	_	_
2	identified	_	O	O	_	_	_	_	_
3	as	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	restriction	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	HIV	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	infection	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	APOBEC	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	found	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	peripheral	_	O	O	_	_	_	_	_
23	blood	_	O	O	_	_	_	_	_
24	lymphocytes	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	macrophages	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	which	_	O	O	_	_	_	_	_
29	represent	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	main	_	O	O	_	_	_	_	_
32	target	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	for	_	O	O	_	_	_	_	_
35	HIV	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	1	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	32	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	TSS	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	located	_	O	O	_	_	_	_	_
5	66	_	O	O	_	_	_	_	_
6	bp	_	O	O	_	_	_	_	_
7	upstream	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	start	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	published	_	O	O	_	_	_	_	_
14	mRNA	_	O	O	_	_	_	_	_
15	sequence	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	GenBanktrade	_	O	O	_	_	_	_	_
18	NM	_	O	O	_	_	_	_	_
19	021822	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Consistent	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	this	_	O	O	_	_	_	_	_
4	data	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	we	_	O	O	_	_	_	_	_
7	observed	_	O	O	_	_	_	_	_
8	an	_	O	O	_	_	_	_	_
9	interferon	_	O	O	_	_	_	_	_
10	induction	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	hepatocytes	_	O	O	_	_	_	_	_
13	for	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	fragments	_	O	O	_	_	_	_	_
16	ranging	_	O	O	_	_	_	_	_
17	between	_	O	O	_	_	_	_	_
18	1025	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	120	_	O	O	_	_	_	_	_
21	bp	_	O	O	_	_	_	_	_
22	length	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	F	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	expressed	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	many	_	O	O	_	_	_	_	_
8	human	_	O	O	_	_	_	_	_
9	tissues	_	O	O	_	_	_	_	_
10	that	_	O	O	_	_	_	_	_
11	also	_	O	O	_	_	_	_	_
12	express	_	O	O	_	_	_	_	_
13	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	both	_	O	O	_	_	_	_	_
18	proteins	_	O	O	_	_	_	_	_
19	have	_	O	O	_	_	_	_	_
20	been	_	O	O	_	_	_	_	_
21	shown	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	form	_	O	O	_	_	_	_	_
24	heteromultimers	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	which	_	O	O	_	_	_	_	_
27	are	_	O	O	_	_	_	_	_
28	most	_	O	O	_	_	_	_	_
29	likely	_	O	O	_	_	_	_	_
30	generated	_	O	O	_	_	_	_	_
31	through	_	O	O	_	_	_	_	_
32	binding	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	an	_	O	O	_	_	_	_	_
35	RNA	_	O	O	_	_	_	_	_
36	intermediate	_	O	O	_	_	_	_	_
37	(	_	O	O	_	_	_	_	_
38	26	_	O	O	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	29	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	30	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_


1	Triplex	_	O	O	_	_	_	_	_
2	formation	_	O	O	_	_	_	_	_
3	by	_	O	O	_	_	_	_	_
4	GM	_	O	O	_	_	_	_	_
5	3	_	O	O	_	_	_	_	_
6	blocked	_	O	O	_	_	_	_	_
7	recombinant	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	nuclear	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappaB	_	O	O	_	_	_	_	_
13	proteins	_	O	O	_	_	_	_	_
14	binding	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	element	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	After	_	O	O	_	_	_	_	_
2	48	_	O	O	_	_	_	_	_
3	h	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	harvested	_	O	O	_	_	_	_	_
8	for	_	O	O	_	_	_	_	_
9	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	assay	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	phosphorylation	_	O	O	_	_	_	_	_
3	appears	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	be	_	O	O	_	_	_	_	_
6	related	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	signaling	_	O	O	_	_	_	_	_
10	events	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	are	_	O	O	_	_	_	_	_
13	activated	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	TRAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	under	_	O	O	_	_	_	_	_
18	these	_	O	O	_	_	_	_	_
19	circumstances	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	since	_	O	O	_	_	_	_	_
22	two	_	O	O	_	_	_	_	_
23	nonfunctional	_	O	O	_	_	_	_	_
24	mutants	_	O	O	_	_	_	_	_
25	were	_	O	O	_	_	_	_	_
26	found	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	be	_	O	O	_	_	_	_	_
29	phosphorylated	_	O	O	_	_	_	_	_
30	significantly	_	O	O	_	_	_	_	_
31	less	_	O	O	_	_	_	_	_
32	than	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	wild	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	type	_	O	O	_	_	_	_	_
37	protein	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	chaffeensis	_	O	O	_	_	_	_	_
2	significantly	_	O	O	_	_	_	_	_
3	enhanced	_	O	O	_	_	_	_	_
4	mRNA	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	THP	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Nuclear	_	O	O	_	_	_	_	_
2	factor	_	O	O	_	_	_	_	_
3	kappa	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	pleiotropic	_	O	O	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	factor	_	O	O	_	_	_	_	_
16	which	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	involved	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	transcriptional	_	O	O	_	_	_	_	_
22	regulation	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	several	_	O	O	_	_	_	_	_
25	specific	_	O	O	_	_	_	_	_
26	genes	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	dose	_	O	O	_	_	_	_	_
7	range	_	O	O	_	_	_	_	_
8	where	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	viability	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	remains	_	O	O	_	_	_	_	_
15	very	_	O	O	_	_	_	_	_
16	high	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	subunits	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	also	_	O	O	_	_	_	_	_
17	shown	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	be	_	O	O	_	_	_	_	_
20	regulated	_	O	O	_	_	_	_	_
21	differentially	_	O	O	_	_	_	_	_
22	after	_	O	O	_	_	_	_	_
23	exposures	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_
27	0	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	2	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_
31	0	_	O	O	_	_	_	_	_
32	Gy	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	efficiently	_	O	O	_	_	_	_	_
5	repressed	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	mediated	_	O	O	_	_	_	_	_
12	induction	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	Figure	_	O	O	_	_	_	_	_
19	5	_	O	O	_	_	_	_	_
20	A	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	concentration	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	dependent	_	O	O	_	_	_	_	_
27	manner	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	Figure	_	O	O	_	_	_	_	_
30	5	_	O	O	_	_	_	_	_
31	B	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	foci	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	which	_	O	O	_	_	_	_	_
5	were	_	O	O	_	_	_	_	_
6	preferentially	_	O	O	_	_	_	_	_
7	found	_	O	O	_	_	_	_	_
8	adjacent	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	nucleoli	_	O	O	_	_	_	_	_
11	or	_	O	O	_	_	_	_	_
12	at	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	nuclear	_	O	O	_	_	_	_	_
15	periphery	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	did	_	O	O	_	_	_	_	_
18	not	_	O	O	_	_	_	_	_
19	represent	_	O	O	_	_	_	_	_
20	sites	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	active	_	O	O	_	_	_	_	_
23	transcription	_	O	O	_	_	_	_	_
24	or	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	consensus	_	O	O	_	_	_	_	_
32	sites	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	loci	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	nuclear	_	O	O	_	_	_	_	_
6	bodies	_	O	O	_	_	_	_	_
7	differed	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	previously	_	O	O	_	_	_	_	_
10	described	_	O	O	_	_	_	_	_
11	nuclear	_	O	O	_	_	_	_	_
12	structures	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	there	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	no	_	O	O	_	_	_	_	_
17	co	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	localization	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	nuclear	_	O	O	_	_	_	_	_
22	antigens	_	O	O	_	_	_	_	_
23	involved	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	RNA	_	O	O	_	_	_	_	_
26	processing	_	O	O	_	_	_	_	_
27	or	_	O	O	_	_	_	_	_
28	other	_	O	O	_	_	_	_	_
29	ubiquitous	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	Spl	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	TBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	or	_	O	O	_	_	_	_	_
40	haemopoietic	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	NF	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	E	_	O	O	_	_	_	_	_
45	2	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	transcription	_	O	O	_	_	_	_	_
48	factors	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	high	_	O	O	_	_	_	_	_
6	level	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	protects	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	vitro	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	vivo	_	O	O	_	_	_	_	_
18	from	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	viral	_	O	O	_	_	_	_	_
21	protease	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	prevents	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	death	_	O	O	_	_	_	_	_
26	following	_	O	O	_	_	_	_	_
27	HIV	_	O	O	_	_	_	_	_
28	infection	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	human	_	O	O	_	_	_	_	_
31	lymphocytes	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	while	_	O	O	_	_	_	_	_
34	reducing	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	yields	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	viral	_	O	O	_	_	_	_	_
39	structural	_	O	O	_	_	_	_	_
40	proteins	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	infectivity	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	and	_	O	O	_	_	_	_	_
45	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_



1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	identified	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	negative	_	O	O	_	_	_	_	_
6	regulatory	_	O	O	_	_	_	_	_
7	element	_	O	O	_	_	_	_	_
8	located	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	region	_	O	O	_	_	_	_	_
12	between	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	685	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	395	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	induced	_	O	O	_	_	_	_	_
5	slightly	_	O	O	_	_	_	_	_
6	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	had	_	O	O	_	_	_	_	_
11	almost	_	O	O	_	_	_	_	_
12	no	_	O	O	_	_	_	_	_
13	effect	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	AP	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	able	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	block	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	Id	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	specific	_	O	O	_	_	_	_	_
10	band	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	blocking	_	O	O	_	_	_	_	_
14	peptide	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	data	_	O	O	_	_	_	_	_
17	not	_	O	O	_	_	_	_	_
18	shown	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Aspirin	_	O	O	_	_	_	_	_
2	appeared	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	prevent	_	O	O	_	_	_	_	_
5	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	transcription	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	since	_	O	O	_	_	_	_	_
11	it	_	O	O	_	_	_	_	_
12	dose	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	dependently	_	O	O	_	_	_	_	_
15	inhibited	_	O	O	_	_	_	_	_
16	induction	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	mRNA	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	previously	_	O	O	_	_	_	_	_
3	reported	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	purification	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	PTF	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	complex	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	four	_	O	O	_	_	_	_	_
14	subunits	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	molecular	_	O	O	_	_	_	_	_
19	cloning	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	characterization	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	PTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	delta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	subunits	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Native	_	O	O	_	_	_	_	_
2	PTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	either	_	O	O	_	_	_	_	_
7	protein	_	O	O	_	_	_	_	_
8	fractions	_	O	O	_	_	_	_	_
9	or	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	PTF	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	Oct	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	DNA	_	O	O	_	_	_	_	_
18	complex	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	can	_	O	O	_	_	_	_	_
21	be	_	O	O	_	_	_	_	_
22	recognized	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	polyclonal	_	O	O	_	_	_	_	_
25	antibodies	_	O	O	_	_	_	_	_
26	raised	_	O	O	_	_	_	_	_
27	against	_	O	O	_	_	_	_	_
28	recombinant	_	O	O	_	_	_	_	_
29	PTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	immunoprecipitation	_	O	O	_	_	_	_	_
5	analyses	_	O	O	_	_	_	_	_
6	demonstrate	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	substantial	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	similar	_	O	O	_	_	_	_	_
11	molar	_	O	O	_	_	_	_	_
12	amounts	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	TATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	binding	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	TBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	TFIIIB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	90	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	can	_	O	O	_	_	_	_	_
25	weakly	_	O	O	_	_	_	_	_
26	associate	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	PTF	_	O	O	_	_	_	_	_
29	at	_	O	O	_	_	_	_	_
30	low	_	O	O	_	_	_	_	_
31	salt	_	O	O	_	_	_	_	_
32	conditions	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	but	_	O	O	_	_	_	_	_
35	this	_	O	O	_	_	_	_	_
36	association	_	O	O	_	_	_	_	_
37	is	_	O	O	_	_	_	_	_
38	dramatically	_	O	O	_	_	_	_	_
39	reduced	_	O	O	_	_	_	_	_
40	at	_	O	O	_	_	_	_	_
41	high	_	O	O	_	_	_	_	_
42	salt	_	O	O	_	_	_	_	_
43	concentrations	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Introduction	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	hallmark	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	Th	_	O	O	_	_	_	_	_
5	1	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	Th	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	differentiation	_	O	O	_	_	_	_	_
10	pathways	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	exclusiveness	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	individual	_	O	O	_	_	_	_	_
17	phenotype	_	O	O	_	_	_	_	_
18	leading	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	either	_	O	O	_	_	_	_	_
21	Th	_	O	O	_	_	_	_	_
22	1	_	O	O	_	_	_	_	_
23	or	_	O	O	_	_	_	_	_
24	Th	_	O	O	_	_	_	_	_
25	2	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	but	_	O	O	_	_	_	_	_
28	not	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	mixed	_	O	O	_	_	_	_	_
31	populations	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	exclusiveness	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	mechanism	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	provided	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	polarization	_	O	O	_	_	_	_	_
11	process	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	where	_	O	O	_	_	_	_	_
14	Th	_	O	O	_	_	_	_	_
15	2	_	O	O	_	_	_	_	_
16	differentiation	_	O	O	_	_	_	_	_
17	inhibits	_	O	O	_	_	_	_	_
18	Th	_	O	O	_	_	_	_	_
19	1	_	O	O	_	_	_	_	_
20	commitment	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	vice	_	O	O	_	_	_	_	_
23	versa	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	sufficient	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	induce	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	Th	_	O	O	_	_	_	_	_
9	2	_	O	O	_	_	_	_	_
10	phenotype	_	O	O	_	_	_	_	_
11	[	_	O	O	_	_	_	_	_
12	3	_	O	O	_	_	_	_	_
13	]	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	acts	_	O	O	_	_	_	_	_
16	not	_	O	O	_	_	_	_	_
17	only	_	O	O	_	_	_	_	_
18	through	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	induction	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	13	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	Th	_	O	O	_	_	_	_	_
36	2	_	O	O	_	_	_	_	_
37	cytokines	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	but	_	O	O	_	_	_	_	_
40	also	_	O	O	_	_	_	_	_
41	through	_	O	O	_	_	_	_	_
42	the	_	O	O	_	_	_	_	_
43	inhibition	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	Th	_	O	O	_	_	_	_	_
46	1	_	O	O	_	_	_	_	_
47	cell	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	specific	_	O	O	_	_	_	_	_
50	factors	_	O	O	_	_	_	_	_
51	[	_	O	O	_	_	_	_	_
52	3	_	O	O	_	_	_	_	_
53	]	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Overexpression	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	dominant	_	O	O	_	_	_	_	_
5	negative	_	O	O	_	_	_	_	_
6	form	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	[	_	O	O	_	_	_	_	_
11	8	_	O	O	_	_	_	_	_
12	]	_	O	O	_	_	_	_	_
13	or	_	O	O	_	_	_	_	_
14	treatment	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	antisense	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	mediated	_	O	O	_	_	_	_	_
19	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	blockade	_	O	O	_	_	_	_	_
22	[	_	O	O	_	_	_	_	_
23	9	_	O	O	_	_	_	_	_
24	]	_	O	O	_	_	_	_	_
25	decreased	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	severity	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	allergic	_	O	O	_	_	_	_	_
31	airway	_	O	O	_	_	_	_	_
32	hyper	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	responsiveness	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	demonstrated	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	IL	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	12	_	O	O	_	_	_	_	_
7	directly	_	O	O	_	_	_	_	_
8	up	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	regulates	_	O	O	_	_	_	_	_
11	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	same	_	O	O	_	_	_	_	_
17	extent	_	O	O	_	_	_	_	_
18	as	_	O	O	_	_	_	_	_
19	IFN	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	alpha	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	normal	_	O	O	_	_	_	_	_
24	human	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	NK	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	showed	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	IL	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	12	_	O	O	_	_	_	_	_
7	had	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	direct	_	O	O	_	_	_	_	_
10	effect	_	O	O	_	_	_	_	_
11	on	_	O	O	_	_	_	_	_
12	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	an	_	O	O	_	_	_	_	_
17	effect	_	O	O	_	_	_	_	_
18	not	_	O	O	_	_	_	_	_
19	mediated	_	O	O	_	_	_	_	_
20	indirectly	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	induction	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	production	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	high	_	O	O	_	_	_	_	_
5	amounts	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	mRNA	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	only	_	O	O	_	_	_	_	_
14	observed	_	O	O	_	_	_	_	_
15	under	_	O	O	_	_	_	_	_
16	Th	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	differentiation	_	O	O	_	_	_	_	_
20	conditions	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	low	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	dose	_	O	O	_	_	_	_	_
25	antigen	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	Figure	_	O	O	_	_	_	_	_
29	6	_	O	O	_	_	_	_	_
30	B	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	this	_	O	O	_	_	_	_	_
35	expression	_	O	O	_	_	_	_	_
36	was	_	O	O	_	_	_	_	_
37	markedly	_	O	O	_	_	_	_	_
38	downregulated	_	O	O	_	_	_	_	_
39	by	_	O	O	_	_	_	_	_
40	both	_	O	O	_	_	_	_	_
41	increasing	_	O	O	_	_	_	_	_
42	antigen	_	O	O	_	_	_	_	_
43	dose	_	O	O	_	_	_	_	_
44	and	_	O	O	_	_	_	_	_
45	coculture	_	O	O	_	_	_	_	_
46	in	_	O	O	_	_	_	_	_
47	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	(	_	O	O	_	_	_	_	_
51	Figure	_	O	O	_	_	_	_	_
52	6	_	O	O	_	_	_	_	_
53	B	_	O	O	_	_	_	_	_
54	)	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	Interestingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	sustained	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	high	_	O	O	_	_	_	_	_
9	expression	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	Maf	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	mRNA	_	O	O	_	_	_	_	_
15	even	_	O	O	_	_	_	_	_
16	at	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	highest	_	O	O	_	_	_	_	_
19	antigen	_	O	O	_	_	_	_	_
20	dose	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	Figure	_	O	O	_	_	_	_	_
23	6	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	Therefore	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	studied	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	pattern	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	LAZ	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	situ	_	O	O	_	_	_	_	_
16	hybridization	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	synthetic	_	O	O	_	_	_	_	_
19	oligonucleotide	_	O	O	_	_	_	_	_
20	probes	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	frozen	_	O	O	_	_	_	_	_
23	tissue	_	O	O	_	_	_	_	_
24	sections	_	O	O	_	_	_	_	_
25	from	_	O	O	_	_	_	_	_
26	five	_	O	O	_	_	_	_	_
27	reactive	_	O	O	_	_	_	_	_
28	lymph	_	O	O	_	_	_	_	_
29	nodes	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	38	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	non	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	NHL	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Interaction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factors	_	O	O	_	_	_	_	_
5	RFX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	MIBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	gamma	_	O	O	_	_	_	_	_
13	motif	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	negative	_	O	O	_	_	_	_	_
17	regulatory	_	O	O	_	_	_	_	_
18	element	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	hepatitis	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	virus	_	O	O	_	_	_	_	_
24	core	_	O	O	_	_	_	_	_
25	promoter	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_



1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	either	_	O	O	_	_	_	_	_
5	or	_	O	O	_	_	_	_	_
6	both	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factors	_	O	O	_	_	_	_	_
11	are	_	O	O	_	_	_	_	_
12	involved	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	survival	_	O	O	_	_	_	_	_
16	or	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	cycle	_	O	O	_	_	_	_	_
19	progression	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	response	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	primary	_	O	O	_	_	_	_	_
28	human	_	O	O	_	_	_	_	_
29	T	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	responsive	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	growth	_	O	O	_	_	_	_	_
35	factor	_	O	O	_	_	_	_	_
36	were	_	O	O	_	_	_	_	_
37	analyzed	_	O	O	_	_	_	_	_
38	for	_	O	O	_	_	_	_	_
39	NF	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	kappa	_	O	O	_	_	_	_	_
42	B	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	AP	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	1	_	O	O	_	_	_	_	_
47	activation	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	Similarly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	neither	_	O	O	_	_	_	_	_
7	activates	_	O	O	_	_	_	_	_
8	JNK	_	O	O	_	_	_	_	_
9	nor	_	O	O	_	_	_	_	_
10	increases	_	O	O	_	_	_	_	_
11	AP	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	binding	_	O	O	_	_	_	_	_
15	activity	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	consensus	_	O	O	_	_	_	_	_
19	o	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	tetradecanoylphorbol	_	O	O	_	_	_	_	_
22	13	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	acetate	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	TPA	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	response	_	O	O	_	_	_	_	_
29	element	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	*,	_	O	O	_	_	_	_	_
2	P	_	O	O	_	_	_	_	_
3	<	_	O	O	_	_	_	_	_
4	0	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_
6	05	_	O	O	_	_	_	_	_
7	between	_	O	O	_	_	_	_	_
8	groups	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	importance	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	many	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	these	_	O	O	_	_	_	_	_
7	genes	_	O	O	_	_	_	_	_
8	relates	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	role	_	O	O	_	_	_	_	_
12	their	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factor	_	O	O	_	_	_	_	_
15	products	_	O	O	_	_	_	_	_
16	play	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	dictating	_	O	O	_	_	_	_	_
19	patterns	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	expression	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	downstream	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	function	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	related	_	O	O	_	_	_	_	_
28	genes	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	line	_	O	O	_	_	_	_	_
3	with	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	AzadC	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	treatment	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	CML	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	LAMA	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	84	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	also	_	O	O	_	_	_	_	_
20	translated	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	an	_	O	O	_	_	_	_	_
23	induction	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	protein	_	O	O	_	_	_	_	_
29	expression	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	Figure	_	O	O	_	_	_	_	_
32	2	_	O	O	_	_	_	_	_
33	C	_	O	O	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	transcriptional	_	O	O	_	_	_	_	_
3	activity	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	requires	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	costimulation	_	O	O	_	_	_	_	_
15	delivered	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	TCR	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	auxiliary	_	O	O	_	_	_	_	_
22	receptor	_	O	O	_	_	_	_	_
23	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Various	_	O	O	_	_	_	_	_
2	antioxidants	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	such	_	O	O	_	_	_	_	_
5	as	_	O	O	_	_	_	_	_
6	pyrrolidine	_	O	O	_	_	_	_	_
7	dithiocarbamate	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	p	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	bromophenacyl	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	bromide	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	nordihydroguaiaretic	_	O	O	_	_	_	_	_
16	acid	_	O	O	_	_	_	_	_
17	could	_	O	O	_	_	_	_	_
18	strongly	_	O	O	_	_	_	_	_
19	reduce	_	O	O	_	_	_	_	_
20	NF	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kappaB	_	O	O	_	_	_	_	_
23	translocation	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	demonstrating	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	importance	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	oxidative	_	O	O	_	_	_	_	_
30	species	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	transduction	_	O	O	_	_	_	_	_
34	mechanism	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	importance	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	release	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	induction	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	HOCl	_	O	O	_	_	_	_	_
15	or	_	O	O	_	_	_	_	_
16	H	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	O	_	O	O	_	_	_	_	_
19	2	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	demonstrated	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	fact	_	O	O	_	_	_	_	_
25	that	_	O	O	_	_	_	_	_
26	:	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	1	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	nuclear	_	O	O	_	_	_	_	_
32	appearance	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	NF	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	kappaB	_	O	O	_	_	_	_	_
37	was	_	O	O	_	_	_	_	_
38	promoted	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	untreated	_	O	O	_	_	_	_	_
41	cells	_	O	O	_	_	_	_	_
42	;	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	(	_	O	O	_	_	_	_	_
45	2	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	synergism	_	O	O	_	_	_	_	_
48	between	_	O	O	_	_	_	_	_
49	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	and	_	O	O	_	_	_	_	_
53	HOCl	_	O	O	_	_	_	_	_
54	was	_	O	O	_	_	_	_	_
55	detected	_	O	O	_	_	_	_	_
56	.	_	O	O	_	_	_	_	_


1	Characterization	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	new	_	O	O	_	_	_	_	_
5	isoform	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	NFAT	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	nuclear	_	O	O	_	_	_	_	_
11	factor	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	activated	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	family	_	O	O	_	_	_	_	_
19	member	_	O	O	_	_	_	_	_
20	NFATc	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	[	_	O	O	_	_	_	_	_
22	published	_	O	O	_	_	_	_	_
23	erratum	_	O	O	_	_	_	_	_
24	appears	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	J	_	O	O	_	_	_	_	_
27	Biol	_	O	O	_	_	_	_	_
28	Chem	_	O	O	_	_	_	_	_
29	1996	_	O	O	_	_	_	_	_
30	Dec	_	O	O	_	_	_	_	_
31	27	_	O	O	_	_	_	_	_
32	;	_	O	O	_	_	_	_	_
33	271	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	52	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	:	_	O	O	_	_	_	_	_
38	33705	_	O	O	_	_	_	_	_
39	]	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	when	_	O	O	_	_	_	_	_
4	HL	_	O	O	_	_	_	_	_
5	60	_	O	O	_	_	_	_	_
6	R	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	transduced	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	functional	_	O	O	_	_	_	_	_
13	copy	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	RAR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	gene	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	RA	_	O	O	_	_	_	_	_
21	induced	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	10	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	fold	_	O	O	_	_	_	_	_
26	increase	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	mRNA	_	O	O	_	_	_	_	_
31	levels	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	Mapping	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	interaction	_	O	O	_	_	_	_	_
5	site	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	defective	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	class	_	O	O	_	_	_	_	_
14	II	_	O	O	_	_	_	_	_
15	major	_	O	O	_	_	_	_	_
16	histocompatibility	_	O	O	_	_	_	_	_
17	complex	_	O	O	_	_	_	_	_
18	mutant	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	line	_	O	O	_	_	_	_	_
21	clone	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	13	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	divergent	_	O	O	_	_	_	_	_
27	X	_	O	O	_	_	_	_	_
28	2	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	box	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	comparison	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	an	_	O	O	_	_	_	_	_
5	isotype	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	matched	_	O	O	_	_	_	_	_
8	antibody	_	O	O	_	_	_	_	_
9	had	_	O	O	_	_	_	_	_
10	no	_	O	O	_	_	_	_	_
11	effect	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappa	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	activation	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	human	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	helper	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	Th	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	clones	_	O	O	_	_	_	_	_
11	functionally	_	O	O	_	_	_	_	_
12	characterized	_	O	O	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	being	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	type	_	O	O	_	_	_	_	_
18	0	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	type	_	O	O	_	_	_	_	_
21	1	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	type	_	O	O	_	_	_	_	_
24	2	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	28	_	O	O	_	_	_	_	_
27	%,	_	O	O	_	_	_	_	_
28	<	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	%	_	O	O	_	_	_	_	_
31	und	_	O	O	_	_	_	_	_
32	93	_	O	O	_	_	_	_	_
33	%	_	O	O	_	_	_	_	_
34	CD	_	O	O	_	_	_	_	_
35	30	_	O	O	_	_	_	_	_
36	+	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	respectively	_	O	O	_	_	_	_	_
39	)	_	O	O	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	extent	_	O	O	_	_	_	_	_
43	of	_	O	O	_	_	_	_	_
44	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	30	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	mediated	_	O	O	_	_	_	_	_
48	NF	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	kappa	_	O	O	_	_	_	_	_
51	B	_	O	O	_	_	_	_	_
52	activation	_	O	O	_	_	_	_	_
53	correlated	_	O	O	_	_	_	_	_
54	with	_	O	O	_	_	_	_	_
55	the	_	O	O	_	_	_	_	_
56	proportion	_	O	O	_	_	_	_	_
57	of	_	O	O	_	_	_	_	_
58	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
59	30	_	IPROTEIN	IPROTEIN	_	_	_	_	_
60	+	_	O	O	_	_	_	_	_
61	cells	_	O	O	_	_	_	_	_
62	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	inducible	_	O	O	_	_	_	_	_
3	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	protein	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	partially	_	O	O	_	_	_	_	_
8	purified	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	three	_	O	O	_	_	_	_	_
11	chromatographic	_	O	O	_	_	_	_	_
12	steps	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	characterized	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	u	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_
18	v	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Aclacinomycin	_	O	O	_	_	_	_	_
2	(	_	O	O	_	_	_	_	_
3	ACLA	_	O	O	_	_	_	_	_
4	)	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	doxorubicin	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	DOX	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	were	_	O	O	_	_	_	_	_
11	used	_	O	O	_	_	_	_	_
12	at	_	O	O	_	_	_	_	_
13	subtoxic	_	O	O	_	_	_	_	_
14	concentrations	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	induce	_	O	O	_	_	_	_	_
17	erythroid	_	O	O	_	_	_	_	_
18	differentiation	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	leukemic	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	line	_	O	O	_	_	_	_	_
25	K	_	O	O	_	_	_	_	_
26	562	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	inhibition	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	mRNA	_	O	O	_	_	_	_	_
7	synthesis	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	actinomycin	_	O	O	_	_	_	_	_
10	D	_	O	O	_	_	_	_	_
11	indicated	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	DOX	_	O	O	_	_	_	_	_
14	induced	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	increased	_	O	O	_	_	_	_	_
17	stability	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	PBGD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	mRNAs	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	whereas	_	O	O	_	_	_	_	_
27	ACLA	_	O	O	_	_	_	_	_
28	did	_	O	O	_	_	_	_	_
29	not	_	O	O	_	_	_	_	_
30	affect	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	half	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	lives	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	these	_	O	O	_	_	_	_	_
37	mRNAs	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	observed	_	O	O	_	_	_	_	_
3	no	_	O	O	_	_	_	_	_
4	genetic	_	O	O	_	_	_	_	_
5	alterations	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	promoter	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	which	_	O	O	_	_	_	_	_
14	can	_	O	O	_	_	_	_	_
15	account	_	O	O	_	_	_	_	_
16	for	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	lack	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	:	_	O	O	_	_	_	_	_
25	The	_	O	O	_	_	_	_	_
26	detected	_	O	O	_	_	_	_	_
27	base	_	O	O	_	_	_	_	_
28	pair	_	O	O	_	_	_	_	_
29	changes	_	O	O	_	_	_	_	_
30	at	_	O	O	_	_	_	_	_
31	position	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	1081	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	T	_	O	O	_	_	_	_	_
36	--	_	O	O	_	_	_	_	_
37	>	_	O	O	_	_	_	_	_
38	C	_	O	O	_	_	_	_	_
39	substitution	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	at	_	O	O	_	_	_	_	_
43	position	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	1068	_	O	O	_	_	_	_	_
46	(	_	O	O	_	_	_	_	_
47	A	_	O	O	_	_	_	_	_
48	--	_	O	O	_	_	_	_	_
49	>	_	O	O	_	_	_	_	_
50	C	_	O	O	_	_	_	_	_
51	substitution	_	O	O	_	_	_	_	_
52	)	_	O	O	_	_	_	_	_
53	and	_	O	O	_	_	_	_	_
54	at	_	O	O	_	_	_	_	_
55	position	_	O	O	_	_	_	_	_
56	-	_	O	O	_	_	_	_	_
57	116	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	A	_	O	O	_	_	_	_	_
60	--	_	O	O	_	_	_	_	_
61	>	_	O	O	_	_	_	_	_
62	C	_	O	O	_	_	_	_	_
63	substitution	_	O	O	_	_	_	_	_
64	)	_	O	O	_	_	_	_	_
65	are	_	O	O	_	_	_	_	_
66	unlikely	_	O	O	_	_	_	_	_
67	responsible	_	O	O	_	_	_	_	_
68	for	_	O	O	_	_	_	_	_
69	absent	_	O	O	_	_	_	_	_
70	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
71	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
72	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
73	-	_	O	O	_	_	_	_	_
74	expression	_	O	O	_	_	_	_	_
75	since	_	O	O	_	_	_	_	_
76	the	_	O	O	_	_	_	_	_
77	first	_	O	O	_	_	_	_	_
78	two	_	O	O	_	_	_	_	_
79	mutations	_	O	O	_	_	_	_	_
80	were	_	O	O	_	_	_	_	_
81	found	_	O	O	_	_	_	_	_
82	both	_	O	O	_	_	_	_	_
83	in	_	O	O	_	_	_	_	_
84	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
85	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
86	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
87	-	_	O	O	_	_	_	_	_
88	positive	_	O	O	_	_	_	_	_
89	and	_	O	O	_	_	_	_	_
90	-	_	O	O	_	_	_	_	_
91	negative	_	O	O	_	_	_	_	_
92	cells	_	O	O	_	_	_	_	_
93	whereas	_	O	O	_	_	_	_	_
94	the	_	O	O	_	_	_	_	_
95	latter	_	O	O	_	_	_	_	_
96	change	_	O	O	_	_	_	_	_
97	was	_	O	O	_	_	_	_	_
98	not	_	O	O	_	_	_	_	_
99	detected	_	O	O	_	_	_	_	_
100	consistently	_	O	O	_	_	_	_	_
101	in	_	O	O	_	_	_	_	_
102	all	_	O	O	_	_	_	_	_
103	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
104	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
105	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
106	-	_	O	O	_	_	_	_	_
107	negative	_	O	O	_	_	_	_	_
108	or	_	O	O	_	_	_	_	_
109	-	_	O	O	_	_	_	_	_
110	positive	_	O	O	_	_	_	_	_
111	cells	_	O	O	_	_	_	_	_
112	and	_	O	O	_	_	_	_	_
113	may	_	O	O	_	_	_	_	_
114	thus	_	O	O	_	_	_	_	_
115	be	_	O	O	_	_	_	_	_
116	a	_	O	O	_	_	_	_	_
117	polymorphism	_	O	O	_	_	_	_	_
118	.	_	O	O	_	_	_	_	_

1	Methylation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	CpG	_	O	O	_	_	_	_	_
4	sites	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	common	_	O	O	_	_	_	_	_
8	mechanism	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	silencing	_	O	O	_	_	_	_	_
11	genes	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	leukemia	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	has	_	O	O	_	_	_	_	_
16	also	_	O	O	_	_	_	_	_
17	been	_	O	O	_	_	_	_	_
18	shown	_	O	O	_	_	_	_	_
19	for	_	O	O	_	_	_	_	_
20	another	_	O	O	_	_	_	_	_
21	IRF	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	35	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	for	_	O	O	_	_	_	_	_
31	PU	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	36	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	an	_	O	O	_	_	_	_	_
39	interacting	_	O	O	_	_	_	_	_
40	partner	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	distinct	_	O	O	_	_	_	_	_
6	regulatory	_	O	O	_	_	_	_	_
7	mechanism	_	O	O	_	_	_	_	_
8	for	_	O	O	_	_	_	_	_
9	these	_	O	O	_	_	_	_	_
10	two	_	O	O	_	_	_	_	_
11	IRFs	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	Phenotype	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	In	_	O	O	_	_	_	_	_
4	Vitro	_	O	O	_	_	_	_	_
5	Differentiated	_	O	O	_	_	_	_	_
6	T	_	O	O	_	_	_	_	_
7	Cells	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	resulted	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	concomitant	_	O	O	_	_	_	_	_
5	decrease	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	nuclear	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	kappaB	_	O	O	_	_	_	_	_
11	DNA	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	endogenous	_	O	O	_	_	_	_	_
17	long	_	O	O	_	_	_	_	_
18	terminal	_	O	O	_	_	_	_	_
19	repeat	_	O	O	_	_	_	_	_
20	transcriptional	_	O	O	_	_	_	_	_
21	activity	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	previous	_	O	O	_	_	_	_	_
3	studies	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	human	_	O	O	_	_	_	_	_
6	monocytes	_	O	O	_	_	_	_	_
7	have	_	O	O	_	_	_	_	_
8	demonstrated	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	inhibits	_	O	O	_	_	_	_	_
17	lipopolysaccharide	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	LPS	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	stimulated	_	O	O	_	_	_	_	_
23	production	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	inflammatory	_	O	O	_	_	_	_	_
26	cytokines	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	TNF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	by	_	O	O	_	_	_	_	_
51	blocking	_	O	O	_	_	_	_	_
52	gene	_	O	O	_	_	_	_	_
53	transcription	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	physiological	_	O	O	_	_	_	_	_
6	coculture	_	O	O	_	_	_	_	_
7	cellular	_	O	O	_	_	_	_	_
8	assay	_	O	O	_	_	_	_	_
9	system	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	we	_	O	O	_	_	_	_	_
12	show	_	O	O	_	_	_	_	_
13	that	_	O	O	_	_	_	_	_
14	membrane	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	bound	_	O	O	_	_	_	_	_
17	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	LT	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	alpha	_	O	O	_	_	_	_	_
24	1	_	O	O	_	_	_	_	_
25	beta	_	O	O	_	_	_	_	_
26	2	_	O	O	_	_	_	_	_
27	act	_	O	O	_	_	_	_	_
28	virtually	_	O	O	_	_	_	_	_
29	identically	_	O	O	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	their	_	O	O	_	_	_	_	_
32	soluble	_	O	O	_	_	_	_	_
33	forms	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	regulation	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	HIV	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	1	_	O	O	_	_	_	_	_
41	replication	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Early	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	EBF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	47	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	participate	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	transcriptional	_	O	O	_	_	_	_	_
15	control	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	early	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	lymphocyte	_	O	O	_	_	_	_	_
20	differentiation	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	cell	_	O	O	_	_	_	_	_
6	leukemia	_	O	O	_	_	_	_	_
7	virus	_	O	O	_	_	_	_	_
8	type	_	O	O	_	_	_	_	_
9	I	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	HTLV	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	I	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	causative	_	O	O	_	_	_	_	_
18	agent	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	adult	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	leukemia	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	stimulates	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	transcription	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	F	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	gene	_	O	O	_	_	_	_	_
17	itself	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	essential	_	O	O	_	_	_	_	_
3	role	_	O	O	_	_	_	_	_
4	for	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappaB	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	human	_	O	O	_	_	_	_	_
10	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	34	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	+	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	bone	_	O	O	_	_	_	_	_
16	marrow	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	survival	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	absence	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	TCR	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	mediated	_	O	O	_	_	_	_	_
8	activation	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	Vpr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	induces	_	O	O	_	_	_	_	_
12	apoptosis	_	O	O	_	_	_	_	_
13	whereas	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	its	_	O	O	_	_	_	_	_
16	presence	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	Vpr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	interrupts	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	expected	_	O	O	_	_	_	_	_
22	induction	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	apoptosis	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_


1	Unlike	_	O	O	_	_	_	_	_
2	full	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	sized	_	O	O	_	_	_	_	_
5	NOTCH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	two	_	O	O	_	_	_	_	_
9	such	_	O	O	_	_	_	_	_
10	truncated	_	O	O	_	_	_	_	_
11	forms	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	protein	_	O	O	_	_	_	_	_
15	either	_	O	O	_	_	_	_	_
16	lacking	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	major	_	O	O	_	_	_	_	_
19	portion	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	extracellular	_	O	O	_	_	_	_	_
23	domain	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	DeltaE	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	or	_	O	O	_	_	_	_	_
28	consisting	_	O	O	_	_	_	_	_
29	only	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	intracellular	_	O	O	_	_	_	_	_
33	domain	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	ICN	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	were	_	O	O	_	_	_	_	_
38	found	_	O	O	_	_	_	_	_
39	to	_	O	O	_	_	_	_	_
40	activate	_	O	O	_	_	_	_	_
41	transcription	_	O	O	_	_	_	_	_
42	in	_	O	O	_	_	_	_	_
43	cultured	_	O	O	_	_	_	_	_
44	cells	_	O	O	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	presumably	_	O	O	_	_	_	_	_
47	through	_	O	O	_	_	_	_	_
48	RBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	Jkappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	response	_	O	O	_	_	_	_	_
52	elements	_	O	O	_	_	_	_	_
53	within	_	O	O	_	_	_	_	_
54	DNA	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	most	_	O	O	_	_	_	_	_
5	consistent	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	NOTCH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	oncogenesis	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	transcriptional	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	being	_	O	O	_	_	_	_	_
14	independent	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	association	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	RBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	Jkappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	at	_	O	O	_	_	_	_	_
22	promoter	_	O	O	_	_	_	_	_
23	sites	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	effects	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	observed	_	O	O	_	_	_	_	_
9	upon	_	O	O	_	_	_	_	_
10	pulse	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	treatment	_	O	O	_	_	_	_	_
13	with	_	O	O	_	_	_	_	_
14	6	_	O	O	_	_	_	_	_
15	microM	_	O	O	_	_	_	_	_
16	ICRF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	193	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	continuous	_	O	O	_	_	_	_	_
4	treatments	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	subcytotoxic	_	O	O	_	_	_	_	_
7	concentrations	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	etoposide	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	0	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_
13	15	_	O	O	_	_	_	_	_
14	microM	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	ICRF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	193	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	0	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_
23	3	_	O	O	_	_	_	_	_
24	microM	_	O	O	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	produced	_	O	O	_	_	_	_	_
27	several	_	O	O	_	_	_	_	_
28	similar	_	O	O	_	_	_	_	_
29	effects	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	namely	_	O	O	_	_	_	_	_
32	decreased	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	proliferation	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	accumulation	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	at	_	O	O	_	_	_	_	_
40	G	_	O	O	_	_	_	_	_
41	2	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	increase	_	O	O	_	_	_	_	_
44	in	_	O	O	_	_	_	_	_
45	cell	_	O	O	_	_	_	_	_
46	mass	_	O	O	_	_	_	_	_
47	,	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	induction	_	O	O	_	_	_	_	_
50	of	_	O	O	_	_	_	_	_
51	differentiation	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	Key	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	effector	_	O	O	_	_	_	_	_
8	CTL	_	O	O	_	_	_	_	_
9	differentiation	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_

1	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Actin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	used	_	O	O	_	_	_	_	_
6	as	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	loading	_	O	O	_	_	_	_	_
9	control	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	D	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	ChIP	_	O	O	_	_	_	_	_
5	analysis	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	binding	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	endogenous	_	O	O	_	_	_	_	_
10	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	Prf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	locus	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Levels	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	FOSB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	mRNA	_	O	O	_	_	_	_	_
5	reach	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	maximum	_	O	O	_	_	_	_	_
8	40	_	O	O	_	_	_	_	_
9	min	_	O	O	_	_	_	_	_
10	after	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	addition	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	lectin	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	decline	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	control	_	O	O	_	_	_	_	_
19	levels	_	O	O	_	_	_	_	_
20	over	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	next	_	O	O	_	_	_	_	_
23	6	_	O	O	_	_	_	_	_
24	hr	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	preincubated	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	cycloheximide	_	O	O	_	_	_	_	_
7	response	_	O	O	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	decreased	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	especially	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	case	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	FOSB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	different	_	O	O	_	_	_	_	_
5	cellular	_	O	O	_	_	_	_	_
6	factors	_	O	O	_	_	_	_	_
7	were	_	O	O	_	_	_	_	_
8	involved	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	E	_	O	O	_	_	_	_	_
11	3	_	O	O	_	_	_	_	_
12	regulation	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	lymphocytes	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	compared	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	HeLa	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	both	_	O	O	_	_	_	_	_
22	DNA	_	O	O	_	_	_	_	_
23	binding	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	transfection	_	O	O	_	_	_	_	_
26	analysis	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	E	_	O	O	_	_	_	_	_
30	3	_	O	O	_	_	_	_	_
31	promoter	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	both	_	O	O	_	_	_	_	_
34	cell	_	O	O	_	_	_	_	_
35	types	_	O	O	_	_	_	_	_
36	were	_	O	O	_	_	_	_	_
37	performed	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Deletion	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	EBNA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	dependent	_	O	O	_	_	_	_	_
8	enhancer	_	O	O	_	_	_	_	_
9	located	_	O	O	_	_	_	_	_
10	upstream	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	Cp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	resulted	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	ca	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	evidence	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	translational	_	O	O	_	_	_	_	_
6	suppression	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	TNF	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	given	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	experiments	_	O	O	_	_	_	_	_
13	using	_	O	O	_	_	_	_	_
14	chloram	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	phenicol	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	acetyltransferase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	constructs	_	O	O	_	_	_	_	_
22	containing	_	O	O	_	_	_	_	_
23	elements	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	TNF	_	O	O	_	_	_	_	_
27	gene	_	O	O	_	_	_	_	_
28	that	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	involved	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	TNF	_	O	O	_	_	_	_	_
33	translational	_	O	O	_	_	_	_	_
34	regulation	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Transcriptional	_	O	O	_	_	_	_	_
2	down	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	regulation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	expression	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	synthesis	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	dependent	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	independent	_	O	O	_	_	_	_	_
18	pathways	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	lymphoblastic	_	O	O	_	_	_	_	_
24	tumor	_	O	O	_	_	_	_	_
25	cell	_	O	O	_	_	_	_	_
26	line	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	block	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	RNA	_	O	O	_	_	_	_	_
5	elongation	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	largely	_	O	O	_	_	_	_	_
8	responsible	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	decreased	_	O	O	_	_	_	_	_
11	c	_	O	O	_	_	_	_	_
12	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Analysis	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	demonstrated	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	perturbation	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	proliferation	_	O	O	_	_	_	_	_
20	response	_	O	O	_	_	_	_	_
21	was	_	O	O	_	_	_	_	_
22	not	_	O	O	_	_	_	_	_
23	attributable	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	an	_	O	O	_	_	_	_	_
26	abnormal	_	O	O	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	these	_	O	O	_	_	_	_	_
30	genes	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Visceral	_	O	O	_	_	_	_	_
2	TSC	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	comparable	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	autopsy	_	O	O	_	_	_	_	_
9	tissues	_	O	O	_	_	_	_	_
10	from	_	O	O	_	_	_	_	_
11	patients	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	without	_	O	O	_	_	_	_	_
15	TSC	_	O	O	_	_	_	_	_
16	;	_	O	O	_	_	_	_	_
17	TSC	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	messenger	_	O	O	_	_	_	_	_
20	RNA	_	O	O	_	_	_	_	_
21	expression	_	O	O	_	_	_	_	_
22	was	_	O	O	_	_	_	_	_
23	most	_	O	O	_	_	_	_	_
24	prominent	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	a	_	O	O	_	_	_	_	_
29	rapid	_	O	O	_	_	_	_	_
30	mitotic	_	O	O	_	_	_	_	_
31	rate	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	turnover	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	e	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_
37	g	_	O	O	_	_	_	_	_
38	.,	_	O	O	_	_	_	_	_
39	epithelia	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	lymphocytes	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	with	_	O	O	_	_	_	_	_
44	central	_	O	O	_	_	_	_	_
45	nervous	_	O	O	_	_	_	_	_
46	system	_	O	O	_	_	_	_	_
47	pyramidal	_	O	O	_	_	_	_	_
48	cells	_	O	O	_	_	_	_	_
49	and	_	O	O	_	_	_	_	_
50	other	_	O	O	_	_	_	_	_
51	neurons	_	O	O	_	_	_	_	_
52	being	_	O	O	_	_	_	_	_
53	an	_	O	O	_	_	_	_	_
54	obvious	_	O	O	_	_	_	_	_
55	exception	_	O	O	_	_	_	_	_
56	,	_	O	O	_	_	_	_	_
57	and	_	O	O	_	_	_	_	_
58	/	_	O	O	_	_	_	_	_
59	or	_	O	O	_	_	_	_	_
60	in	_	O	O	_	_	_	_	_
61	cells	_	O	O	_	_	_	_	_
62	with	_	O	O	_	_	_	_	_
63	important	_	O	O	_	_	_	_	_
64	secretory	_	O	O	_	_	_	_	_
65	/	_	O	O	_	_	_	_	_
66	transport	_	O	O	_	_	_	_	_
67	functions	_	O	O	_	_	_	_	_
68	.	_	O	O	_	_	_	_	_

1	Characterization	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	this	_	O	O	_	_	_	_	_
4	cDNA	_	O	O	_	_	_	_	_
5	clone	_	O	O	_	_	_	_	_
6	revealed	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	its	_	O	O	_	_	_	_	_
9	induction	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	dependent	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	LPS	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	THP	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	;	_	O	O	_	_	_	_	_
21	hence	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	name	_	O	O	_	_	_	_	_
25	LPS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	induced	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	TNF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	LITAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	lymphoid	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	specific	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	a	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	implicated	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	specific	_	O	O	_	_	_	_	_
18	transcriptional	_	O	O	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	via	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	octamer	_	O	O	_	_	_	_	_
23	motif	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Ascorbic	_	O	O	_	_	_	_	_
2	acid	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	ascorbate	_	O	O	_	_	_	_	_
5	or	_	O	O	_	_	_	_	_
6	vitamin	_	O	O	_	_	_	_	_
7	C	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	shown	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	suppress	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	induction	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	HIV	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	latently	_	O	O	_	_	_	_	_
20	infected	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	lymphocytic	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	following	_	O	O	_	_	_	_	_
25	stimulation	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	tumor	_	O	O	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	PMA	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	inflammatory	_	O	O	_	_	_	_	_
35	cytokine	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	molecular	_	O	O	_	_	_	_	_
7	mechanism	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	HIV	_	O	O	_	_	_	_	_
10	inhibition	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	ascorbate	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	not	_	O	O	_	_	_	_	_
15	mediated	_	O	O	_	_	_	_	_
16	via	_	O	O	_	_	_	_	_
17	NF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	inhibition	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	unlike	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	seen	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	other	_	O	O	_	_	_	_	_
28	antioxidants	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_



1	Reaction	_	O	O	_	_	_	_	_
2	products	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	analyzed	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	agarose	_	O	O	_	_	_	_	_
7	gel	_	O	O	_	_	_	_	_
8	electrophoresis	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	purified	_	O	O	_	_	_	_	_
11	using	_	O	O	_	_	_	_	_
12	QIAquick	_	O	O	_	_	_	_	_
13	gel	_	O	O	_	_	_	_	_
14	extraction	_	O	O	_	_	_	_	_
15	kit	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	Qiagen	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	/	_	O	O	_	_	_	_	_
22	A	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	cloned	_	O	O	_	_	_	_	_
25	into	_	O	O	_	_	_	_	_
26	vector	_	O	O	_	_	_	_	_
27	pCR	_	O	O	_	_	_	_	_
28	4	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	TOPO	_	O	O	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	Invitrogen	_	O	O	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	sequenced	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	protooncogene	_	O	O	_	_	_	_	_
6	c	_	O	O	_	_	_	_	_
7	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	induced	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	differentiation	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	assessed	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	isolated	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	genomic	_	O	O	_	_	_	_	_
9	DNA	_	O	O	_	_	_	_	_
10	for	_	O	O	_	_	_	_	_
11	human	_	O	O	_	_	_	_	_
12	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	gene	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	determined	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	intron	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	exon	_	O	O	_	_	_	_	_
22	structure	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	human	_	O	O	_	_	_	_	_
26	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	gene	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	mapped	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	major	_	O	O	_	_	_	_	_
34	transcription	_	O	O	_	_	_	_	_
35	initiation	_	O	O	_	_	_	_	_
36	site	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	identified	_	O	O	_	_	_	_	_
39	a	_	O	O	_	_	_	_	_
40	number	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	potential	_	O	O	_	_	_	_	_
43	regulatory	_	O	O	_	_	_	_	_
44	elements	_	O	O	_	_	_	_	_
45	in	_	O	O	_	_	_	_	_
46	the	_	O	O	_	_	_	_	_
47	5	_	O	O	_	_	_	_	_
48	'	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	flanking	_	O	O	_	_	_	_	_
51	region	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	and	_	O	O	_	_	_	_	_
54	localized	_	O	O	_	_	_	_	_
55	the	_	O	O	_	_	_	_	_
56	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
57	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
59	gene	_	O	O	_	_	_	_	_
60	on	_	O	O	_	_	_	_	_
61	human	_	O	O	_	_	_	_	_
62	chromosome	_	O	O	_	_	_	_	_
63	4	_	O	O	_	_	_	_	_
64	.	_	O	O	_	_	_	_	_

1	Induction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	enhancer	_	O	O	_	_	_	_	_
5	may	_	O	O	_	_	_	_	_
6	have	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	role	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	increase	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	globin	_	O	O	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	transcription	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	characterizes	_	O	O	_	_	_	_	_
18	erythroid	_	O	O	_	_	_	_	_
19	maturation	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Differentiation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	helper	_	O	O	_	_	_	_	_
6	lymphocytes	_	O	O	_	_	_	_	_
7	:	_	O	O	_	_	_	_	_
8	selective	_	O	O	_	_	_	_	_
9	regulation	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	members	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	STAT	_	O	O	_	_	_	_	_
15	family	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	transcription	_	O	O	_	_	_	_	_
18	factors	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Cell	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	specific	_	O	O	_	_	_	_	_
4	differences	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	kappa	_	O	O	_	_	_	_	_
11	B	_	O	O	_	_	_	_	_
12	regulatory	_	O	O	_	_	_	_	_
13	elements	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	human	_	O	O	_	_	_	_	_
16	immunodeficiency	_	O	O	_	_	_	_	_
17	virus	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	beta	_	O	O	_	_	_	_	_
20	interferon	_	O	O	_	_	_	_	_
21	promoters	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	RNA	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	undetectable	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	U	_	O	O	_	_	_	_	_
9	937	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	whereas	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	low	_	O	O	_	_	_	_	_
15	constitutive	_	O	O	_	_	_	_	_
16	level	_	O	O	_	_	_	_	_
17	was	_	O	O	_	_	_	_	_
18	detected	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	U	_	O	O	_	_	_	_	_
21	9	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	IIIB	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	Promoter	_	O	O	_	_	_	_	_
5	enzyme	_	O	O	_	_	_	_	_
6	immunoassay	_	O	O	_	_	_	_	_
7	using	_	O	O	_	_	_	_	_
8	wild	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	type	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	mutated	_	O	O	_	_	_	_	_
13	oligonucleotides	_	O	O	_	_	_	_	_
14	within	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Alpha	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	tocopherol	_	O	O	_	_	_	_	_
4	inhibits	_	O	O	_	_	_	_	_
5	agonist	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	monocytic	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	adhesion	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	cultured	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	endothelial	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_



1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assays	_	O	O	_	_	_	_	_
5	showed	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	/	_	O	O	_	_	_	_	_
13	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	Rel	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	are	_	O	O	_	_	_	_	_
21	effectively	_	O	O	_	_	_	_	_
22	induced	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	L	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	respectively	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	bind	_	O	O	_	_	_	_	_
36	to	_	O	O	_	_	_	_	_
37	specific	_	O	O	_	_	_	_	_
38	DNA	_	O	O	_	_	_	_	_
39	motifs	_	O	O	_	_	_	_	_
40	within	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	ECS	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Induction	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	Bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	x	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	L	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	expression	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	human	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	leukemia	_	O	O	_	_	_	_	_
16	virus	_	O	O	_	_	_	_	_
17	type	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	through	_	O	O	_	_	_	_	_
21	NF	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	kappaB	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	apoptosis	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	resistant	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	cell	_	O	O	_	_	_	_	_
31	transfectants	_	O	O	_	_	_	_	_
32	with	_	O	O	_	_	_	_	_
33	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	NF	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	kappaB	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	like	_	O	O	_	_	_	_	_
7	element	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	able	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	form	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	complex	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	NF	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	kappaB	_	O	O	_	_	_	_	_
18	family	_	O	O	_	_	_	_	_
19	proteins	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	vitro	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	O	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	side	_	O	O	_	_	_	_	_
4	chain	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	specific	_	O	O	_	_	_	_	_
7	mAb	_	O	O	_	_	_	_	_
8	concurrently	_	O	O	_	_	_	_	_
9	enhanced	_	O	O	_	_	_	_	_
10	complement	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	LPS	_	O	O	_	_	_	_	_
14	uptake	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	monocytes	_	O	O	_	_	_	_	_
17	through	_	O	O	_	_	_	_	_
18	complement	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	CR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	uptake	_	O	O	_	_	_	_	_
28	by	_	O	O	_	_	_	_	_
29	CHO	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	involving	_	O	O	_	_	_	_	_
35	another	_	O	O	_	_	_	_	_
36	heat	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	labile	_	O	O	_	_	_	_	_
39	serum	_	O	O	_	_	_	_	_
40	factor	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	s	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	and	_	O	O	_	_	_	_	_
45	cell	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	associated	_	O	O	_	_	_	_	_
48	recognition	_	O	O	_	_	_	_	_
49	molecule	_	O	O	_	_	_	_	_
50	(	_	O	O	_	_	_	_	_
51	s	_	O	O	_	_	_	_	_
52	)	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	present	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	naive	_	O	O	_	_	_	_	_
7	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	+	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	before	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	12	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Additional	_	O	O	_	_	_	_	_
2	experiments	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	needed	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	determine	_	O	O	_	_	_	_	_
7	whether	_	O	O	_	_	_	_	_
8	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	are	_	O	O	_	_	_	_	_
13	also	_	O	O	_	_	_	_	_
14	direct	_	O	O	_	_	_	_	_
15	target	_	O	O	_	_	_	_	_
16	genes	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	4	_	O	O	_	_	_	_	_
2	A	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_

1	Indeed	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	both	_	O	O	_	_	_	_	_
9	contribute	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	NK	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	8	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	26	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	induces	_	O	O	_	_	_	_	_
25	granzyme	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	as	_	O	O	_	_	_	_	_
28	effectively	_	O	O	_	_	_	_	_
29	as	_	O	O	_	_	_	_	_
30	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	developing	_	O	O	_	_	_	_	_
35	Th	_	O	O	_	_	_	_	_
36	2	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	7	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	;	_	O	O	_	_	_	_	_
42	thus	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	the	_	O	O	_	_	_	_	_
45	relative	_	O	O	_	_	_	_	_
46	roles	_	O	O	_	_	_	_	_
47	of	_	O	O	_	_	_	_	_
48	these	_	O	O	_	_	_	_	_
49	T	_	O	O	_	_	_	_	_
50	-	_	O	O	_	_	_	_	_
51	box	_	O	O	_	_	_	_	_
52	transcription	_	O	O	_	_	_	_	_
53	factors	_	O	O	_	_	_	_	_
54	vary	_	O	O	_	_	_	_	_
55	depending	_	O	O	_	_	_	_	_
56	on	_	O	O	_	_	_	_	_
57	cell	_	O	O	_	_	_	_	_
58	type	_	O	O	_	_	_	_	_
59	.	_	O	O	_	_	_	_	_

1	Collectively	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	therefore	_	O	O	_	_	_	_	_
6	suggest	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	exclusive	_	O	O	_	_	_	_	_
10	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	induced	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	on	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	may	_	O	O	_	_	_	_	_
22	represent	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	pivotal	_	O	O	_	_	_	_	_
25	event	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	progression	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	HTLV	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	associated	_	O	O	_	_	_	_	_
35	diseases	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	A	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	Intracellular	_	O	O	_	_	_	_	_
5	FACS	_	O	O	_	_	_	_	_
6	analysis	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	Th	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	Th	_	O	O	_	_	_	_	_
16	2	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	or	_	O	O	_	_	_	_	_
19	iTreg	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	differentiated	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	two	_	O	O	_	_	_	_	_
25	rounds	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	phenotype	_	O	O	_	_	_	_	_
28	see	_	O	O	_	_	_	_	_
29	Figure	_	O	O	_	_	_	_	_
30	S	_	O	O	_	_	_	_	_
31	1	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	rested	_	O	O	_	_	_	_	_
35	or	_	O	O	_	_	_	_	_
36	activated	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	with	_	O	O	_	_	_	_	_
39	or	_	O	O	_	_	_	_	_
40	without	_	O	O	_	_	_	_	_
41	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_


1	(	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	Human	_	O	O	_	_	_	_	_
5	primary	_	O	O	_	_	_	_	_
6	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	+	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	were	_	O	O	_	_	_	_	_
11	transfected	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	an	_	O	O	_	_	_	_	_
14	empty	_	O	O	_	_	_	_	_
15	vector	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	pGL	_	O	O	_	_	_	_	_
18	3	_	O	O	_	_	_	_	_
19	Basic	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	vector	_	O	O	_	_	_	_	_
24	containing	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	putative	_	O	O	_	_	_	_	_
27	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	region	_	O	O	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	511	_	O	O	_	_	_	_	_
36	/	_	O	O	_	_	_	_	_
37	+	_	O	O	_	_	_	_	_
38	176	_	O	O	_	_	_	_	_
39	)	_	O	O	_	_	_	_	_
40	fused	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	the	_	O	O	_	_	_	_	_
43	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	reporter	_	O	O	_	_	_	_	_
45	gene	_	O	O	_	_	_	_	_
46	,	_	O	O	_	_	_	_	_
47	or	_	O	O	_	_	_	_	_
48	with	_	O	O	_	_	_	_	_
49	a	_	O	O	_	_	_	_	_
50	vector	_	O	O	_	_	_	_	_
51	containing	_	O	O	_	_	_	_	_
52	the	_	O	O	_	_	_	_	_
53	putative	_	O	O	_	_	_	_	_
54	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
55	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	promoter	_	O	O	_	_	_	_	_
57	region	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	FOXP	_	O	O	_	_	_	_	_
60	3	_	O	O	_	_	_	_	_
61	-	_	O	O	_	_	_	_	_
62	511	_	O	O	_	_	_	_	_
63	/	_	O	O	_	_	_	_	_
64	+	_	O	O	_	_	_	_	_
65	176	_	O	O	_	_	_	_	_
66	)	_	O	O	_	_	_	_	_
67	with	_	O	O	_	_	_	_	_
68	single	_	O	O	_	_	_	_	_
69	RUNX	_	O	O	_	_	_	_	_
70	binding	_	O	O	_	_	_	_	_
71	sites	_	O	O	_	_	_	_	_
72	mutated	_	O	O	_	_	_	_	_
73	(	_	O	O	_	_	_	_	_
74	53	_	O	O	_	_	_	_	_
75	,	_	O	O	_	_	_	_	_
76	287	_	O	O	_	_	_	_	_
77	,	_	O	O	_	_	_	_	_
78	or	_	O	O	_	_	_	_	_
79	333	_	O	O	_	_	_	_	_
80	)	_	O	O	_	_	_	_	_
81	or	_	O	O	_	_	_	_	_
82	with	_	O	O	_	_	_	_	_
83	the	_	O	O	_	_	_	_	_
84	combination	_	O	O	_	_	_	_	_
85	of	_	O	O	_	_	_	_	_
86	two	_	O	O	_	_	_	_	_
87	or	_	O	O	_	_	_	_	_
88	three	_	O	O	_	_	_	_	_
89	RUNX	_	O	O	_	_	_	_	_
90	binding	_	O	O	_	_	_	_	_
91	sites	_	O	O	_	_	_	_	_
92	mutated	_	O	O	_	_	_	_	_
93	(	_	O	O	_	_	_	_	_
94	53	_	O	O	_	_	_	_	_
95	,	_	O	O	_	_	_	_	_
96	287	_	O	O	_	_	_	_	_
97	,	_	O	O	_	_	_	_	_
98	or	_	O	O	_	_	_	_	_
99	333	_	O	O	_	_	_	_	_
100	)	_	O	O	_	_	_	_	_
101	fused	_	O	O	_	_	_	_	_
102	to	_	O	O	_	_	_	_	_
103	the	_	O	O	_	_	_	_	_
104	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
105	reporter	_	O	O	_	_	_	_	_
106	gene	_	O	O	_	_	_	_	_
107	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	regulatory	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	both	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	immediate	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	early	_	O	O	_	_	_	_	_
19	G	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	phase	_	O	O	_	_	_	_	_
22	gene	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	an	_	O	O	_	_	_	_	_
25	S	_	O	O	_	_	_	_	_
26	phase	_	O	O	_	_	_	_	_
27	gene	_	O	O	_	_	_	_	_
28	inducible	_	O	O	_	_	_	_	_
29	by	_	O	O	_	_	_	_	_
30	PRL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	rat	_	O	O	_	_	_	_	_
33	Nb	_	O	O	_	_	_	_	_
34	2	_	O	O	_	_	_	_	_
35	T	_	O	O	_	_	_	_	_
36	lymphocytes	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Cytokine	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	stimulated	_	O	O	_	_	_	_	_
4	cell	_	O	O	_	_	_	_	_
5	surface	_	O	O	_	_	_	_	_
6	expression	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	vascular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	106	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	ELAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	62	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	E	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	but	_	O	O	_	_	_	_	_
37	not	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	intercellular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	(	_	O	O	_	_	_	_	_
45	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	,	_	O	O	_	_	_	_	_
49	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	54	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	)	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	was	_	O	O	_	_	_	_	_
54	time	_	O	O	_	_	_	_	_
55	-	_	O	O	_	_	_	_	_
56	and	_	O	O	_	_	_	_	_
57	dose	_	O	O	_	_	_	_	_
58	-	_	O	O	_	_	_	_	_
59	dependently	_	O	O	_	_	_	_	_
60	inhibited	_	O	O	_	_	_	_	_
61	by	_	O	O	_	_	_	_	_
62	TCP	_	O	O	_	_	_	_	_
63	succinate	_	O	O	_	_	_	_	_
64	but	_	O	O	_	_	_	_	_
65	not	_	O	O	_	_	_	_	_
66	by	_	O	O	_	_	_	_	_
67	TCP	_	O	O	_	_	_	_	_
68	or	_	O	O	_	_	_	_	_
69	TCP	_	O	O	_	_	_	_	_
70	acetate	_	O	O	_	_	_	_	_
71	.	_	O	O	_	_	_	_	_


1	At	_	O	O	_	_	_	_	_
2	day	_	O	O	_	_	_	_	_
3	5	_	O	O	_	_	_	_	_
4	or	_	O	O	_	_	_	_	_
5	7	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	restimulated	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	immobilized	_	O	O	_	_	_	_	_
12	anti	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	mug	_	O	O	_	_	_	_	_
19	/	_	O	O	_	_	_	_	_
20	ml	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	anti	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	2	_	O	O	_	_	_	_	_
29	mug	_	O	O	_	_	_	_	_
30	/	_	O	O	_	_	_	_	_
31	ml	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	4	_	O	O	_	_	_	_	_
35	hr	_	O	O	_	_	_	_	_
36	with	_	O	O	_	_	_	_	_
37	BrefeldinA	_	O	O	_	_	_	_	_
38	[	_	O	O	_	_	_	_	_
39	10	_	O	O	_	_	_	_	_
40	mug	_	O	O	_	_	_	_	_
41	/	_	O	O	_	_	_	_	_
42	ml	_	O	O	_	_	_	_	_
43	]	_	O	O	_	_	_	_	_
44	in	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	last	_	O	O	_	_	_	_	_
47	2	_	O	O	_	_	_	_	_
48	hr	_	O	O	_	_	_	_	_
49	)	_	O	O	_	_	_	_	_
50	or	_	O	O	_	_	_	_	_
51	with	_	O	O	_	_	_	_	_
52	PdBU	_	O	O	_	_	_	_	_
53	and	_	O	O	_	_	_	_	_
54	Ionomycin	_	O	O	_	_	_	_	_
55	(	_	O	O	_	_	_	_	_
56	5	_	O	O	_	_	_	_	_
57	hr	_	O	O	_	_	_	_	_
58	with	_	O	O	_	_	_	_	_
59	BrefeldinA	_	O	O	_	_	_	_	_
60	[	_	O	O	_	_	_	_	_
61	1	_	O	O	_	_	_	_	_
62	mug	_	O	O	_	_	_	_	_
63	/	_	O	O	_	_	_	_	_
64	ml	_	O	O	_	_	_	_	_
65	])	_	O	O	_	_	_	_	_
66	.	_	O	O	_	_	_	_	_

1	After	_	O	O	_	_	_	_	_
2	ICS	_	O	O	_	_	_	_	_
3	FACS	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	collected	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	FACSCalibur	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	Becton	_	O	O	_	_	_	_	_
13	Dickinson	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	analyzed	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	FlowJo	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	Tree	_	O	O	_	_	_	_	_
21	Star	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	Using	_	O	O	_	_	_	_	_
2	electrophoretic	_	O	O	_	_	_	_	_
3	mobility	_	O	O	_	_	_	_	_
4	shift	_	O	O	_	_	_	_	_
5	assays	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	levels	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	nuclear	_	O	O	_	_	_	_	_
11	regulatory	_	O	O	_	_	_	_	_
12	proteins	_	O	O	_	_	_	_	_
13	recognizing	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	AP	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	consensus	_	O	O	_	_	_	_	_
19	TRE	_	O	O	_	_	_	_	_
20	motif	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	proximal	_	O	O	_	_	_	_	_
24	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	TRE	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	like	_	O	O	_	_	_	_	_
30	promoter	_	O	O	_	_	_	_	_
31	element	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	serum	_	O	O	_	_	_	_	_
39	response	_	O	O	_	_	_	_	_
40	element	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	SRE	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	were	_	O	O	_	_	_	_	_
45	determined	_	O	O	_	_	_	_	_
46	in	_	O	O	_	_	_	_	_
47	resting	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	stimulated	_	O	O	_	_	_	_	_
50	T	_	O	O	_	_	_	_	_
51	cells	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	Lastly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	demonstrate	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	selective	_	O	O	_	_	_	_	_
7	inhibition	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	p	_	O	O	_	_	_	_	_
10	24	_	O	O	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	infected	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	macrophages	_	O	O	_	_	_	_	_
18	when	_	O	O	_	_	_	_	_
19	treated	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	AO	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	PKC	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	zeta	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Progression	_	O	O	_	_	_	_	_
2	to	_	O	O	_	_	_	_	_
3	lymphoma	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	both	_	O	O	_	_	_	_	_
6	wild	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	type	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	transgenic	_	O	O	_	_	_	_	_
13	lymphoma	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	led	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	increased	_	O	O	_	_	_	_	_
18	levels	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	Rb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	correspondingly	_	O	O	_	_	_	_	_
23	high	_	O	O	_	_	_	_	_
24	levels	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	Cdk	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	decreased	_	O	O	_	_	_	_	_
31	levels	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	Figure	_	O	O	_	_	_	_	_
37	6	_	O	O	_	_	_	_	_
38	C	_	O	O	_	_	_	_	_
39	)	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_


1	Fusion	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	upstream	_	O	O	_	_	_	_	_
5	portion	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	delta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	truncated	_	O	O	_	_	_	_	_
13	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	promoter	_	O	O	_	_	_	_	_
16	yielded	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	modest	_	O	O	_	_	_	_	_
19	increase	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	promoter	_	O	O	_	_	_	_	_
22	strength	_	O	O	_	_	_	_	_
23	relative	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	truncated	_	O	O	_	_	_	_	_
27	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	gene	_	O	O	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	indicating	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	presence	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	a	_	O	O	_	_	_	_	_
36	positive	_	O	O	_	_	_	_	_
37	transcriptional	_	O	O	_	_	_	_	_
38	element	_	O	O	_	_	_	_	_
39	(	_	O	O	_	_	_	_	_
40	s	_	O	O	_	_	_	_	_
41	)	_	O	O	_	_	_	_	_
42	in	_	O	O	_	_	_	_	_
43	the	_	O	O	_	_	_	_	_
44	upstream	_	O	O	_	_	_	_	_
45	delta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	regulatory	_	O	O	_	_	_	_	_
48	region	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	confirm	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	sequences	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	upstream	_	O	O	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	region	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	adult	_	O	O	_	_	_	_	_
14	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	gene	_	O	O	_	_	_	_	_
17	contribute	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	its	_	O	O	_	_	_	_	_
20	factor	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	mediated	_	O	O	_	_	_	_	_
23	suppression	_	O	O	_	_	_	_	_
24	early	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	development	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	then	_	O	O	_	_	_	_	_
29	may	_	O	O	_	_	_	_	_
30	modulate	_	O	O	_	_	_	_	_
31	its	_	O	O	_	_	_	_	_
32	expression	_	O	O	_	_	_	_	_
33	at	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	later	_	O	O	_	_	_	_	_
36	stage	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	protein	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	previously	_	O	O	_	_	_	_	_
5	identified	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	its	_	O	O	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	Ig	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	3	_	O	O	_	_	_	_	_
14	'	_	O	O	_	_	_	_	_
15	enhancer	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	Ig	_	O	O	_	_	_	_	_
19	heavy	_	O	O	_	_	_	_	_
20	chain	_	O	O	_	_	_	_	_
21	mu	_	O	O	_	_	_	_	_
22	E	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	site	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	thus	_	O	O	_	_	_	_	_
27	also	_	O	O	_	_	_	_	_
28	appears	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	be	_	O	O	_	_	_	_	_
31	quite	_	O	O	_	_	_	_	_
32	important	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	regulation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	MHC	_	O	O	_	_	_	_	_
38	class	_	O	O	_	_	_	_	_
39	II	_	O	O	_	_	_	_	_
40	gene	_	O	O	_	_	_	_	_
41	expression	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	promotes	_	O	O	_	_	_	_	_
4	N	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	terminal	_	O	O	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	degradation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	principal	_	O	O	_	_	_	_	_
16	cytoplasmic	_	O	O	_	_	_	_	_
17	inhibitor	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	kappaB	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Constitutive	_	O	O	_	_	_	_	_
2	NF	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	kappa	_	O	O	_	_	_	_	_
5	B	_	O	O	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	enhanced	_	O	O	_	_	_	_	_
9	granulopoiesis	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	neonatal	_	O	O	_	_	_	_	_
13	lethality	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	deficient	_	O	O	_	_	_	_	_
21	mice	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	factors	_	O	O	_	_	_	_	_
3	belonging	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	family	_	O	O	_	_	_	_	_
11	are	_	O	O	_	_	_	_	_
12	controlled	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	inhibitory	_	O	O	_	_	_	_	_
15	I	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	proteins	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	mainly	_	O	O	_	_	_	_	_
21	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	biologic	_	O	O	_	_	_	_	_
4	functions	_	O	O	_	_	_	_	_
5	are	_	O	O	_	_	_	_	_
6	modulated	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	hormone	_	O	O	_	_	_	_	_
12	inhibits	_	O	O	_	_	_	_	_
13	proliferation	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	subset	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	activated	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	observations	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	reactivity	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	alpha	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	25	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	OH	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	2	_	O	O	_	_	_	_	_
15	D	_	O	O	_	_	_	_	_
16	3	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	tightly	_	O	O	_	_	_	_	_
19	regulated	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	lymphocytes	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	requiring	_	O	O	_	_	_	_	_
25	specific	_	O	O	_	_	_	_	_
26	signals	_	O	O	_	_	_	_	_
27	for	_	O	O	_	_	_	_	_
28	its	_	O	O	_	_	_	_	_
29	initiation	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Chromatin	_	O	O	_	_	_	_	_
2	immunoprecipitation	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	ChIP	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	assay	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	examined	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	role	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	modulating	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	'	_	O	O	_	_	_	_	_
13	naive	_	O	O	_	_	_	_	_
14	'	_	O	O	_	_	_	_	_
15	neonatal	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	response	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	anti	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	CD	_	O	O	_	_	_	_	_
23	2	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	mediated	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	cellular	_	O	O	_	_	_	_	_
3	mechanism	_	O	O	_	_	_	_	_
4	governing	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	diminished	_	O	O	_	_	_	_	_
7	proliferative	_	O	O	_	_	_	_	_
8	response	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	neonatal	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	lymphocytes	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	anti	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	CD	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	may	_	O	O	_	_	_	_	_
19	therefore	_	O	O	_	_	_	_	_
20	be	_	O	O	_	_	_	_	_
21	due	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	decreased	_	O	O	_	_	_	_	_
24	NF	_	O	O	_	_	_	_	_
25	kappa	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	induction	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	reduced	_	O	O	_	_	_	_	_
30	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	mRNA	_	O	O	_	_	_	_	_
34	expression	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	deficient	_	O	O	_	_	_	_	_
37	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	production	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_


1	Differential	_	O	O	_	_	_	_	_
2	RNA	_	O	O	_	_	_	_	_
3	display	_	O	O	_	_	_	_	_
4	identifies	_	O	O	_	_	_	_	_
5	novel	_	O	O	_	_	_	_	_
6	genes	_	O	O	_	_	_	_	_
7	associated	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	decreased	_	O	O	_	_	_	_	_
10	vitamin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	D	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	Employing	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	EBV	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	transformed	_	O	O	_	_	_	_	_
6	human	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	cell	_	O	O	_	_	_	_	_
9	line	_	O	O	_	_	_	_	_
10	SKW	_	O	O	_	_	_	_	_
11	6	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_
13	4	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	we	_	O	O	_	_	_	_	_
16	demonstrate	_	O	O	_	_	_	_	_
17	that	_	O	O	_	_	_	_	_
18	platelet	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	activating	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	significantly	_	O	O	_	_	_	_	_
23	alters	_	O	O	_	_	_	_	_
24	membrane	_	O	O	_	_	_	_	_
25	phospholipid	_	O	O	_	_	_	_	_
26	metabolism	_	O	O	_	_	_	_	_
27	indicated	_	O	O	_	_	_	_	_
28	by	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	incorporation	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	32	_	O	O	_	_	_	_	_
33	P	_	O	O	_	_	_	_	_
34	into	_	O	O	_	_	_	_	_
35	phosphatidylcholine	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	phosphatidylinositol	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	phosphatidic	_	O	O	_	_	_	_	_
41	acid	_	O	O	_	_	_	_	_
42	but	_	O	O	_	_	_	_	_
43	not	_	O	O	_	_	_	_	_
44	significantly	_	O	O	_	_	_	_	_
45	into	_	O	O	_	_	_	_	_
46	phosphatidylethanolamine	_	O	O	_	_	_	_	_
47	at	_	O	O	_	_	_	_	_
48	concentrations	_	O	O	_	_	_	_	_
49	ranging	_	O	O	_	_	_	_	_
50	from	_	O	O	_	_	_	_	_
51	10	_	O	O	_	_	_	_	_
52	(	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	9	_	O	O	_	_	_	_	_
55	)	_	O	O	_	_	_	_	_
56	to	_	O	O	_	_	_	_	_
57	10	_	O	O	_	_	_	_	_
58	(	_	O	O	_	_	_	_	_
59	-	_	O	O	_	_	_	_	_
60	6	_	O	O	_	_	_	_	_
61	)	_	O	O	_	_	_	_	_
62	M	_	O	O	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_

1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	platelet	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	activating	_	O	O	_	_	_	_	_
6	factor	_	O	O	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	capable	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	inducing	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	nuclear	_	O	O	_	_	_	_	_
15	proto	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	oncogenes	_	O	O	_	_	_	_	_
18	c	_	O	O	_	_	_	_	_
19	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Finally	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	explored	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	possible	_	O	O	_	_	_	_	_
6	role	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	5	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	hydroxyeicosatetraenoic	_	O	O	_	_	_	_	_
11	acid	_	O	O	_	_	_	_	_
12	as	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	regulator	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	arachidonic	_	O	O	_	_	_	_	_
17	acid	_	O	O	_	_	_	_	_
18	liberation	_	O	O	_	_	_	_	_
19	demonstrating	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	endogenous	_	O	O	_	_	_	_	_
22	5	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	lipoxygenase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	activity	_	O	O	_	_	_	_	_
26	modulates	_	O	O	_	_	_	_	_
27	platelet	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	activating	_	O	O	_	_	_	_	_
30	factor	_	O	O	_	_	_	_	_
31	induced	_	O	O	_	_	_	_	_
32	arachidonic	_	O	O	_	_	_	_	_
33	acid	_	O	O	_	_	_	_	_
34	release	_	O	O	_	_	_	_	_
35	perhaps	_	O	O	_	_	_	_	_
36	acting	_	O	O	_	_	_	_	_
37	at	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	level	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	phospholipase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Online	_	O	O	_	_	_	_	_
2	supplemental	_	O	O	_	_	_	_	_
3	material	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_

1	Fig	_	O	O	_	_	_	_	_
2	.	_	O	O	_	_	_	_	_

1	Communication	_	O	O	_	_	_	_	_
2	between	_	O	O	_	_	_	_	_
3	resident	_	O	O	_	_	_	_	_
4	tissue	_	O	O	_	_	_	_	_
5	fibroblasts	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	necessary	_	O	O	_	_	_	_	_
11	for	_	O	O	_	_	_	_	_
12	normal	_	O	O	_	_	_	_	_
13	wound	_	O	O	_	_	_	_	_
14	healing	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	can	_	O	O	_	_	_	_	_
18	be	_	O	O	_	_	_	_	_
19	pathologic	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	resulting	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	tissue	_	O	O	_	_	_	_	_
24	fibrosis	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	used	_	O	O	_	_	_	_	_
3	TCR	_	O	O	_	_	_	_	_
4	transgenic	_	O	O	_	_	_	_	_
5	mice	_	O	O	_	_	_	_	_
6	for	_	O	O	_	_	_	_	_
7	these	_	O	O	_	_	_	_	_
8	experiments	_	O	O	_	_	_	_	_
9	because	_	O	O	_	_	_	_	_
10	they	_	O	O	_	_	_	_	_
11	provide	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	reliable	_	O	O	_	_	_	_	_
14	source	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	+	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	are	_	O	O	_	_	_	_	_
23	truly	_	O	O	_	_	_	_	_
24	naive	_	O	O	_	_	_	_	_
25	;	_	O	O	_	_	_	_	_
26	however	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	we	_	O	O	_	_	_	_	_
29	chose	_	O	O	_	_	_	_	_
30	not	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	stimulate	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	antigen	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	most	_	O	O	_	_	_	_	_
38	experiments	_	O	O	_	_	_	_	_
39	so	_	O	O	_	_	_	_	_
40	as	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	avoid	_	O	O	_	_	_	_	_
43	contamination	_	O	O	_	_	_	_	_
44	with	_	O	O	_	_	_	_	_
45	proteins	_	O	O	_	_	_	_	_
46	and	_	O	O	_	_	_	_	_
47	nucleic	_	O	O	_	_	_	_	_
48	acids	_	O	O	_	_	_	_	_
49	derived	_	O	O	_	_	_	_	_
50	from	_	O	O	_	_	_	_	_
51	APCs	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_



1	Fludarabine	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	induced	_	O	O	_	_	_	_	_
4	immunosuppression	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	associated	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	inhibition	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	signaling	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_


1	Fludarabine	_	O	O	_	_	_	_	_
2	caused	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	specific	_	O	O	_	_	_	_	_
5	depletion	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	protein	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	mRNA	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	but	_	O	O	_	_	_	_	_
15	not	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	other	_	O	O	_	_	_	_	_
18	STATs	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	anti	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	antibodies	_	O	O	_	_	_	_	_
8	inhibit	_	O	O	_	_	_	_	_
9	these	_	O	O	_	_	_	_	_
10	effects	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	infected	_	O	O	_	_	_	_	_
15	individuals	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	examined	_	O	O	_	_	_	_	_
7	interrelationships	_	O	O	_	_	_	_	_
8	between	_	O	O	_	_	_	_	_
9	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	HIV	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	further	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_


1	Interestingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	transfected	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	hybrids	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	cell	_	O	O	_	_	_	_	_
11	surface	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	human	_	O	O	_	_	_	_	_
16	HLA	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	DQ	_	O	O	_	_	_	_	_
19	heterodimer	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	not	_	O	O	_	_	_	_	_
22	observed	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	further	_	O	O	_	_	_	_	_
4	support	_	O	O	_	_	_	_	_
5	our	_	O	O	_	_	_	_	_
6	previous	_	O	O	_	_	_	_	_
7	observations	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	distinct	_	O	O	_	_	_	_	_
11	regulation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	HLA	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	DQ	_	O	O	_	_	_	_	_
20	class	_	O	O	_	_	_	_	_
21	II	_	O	O	_	_	_	_	_
22	subset	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	which	_	O	O	_	_	_	_	_
25	may	_	O	O	_	_	_	_	_
26	be	_	O	O	_	_	_	_	_
27	thus	_	O	O	_	_	_	_	_
28	controlled	_	O	O	_	_	_	_	_
29	at	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	posttranscriptional	_	O	O	_	_	_	_	_
32	level	_	O	O	_	_	_	_	_
33	by	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	independent	_	O	O	_	_	_	_	_
38	mechanism	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	+	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	gated	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	basis	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	RO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	surface	_	O	O	_	_	_	_	_
19	expression	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	upper	_	O	O	_	_	_	_	_
22	panel	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	gated	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	are	_	O	O	_	_	_	_	_
29	shown	_	O	O	_	_	_	_	_
30	below	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	RO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	+	_	O	O	_	_	_	_	_
37	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	A	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	left	_	O	O	_	_	_	_	_
44	panel	_	O	O	_	_	_	_	_
45	)	_	O	O	_	_	_	_	_
46	,	_	O	O	_	_	_	_	_
47	the	_	O	O	_	_	_	_	_
48	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
49	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	RO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	+	_	O	O	_	_	_	_	_
52	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
53	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	+	_	O	O	_	_	_	_	_
55	(	_	O	O	_	_	_	_	_
56	right	_	O	O	_	_	_	_	_
57	panel	_	O	O	_	_	_	_	_
58	)	_	O	O	_	_	_	_	_
59	,	_	O	O	_	_	_	_	_
60	and	_	O	O	_	_	_	_	_
61	the	_	O	O	_	_	_	_	_
62	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
63	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
64	RO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
65	-	_	O	O	_	_	_	_	_
66	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
67	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
68	-	_	O	O	_	_	_	_	_
69	subsets	_	O	O	_	_	_	_	_
70	(	_	O	O	_	_	_	_	_
71	central	_	O	O	_	_	_	_	_
72	panel	_	O	O	_	_	_	_	_
73	)	_	O	O	_	_	_	_	_
74	.	_	O	O	_	_	_	_	_

1	Yet	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	same	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	do	_	O	O	_	_	_	_	_
6	initiate	_	O	O	_	_	_	_	_
7	early	_	O	O	_	_	_	_	_
8	TCR	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	mediated	_	O	O	_	_	_	_	_
11	signaling	_	O	O	_	_	_	_	_
12	events	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	such	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	generation	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	inositol	_	O	O	_	_	_	_	_
19	phosphates	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	increased	_	O	O	_	_	_	_	_
22	intracellular	_	O	O	_	_	_	_	_
23	calcium	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	RESULTS	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	Interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	mRNA	_	O	O	_	_	_	_	_
9	production	_	O	O	_	_	_	_	_
10	were	_	O	O	_	_	_	_	_
11	significantly	_	O	O	_	_	_	_	_
12	increased	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	transfected	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	CMV	_	O	O	_	_	_	_	_
19	IE	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	stimulated	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	LPS	_	O	O	_	_	_	_	_
25	compared	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	LPS	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	stimulated	_	O	O	_	_	_	_	_
30	control	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Cytomegalovirus	_	O	O	_	_	_	_	_
2	IE	_	O	O	_	_	_	_	_
3	gene	_	O	O	_	_	_	_	_
4	products	_	O	O	_	_	_	_	_
5	significantly	_	O	O	_	_	_	_	_
6	enhanced	_	O	O	_	_	_	_	_
7	LPS	_	O	O	_	_	_	_	_
8	stimulation	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	promoter	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	both	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	luciferase	_	O	O	_	_	_	_	_
26	assays	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	increase	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	luciferase	_	O	O	_	_	_	_	_
8	activity	_	O	O	_	_	_	_	_
9	occurs	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	absence	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	multiple	_	O	O	_	_	_	_	_
16	response	_	O	O	_	_	_	_	_
17	region	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	area	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	promoter	_	O	O	_	_	_	_	_
27	responsive	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	IL	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	1	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	cyclic	_	O	O	_	_	_	_	_
37	amp	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	phorbol	_	O	O	_	_	_	_	_
41	12	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	myristate	_	O	O	_	_	_	_	_
44	13	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	acetate	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	regulation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	coding	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	main	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	growth	_	O	O	_	_	_	_	_
15	factor	_	O	O	_	_	_	_	_
16	changes	_	O	O	_	_	_	_	_
17	irreversibly	_	O	O	_	_	_	_	_
18	after	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	first	_	O	O	_	_	_	_	_
21	encounter	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	with	_	O	O	_	_	_	_	_
26	antigen	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	MTS	_	O	O	_	_	_	_	_
2	assay	_	O	O	_	_	_	_	_
3	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	3	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	4	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	5	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	dimethylthiazol	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	yl	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	5	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	3	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	carboxymethoxyphenyl	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	2	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	4	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	sulfophenyl	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	2	_	O	O	_	_	_	_	_
33	H	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	tetrazolium	_	O	O	_	_	_	_	_
36	inner	_	O	O	_	_	_	_	_
37	salt	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	MTS	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	cell	_	O	O	_	_	_	_	_
42	cytotoxicity	_	O	O	_	_	_	_	_
43	/	_	O	O	_	_	_	_	_
44	proliferation	_	O	O	_	_	_	_	_
45	assays	_	O	O	_	_	_	_	_
46	were	_	O	O	_	_	_	_	_
47	performed	_	O	O	_	_	_	_	_
48	using	_	O	O	_	_	_	_	_
49	the	_	O	O	_	_	_	_	_
50	CellTiter	_	O	O	_	_	_	_	_
51	96	_	O	O	_	_	_	_	_
52	aqueous	_	O	O	_	_	_	_	_
53	one	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	solution	_	O	O	_	_	_	_	_
56	cell	_	O	O	_	_	_	_	_
57	proliferation	_	O	O	_	_	_	_	_
58	assay	_	O	O	_	_	_	_	_
59	(	_	O	O	_	_	_	_	_
60	Promega	_	O	O	_	_	_	_	_
61	)	_	O	O	_	_	_	_	_
62	,	_	O	O	_	_	_	_	_
63	according	_	O	O	_	_	_	_	_
64	to	_	O	O	_	_	_	_	_
65	manufacturer	_	O	O	_	_	_	_	_
66	'	_	O	O	_	_	_	_	_
67	s	_	O	O	_	_	_	_	_
68	instructions	_	O	O	_	_	_	_	_
69	.	_	O	O	_	_	_	_	_

1	For	_	O	O	_	_	_	_	_
2	inhibitor	_	O	O	_	_	_	_	_
3	studies	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	splenocytes	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	seeded	_	O	O	_	_	_	_	_
8	at	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	x	_	O	O	_	_	_	_	_
11	107	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	ml	_	O	O	_	_	_	_	_
15	at	_	O	O	_	_	_	_	_
16	100	_	O	O	_	_	_	_	_
17	mul	_	O	O	_	_	_	_	_
18	per	_	O	O	_	_	_	_	_
19	well	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	day	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	harvest	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	inhibitors	_	O	O	_	_	_	_	_
27	were	_	O	O	_	_	_	_	_
28	added	_	O	O	_	_	_	_	_
29	at	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	concentrations	_	O	O	_	_	_	_	_
32	indicated	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	figures	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	reveal	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	inactivation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	v	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	abl	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	tyrosine	_	O	O	_	_	_	_	_
13	kinase	_	O	O	_	_	_	_	_
14	triggers	_	O	O	_	_	_	_	_
15	high	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	frequency	_	O	O	_	_	_	_	_
18	rearrangement	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	kappa	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	lambda	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	light	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	chain	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	genes	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	During	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	induction	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	anergy	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	phenotypically	_	O	O	_	_	_	_	_
11	similar	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	responding	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	an	_	O	O	_	_	_	_	_
17	immunogenic	_	O	O	_	_	_	_	_
18	stimulus	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Calcineurin	_	O	O	_	_	_	_	_
2	potentiates	_	O	O	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	colony	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	stimulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	gene	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	:	_	O	O	_	_	_	_	_
18	involvement	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	conserved	_	O	O	_	_	_	_	_
22	lymphokine	_	O	O	_	_	_	_	_
23	element	_	O	O	_	_	_	_	_
24	0	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Run	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	on	_	O	O	_	_	_	_	_
4	analysis	_	O	O	_	_	_	_	_
5	demonstrated	_	O	O	_	_	_	_	_
6	detectable	_	O	O	_	_	_	_	_
7	levels	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	transcription	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	U	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	937	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	this	_	O	O	_	_	_	_	_
21	rate	_	O	O	_	_	_	_	_
22	is	_	O	O	_	_	_	_	_
23	increased	_	O	O	_	_	_	_	_
24	approximately	_	O	O	_	_	_	_	_
25	40	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	fold	_	O	O	_	_	_	_	_
28	following	_	O	O	_	_	_	_	_
29	okadaic	_	O	O	_	_	_	_	_
30	acid	_	O	O	_	_	_	_	_
31	exposure	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	mRNA	_	O	O	_	_	_	_	_
5	levels	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	superinduced	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	treated	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	okadaic	_	O	O	_	_	_	_	_
14	acid	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	cycloheximide	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	whereas	_	O	O	_	_	_	_	_
19	inhibition	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	protein	_	O	O	_	_	_	_	_
22	synthesis	_	O	O	_	_	_	_	_
23	had	_	O	O	_	_	_	_	_
24	little	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	if	_	O	O	_	_	_	_	_
27	any	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	effect	_	O	O	_	_	_	_	_
30	on	_	O	O	_	_	_	_	_
31	okadaic	_	O	O	_	_	_	_	_
32	acid	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	induced	_	O	O	_	_	_	_	_
35	c	_	O	O	_	_	_	_	_
36	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	transcription	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Cells	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	subsequently	_	O	O	_	_	_	_	_
4	stimulated	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	PMA	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	24	_	O	O	_	_	_	_	_
11	h	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	inducing	_	O	O	_	_	_	_	_
14	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	activity	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_
19	6	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	fold	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	2	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	fibrinogen	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	Mn	_	O	O	_	_	_	_	_
28	2	_	O	O	_	_	_	_	_
29	+	_	O	O	_	_	_	_	_
30	for	_	O	O	_	_	_	_	_
31	2	_	O	O	_	_	_	_	_
32	h	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	inducing	_	O	O	_	_	_	_	_
35	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	activity	_	O	O	_	_	_	_	_
37	by	_	O	O	_	_	_	_	_
38	3	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_
40	2	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	fold	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	or	_	O	O	_	_	_	_	_
45	3	_	O	O	_	_	_	_	_
46	)	_	O	O	_	_	_	_	_
47	costimulation	_	O	O	_	_	_	_	_
48	with	_	O	O	_	_	_	_	_
49	fibrinogen	_	O	O	_	_	_	_	_
50	and	_	O	O	_	_	_	_	_
51	PMA	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	inducing	_	O	O	_	_	_	_	_
54	5	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_
56	7	_	O	O	_	_	_	_	_
57	-	_	O	O	_	_	_	_	_
58	fold	_	O	O	_	_	_	_	_
59	the	_	O	O	_	_	_	_	_
60	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
61	activity	_	O	O	_	_	_	_	_
62	induced	_	O	O	_	_	_	_	_
63	by	_	O	O	_	_	_	_	_
64	PMA	_	O	O	_	_	_	_	_
65	alone	_	O	O	_	_	_	_	_
66	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	2	_	O	O	_	_	_	_	_
4	factor	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	induced	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	nuclei	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	these	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	only	_	O	O	_	_	_	_	_
14	upon	_	O	O	_	_	_	_	_
15	HIV	_	O	O	_	_	_	_	_
16	1	_	O	O	_	_	_	_	_
17	infection	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	found	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	two	_	O	O	_	_	_	_	_
5	members	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	NSAIDs	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	sodium	_	O	O	_	_	_	_	_
11	salicylate	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	sulindac	_	O	O	_	_	_	_	_
14	repress	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	promoter	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	similar	_	O	O	_	_	_	_	_
22	degree	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	heat	_	O	O	_	_	_	_	_
25	shock	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	HSF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	overexpression	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Exposure	_	O	O	_	_	_	_	_
2	to	_	O	O	_	_	_	_	_
3	NSAIDs	_	O	O	_	_	_	_	_
4	had	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	complex	_	O	O	_	_	_	_	_
7	effect	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	HSP	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	while	_	O	O	_	_	_	_	_
14	sulindac	_	O	O	_	_	_	_	_
15	activated	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	stress	_	O	O	_	_	_	_	_
18	responsive	_	O	O	_	_	_	_	_
19	HSP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	70	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	promoter	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	sodium	_	O	O	_	_	_	_	_
25	salicylate	_	O	O	_	_	_	_	_
26	did	_	O	O	_	_	_	_	_
27	not	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	current	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	focuses	_	O	O	_	_	_	_	_
5	on	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	role	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	two	_	O	O	_	_	_	_	_
10	key	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	factors	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	controlling	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	commitment	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	these	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Substitution	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	optimized	_	O	O	_	_	_	_	_
5	peptide	_	O	O	_	_	_	_	_
6	sequence	_	O	O	_	_	_	_	_
7	into	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	natural	_	O	O	_	_	_	_	_
10	calcineurin	_	O	O	_	_	_	_	_
11	docking	_	O	O	_	_	_	_	_
12	site	_	O	O	_	_	_	_	_
13	increased	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	calcineurin	_	O	O	_	_	_	_	_
16	responsiveness	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	NFAT	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_


1	Administration	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	dexamethasone	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	temporal	_	O	O	_	_	_	_	_
6	artery	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	SCID	_	O	O	_	_	_	_	_
9	chimeras	_	O	O	_	_	_	_	_
10	for	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	wk	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	partial	_	O	O	_	_	_	_	_
16	suppression	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	macrophage	_	O	O	_	_	_	_	_
22	function	_	O	O	_	_	_	_	_
23	as	_	O	O	_	_	_	_	_
24	indicated	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	reduced	_	O	O	_	_	_	_	_
28	tissue	_	O	O	_	_	_	_	_
29	concentrations	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	mRNA	_	O	O	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	and	_	O	O	_	_	_	_	_
47	by	_	O	O	_	_	_	_	_
48	the	_	O	O	_	_	_	_	_
49	diminished	_	O	O	_	_	_	_	_
50	expression	_	O	O	_	_	_	_	_
51	of	_	O	O	_	_	_	_	_
52	inducible	_	O	O	_	_	_	_	_
53	NO	_	O	O	_	_	_	_	_
54	synthase	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	Immune	_	O	O	_	_	_	_	_
2	hyperactivation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	HIV	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	infected	_	O	O	_	_	_	_	_
9	T	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	mediated	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	Tat	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	pathway	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	superinduction	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	Tat	_	O	O	_	_	_	_	_
7	occurred	_	O	O	_	_	_	_	_
8	at	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	transcriptional	_	O	O	_	_	_	_	_
11	level	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	was	_	O	O	_	_	_	_	_
14	mediated	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	responsive	_	O	O	_	_	_	_	_
21	element	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	promoter	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	was	_	O	O	_	_	_	_	_
31	exclusively	_	O	O	_	_	_	_	_
32	dependent	_	O	O	_	_	_	_	_
33	on	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	29	_	O	O	_	_	_	_	_
36	amino	_	O	O	_	_	_	_	_
37	acids	_	O	O	_	_	_	_	_
38	encoded	_	O	O	_	_	_	_	_
39	by	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	second	_	O	O	_	_	_	_	_
42	exon	_	O	O	_	_	_	_	_
43	of	_	O	O	_	_	_	_	_
44	Tat	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	34	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	+	_	O	O	_	_	_	_	_
5	myelomonocytic	_	O	O	_	_	_	_	_
6	cell	_	O	O	_	_	_	_	_
7	line	_	O	O	_	_	_	_	_
8	KG	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	differentiates	_	O	O	_	_	_	_	_
11	into	_	O	O	_	_	_	_	_
12	dendritic	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	like	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	response	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	plus	_	O	O	_	_	_	_	_
24	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	PMA	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	with	_	O	O	_	_	_	_	_
32	or	_	O	O	_	_	_	_	_
33	without	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	calcium	_	O	O	_	_	_	_	_
36	ionophore	_	O	O	_	_	_	_	_
37	ionomycin	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	or	_	O	O	_	_	_	_	_
40	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	with	_	O	O	_	_	_	_	_
46	different	_	O	O	_	_	_	_	_
47	stimuli	_	O	O	_	_	_	_	_
48	mediating	_	O	O	_	_	_	_	_
49	different	_	O	O	_	_	_	_	_
50	aspects	_	O	O	_	_	_	_	_
51	of	_	O	O	_	_	_	_	_
52	the	_	O	O	_	_	_	_	_
53	process	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Results	_	O	O	_	_	_	_	_
2	indicate	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	TIMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	positive	_	O	O	_	_	_	_	_
9	BL	_	O	O	_	_	_	_	_
10	lines	_	O	O	_	_	_	_	_
11	show	_	O	O	_	_	_	_	_
12	resistance	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	cold	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	shock	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	apoptosis	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Cell	_	O	O	_	_	_	_	_
2	activation	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	apoptosis	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	bacterial	_	O	O	_	_	_	_	_
7	lipoproteins	_	O	O	_	_	_	_	_
8	through	_	O	O	_	_	_	_	_
9	toll	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	like	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_


1	Treatment	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	umbilical	_	O	O	_	_	_	_	_
5	vein	_	O	O	_	_	_	_	_
6	endothelial	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	HUVEC	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	monolayers	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	6	_	O	O	_	_	_	_	_
14	hours	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	0	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	mmol	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	L	_	O	O	_	_	_	_	_
22	diamide	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	1	_	O	O	_	_	_	_	_
25	mmol	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	L	_	O	O	_	_	_	_	_
28	buthionine	_	O	O	_	_	_	_	_
29	sulfoximine	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	BSO	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	decreased	_	O	O	_	_	_	_	_
34	GSH	_	O	O	_	_	_	_	_
35	levels	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	increased	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	ratio	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	GSSG	_	O	O	_	_	_	_	_
42	to	_	O	O	_	_	_	_	_
43	GSH	_	O	O	_	_	_	_	_
44	without	_	O	O	_	_	_	_	_
45	cell	_	O	O	_	_	_	_	_
46	toxicity	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	N	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	Acetylcysteine	_	O	O	_	_	_	_	_
4	treatment	_	O	O	_	_	_	_	_
5	attenuated	_	O	O	_	_	_	_	_
6	neutrophil	_	O	O	_	_	_	_	_
7	adhesion	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	both	_	O	O	_	_	_	_	_
10	phases	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	which	_	O	O	_	_	_	_	_
13	indicated	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	role	_	O	O	_	_	_	_	_
16	for	_	O	O	_	_	_	_	_
17	GSH	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	adhesion	_	O	O	_	_	_	_	_
21	responses	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	functional	_	O	O	_	_	_	_	_
3	role	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	GrpL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	SLP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	76	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	complex	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	suggested	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	ability	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	GrpL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	act	_	O	O	_	_	_	_	_
21	alone	_	O	O	_	_	_	_	_
22	or	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	concert	_	O	O	_	_	_	_	_
25	with	_	O	O	_	_	_	_	_
26	SLP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	76	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	augment	_	O	O	_	_	_	_	_
31	NF	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	AT	_	O	O	_	_	_	_	_
34	activation	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	Jurkat	_	O	O	_	_	_	_	_
37	T	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	A	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	promoter	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	inducible	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	increasing	_	O	O	_	_	_	_	_
5	amounts	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	plasmid	_	O	O	_	_	_	_	_
9	pNL	_	O	O	_	_	_	_	_
10	4	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	3	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	containing	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	full	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	length	_	O	O	_	_	_	_	_
19	genome	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	HIV	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	1	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	were	_	O	O	_	_	_	_	_
26	transfected	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	not	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	case	_	O	O	_	_	_	_	_
6	when	_	O	O	_	_	_	_	_
7	PBMC	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	pre	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	cultured	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	plastic	_	O	O	_	_	_	_	_
14	multidishes	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	presence	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Altogether	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	indicate	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	induced	_	O	O	_	_	_	_	_
13	up	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	regulation	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	cytokine	_	O	O	_	_	_	_	_
18	production	_	O	O	_	_	_	_	_
19	depends	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	prevention	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	monocyte	_	O	O	_	_	_	_	_
25	adherence	_	O	O	_	_	_	_	_
26	by	_	O	O	_	_	_	_	_
27	red	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	whole	_	O	O	_	_	_	_	_
32	blood	_	O	O	_	_	_	_	_
33	assays	_	O	O	_	_	_	_	_
34	or	_	O	O	_	_	_	_	_
35	by	_	O	O	_	_	_	_	_
36	cultures	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	PBMC	_	O	O	_	_	_	_	_
39	on	_	O	O	_	_	_	_	_
40	Teflon	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	DeltaFKH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	did	_	O	O	_	_	_	_	_
3	not	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	discernable	_	O	O	_	_	_	_	_
7	affect	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Peripheral	_	O	O	_	_	_	_	_
2	blood	_	O	O	_	_	_	_	_
3	mononuclear	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	from	_	O	O	_	_	_	_	_
6	seventeen	_	O	O	_	_	_	_	_
7	patients	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	primary	_	O	O	_	_	_	_	_
10	myelodysplastic	_	O	O	_	_	_	_	_
11	syndromes	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	MDS	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	advanced	_	O	O	_	_	_	_	_
17	stage	_	O	O	_	_	_	_	_
18	were	_	O	O	_	_	_	_	_
19	enriched	_	O	O	_	_	_	_	_
20	for	_	O	O	_	_	_	_	_
21	blasts	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	tested	_	O	O	_	_	_	_	_
24	for	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	1	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	karyotype	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	2	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	genomic	_	O	O	_	_	_	_	_
34	configuration	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	3	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	expression	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	,	_	O	O	_	_	_	_	_
45	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	,	_	O	O	_	_	_	_	_
49	FMS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	and	_	O	O	_	_	_	_	_
51	EGR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
52	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
53	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	genes	_	O	O	_	_	_	_	_
55	which	_	O	O	_	_	_	_	_
56	are	_	O	O	_	_	_	_	_
57	all	_	O	O	_	_	_	_	_
58	located	_	O	O	_	_	_	_	_
59	on	_	O	O	_	_	_	_	_
60	the	_	O	O	_	_	_	_	_
61	long	_	O	O	_	_	_	_	_
62	arm	_	O	O	_	_	_	_	_
63	of	_	O	O	_	_	_	_	_
64	chromosome	_	O	O	_	_	_	_	_
65	5	_	O	O	_	_	_	_	_
66	.	_	O	O	_	_	_	_	_

1	Aims	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	study	_	O	O	_	_	_	_	_
5	were	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	1	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	assess	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	potential	_	O	O	_	_	_	_	_
13	role	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	these	_	O	O	_	_	_	_	_
19	genes	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	maintenance	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	expansion	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	neoplastic	_	O	O	_	_	_	_	_
28	clones	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	2	_	O	O	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	search	_	O	O	_	_	_	_	_
34	for	_	O	O	_	_	_	_	_
35	constitutional	_	O	O	_	_	_	_	_
36	losses	_	O	O	_	_	_	_	_
37	or	_	O	O	_	_	_	_	_
38	rearrangements	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	one	_	O	O	_	_	_	_	_
41	allele	_	O	O	_	_	_	_	_
42	followed	_	O	O	_	_	_	_	_
43	by	_	O	O	_	_	_	_	_
44	a	_	O	O	_	_	_	_	_
45	deletion	_	O	O	_	_	_	_	_
46	of	_	O	O	_	_	_	_	_
47	the	_	O	O	_	_	_	_	_
48	second	_	O	O	_	_	_	_	_
49	allele	_	O	O	_	_	_	_	_
50	of	_	O	O	_	_	_	_	_
51	the	_	O	O	_	_	_	_	_
52	same	_	O	O	_	_	_	_	_
53	genes	_	O	O	_	_	_	_	_
54	in	_	O	O	_	_	_	_	_
55	the	_	O	O	_	_	_	_	_
56	leukemic	_	O	O	_	_	_	_	_
57	cells	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	T	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	cell	_	O	O	_	_	_	_	_
5	leukemia	_	O	O	_	_	_	_	_
6	virus	_	O	O	_	_	_	_	_
7	type	_	O	O	_	_	_	_	_
8	I	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	HTLV	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	I	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	etiologic	_	O	O	_	_	_	_	_
17	agent	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	adult	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	leukemia	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	ATL	_	O	O	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Understanding	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	molecular	_	O	O	_	_	_	_	_
4	mechanisms	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	FasL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	regulation	_	O	O	_	_	_	_	_
8	could	_	O	O	_	_	_	_	_
9	be	_	O	O	_	_	_	_	_
10	very	_	O	O	_	_	_	_	_
11	useful	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	elucidating	_	O	O	_	_	_	_	_
14	how	_	O	O	_	_	_	_	_
15	these	_	O	O	_	_	_	_	_
16	diseases	_	O	O	_	_	_	_	_
17	develop	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	identifying	_	O	O	_	_	_	_	_
21	potential	_	O	O	_	_	_	_	_
22	therapeutic	_	O	O	_	_	_	_	_
23	targets	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Different	_	O	O	_	_	_	_	_
2	types	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	acute	_	O	O	_	_	_	_	_
5	myeloid	_	O	O	_	_	_	_	_
6	leukemia	_	O	O	_	_	_	_	_
7	blast	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	were	_	O	O	_	_	_	_	_
10	induced	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	differentiate	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	vitro	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	all	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	trans	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	retinoic	_	O	O	_	_	_	_	_
21	acid	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	ATRA	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	vitamin	_	O	O	_	_	_	_	_
27	D	_	O	O	_	_	_	_	_
28	3	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	VD	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Epstein	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	Barr	_	O	O	_	_	_	_	_
4	virus	_	O	O	_	_	_	_	_
5	replicative	_	O	O	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	during	_	O	O	_	_	_	_	_
9	de	_	O	O	_	_	_	_	_
10	novo	_	O	O	_	_	_	_	_
11	infection	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	thymocytes	_	O	O	_	_	_	_	_
15	:	_	O	O	_	_	_	_	_
16	simultaneous	_	O	O	_	_	_	_	_
17	early	_	O	O	_	_	_	_	_
18	expression	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	BZLF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	its	_	O	O	_	_	_	_	_
25	repressor	_	O	O	_	_	_	_	_
26	RAZ	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	others	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	shown	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	EBV	_	O	O	_	_	_	_	_
8	can	_	O	O	_	_	_	_	_
9	also	_	O	O	_	_	_	_	_
10	infect	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	subset	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	thymocytes	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	we	_	O	O	_	_	_	_	_
5	demonstrated	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	EBNA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	infected	_	O	O	_	_	_	_	_
14	thymocytes	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	transcribed	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	Fp	_	O	O	_	_	_	_	_
20	promoter	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	rather	_	O	O	_	_	_	_	_
23	than	_	O	O	_	_	_	_	_
24	from	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	Cp	_	O	O	_	_	_	_	_
27	/	_	O	O	_	_	_	_	_
28	Wp	_	O	O	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	which	_	O	O	_	_	_	_	_
31	is	_	O	O	_	_	_	_	_
32	used	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	latently	_	O	O	_	_	_	_	_
35	infected	_	O	O	_	_	_	_	_
36	B	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Granzyme	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	staining	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	specific	_	O	O	_	_	_	_	_
6	relative	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	an	_	O	O	_	_	_	_	_
9	isotype	_	O	O	_	_	_	_	_
10	control	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	not	_	O	O	_	_	_	_	_
13	depicted	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Cytolytic	_	O	O	_	_	_	_	_
2	activity	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	blocked	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	incubation	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	mM	_	O	O	_	_	_	_	_
10	EGTA	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	not	_	O	O	_	_	_	_	_
13	depicted	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	confirming	_	O	O	_	_	_	_	_
17	involvement	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	granule	_	O	O	_	_	_	_	_
21	exocytosis	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	granzyme	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	pathway	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	PDTC	_	O	O	_	_	_	_	_
4	failed	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	inhibit	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	endonuclease	_	O	O	_	_	_	_	_
9	activity	_	O	O	_	_	_	_	_
10	contained	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	whole	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	lysates	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	X	_	O	O	_	_	_	_	_
4	2	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	binds	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	DRA	_	O	O	_	_	_	_	_
10	X	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	box	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	activator	_	O	O	_	_	_	_	_
16	protein	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	cDNA	_	O	O	_	_	_	_	_
3	clone	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	isolated	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	cDNA	_	O	O	_	_	_	_	_
9	cloning	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	encodes	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	human	_	O	O	_	_	_	_	_
15	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	protein	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	which	_	O	O	_	_	_	_	_
21	together	_	O	O	_	_	_	_	_
22	with	_	O	O	_	_	_	_	_
23	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	forms	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	heterodimeric	_	O	O	_	_	_	_	_
29	activator	_	O	O	_	_	_	_	_
30	protein	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	transcription	_	O	O	_	_	_	_	_
34	complex	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	Bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	acts	_	O	O	_	_	_	_	_
9	downstream	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	MAPK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	but	_	O	O	_	_	_	_	_
16	upstream	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	MAPK	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	suggest	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	signaling	_	O	O	_	_	_	_	_
26	pathway	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	apoptotic	_	O	O	_	_	_	_	_
30	process	_	O	O	_	_	_	_	_
31	induced	_	O	O	_	_	_	_	_
32	by	_	O	O	_	_	_	_	_
33	bufalin	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	transcriptional	_	O	O	_	_	_	_	_
37	activity	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	activator	_	O	O	_	_	_	_	_
40	protein	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	1	_	O	O	_	_	_	_	_
43	may	_	O	O	_	_	_	_	_
44	be	_	O	O	_	_	_	_	_
45	down	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	regulated	_	O	O	_	_	_	_	_
48	through	_	O	O	_	_	_	_	_
49	the	_	O	O	_	_	_	_	_
50	inhibition	_	O	O	_	_	_	_	_
51	of	_	O	O	_	_	_	_	_
52	MAPK	_	O	O	_	_	_	_	_
53	activity	_	O	O	_	_	_	_	_
54	by	_	O	O	_	_	_	_	_
55	Bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
56	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	show	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	nNOS	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	predominant	_	O	O	_	_	_	_	_
8	isoform	_	O	O	_	_	_	_	_
9	constitutively	_	O	O	_	_	_	_	_
10	expressed	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	glia	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_

1	Pyrrolidine	_	O	O	_	_	_	_	_
2	dithiocarbamate	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	PDTC	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	inhibitor	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	most	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	;	_	O	O	_	_	_	_	_
16	however	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	we	_	O	O	_	_	_	_	_
19	show	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	PDTC	_	O	O	_	_	_	_	_
22	is	_	O	O	_	_	_	_	_
23	also	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	potent	_	O	O	_	_	_	_	_
26	scavenger	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	NO	_	O	O	_	_	_	_	_
29	through	_	O	O	_	_	_	_	_
30	formation	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	mononitrosyl	_	O	O	_	_	_	_	_
33	iron	_	O	O	_	_	_	_	_
34	complexes	_	O	O	_	_	_	_	_
35	with	_	O	O	_	_	_	_	_
36	PDTC	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	test	_	O	O	_	_	_	_	_
3	this	_	O	O	_	_	_	_	_
4	hypothesis	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	knocked	_	O	O	_	_	_	_	_
14	down	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	naive	_	O	O	_	_	_	_	_
18	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	+	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	transfection	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	small	_	O	O	_	_	_	_	_
27	interfering	_	O	O	_	_	_	_	_
28	RNAs	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	siRNAs	_	O	O	_	_	_	_	_
31	;	_	O	O	_	_	_	_	_
32	Fig	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	1	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_

1	1	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	influence	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	development	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	other	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	subsets	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	their	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	transcription	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	expression	_	O	O	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	further	_	O	O	_	_	_	_	_
25	investigated	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	only	_	O	O	_	_	_	_	_
5	slightly	_	O	O	_	_	_	_	_
6	reduced	_	O	O	_	_	_	_	_
7	after	_	O	O	_	_	_	_	_
8	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	silencing	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	1	_	O	O	_	_	_	_	_
2	D	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	also	_	O	O	_	_	_	_	_
11	expressed	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	reg	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	vivo	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	we	_	O	O	_	_	_	_	_
21	isolated	_	O	O	_	_	_	_	_
22	peripheral	_	O	O	_	_	_	_	_
23	blood	_	O	O	_	_	_	_	_
24	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	+	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	127	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	high	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	reg	_	O	O	_	_	_	_	_
35	cells	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	compared	_	O	O	_	_	_	_	_
38	them	_	O	O	_	_	_	_	_
39	with	_	O	O	_	_	_	_	_
40	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	+	_	O	O	_	_	_	_	_
43	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	127	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	+	_	O	O	_	_	_	_	_
46	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
47	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	T	_	O	O	_	_	_	_	_
50	cells	_	O	O	_	_	_	_	_
51	.	_	O	O	_	_	_	_	_


1	Interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	modulates	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	several	_	O	O	_	_	_	_	_
14	cytokines	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	monocytes	_	O	O	_	_	_	_	_
18	at	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	transcriptional	_	O	O	_	_	_	_	_
21	level	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assays	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	EMSAs	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	demonstrated	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	unstimulated	_	O	O	_	_	_	_	_
11	monocytes	_	O	O	_	_	_	_	_
12	predominantly	_	O	O	_	_	_	_	_
13	expressed	_	O	O	_	_	_	_	_
14	p	_	O	O	_	_	_	_	_
15	50	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	effects	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	on	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factors	_	O	O	_	_	_	_	_
11	were	_	O	O	_	_	_	_	_
12	specific	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	since	_	O	O	_	_	_	_	_
15	no	_	O	O	_	_	_	_	_
16	change	_	O	O	_	_	_	_	_
17	was	_	O	O	_	_	_	_	_
18	observed	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	expression	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	inhibitor	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	NF	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	kappa	_	O	O	_	_	_	_	_
40	B	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	For	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	vivo	_	O	O	_	_	_	_	_
5	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	conversion	_	O	O	_	_	_	_	_
8	assay	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	naive	_	O	O	_	_	_	_	_
11	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	+	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	from	_	O	O	_	_	_	_	_
17	Cbfb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	cre	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	or	_	O	O	_	_	_	_	_
23	control	_	O	O	_	_	_	_	_
24	mice	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	harboring	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	IRES	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	GFP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	allele	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	were	_	O	O	_	_	_	_	_
37	adoptively	_	O	O	_	_	_	_	_
38	transferred	_	O	O	_	_	_	_	_
39	into	_	O	O	_	_	_	_	_
40	Rag	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	deficient	_	O	O	_	_	_	_	_
43	mice	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_


1	For	_	O	O	_	_	_	_	_
2	Th	_	O	O	_	_	_	_	_
3	1	_	O	O	_	_	_	_	_
4	differentiation	_	O	O	_	_	_	_	_
5	conditions	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	were	_	O	O	_	_	_	_	_
9	stimulated	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	following	_	O	O	_	_	_	_	_
13	:	_	O	O	_	_	_	_	_
14	40	_	O	O	_	_	_	_	_
15	ng	_	O	O	_	_	_	_	_
16	/	_	O	O	_	_	_	_	_
17	ml	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	5	_	O	O	_	_	_	_	_
23	microg	_	O	O	_	_	_	_	_
24	/	_	O	O	_	_	_	_	_
25	ml	_	O	O	_	_	_	_	_
26	anti	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	25	_	O	O	_	_	_	_	_
34	ng	_	O	O	_	_	_	_	_
35	/	_	O	O	_	_	_	_	_
36	ml	_	O	O	_	_	_	_	_
37	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	R	_	O	O	_	_	_	_	_
42	&	_	O	O	_	_	_	_	_
43	D	_	O	O	_	_	_	_	_
44	Systems	_	O	O	_	_	_	_	_
45	)	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	tonsils	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	obtained	_	O	O	_	_	_	_	_
5	from	_	O	O	_	_	_	_	_
6	tonsillectomy	_	O	O	_	_	_	_	_
7	samples	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	hypertrophic	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	obstructive	_	O	O	_	_	_	_	_
12	tonsils	_	O	O	_	_	_	_	_
13	without	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	current	_	O	O	_	_	_	_	_
16	infection	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	total	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	4	_	O	O	_	_	_	_	_
5	x	_	O	O	_	_	_	_	_
6	105	_	O	O	_	_	_	_	_
7	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	+	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	CFSE	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	loaded	_	O	O	_	_	_	_	_
15	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	plus	_	O	O	_	_	_	_	_
19	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	GFP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	+	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	was	_	O	O	_	_	_	_	_
26	mixed	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	105	_	O	O	_	_	_	_	_
29	APCs	_	O	O	_	_	_	_	_
30	+	_	O	O	_	_	_	_	_
31	1	_	O	O	_	_	_	_	_
32	microg	_	O	O	_	_	_	_	_
33	/	_	O	O	_	_	_	_	_
34	ml	_	O	O	_	_	_	_	_
35	anti	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	mAb	_	O	O	_	_	_	_	_
40	per	_	O	O	_	_	_	_	_
41	well	_	O	O	_	_	_	_	_
42	of	_	O	O	_	_	_	_	_
43	a	_	O	O	_	_	_	_	_
44	96	_	O	O	_	_	_	_	_
45	well	_	O	O	_	_	_	_	_
46	round	_	O	O	_	_	_	_	_
47	bottom	_	O	O	_	_	_	_	_
48	plate	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	check	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	proliferation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	+	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	without	_	O	O	_	_	_	_	_
13	suppression	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	no	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	reg	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	were	_	O	O	_	_	_	_	_
20	added	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	control	_	O	O	_	_	_	_	_
24	group	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	Silencer	_	O	O	_	_	_	_	_
3	Negative	_	O	O	_	_	_	_	_
4	Control	_	O	O	_	_	_	_	_
5	#	_	O	O	_	_	_	_	_
6	1	_	O	O	_	_	_	_	_
7	siRNA	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	Applied	_	O	O	_	_	_	_	_
10	Biosystems	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	used	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	normalization	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_


1	PCR	_	O	O	_	_	_	_	_
2	amplification	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	housekeeping	_	O	O	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	encoding	_	O	O	_	_	_	_	_
8	elongation	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	EF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	or	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	using	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	18	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	S	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	rRNA	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	Gene	_	O	O	_	_	_	_	_
24	Expression	_	O	O	_	_	_	_	_
25	Assay	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	Applied	_	O	O	_	_	_	_	_
28	Biosystems	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	was	_	O	O	_	_	_	_	_
31	performed	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	allow	_	O	O	_	_	_	_	_
34	normalization	_	O	O	_	_	_	_	_
35	between	_	O	O	_	_	_	_	_
36	samples	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	For	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	analysis	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	level	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	106	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	were	_	O	O	_	_	_	_	_
17	lysed	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	loaded	_	O	O	_	_	_	_	_
20	next	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	protein	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	mass	_	O	O	_	_	_	_	_
26	ladder	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	Invitrogen	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	on	_	O	O	_	_	_	_	_
31	a	_	O	O	_	_	_	_	_
32	NuPAGE	_	O	O	_	_	_	_	_
33	4	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	12	_	O	O	_	_	_	_	_
36	%	_	O	O	_	_	_	_	_
37	Bis	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	Tris	_	O	O	_	_	_	_	_
40	gel	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	Invitrogen	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Specific	_	O	O	_	_	_	_	_
2	primers	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	promoter	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	spanning	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	region	_	O	O	_	_	_	_	_
12	from	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	87	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	3	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	promoter	_	O	O	_	_	_	_	_
22	forward	_	O	O	_	_	_	_	_
23	primer	_	O	O	_	_	_	_	_
24	5	_	O	O	_	_	_	_	_
25	'	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	AGAGGTCTGCGGCTTCCA	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	3	_	O	O	_	_	_	_	_
30	',	_	O	O	_	_	_	_	_
31	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	promoter	_	O	O	_	_	_	_	_
34	reverse	_	O	O	_	_	_	_	_
35	primer	_	O	O	_	_	_	_	_
36	5	_	O	O	_	_	_	_	_
37	'	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	GGAAACTGTCACGTATCAAAAACAA	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	3	_	O	O	_	_	_	_	_
42	',	_	O	O	_	_	_	_	_
43	or	_	O	O	_	_	_	_	_
44	control	_	O	O	_	_	_	_	_
45	GAPDH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	primer	_	O	O	_	_	_	_	_
47	(	_	O	O	_	_	_	_	_
48	SA	_	O	O	_	_	_	_	_
49	Biosciences	_	O	O	_	_	_	_	_
50	)	_	O	O	_	_	_	_	_
51	for	_	O	O	_	_	_	_	_
52	the	_	O	O	_	_	_	_	_
53	RNA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
54	polymerase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
55	II	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	were	_	O	O	_	_	_	_	_
57	used	_	O	O	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_


1	S	_	O	O	_	_	_	_	_
2	4	_	O	O	_	_	_	_	_
3	shows	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	putative	_	O	O	_	_	_	_	_
6	RUNX	_	O	O	_	_	_	_	_
7	binding	_	O	O	_	_	_	_	_
8	sites	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	core	_	O	O	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	sequence	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	human	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	mouse	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	rat	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_



1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	examination	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	induction	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	autoimmunity	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	transgenic	_	O	O	_	_	_	_	_
11	mice	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	evidence	_	O	O	_	_	_	_	_
14	has	_	O	O	_	_	_	_	_
15	been	_	O	O	_	_	_	_	_
16	obtained	_	O	O	_	_	_	_	_
17	further	_	O	O	_	_	_	_	_
18	implicating	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	lymphokine	_	O	O	_	_	_	_	_
21	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	etiology	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	autoimmunity	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Overexpression	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	hematopoietic	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	tyrosine	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	phosphatase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	HePTP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	results	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	suppression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	lymphocyte	_	O	O	_	_	_	_	_
17	activation	_	O	O	_	_	_	_	_
18	as	_	O	O	_	_	_	_	_
19	measured	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	antigen	_	O	O	_	_	_	_	_
24	receptor	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	induced	_	O	O	_	_	_	_	_
27	activation	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	transcription	_	O	O	_	_	_	_	_
30	factors	_	O	O	_	_	_	_	_
31	binding	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	5	_	O	O	_	_	_	_	_
35	'	_	O	O	_	_	_	_	_
36	promoter	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	gene	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	granzyme	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	appreciably	_	O	O	_	_	_	_	_
9	regulated	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_

1	1	_	O	O	_	_	_	_	_
2	)	_	O	O	_	_	_	_	_
3	.	_	O	O	_	_	_	_	_

1	Eo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	VP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	16	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	but	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	empty	_	O	O	_	_	_	_	_
10	GFP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	retrovirus	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	increased	_	O	O	_	_	_	_	_
14	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	both	_	O	O	_	_	_	_	_
18	WT	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	deficient	_	O	O	_	_	_	_	_
25	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	+	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	Fig	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	identify	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factors	_	O	O	_	_	_	_	_
5	binding	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	PRE	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	I	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	we	_	O	O	_	_	_	_	_
12	screened	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	cDNA	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	library	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	Jurkat	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	isolated	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	cDNA	_	O	O	_	_	_	_	_
25	encoding	_	O	O	_	_	_	_	_
26	nuclear	_	O	O	_	_	_	_	_
27	factor	_	O	O	_	_	_	_	_
28	(	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	NF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	also	_	O	O	_	_	_	_	_
36	known	_	O	O	_	_	_	_	_
37	as	_	O	O	_	_	_	_	_
38	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	)	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	rNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	expressed	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	bacteria	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	shown	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	specifically	_	O	O	_	_	_	_	_
12	bind	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	PRE	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	I	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Some	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	complexes	_	O	O	_	_	_	_	_
5	were	_	O	O	_	_	_	_	_
6	demonstrated	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	contain	_	O	O	_	_	_	_	_
9	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	using	_	O	O	_	_	_	_	_
15	anti	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	Abs	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	T	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	activated	_	O	O	_	_	_	_	_
11	upon	_	O	O	_	_	_	_	_
12	cellular	_	O	O	_	_	_	_	_
13	treatment	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	phorbol	_	O	O	_	_	_	_	_
16	esters	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	cytokine	_	O	O	_	_	_	_	_
20	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	stably	_	O	O	_	_	_	_	_
3	introduced	_	O	O	_	_	_	_	_
4	into	_	O	O	_	_	_	_	_
5	primary	_	O	O	_	_	_	_	_
6	erythroblasts	_	O	O	_	_	_	_	_
7	or	_	O	O	_	_	_	_	_
8	conditionally	_	O	O	_	_	_	_	_
9	transformed	_	O	O	_	_	_	_	_
10	erythroid	_	O	O	_	_	_	_	_
11	progenitors	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	exogenous	_	O	O	_	_	_	_	_
15	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	/	_	O	O	_	_	_	_	_
19	ER	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	promoted	_	O	O	_	_	_	_	_
21	proliferation	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	inhibited	_	O	O	_	_	_	_	_
24	terminal	_	O	O	_	_	_	_	_
25	differentiation	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	an	_	O	O	_	_	_	_	_
28	estrogen	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	dependent	_	O	O	_	_	_	_	_
31	manner	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Relationship	_	O	O	_	_	_	_	_
2	between	_	O	O	_	_	_	_	_
3	IkappaBalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	constitutive	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	synthesis	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	apoptosis	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	EBV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	infected	_	O	O	_	_	_	_	_
16	lymphoblastoid	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	suggest	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	could	_	O	O	_	_	_	_	_
9	be	_	O	O	_	_	_	_	_
10	one	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	targets	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	NF	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	kappaB	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	EBV	_	O	O	_	_	_	_	_
20	infected	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	that	_	O	O	_	_	_	_	_
24	NF	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	kappaB	_	O	O	_	_	_	_	_
27	protects	_	O	O	_	_	_	_	_
28	EBV	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	infected	_	O	O	_	_	_	_	_
31	cells	_	O	O	_	_	_	_	_
32	from	_	O	O	_	_	_	_	_
33	apoptosis	_	O	O	_	_	_	_	_
34	induced	_	O	O	_	_	_	_	_
35	by	_	O	O	_	_	_	_	_
36	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	which	_	O	O	_	_	_	_	_
39	may	_	O	O	_	_	_	_	_
40	favour	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	proliferative	_	O	O	_	_	_	_	_
43	effect	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	this	_	O	O	_	_	_	_	_
46	cytokine	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	Regulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	during	_	O	O	_	_	_	_	_
7	monocytic	_	O	O	_	_	_	_	_
8	differentiation	_	O	O	_	_	_	_	_
9	induced	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	alpha	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	25	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	dihydroxyvitamin	_	O	O	_	_	_	_	_
17	D	_	O	O	_	_	_	_	_
18	3	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	recently	_	O	O	_	_	_	_	_
4	cloned	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	14	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	5	_	O	O	_	_	_	_	_
9	'	_	O	O	_	_	_	_	_
10	upstream	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	demonstrated	_	O	O	_	_	_	_	_
14	its	_	O	O	_	_	_	_	_
15	tissue	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	specific	_	O	O	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_


1	Increased	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	IFNgamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	induced	_	O	O	_	_	_	_	_
7	IP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	mRNA	_	O	O	_	_	_	_	_
11	following	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	differentiation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	U	_	O	O	_	_	_	_	_
16	937	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	mediated	_	O	O	_	_	_	_	_
20	largely	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	augmented	_	O	O	_	_	_	_	_
23	transcriptional	_	O	O	_	_	_	_	_
24	activity	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	gene	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	was	_	O	O	_	_	_	_	_
30	related	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	differentiation	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	dependent	_	O	O	_	_	_	_	_
35	changes	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	proteins	_	O	O	_	_	_	_	_
39	bound	_	O	O	_	_	_	_	_
40	to	_	O	O	_	_	_	_	_
41	IFN	_	O	O	_	_	_	_	_
42	stimulus	_	O	O	_	_	_	_	_
43	response	_	O	O	_	_	_	_	_
44	element	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	ISRE	_	O	O	_	_	_	_	_
47	)	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	kB	_	O	O	_	_	_	_	_
50	sites	_	O	O	_	_	_	_	_
51	,	_	O	O	_	_	_	_	_
52	suggesting	_	O	O	_	_	_	_	_
53	that	_	O	O	_	_	_	_	_
54	these	_	O	O	_	_	_	_	_
55	nuclear	_	O	O	_	_	_	_	_
56	proteins	_	O	O	_	_	_	_	_
57	may	_	O	O	_	_	_	_	_
58	determine	_	O	O	_	_	_	_	_
59	the	_	O	O	_	_	_	_	_
60	IP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
61	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
62	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
63	mRNA	_	O	O	_	_	_	_	_
64	inducibility	_	O	O	_	_	_	_	_
65	by	_	O	O	_	_	_	_	_
66	IFNgamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
67	.	_	O	O	_	_	_	_	_

1	Loss	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	HSP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	phosphorylation	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	DT	_	O	O	_	_	_	_	_
8	40	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	lacking	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	PKD	_	O	O	_	_	_	_	_
15	family	_	O	O	_	_	_	_	_
16	kinases	_	O	O	_	_	_	_	_

1	1	_	O	O	_	_	_	_	_
2	A	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_

1	BCR	_	O	O	_	_	_	_	_
2	and	_	O	O	_	_	_	_	_
3	phorbol	_	O	O	_	_	_	_	_
4	ester	_	O	O	_	_	_	_	_
5	signals	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	also	_	O	O	_	_	_	_	_
8	able	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	increase	_	O	O	_	_	_	_	_
11	HSP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	phosphorylation	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	single	_	O	O	_	_	_	_	_
21	knockout	_	O	O	_	_	_	_	_
22	DT	_	O	O	_	_	_	_	_
23	40	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	Fig	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	kinase	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	deficient	_	O	O	_	_	_	_	_
10	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	mutant	_	O	O	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	double	_	O	O	_	_	_	_	_
17	knockout	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	was	_	O	O	_	_	_	_	_
20	not	_	O	O	_	_	_	_	_
21	able	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	restore	_	O	O	_	_	_	_	_
24	BCR	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	or	_	O	O	_	_	_	_	_
27	phorbol	_	O	O	_	_	_	_	_
28	ester	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	induced	_	O	O	_	_	_	_	_
31	HSP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	phosphorylation	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	Fig	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	Sequence	_	O	O	_	_	_	_	_
2	variation	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	long	_	O	O	_	_	_	_	_
6	terminal	_	O	O	_	_	_	_	_
7	repeat	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	LTR	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	region	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	was	_	O	O	_	_	_	_	_
17	analyzed	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	viral	_	O	O	_	_	_	_	_
20	isolates	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	17	_	O	O	_	_	_	_	_
23	infected	_	O	O	_	_	_	_	_
24	individuals	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Another	_	O	O	_	_	_	_	_
2	LTR	_	O	O	_	_	_	_	_
3	size	_	O	O	_	_	_	_	_
4	variation	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	observed	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	four	_	O	O	_	_	_	_	_
9	patients	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	region	_	O	O	_	_	_	_	_
13	just	_	O	O	_	_	_	_	_
14	upstream	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	NF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	enhancer	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	T	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	box	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	factors	_	O	O	_	_	_	_	_
7	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	have	_	O	O	_	_	_	_	_
13	been	_	O	O	_	_	_	_	_
14	linked	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	regulation	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	genes	_	O	O	_	_	_	_	_
20	encoding	_	O	O	_	_	_	_	_
21	effector	_	O	O	_	_	_	_	_
22	cytokines	_	O	O	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	e	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_
26	g	_	O	O	_	_	_	_	_
27	.,	_	O	O	_	_	_	_	_
28	Ifng	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	genes	_	O	O	_	_	_	_	_
32	important	_	O	O	_	_	_	_	_
33	for	_	O	O	_	_	_	_	_
34	cytolytic	_	O	O	_	_	_	_	_
35	function	_	O	O	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	e	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_
39	g	_	O	O	_	_	_	_	_
40	.,	_	O	O	_	_	_	_	_
41	Prf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	GzmB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	)	_	O	O	_	_	_	_	_
46	(	_	O	O	_	_	_	_	_
47	20	_	O	O	_	_	_	_	_
48	)	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	Regulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	gene	_	O	O	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	double	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	stranded	_	O	O	_	_	_	_	_
9	phosphorothioate	_	O	O	_	_	_	_	_
10	oligonucleotides	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	Alteration	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	gene	_	O	O	_	_	_	_	_
4	transcription	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	inhibition	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	specific	_	O	O	_	_	_	_	_
9	transcriptional	_	O	O	_	_	_	_	_
10	regulatory	_	O	O	_	_	_	_	_
11	proteins	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	necessary	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	determining	_	O	O	_	_	_	_	_
16	how	_	O	O	_	_	_	_	_
17	these	_	O	O	_	_	_	_	_
18	factors	_	O	O	_	_	_	_	_
19	participate	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	cellular	_	O	O	_	_	_	_	_
22	differentiation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	modified	_	O	O	_	_	_	_	_
3	oligonucleotides	_	O	O	_	_	_	_	_
4	accumulated	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	more	_	O	O	_	_	_	_	_
8	effectively	_	O	O	_	_	_	_	_
9	than	_	O	O	_	_	_	_	_
10	standard	_	O	O	_	_	_	_	_
11	ds	_	O	O	_	_	_	_	_
12	oligonucleotides	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	modulated	_	O	O	_	_	_	_	_
15	gene	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	manner	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Considering	_	O	O	_	_	_	_	_
2	that	_	O	O	_	_	_	_	_
3	nuclear	_	O	O	_	_	_	_	_
4	regulatory	_	O	O	_	_	_	_	_
5	factor	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	beta	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	/	_	O	O	_	_	_	_	_
16	Rel	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	common	_	O	O	_	_	_	_	_
20	regulatory	_	O	O	_	_	_	_	_
21	element	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	promoter	_	O	O	_	_	_	_	_
25	region	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	inflammatory	_	O	O	_	_	_	_	_
29	cytokine	_	O	O	_	_	_	_	_
30	genes	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	herein	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	we	_	O	O	_	_	_	_	_
35	tested	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	hypothesis	_	O	O	_	_	_	_	_
38	that	_	O	O	_	_	_	_	_
39	acute	_	O	O	_	_	_	_	_
40	ethanol	_	O	O	_	_	_	_	_
41	affects	_	O	O	_	_	_	_	_
42	NF	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	kappa	_	O	O	_	_	_	_	_
45	B	_	O	O	_	_	_	_	_
46	activation	_	O	O	_	_	_	_	_
47	in	_	O	O	_	_	_	_	_
48	human	_	O	O	_	_	_	_	_
49	monocytes	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	Consequently	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	suggest	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	physiologically	_	O	O	_	_	_	_	_
8	relevant	_	O	O	_	_	_	_	_
9	concentrations	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	ethanol	_	O	O	_	_	_	_	_
12	may	_	O	O	_	_	_	_	_
13	affect	_	O	O	_	_	_	_	_
14	production	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	inflammatory	_	O	O	_	_	_	_	_
17	cytokines	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	such	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	by	_	O	O	_	_	_	_	_
37	disrupting	_	O	O	_	_	_	_	_
38	NF	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	kappa	_	O	O	_	_	_	_	_
41	B	_	O	O	_	_	_	_	_
42	signaling	_	O	O	_	_	_	_	_
43	in	_	O	O	_	_	_	_	_
44	monocytes	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Intracellular	_	O	O	_	_	_	_	_
2	deletion	_	O	O	_	_	_	_	_
3	variants	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	TLR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	lacking	_	O	O	_	_	_	_	_
8	C	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	terminal	_	O	O	_	_	_	_	_
11	13	_	O	O	_	_	_	_	_
12	or	_	O	O	_	_	_	_	_
13	141	_	O	O	_	_	_	_	_
14	aa	_	O	O	_	_	_	_	_
15	fail	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	recruit	_	O	O	_	_	_	_	_
18	IRAK	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	which	_	O	O	_	_	_	_	_
21	is	_	O	O	_	_	_	_	_
22	consistent	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	inability	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	these	_	O	O	_	_	_	_	_
28	mutants	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	transmit	_	O	O	_	_	_	_	_
31	LPS	_	O	O	_	_	_	_	_
32	cellular	_	O	O	_	_	_	_	_
33	signaling	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	support	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	view	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	stimulation	_	O	O	_	_	_	_	_
8	through	_	O	O	_	_	_	_	_
9	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	can	_	O	O	_	_	_	_	_
12	induce	_	O	O	_	_	_	_	_
13	some	_	O	O	_	_	_	_	_
14	effector	_	O	O	_	_	_	_	_
15	functions	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	suggest	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	this	_	O	O	_	_	_	_	_
23	capacity	_	O	O	_	_	_	_	_
24	is	_	O	O	_	_	_	_	_
25	associated	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	particular	_	O	O	_	_	_	_	_
29	pattern	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	early	_	O	O	_	_	_	_	_
32	signaling	_	O	O	_	_	_	_	_
33	events	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_


1	All	_	O	O	_	_	_	_	_
2	sequence	_	O	O	_	_	_	_	_
3	motifs	_	O	O	_	_	_	_	_
4	within	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	functional	_	O	O	_	_	_	_	_
7	core	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	HS	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	40	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	mapped	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	transient	_	O	O	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	analysis	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	appeared	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	bind	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	nuclear	_	O	O	_	_	_	_	_
25	factor	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	s	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	living	_	O	O	_	_	_	_	_
31	K	_	O	O	_	_	_	_	_
32	562	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	but	_	O	O	_	_	_	_	_
35	not	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	nonerythroid	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	SCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	protein	_	O	O	_	_	_	_	_
3	levels	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	BFU	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	E	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	derived	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	were	_	O	O	_	_	_	_	_
12	highest	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	day	_	O	O	_	_	_	_	_
15	7	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	decreased	_	O	O	_	_	_	_	_
19	progressively	_	O	O	_	_	_	_	_
20	from	_	O	O	_	_	_	_	_
21	day	_	O	O	_	_	_	_	_
22	7	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	day	_	O	O	_	_	_	_	_
25	14	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	culture	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	suggesting	_	O	O	_	_	_	_	_
30	an	_	O	O	_	_	_	_	_
31	association	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	SCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	erythroid	_	O	O	_	_	_	_	_
36	proliferation	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	BFU	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	E	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	derived	_	O	O	_	_	_	_	_
7	colonies	_	O	O	_	_	_	_	_
8	cultured	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	Steel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	colony	_	O	O	_	_	_	_	_
14	size	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	significantly	_	O	O	_	_	_	_	_
17	increased	_	O	O	_	_	_	_	_
18	compared	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	control	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	day	_	O	O	_	_	_	_	_
3	7	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	day	_	O	O	_	_	_	_	_
6	10	_	O	O	_	_	_	_	_
7	erythroid	_	O	O	_	_	_	_	_
8	precursors	_	O	O	_	_	_	_	_
9	cultured	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	Steel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	SCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	protein	_	O	O	_	_	_	_	_
16	was	_	O	O	_	_	_	_	_
17	increased	_	O	O	_	_	_	_	_
18	significantly	_	O	O	_	_	_	_	_
19	compared	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	control	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	OM	_	O	O	_	_	_	_	_
2	10	_	O	O	_	_	_	_	_
3	.	_	O	O	_	_	_	_	_
4	1	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	promyelocyte	_	O	O	_	_	_	_	_
8	cell	_	O	O	_	_	_	_	_
9	line	_	O	O	_	_	_	_	_
10	latently	_	O	O	_	_	_	_	_
11	infected	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	has	_	O	O	_	_	_	_	_
18	been	_	O	O	_	_	_	_	_
19	developed	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	model	_	O	O	_	_	_	_	_
23	for	_	O	O	_	_	_	_	_
24	studying	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	mechanism	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	viral	_	O	O	_	_	_	_	_
29	latency	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	activation	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	virus	_	O	O	_	_	_	_	_
35	expression	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	mechanism	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	HIV	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	activation	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	heat	_	O	O	_	_	_	_	_
11	shock	_	O	O	_	_	_	_	_
12	has	_	O	O	_	_	_	_	_
13	not	_	O	O	_	_	_	_	_
14	been	_	O	O	_	_	_	_	_
15	fully	_	O	O	_	_	_	_	_
16	elucidated	_	O	O	_	_	_	_	_
17	yet	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	it	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	presumed	_	O	O	_	_	_	_	_
22	PKC	_	O	O	_	_	_	_	_
23	plays	_	O	O	_	_	_	_	_
24	an	_	O	O	_	_	_	_	_
25	important	_	O	O	_	_	_	_	_
26	role	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	HIV	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	activation	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	Human	_	O	O	_	_	_	_	_
2	herpesvirus	_	O	O	_	_	_	_	_
3	6	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	HHV	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	6	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	can	_	O	O	_	_	_	_	_
10	activate	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	immunodeficiency	_	O	O	_	_	_	_	_
14	virus	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	)	_	O	O	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	accelerate	_	O	O	_	_	_	_	_
21	cytopathic	_	O	O	_	_	_	_	_
22	effects	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	HIV	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	infected	_	O	O	_	_	_	_	_
27	human	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Differentiation	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	dependent	_	O	O	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	carboxylesterase	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	monocytic	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factor	_	O	O	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	promoter	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	data	_	O	O	_	_	_	_	_
5	indicate	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	carboxylesterase	_	O	O	_	_	_	_	_
8	gene	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	THP	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	starts	_	O	O	_	_	_	_	_
16	at	_	O	O	_	_	_	_	_
17	multiple	_	O	O	_	_	_	_	_
18	initiation	_	O	O	_	_	_	_	_
19	sites	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	IRBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	may	_	O	O	_	_	_	_	_
27	be	_	O	O	_	_	_	_	_
28	critical	_	O	O	_	_	_	_	_
29	factors	_	O	O	_	_	_	_	_
30	for	_	O	O	_	_	_	_	_
31	modulating	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	differentiation	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	dependent	_	O	O	_	_	_	_	_
36	transcription	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	this	_	O	O	_	_	_	_	_
39	human	_	O	O	_	_	_	_	_
40	carboxylesterase	_	O	O	_	_	_	_	_
41	gene	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	enhanced	_	O	O	_	_	_	_	_
4	tyrosine	_	O	O	_	_	_	_	_
5	phosphorylation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	multiple	_	O	O	_	_	_	_	_
8	cellular	_	O	O	_	_	_	_	_
9	proteins	_	O	O	_	_	_	_	_
10	as	_	O	O	_	_	_	_	_
11	well	_	O	O	_	_	_	_	_
12	as	_	O	O	_	_	_	_	_
13	an	_	O	O	_	_	_	_	_
14	increase	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	intracellular	_	O	O	_	_	_	_	_
17	calcium	_	O	O	_	_	_	_	_
18	levels	_	O	O	_	_	_	_	_
19	was	_	O	O	_	_	_	_	_
20	also	_	O	O	_	_	_	_	_
21	observed	_	O	O	_	_	_	_	_
22	following	_	O	O	_	_	_	_	_
23	BCR	_	O	O	_	_	_	_	_
24	stimulation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	/	_	O	O	_	_	_	_	_
29	3	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	null	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	data	_	O	O	_	_	_	_	_
36	not	_	O	O	_	_	_	_	_
37	shown	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	BCR	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	induced	_	O	O	_	_	_	_	_
6	Erk	_	O	O	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	also	_	O	O	_	_	_	_	_
10	reduced	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	/	_	O	O	_	_	_	_	_
15	3	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	--	_	O	O	_	_	_	_	_
19	Flag	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	+	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	data	_	O	O	_	_	_	_	_
28	not	_	O	O	_	_	_	_	_
29	shown	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	suggesting	_	O	O	_	_	_	_	_
32	that	_	O	O	_	_	_	_	_
33	reduced	_	O	O	_	_	_	_	_
34	BCR	_	O	O	_	_	_	_	_
35	levels	_	O	O	_	_	_	_	_
36	on	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	surface	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	/	_	O	O	_	_	_	_	_
43	3	_	BPROTEIN	BPROTEIN	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	/	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	(	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	/	_	O	O	_	_	_	_	_
52	3	_	BPROTEIN	BPROTEIN	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	/	_	O	O	_	_	_	_	_
55	--	_	O	O	_	_	_	_	_
56	Flag	_	O	O	_	_	_	_	_
57	-	_	O	O	_	_	_	_	_
58	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
59	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
60	+	_	O	O	_	_	_	_	_
61	)	_	O	O	_	_	_	_	_
62	B	_	O	O	_	_	_	_	_
63	cells	_	O	O	_	_	_	_	_
64	may	_	O	O	_	_	_	_	_
65	itself	_	O	O	_	_	_	_	_
66	impact	_	O	O	_	_	_	_	_
67	on	_	O	O	_	_	_	_	_
68	the	_	O	O	_	_	_	_	_
69	strength	_	O	O	_	_	_	_	_
70	of	_	O	O	_	_	_	_	_
71	activation	_	O	O	_	_	_	_	_
72	of	_	O	O	_	_	_	_	_
73	this	_	O	O	_	_	_	_	_
74	specific	_	O	O	_	_	_	_	_
75	intracellular	_	O	O	_	_	_	_	_
76	signalling	_	O	O	_	_	_	_	_
77	pathway	_	O	O	_	_	_	_	_
78	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	experiments	_	O	O	_	_	_	_	_
4	do	_	O	O	_	_	_	_	_
5	provide	_	O	O	_	_	_	_	_
6	further	_	O	O	_	_	_	_	_
7	evidence	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	phosphospecific	_	O	O	_	_	_	_	_
10	antisera	_	O	O	_	_	_	_	_
11	are	_	O	O	_	_	_	_	_
12	not	_	O	O	_	_	_	_	_
13	sufficiently	_	O	O	_	_	_	_	_
14	selective	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	be	_	O	O	_	_	_	_	_
17	designated	_	O	O	_	_	_	_	_
18	kinase	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	substrate	_	O	O	_	_	_	_	_
21	antisera	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	PKD	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	mediated	_	O	O	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	NFkappaB	_	O	O	_	_	_	_	_
9	occurs	_	O	O	_	_	_	_	_
10	downstream	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	variety	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	different	_	O	O	_	_	_	_	_
16	signals	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	including	_	O	O	_	_	_	_	_
19	mROS	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	oxidative	_	O	O	_	_	_	_	_
22	stress	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	lysophosphatidic	_	O	O	_	_	_	_	_
25	acid	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	Bcr	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	Abl	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	oncogene	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	[	_	O	O	_	_	_	_	_
33	17	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	21	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	23	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	30	_	O	O	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	37	_	O	O	_	_	_	_	_
42	]	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	an	_	O	O	_	_	_	_	_
6	activated	_	O	O	_	_	_	_	_
7	PKD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	mutant	_	O	O	_	_	_	_	_
10	enhances	_	O	O	_	_	_	_	_
11	HPK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	mediated	_	O	O	_	_	_	_	_
15	NFkappaB	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	[	_	O	O	_	_	_	_	_
18	38	_	O	O	_	_	_	_	_
19	]	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	PKD	_	O	O	_	_	_	_	_
4	kinases	_	O	O	_	_	_	_	_
5	are	_	O	O	_	_	_	_	_
6	neither	_	O	O	_	_	_	_	_
7	essential	_	O	O	_	_	_	_	_
8	nor	_	O	O	_	_	_	_	_
9	sufficient	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	mediate	_	O	O	_	_	_	_	_
12	BCR	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	induced	_	O	O	_	_	_	_	_
15	NFkappaB	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	DT	_	O	O	_	_	_	_	_
19	40	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	hence	_	O	O	_	_	_	_	_
24	do	_	O	O	_	_	_	_	_
25	not	_	O	O	_	_	_	_	_
26	participate	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	DAG	_	O	O	_	_	_	_	_
29	/	_	O	O	_	_	_	_	_
30	PKC	_	O	O	_	_	_	_	_
31	mediated	_	O	O	_	_	_	_	_
32	control	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	NFkappaB	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	HIV	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	1	_	O	O	_	_	_	_	_
4	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	potentiates	_	O	O	_	_	_	_	_
6	TNF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	induced	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	cytotoxicity	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	altering	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	cellular	_	O	O	_	_	_	_	_
20	redox	_	O	O	_	_	_	_	_
21	state	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	truncated	_	O	O	_	_	_	_	_
3	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	protein	_	O	O	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	Tat	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	72	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	known	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	transactivate	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	long	_	O	O	_	_	_	_	_
20	terminal	_	O	O	_	_	_	_	_
21	repeat	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	LTR	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	no	_	O	O	_	_	_	_	_
27	longer	_	O	O	_	_	_	_	_
28	affected	_	O	O	_	_	_	_	_
29	Mn	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	SOD	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	expression	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	cellular	_	O	O	_	_	_	_	_
36	redox	_	O	O	_	_	_	_	_
37	state	_	O	O	_	_	_	_	_
38	or	_	O	O	_	_	_	_	_
39	TNF	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	mediated	_	O	O	_	_	_	_	_
42	cytotoxicity	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	treatment	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	nuclear	_	O	O	_	_	_	_	_
6	extracts	_	O	O	_	_	_	_	_
7	from	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	that	_	O	O	_	_	_	_	_
11	had	_	O	O	_	_	_	_	_
12	restricted	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	lipopolysaccharide	_	O	O	_	_	_	_	_
16	increased	_	O	O	_	_	_	_	_
17	viral	_	O	O	_	_	_	_	_
18	production	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	NF	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kappa	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	activity	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	initiated	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	recognition	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	antigen	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	antigen	_	O	O	_	_	_	_	_
14	presenting	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	exert	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	effector	_	O	O	_	_	_	_	_
20	functions	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	immune	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	inflammatory	_	O	O	_	_	_	_	_
25	responses	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	analysis	_	O	O	_	_	_	_	_
3	identified	_	O	O	_	_	_	_	_
4	three	_	O	O	_	_	_	_	_
5	elements	_	O	O	_	_	_	_	_
6	required	_	O	O	_	_	_	_	_
7	for	_	O	O	_	_	_	_	_
8	efficient	_	O	O	_	_	_	_	_
9	induction	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	referred	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	as	_	O	O	_	_	_	_	_
14	GM	_	O	O	_	_	_	_	_
15	2	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	GC	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	box	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	conserved	_	O	O	_	_	_	_	_
22	lymphokine	_	O	O	_	_	_	_	_
23	element	_	O	O	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	CLE	_	O	O	_	_	_	_	_
26	0	_	O	O	_	_	_	_	_
27	)	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Viral	_	O	O	_	_	_	_	_
2	trans	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	activators	_	O	O	_	_	_	_	_
5	such	_	O	O	_	_	_	_	_
6	as	_	O	O	_	_	_	_	_
7	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	human	_	O	O	_	_	_	_	_
10	T	_	O	O	_	_	_	_	_
11	cell	_	O	O	_	_	_	_	_
12	leukemia	_	O	O	_	_	_	_	_
13	virus	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	HTLV	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	1	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	bovine	_	O	O	_	_	_	_	_
26	papilloma	_	O	O	_	_	_	_	_
27	virus	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	BPV	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	proteins	_	O	O	_	_	_	_	_
32	are	_	O	O	_	_	_	_	_
33	other	_	O	O	_	_	_	_	_
34	agents	_	O	O	_	_	_	_	_
35	which	_	O	O	_	_	_	_	_
36	activate	_	O	O	_	_	_	_	_
37	lymphokine	_	O	O	_	_	_	_	_
38	gene	_	O	O	_	_	_	_	_
39	expression	_	O	O	_	_	_	_	_
40	by	_	O	O	_	_	_	_	_
41	bypassing	_	O	O	_	_	_	_	_
42	T	_	O	O	_	_	_	_	_
43	cell	_	O	O	_	_	_	_	_
44	receptor	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	TCR	_	O	O	_	_	_	_	_
47	)	_	O	O	_	_	_	_	_
48	mediated	_	O	O	_	_	_	_	_
49	signaling	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	trans	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	activation	_	O	O	_	_	_	_	_
5	domain	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	interchangeable	_	O	O	_	_	_	_	_
13	although	_	O	O	_	_	_	_	_
14	they	_	O	O	_	_	_	_	_
15	have	_	O	O	_	_	_	_	_
16	no	_	O	O	_	_	_	_	_
17	obvious	_	O	O	_	_	_	_	_
18	sequence	_	O	O	_	_	_	_	_
19	homology	_	O	O	_	_	_	_	_
20	between	_	O	O	_	_	_	_	_
21	them	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	cross	_	O	O	_	_	_	_	_
3	communication	_	O	O	_	_	_	_	_
4	involves	_	O	O	_	_	_	_	_
5	soluble	_	O	O	_	_	_	_	_
6	mediators	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	including	_	O	O	_	_	_	_	_
9	various	_	O	O	_	_	_	_	_
10	growth	_	O	O	_	_	_	_	_
11	factors	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	cytokines	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	neuropeptides	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	correlates	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	loss	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	an	_	O	O	_	_	_	_	_
17	80	_	O	O	_	_	_	_	_
18	kDA	_	O	O	_	_	_	_	_
19	glial	_	O	O	_	_	_	_	_
20	labile	_	O	O	_	_	_	_	_
21	repressor	_	O	O	_	_	_	_	_
22	protein	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	GLRP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	responsive	_	O	O	_	_	_	_	_
29	region	_	O	O	_	_	_	_	_
30	within	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	TFG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	promoter	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	factor	_	O	O	_	_	_	_	_
3	NF	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	kappaB	_	O	O	_	_	_	_	_
6	regulates	_	O	O	_	_	_	_	_
7	inducible	_	O	O	_	_	_	_	_
8	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	precursor	_	O	O	_	_	_	_	_
15	B	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Using	_	O	O	_	_	_	_	_
2	a	_	O	O	_	_	_	_	_
3	series	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	5	_	O	O	_	_	_	_	_
6	'	_	O	O	_	_	_	_	_
7	deletion	_	O	O	_	_	_	_	_
8	promoter	_	O	O	_	_	_	_	_
9	constructs	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	reporter	_	O	O	_	_	_	_	_
13	assays	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	we	_	O	O	_	_	_	_	_
16	identified	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	180	_	O	O	_	_	_	_	_
19	bp	_	O	O	_	_	_	_	_
20	region	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	was	_	O	O	_	_	_	_	_
23	sufficient	_	O	O	_	_	_	_	_
24	for	_	O	O	_	_	_	_	_
25	full	_	O	O	_	_	_	_	_
26	promoter	_	O	O	_	_	_	_	_
27	activity	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Transcriptional	_	O	O	_	_	_	_	_
2	activity	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	A	_	O	O	_	_	_	_	_
6	3	_	O	O	_	_	_	_	_
7	G	_	O	O	_	_	_	_	_
8	core	_	O	O	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	was	_	O	O	_	_	_	_	_
11	dependent	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	GC	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	box	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	located	_	O	O	_	_	_	_	_
19	at	_	O	O	_	_	_	_	_
20	position	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	87	_	O	O	_	_	_	_	_
23	/	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	78	_	O	O	_	_	_	_	_
26	relative	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	major	_	O	O	_	_	_	_	_
30	transcriptional	_	O	O	_	_	_	_	_
31	start	_	O	O	_	_	_	_	_
32	site	_	O	O	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	was	_	O	O	_	_	_	_	_
36	abolished	_	O	O	_	_	_	_	_
37	after	_	O	O	_	_	_	_	_
38	mutation	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	this	_	O	O	_	_	_	_	_
41	DNA	_	O	O	_	_	_	_	_
42	element	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	found	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	overexpression	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	endothelial	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	using	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	recombinant	_	O	O	_	_	_	_	_
15	adenovirus	_	O	O	_	_	_	_	_
16	prevented	_	O	O	_	_	_	_	_
17	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	induced	_	O	O	_	_	_	_	_
29	degradation	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	suppressed	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	upregulation	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	vascular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
47	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	)	_	O	O	_	_	_	_	_
50	,	_	O	O	_	_	_	_	_
51	intercellular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
52	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
53	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
55	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	(	_	O	O	_	_	_	_	_
57	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
58	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
59	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
60	)	_	O	O	_	_	_	_	_
61	,	_	O	O	_	_	_	_	_
62	and	_	O	O	_	_	_	_	_
63	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
64	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
65	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
66	mRNA	_	O	O	_	_	_	_	_
67	and	_	O	O	_	_	_	_	_
68	surface	_	O	O	_	_	_	_	_
69	protein	_	O	O	_	_	_	_	_
70	expression	_	O	O	_	_	_	_	_
71	and	_	O	O	_	_	_	_	_
72	the	_	O	O	_	_	_	_	_
73	upregulation	_	O	O	_	_	_	_	_
74	of	_	O	O	_	_	_	_	_
75	transcripts	_	O	O	_	_	_	_	_
76	for	_	O	O	_	_	_	_	_
77	the	_	O	O	_	_	_	_	_
78	chemokines	_	O	O	_	_	_	_	_
79	monocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
80	chemoattractant	_	IPROTEIN	IPROTEIN	_	_	_	_	_
81	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
82	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
83	(	_	O	O	_	_	_	_	_
84	MCP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
85	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
86	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
87	)	_	O	O	_	_	_	_	_
88	and	_	O	O	_	_	_	_	_
89	growth	_	BPROTEIN	BPROTEIN	_	_	_	_	_
90	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
91	related	_	IPROTEIN	IPROTEIN	_	_	_	_	_
92	activity	_	IPROTEIN	IPROTEIN	_	_	_	_	_
93	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
94	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
95	(	_	O	O	_	_	_	_	_
96	GRO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
97	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
98	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
99	)	_	O	O	_	_	_	_	_
100	by	_	O	O	_	_	_	_	_
101	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
102	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
103	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
104	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	associated	_	O	O	_	_	_	_	_
4	with	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	reduction	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	endothelial	_	O	O	_	_	_	_	_
9	MCP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	secretion	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	GRO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	immobilization	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Adhesion	_	O	O	_	_	_	_	_
2	assays	_	O	O	_	_	_	_	_
3	under	_	O	O	_	_	_	_	_
4	physiological	_	O	O	_	_	_	_	_
5	shear	_	O	O	_	_	_	_	_
6	flow	_	O	O	_	_	_	_	_
7	conditions	_	O	O	_	_	_	_	_
8	showed	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	firm	_	O	O	_	_	_	_	_
11	arrest	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	spreading	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	transmigration	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	monocytes	_	O	O	_	_	_	_	_
19	on	_	O	O	_	_	_	_	_
20	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	activated	_	O	O	_	_	_	_	_
25	endothelium	_	O	O	_	_	_	_	_
26	was	_	O	O	_	_	_	_	_
27	markedly	_	O	O	_	_	_	_	_
28	inhibited	_	O	O	_	_	_	_	_
29	by	_	O	O	_	_	_	_	_
30	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	overexpression	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	monoclonal	_	O	O	_	_	_	_	_
4	antibodies	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	peptide	_	O	O	_	_	_	_	_
7	antagonists	_	O	O	_	_	_	_	_
8	inferred	_	O	O	_	_	_	_	_
9	that	_	O	O	_	_	_	_	_
10	this	_	O	O	_	_	_	_	_
11	was	_	O	O	_	_	_	_	_
12	due	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	reduced	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	Ig	_	O	O	_	_	_	_	_
18	integrin	_	O	O	_	_	_	_	_
19	ligand	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	well	_	O	O	_	_	_	_	_
22	as	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	chemokines	_	O	O	_	_	_	_	_
25	specifically	_	O	O	_	_	_	_	_
26	involved	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	these	_	O	O	_	_	_	_	_
29	events	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	rolling	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	monocytes	_	O	O	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	increased	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	transfer	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	partly	_	O	O	_	_	_	_	_
17	mediated	_	O	O	_	_	_	_	_
18	by	_	O	O	_	_	_	_	_
19	P	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	;	_	O	O	_	_	_	_	_
23	however	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	it	_	O	O	_	_	_	_	_
26	appeared	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	be	_	O	O	_	_	_	_	_
29	unaffected	_	O	O	_	_	_	_	_
30	by	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	inhibition	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	selectin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	induction	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	21	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	ras	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	signals	_	O	O	_	_	_	_	_
8	are	_	O	O	_	_	_	_	_
9	unable	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	induce	_	O	O	_	_	_	_	_
12	Akt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	PKB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	activity	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	nor	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	Ras	_	O	O	_	_	_	_	_
22	function	_	O	O	_	_	_	_	_
23	required	_	O	O	_	_	_	_	_
24	for	_	O	O	_	_	_	_	_
25	Akt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	PKB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	activation	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	response	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	TCR	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	polymorphonuclear	_	O	O	_	_	_	_	_
2	neutrophilic	_	O	O	_	_	_	_	_
3	granulocytes	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	PMN	_	O	O	_	_	_	_	_
6	)	_	O	O	_	_	_	_	_
7	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	region	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	involved	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	transcriptional	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	our	_	O	O	_	_	_	_	_
15	findings	_	O	O	_	_	_	_	_
16	suggest	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	possibility	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	may	_	O	O	_	_	_	_	_
24	be	_	O	O	_	_	_	_	_
25	transcriptionally	_	O	O	_	_	_	_	_
26	inactive	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	may	_	O	O	_	_	_	_	_
29	compete	_	O	O	_	_	_	_	_
30	with	_	O	O	_	_	_	_	_
31	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	for	_	O	O	_	_	_	_	_
35	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	binding	_	O	O	_	_	_	_	_
38	sites	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	these	_	O	O	_	_	_	_	_
41	terminally	_	O	O	_	_	_	_	_
42	differentiated	_	O	O	_	_	_	_	_
43	myeloid	_	O	O	_	_	_	_	_
44	cells	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Reporter	_	O	O	_	_	_	_	_
2	plasmids	_	O	O	_	_	_	_	_
3	containing	_	O	O	_	_	_	_	_
4	shorter	_	O	O	_	_	_	_	_
5	fragments	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	APOBEC	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	G	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	promoter	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	constructed	_	O	O	_	_	_	_	_
14	using	_	O	O	_	_	_	_	_
15	pGL	_	O	O	_	_	_	_	_
16	3	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	APOprom	_	O	O	_	_	_	_	_
19	1025	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	template	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	following	_	O	O	_	_	_	_	_
25	forward	_	O	O	_	_	_	_	_
26	primers	_	O	O	_	_	_	_	_
27	:	_	O	O	_	_	_	_	_
28	for	_	O	O	_	_	_	_	_
29	plasmid	_	O	O	_	_	_	_	_
30	pGL	_	O	O	_	_	_	_	_
31	3	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	APOprom	_	O	O	_	_	_	_	_
34	502	_	O	O	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	containing	_	O	O	_	_	_	_	_
37	sequence	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	436	_	O	O	_	_	_	_	_
40	/	_	O	O	_	_	_	_	_
41	+	_	O	O	_	_	_	_	_
42	66	_	O	O	_	_	_	_	_
43	)	_	O	O	_	_	_	_	_
44	:	_	O	O	_	_	_	_	_
45	3	_	O	O	_	_	_	_	_
46	Gprom	_	O	O	_	_	_	_	_
47	502	_	O	O	_	_	_	_	_
48	(	_	O	O	_	_	_	_	_
49	5	_	O	O	_	_	_	_	_
50	'	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	TGTGAACGCGTTCCATAACATGGGGACAAGA	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	3	_	O	O	_	_	_	_	_
55	'	_	O	O	_	_	_	_	_
56	)	_	O	O	_	_	_	_	_
57	;	_	O	O	_	_	_	_	_
58	for	_	O	O	_	_	_	_	_
59	plasmid	_	O	O	_	_	_	_	_
60	pGL	_	O	O	_	_	_	_	_
61	3	_	O	O	_	_	_	_	_
62	-	_	O	O	_	_	_	_	_
63	APOprom	_	O	O	_	_	_	_	_
64	225	_	O	O	_	_	_	_	_
65	(	_	O	O	_	_	_	_	_
66	containing	_	O	O	_	_	_	_	_
67	sequence	_	O	O	_	_	_	_	_
68	-	_	O	O	_	_	_	_	_
69	159	_	O	O	_	_	_	_	_
70	/	_	O	O	_	_	_	_	_
71	+	_	O	O	_	_	_	_	_
72	66	_	O	O	_	_	_	_	_
73	)	_	O	O	_	_	_	_	_
74	:	_	O	O	_	_	_	_	_
75	3	_	O	O	_	_	_	_	_
76	Gprom	_	O	O	_	_	_	_	_
77	225	_	O	O	_	_	_	_	_
78	(	_	O	O	_	_	_	_	_
79	5	_	O	O	_	_	_	_	_
80	'	_	O	O	_	_	_	_	_
81	-	_	O	O	_	_	_	_	_
82	TGTGAACGCGTCGAGGGCAGGATCCGGGAGT	_	O	O	_	_	_	_	_
83	-	_	O	O	_	_	_	_	_
84	3	_	O	O	_	_	_	_	_
85	'	_	O	O	_	_	_	_	_
86	)	_	O	O	_	_	_	_	_
87	;	_	O	O	_	_	_	_	_
88	for	_	O	O	_	_	_	_	_
89	plasmid	_	O	O	_	_	_	_	_
90	pGL	_	O	O	_	_	_	_	_
91	3	_	O	O	_	_	_	_	_
92	-	_	O	O	_	_	_	_	_
93	APOprom	_	O	O	_	_	_	_	_
94	180	_	O	O	_	_	_	_	_
95	(	_	O	O	_	_	_	_	_
96	containing	_	O	O	_	_	_	_	_
97	sequence	_	O	O	_	_	_	_	_
98	-	_	O	O	_	_	_	_	_
99	114	_	O	O	_	_	_	_	_
100	/	_	O	O	_	_	_	_	_
101	+	_	O	O	_	_	_	_	_
102	66	_	O	O	_	_	_	_	_
103	)	_	O	O	_	_	_	_	_
104	:	_	O	O	_	_	_	_	_
105	3	_	O	O	_	_	_	_	_
106	Gprom	_	O	O	_	_	_	_	_
107	180	_	O	O	_	_	_	_	_
108	(	_	O	O	_	_	_	_	_
109	5	_	O	O	_	_	_	_	_
110	'	_	O	O	_	_	_	_	_
111	-	_	O	O	_	_	_	_	_
112	TGTGAACGCGTTCTTGATGGTGGAGAGGAGG	_	O	O	_	_	_	_	_
113	-	_	O	O	_	_	_	_	_
114	3	_	O	O	_	_	_	_	_
115	'	_	O	O	_	_	_	_	_
116	)	_	O	O	_	_	_	_	_
117	;	_	O	O	_	_	_	_	_
118	for	_	O	O	_	_	_	_	_
119	plasmid	_	O	O	_	_	_	_	_
120	pGL	_	O	O	_	_	_	_	_
121	3	_	O	O	_	_	_	_	_
122	-	_	O	O	_	_	_	_	_
123	APOprom	_	O	O	_	_	_	_	_
124	150	_	O	O	_	_	_	_	_
125	(	_	O	O	_	_	_	_	_
126	containing	_	O	O	_	_	_	_	_
127	sequence	_	O	O	_	_	_	_	_
128	-	_	O	O	_	_	_	_	_
129	84	_	O	O	_	_	_	_	_
130	/	_	O	O	_	_	_	_	_
131	+	_	O	O	_	_	_	_	_
132	66	_	O	O	_	_	_	_	_
133	)	_	O	O	_	_	_	_	_
134	:	_	O	O	_	_	_	_	_
135	3	_	O	O	_	_	_	_	_
136	Gprom	_	O	O	_	_	_	_	_
137	150	_	O	O	_	_	_	_	_
138	(	_	O	O	_	_	_	_	_
139	5	_	O	O	_	_	_	_	_
140	'	_	O	O	_	_	_	_	_
141	-	_	O	O	_	_	_	_	_
142	TGTGAACGCGTGCGGGACCACCAGGGGAGGGGCTT	_	O	O	_	_	_	_	_
143	-	_	O	O	_	_	_	_	_
144	3	_	O	O	_	_	_	_	_
145	'	_	O	O	_	_	_	_	_
146	)	_	O	O	_	_	_	_	_
147	;	_	O	O	_	_	_	_	_
148	for	_	O	O	_	_	_	_	_
149	plasmid	_	O	O	_	_	_	_	_
150	pGL	_	O	O	_	_	_	_	_
151	3	_	O	O	_	_	_	_	_
152	-	_	O	O	_	_	_	_	_
153	APOprom	_	O	O	_	_	_	_	_
154	120	_	O	O	_	_	_	_	_
155	(	_	O	O	_	_	_	_	_
156	containing	_	O	O	_	_	_	_	_
157	sequence	_	O	O	_	_	_	_	_
158	-	_	O	O	_	_	_	_	_
159	54	_	O	O	_	_	_	_	_
160	/	_	O	O	_	_	_	_	_
161	+	_	O	O	_	_	_	_	_
162	66	_	O	O	_	_	_	_	_
163	)	_	O	O	_	_	_	_	_
164	:	_	O	O	_	_	_	_	_
165	3	_	O	O	_	_	_	_	_
166	Gprom	_	O	O	_	_	_	_	_
167	120	_	O	O	_	_	_	_	_
168	(	_	O	O	_	_	_	_	_
169	5	_	O	O	_	_	_	_	_
170	'	_	O	O	_	_	_	_	_
171	-	_	O	O	_	_	_	_	_
172	TGTGAACGCGTTGCTGGCTCAGCCTGGTGTG	_	O	O	_	_	_	_	_
173	-	_	O	O	_	_	_	_	_
174	3	_	O	O	_	_	_	_	_
175	'	_	O	O	_	_	_	_	_
176	)	_	O	O	_	_	_	_	_
177	;	_	O	O	_	_	_	_	_
178	for	_	O	O	_	_	_	_	_
179	plasmid	_	O	O	_	_	_	_	_
180	pGL	_	O	O	_	_	_	_	_
181	3	_	O	O	_	_	_	_	_
182	-	_	O	O	_	_	_	_	_
183	APOprom	_	O	O	_	_	_	_	_
184	60	_	O	O	_	_	_	_	_
185	(	_	O	O	_	_	_	_	_
186	containing	_	O	O	_	_	_	_	_
187	sequence	_	O	O	_	_	_	_	_
188	+	_	O	O	_	_	_	_	_
189	7	_	O	O	_	_	_	_	_
190	/	_	O	O	_	_	_	_	_
191	+	_	O	O	_	_	_	_	_
192	66	_	O	O	_	_	_	_	_
193	)	_	O	O	_	_	_	_	_
194	:	_	O	O	_	_	_	_	_
195	3	_	O	O	_	_	_	_	_
196	Gprom	_	O	O	_	_	_	_	_
197	60	_	O	O	_	_	_	_	_
198	(	_	O	O	_	_	_	_	_
199	5	_	O	O	_	_	_	_	_
200	'	_	O	O	_	_	_	_	_
201	-	_	O	O	_	_	_	_	_
202	TGTGAACGCGTCCCTTTGCAATTGCCTTG	_	O	O	_	_	_	_	_
203	-	_	O	O	_	_	_	_	_
204	3	_	O	O	_	_	_	_	_
205	'	_	O	O	_	_	_	_	_
206	)	_	O	O	_	_	_	_	_
207	;	_	O	O	_	_	_	_	_
208	each	_	O	O	_	_	_	_	_
209	in	_	O	O	_	_	_	_	_
210	combination	_	O	O	_	_	_	_	_
211	with	_	O	O	_	_	_	_	_
212	the	_	O	O	_	_	_	_	_
213	reverse	_	O	O	_	_	_	_	_
214	primer	_	O	O	_	_	_	_	_
215	3	_	O	O	_	_	_	_	_
216	Gpromreverse	_	O	O	_	_	_	_	_
217	(	_	O	O	_	_	_	_	_
218	described	_	O	O	_	_	_	_	_
219	above	_	O	O	_	_	_	_	_
220	)	_	O	O	_	_	_	_	_
221	.	_	O	O	_	_	_	_	_

1	pGL	_	O	O	_	_	_	_	_
2	2	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	CVX	_	O	O	_	_	_	_	_
5	contains	_	O	O	_	_	_	_	_
6	two	_	O	O	_	_	_	_	_
7	repeats	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	IFN	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	responsive	_	O	O	_	_	_	_	_
13	GAS	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	gamma	_	O	O	_	_	_	_	_
16	activated	_	O	O	_	_	_	_	_
17	sequence	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	elements	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	GATCTGGATTTAGAGTAATATGAAACTGAAAGTACTTCG	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	guanylate	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	binding	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	GBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	gene	_	O	O	_	_	_	_	_
33	in	_	O	O	_	_	_	_	_
34	front	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	a	_	O	O	_	_	_	_	_
37	CMV	_	O	O	_	_	_	_	_
38	minimal	_	O	O	_	_	_	_	_
39	promoter	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	was	_	O	O	_	_	_	_	_
42	kindly	_	O	O	_	_	_	_	_
43	provided	_	O	O	_	_	_	_	_
44	by	_	O	O	_	_	_	_	_
45	Ute	_	O	O	_	_	_	_	_
46	Pagelow	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	Mario	_	O	O	_	_	_	_	_
49	Koster	_	O	O	_	_	_	_	_
50	from	_	O	O	_	_	_	_	_
51	the	_	O	O	_	_	_	_	_
52	Helmholtz	_	O	O	_	_	_	_	_
53	-	_	O	O	_	_	_	_	_
54	Zentrum	_	O	O	_	_	_	_	_
55	fur	_	O	O	_	_	_	_	_
56	Infektionsforschung	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_

1	Landau	_	O	O	_	_	_	_	_
2	from	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	Salk	_	O	O	_	_	_	_	_
5	Institute	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	La	_	O	O	_	_	_	_	_
8	Jolla	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	DCs	_	O	O	_	_	_	_	_
4	lack	_	O	O	_	_	_	_	_
5	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	which	_	O	O	_	_	_	_	_
9	may	_	O	O	_	_	_	_	_
10	explain	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	failure	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	HIV	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	1	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	replicate	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	purified	_	O	O	_	_	_	_	_
21	DCs	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	amplified	_	O	O	_	_	_	_	_
3	insert	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	digested	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	ligated	_	O	O	_	_	_	_	_
8	into	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	BamHI	_	O	O	_	_	_	_	_
11	/	_	O	O	_	_	_	_	_
12	BglII	_	O	O	_	_	_	_	_
13	sites	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	pFA	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	CMV	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Activated	_	O	O	_	_	_	_	_
2	Stat	_	O	O	_	_	_	_	_
3	proteins	_	O	O	_	_	_	_	_
4	form	_	O	O	_	_	_	_	_
5	homo	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	or	_	O	O	_	_	_	_	_
8	heterodimers	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	translocate	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	nucleus	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	induce	_	O	O	_	_	_	_	_
17	transcription	_	O	O	_	_	_	_	_
18	from	_	O	O	_	_	_	_	_
19	responsive	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	factors	_	O	O	_	_	_	_	_
9	active	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	mammary	_	O	O	_	_	_	_	_
12	epithelial	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	immune	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	METHODS	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	Cultured	_	O	O	_	_	_	_	_
4	bovine	_	O	O	_	_	_	_	_
5	corneal	_	O	O	_	_	_	_	_
6	endothelium	_	O	O	_	_	_	_	_
7	was	_	O	O	_	_	_	_	_
8	stimulated	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	6	_	O	O	_	_	_	_	_
11	hours	_	O	O	_	_	_	_	_
12	by	_	O	O	_	_	_	_	_
13	40	_	O	O	_	_	_	_	_
14	micron	_	O	O	_	_	_	_	_
15	/	_	O	O	_	_	_	_	_
16	ml	_	O	O	_	_	_	_	_
17	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	signaling	_	O	O	_	_	_	_	_
5	events	_	O	O	_	_	_	_	_
6	responsible	_	O	O	_	_	_	_	_
7	for	_	O	O	_	_	_	_	_
8	these	_	O	O	_	_	_	_	_
9	effects	_	O	O	_	_	_	_	_
10	remain	_	O	O	_	_	_	_	_
11	unclear	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	present	_	O	O	_	_	_	_	_
3	studies	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	examined	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	effects	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	M	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	CSF	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	potential	_	O	O	_	_	_	_	_
14	signaling	_	O	O	_	_	_	_	_
15	pathways	_	O	O	_	_	_	_	_
16	involving	_	O	O	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	jun	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	fos	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	early	_	O	O	_	_	_	_	_
24	response	_	O	O	_	_	_	_	_
25	genes	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Treatment	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	10	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	3	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	units	_	O	O	_	_	_	_	_
11	/	_	O	O	_	_	_	_	_
12	ml	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	recombinant	_	O	O	_	_	_	_	_
15	M	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	CSF	_	O	O	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	associated	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	rapid	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	transient	_	O	O	_	_	_	_	_
24	increases	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	mRNA	_	O	O	_	_	_	_	_
30	levels	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	defensin	_	O	O	_	_	_	_	_
3	sensitivities	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	Salmonella	_	O	O	_	_	_	_	_
6	typhimurium	_	O	O	_	_	_	_	_
7	strains	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	mutations	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	phoP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	phoQ	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	two	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	component	_	O	O	_	_	_	_	_
18	virulence	_	O	O	_	_	_	_	_
19	regulon	_	O	O	_	_	_	_	_
20	were	_	O	O	_	_	_	_	_
21	tested	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	using	_	O	O	_	_	_	_	_
24	purified	_	O	O	_	_	_	_	_
25	defensins	_	O	O	_	_	_	_	_
26	NP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	NP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	implied	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	pag	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	phoP	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	activated	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	product	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	responsible	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	defensin	_	O	O	_	_	_	_	_
17	resistance	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Recent	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	demonstrate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	TCR	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	stimulated	_	O	O	_	_	_	_	_
8	apoptosis	_	O	O	_	_	_	_	_
9	requires	_	O	O	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	95	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	on	_	O	O	_	_	_	_	_
16	activated	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	followed	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	an	_	O	O	_	_	_	_	_
22	interaction	_	O	O	_	_	_	_	_
23	between	_	O	O	_	_	_	_	_
24	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	95	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	95	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	receptor	_	O	O	_	_	_	_	_
32	also	_	O	O	_	_	_	_	_
33	expressed	_	O	O	_	_	_	_	_
34	on	_	O	O	_	_	_	_	_
35	this	_	O	O	_	_	_	_	_
36	population	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	experiments	_	O	O	_	_	_	_	_
3	reported	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	this	_	O	O	_	_	_	_	_
6	study	_	O	O	_	_	_	_	_
7	were	_	O	O	_	_	_	_	_
8	designed	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	address	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	signaling	_	O	O	_	_	_	_	_
13	events	_	O	O	_	_	_	_	_
14	triggered	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	TCR	_	O	O	_	_	_	_	_
17	engagement	_	O	O	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	are	_	O	O	_	_	_	_	_
20	important	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	regulating	_	O	O	_	_	_	_	_
23	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	95	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	gene	_	O	O	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	induction	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	cell	_	O	O	_	_	_	_	_
5	death	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	lymphoid	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	glucocorticoids	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	one	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	earliest	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	most	_	O	O	_	_	_	_	_
18	thoroughly	_	O	O	_	_	_	_	_
19	studied	_	O	O	_	_	_	_	_
20	models	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	apoptosis	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	finding	_	O	O	_	_	_	_	_
3	suggests	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	inhibition	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	NFkappaB	_	O	O	_	_	_	_	_
8	can	_	O	O	_	_	_	_	_
9	induce	_	O	O	_	_	_	_	_
10	cell	_	O	O	_	_	_	_	_
11	death	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	transgenic	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	lymphoma	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	without	_	O	O	_	_	_	_	_
21	significant	_	O	O	_	_	_	_	_
22	effects	_	O	O	_	_	_	_	_
23	on	_	O	O	_	_	_	_	_
24	activation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	Akt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	or	_	O	O	_	_	_	_	_
28	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	second	_	O	O	_	_	_	_	_
3	reported	_	O	O	_	_	_	_	_
4	inhibitor	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	AG	_	O	O	_	_	_	_	_
10	490	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	had	_	O	O	_	_	_	_	_
13	no	_	O	O	_	_	_	_	_
14	effect	_	O	O	_	_	_	_	_
15	on	_	O	O	_	_	_	_	_
16	growth	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	Figure	_	O	O	_	_	_	_	_
19	7	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	but	_	O	O	_	_	_	_	_
23	activation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	Akt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	Stat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	or	_	O	O	_	_	_	_	_
31	levels	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	IkappaBalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	were	_	O	O	_	_	_	_	_
35	also	_	O	O	_	_	_	_	_
36	not	_	O	O	_	_	_	_	_
37	affected	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	Figure	_	O	O	_	_	_	_	_
40	8	_	O	O	_	_	_	_	_
41	)	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_


1	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	lymphoid	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	specific	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factor	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	belongs	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	ETS	_	O	O	_	_	_	_	_
16	protein	_	O	O	_	_	_	_	_
17	family	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	constitutively	_	O	O	_	_	_	_	_
9	localized	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	nucleus	_	O	O	_	_	_	_	_
13	which	_	O	O	_	_	_	_	_
14	is	_	O	O	_	_	_	_	_
15	dependent	_	O	O	_	_	_	_	_
16	on	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	presence	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	amino	_	O	O	_	_	_	_	_
21	acids	_	O	O	_	_	_	_	_
22	86	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	265	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	report	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	5	_	O	O	_	_	_	_	_
9	'	_	O	O	_	_	_	_	_
10	flanking	_	O	O	_	_	_	_	_
11	DNA	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	15	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	lox	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	contains	_	O	O	_	_	_	_	_
19	sequences	_	O	O	_	_	_	_	_
20	which	_	O	O	_	_	_	_	_
21	down	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	regulate	_	O	O	_	_	_	_	_
24	its	_	O	O	_	_	_	_	_
25	activity	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	variety	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	non	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	erythroid	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	lines	_	O	O	_	_	_	_	_
35	but	_	O	O	_	_	_	_	_
36	not	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	two	_	O	O	_	_	_	_	_
39	erythroid	_	O	O	_	_	_	_	_
40	cell	_	O	O	_	_	_	_	_
41	lines	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	element	_	O	O	_	_	_	_	_
3	has	_	O	O	_	_	_	_	_
4	characteristics	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	transcriptional	_	O	O	_	_	_	_	_
8	'	_	O	O	_	_	_	_	_
9	silencer	_	O	O	_	_	_	_	_
10	'	_	O	O	_	_	_	_	_
11	since	_	O	O	_	_	_	_	_
12	it	_	O	O	_	_	_	_	_
13	functions	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	both	_	O	O	_	_	_	_	_
16	orientations	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_


1	A	_	O	O	_	_	_	_	_
2	variety	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	other	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	including	_	O	O	_	_	_	_	_
8	transformed	_	O	O	_	_	_	_	_
9	erythroid	_	O	O	_	_	_	_	_
10	precursors	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	do	_	O	O	_	_	_	_	_
13	not	_	O	O	_	_	_	_	_
14	have	_	O	O	_	_	_	_	_
15	IBR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	but	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	factor	_	O	O	_	_	_	_	_
19	referred	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	IBF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	68	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	70	_	O	O	_	_	_	_	_
27	kDa	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	that	_	O	O	_	_	_	_	_
30	recognizes	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	same	_	O	O	_	_	_	_	_
33	IBR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	sites	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	METHODS	_	O	O	_	_	_	_	_
2	AND	_	O	O	_	_	_	_	_
3	RESULTS	_	O	O	_	_	_	_	_
4	:	_	O	O	_	_	_	_	_
5	We	_	O	O	_	_	_	_	_
6	obtained	_	O	O	_	_	_	_	_
7	peripheral	_	O	O	_	_	_	_	_
8	venous	_	O	O	_	_	_	_	_
9	blood	_	O	O	_	_	_	_	_
10	samples	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	20	_	O	O	_	_	_	_	_
13	patients	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	AMI	_	O	O	_	_	_	_	_
16	before	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	daily	_	O	O	_	_	_	_	_
19	for	_	O	O	_	_	_	_	_
20	5	_	O	O	_	_	_	_	_
21	days	_	O	O	_	_	_	_	_
22	after	_	O	O	_	_	_	_	_
23	direct	_	O	O	_	_	_	_	_
24	percutaneous	_	O	O	_	_	_	_	_
25	transluminal	_	O	O	_	_	_	_	_
26	coronary	_	O	O	_	_	_	_	_
27	angioplasty	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	PTCA	_	O	O	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	in	_	O	O	_	_	_	_	_
33	20	_	O	O	_	_	_	_	_
34	patients	_	O	O	_	_	_	_	_
35	undergoing	_	O	O	_	_	_	_	_
36	elective	_	O	O	_	_	_	_	_
37	PTCA	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Throughout	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	study	_	O	O	_	_	_	_	_
4	period	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	41	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	immunofluorescence	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	leukocytes	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	flow	_	O	O	_	_	_	_	_
13	cytometry	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	revealed	_	O	O	_	_	_	_	_
16	increased	_	O	O	_	_	_	_	_
17	leukocyte	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	platelet	_	O	O	_	_	_	_	_
20	adhesion	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	patients	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	AMI	_	O	O	_	_	_	_	_
25	compared	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	control	_	O	O	_	_	_	_	_
28	patients	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	mean	_	O	O	_	_	_	_	_
31	+	_	O	O	_	_	_	_	_
32	/	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	SE	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	fluorescence	_	O	O	_	_	_	_	_
37	[	_	O	O	_	_	_	_	_
38	channels	_	O	O	_	_	_	_	_
39	]	_	O	O	_	_	_	_	_
40	before	_	O	O	_	_	_	_	_
41	PTCA	_	O	O	_	_	_	_	_
42	:	_	O	O	_	_	_	_	_
43	77	_	O	O	_	_	_	_	_
44	+	_	O	O	_	_	_	_	_
45	/	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	16	_	O	O	_	_	_	_	_
48	versus	_	O	O	_	_	_	_	_
49	35	_	O	O	_	_	_	_	_
50	+	_	O	O	_	_	_	_	_
51	/	_	O	O	_	_	_	_	_
52	-	_	O	O	_	_	_	_	_
53	9	_	O	O	_	_	_	_	_
54	;	_	O	O	_	_	_	_	_
55	P	_	O	O	_	_	_	_	_
56	=	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_
58	003	_	O	O	_	_	_	_	_
59	)	_	O	O	_	_	_	_	_
60	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assay	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	using	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	vitro	_	O	O	_	_	_	_	_
9	translated	_	O	O	_	_	_	_	_
10	TR	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	orphan	_	O	O	_	_	_	_	_
13	receptor	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	molecular	_	O	O	_	_	_	_	_
17	mass	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	67	_	O	O	_	_	_	_	_
20	kilodaltons	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	showed	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	specific	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	with	_	O	O	_	_	_	_	_
27	high	_	O	O	_	_	_	_	_
28	affinity	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	dissociation	_	O	O	_	_	_	_	_
31	constant	_	O	O	_	_	_	_	_
32	=	_	O	O	_	_	_	_	_
33	9	_	O	O	_	_	_	_	_
34	nM	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	for	_	O	O	_	_	_	_	_
37	this	_	O	O	_	_	_	_	_
38	DNA	_	O	O	_	_	_	_	_
39	sequence	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	several	_	O	O	_	_	_	_	_
3	inflammatory	_	O	O	_	_	_	_	_
4	cytokines	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	oxidative	_	O	O	_	_	_	_	_
7	stresses	_	O	O	_	_	_	_	_
8	are	_	O	O	_	_	_	_	_
9	involved	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	pathogenesis	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	HIV	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	1	_	O	O	_	_	_	_	_
17	infection	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	we	_	O	O	_	_	_	_	_
20	investigated	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	inhibitory	_	O	O	_	_	_	_	_
23	effects	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	cepharanthine	_	O	O	_	_	_	_	_
26	on	_	O	O	_	_	_	_	_
27	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	phorbol	_	O	O	_	_	_	_	_
39	12	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	myristate	_	O	O	_	_	_	_	_
42	13	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	acetate	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	PMA	_	O	O	_	_	_	_	_
47	)	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	induced	_	O	O	_	_	_	_	_
50	HIV	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	1	_	O	O	_	_	_	_	_
53	replication	_	O	O	_	_	_	_	_
54	in	_	O	O	_	_	_	_	_
55	chronically	_	O	O	_	_	_	_	_
56	infected	_	O	O	_	_	_	_	_
57	cell	_	O	O	_	_	_	_	_
58	lines	_	O	O	_	_	_	_	_
59	.	_	O	O	_	_	_	_	_

1	Consequently	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IkappaBbeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	protein	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	chronically	_	O	O	_	_	_	_	_
8	downregulated	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	HTLV	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	infected	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_


1	It	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	further	_	O	O	_	_	_	_	_
4	demonstrated	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	both	_	O	O	_	_	_	_	_
7	Th	_	O	O	_	_	_	_	_
8	1	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	Th	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	transcription	_	O	O	_	_	_	_	_
13	factors	_	O	O	_	_	_	_	_
14	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	oppose	_	O	O	_	_	_	_	_
21	peripheral	_	O	O	_	_	_	_	_
22	induction	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	+	_	O	O	_	_	_	_	_
27	T	_	O	O	_	_	_	_	_
28	reg	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	mice	_	O	O	_	_	_	_	_
32	through	_	O	O	_	_	_	_	_
33	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	dependent	_	O	O	_	_	_	_	_
46	pathways	_	O	O	_	_	_	_	_
47	(	_	O	O	_	_	_	_	_
48	Wei	_	O	O	_	_	_	_	_
49	et	_	O	O	_	_	_	_	_
50	al	_	O	O	_	_	_	_	_
51	.,	_	O	O	_	_	_	_	_
52	2007	_	O	O	_	_	_	_	_
53	)	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	crucial	_	O	O	_	_	_	_	_
3	role	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	their	_	O	O	_	_	_	_	_
10	generation	_	O	O	_	_	_	_	_
11	has	_	O	O	_	_	_	_	_
12	been	_	O	O	_	_	_	_	_
13	demonstrated	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	Runt	_	O	O	_	_	_	_	_
3	domain	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	containing	_	O	O	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	constitutes	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	alpha	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	chain	_	O	O	_	_	_	_	_
12	partner	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	heterodimeric	_	O	O	_	_	_	_	_
16	CBF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	complex	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	enhancement	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	eliminated	_	O	O	_	_	_	_	_
5	if	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	conserved	_	O	O	_	_	_	_	_
8	20	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	bp	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	removed	_	O	O	_	_	_	_	_
14	from	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	intron	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	if	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	dominant	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	negative	_	O	O	_	_	_	_	_
23	ets	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	factor	_	O	O	_	_	_	_	_
27	was	_	O	O	_	_	_	_	_
28	co	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	transfected	_	O	O	_	_	_	_	_
31	with	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	reporter	_	O	O	_	_	_	_	_
34	gene	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	63	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	kDa	_	O	O	_	_	_	_	_
5	isoform	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	termed	_	O	O	_	_	_	_	_
8	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	which	_	O	O	_	_	_	_	_
16	lacks	_	O	O	_	_	_	_	_
17	59	_	O	O	_	_	_	_	_
18	amino	_	O	O	_	_	_	_	_
19	acids	_	O	O	_	_	_	_	_
20	C	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	terminal	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	ankyrin	_	O	O	_	_	_	_	_
25	repeat	_	O	O	_	_	_	_	_
26	7	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	has	_	O	O	_	_	_	_	_
29	a	_	O	O	_	_	_	_	_
30	novel	_	O	O	_	_	_	_	_
31	35	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	amino	_	O	O	_	_	_	_	_
34	acid	_	O	O	_	_	_	_	_
35	C	_	O	O	_	_	_	_	_
36	terminus	_	O	O	_	_	_	_	_
37	encoded	_	O	O	_	_	_	_	_
38	by	_	O	O	_	_	_	_	_
39	an	_	O	O	_	_	_	_	_
40	alternative	_	O	O	_	_	_	_	_
41	reading	_	O	O	_	_	_	_	_
42	frame	_	O	O	_	_	_	_	_
43	of	_	O	O	_	_	_	_	_
44	the	_	O	O	_	_	_	_	_
45	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	gene	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	55	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	kDa	_	O	O	_	_	_	_	_
5	isoform	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	lacks	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	190	_	O	O	_	_	_	_	_
17	C	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	terminal	_	O	O	_	_	_	_	_
20	amino	_	O	O	_	_	_	_	_
21	acids	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	70	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	I	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_



1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	TRAIL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	related	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	apoptosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	inducing	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	ligand	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	recently	_	O	O	_	_	_	_	_
18	identified	_	O	O	_	_	_	_	_
19	DIL	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	also	_	O	O	_	_	_	_	_
22	activates	_	O	O	_	_	_	_	_
23	NFkappaB	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	lymphoid	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	lines	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	a	_	O	O	_	_	_	_	_
30	kinetic	_	O	O	_	_	_	_	_
31	similar	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	TNFalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_


1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	early	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	growth	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	response	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	transcription	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	pp	_	O	O	_	_	_	_	_
11	90	_	O	O	_	_	_	_	_
12	rsk	_	O	O	_	_	_	_	_
13	during	_	O	O	_	_	_	_	_
14	induction	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	monocytic	_	O	O	_	_	_	_	_
17	differentiation	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Western	_	O	O	_	_	_	_	_
2	blot	_	O	O	_	_	_	_	_
3	analysis	_	O	O	_	_	_	_	_
4	showed	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	N	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	acetyl	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	cysteine	_	O	O	_	_	_	_	_
11	reduced	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	accumulation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	47	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kD	_	O	O	_	_	_	_	_
19	mature	_	O	O	_	_	_	_	_
20	glycoprotein	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	LPS	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	treated	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	finding	_	O	O	_	_	_	_	_
29	consistent	_	O	O	_	_	_	_	_
30	with	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	results	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	immunofluorescence	_	O	O	_	_	_	_	_
36	studies	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	gene	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	interest	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	glycoprotein	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	IIb	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	GPIIb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	;	_	O	O	_	_	_	_	_
14	GPIIb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	alpha	_	O	O	_	_	_	_	_
18	subunit	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	platelet	_	O	O	_	_	_	_	_
22	cytoadhesin	_	O	O	_	_	_	_	_
23	GPIIb	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	IIIa	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	is	_	O	O	_	_	_	_	_
28	produced	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	megakaryocytes	_	O	O	_	_	_	_	_
31	at	_	O	O	_	_	_	_	_
32	an	_	O	O	_	_	_	_	_
33	early	_	O	O	_	_	_	_	_
34	stage	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	differentiation	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	whereas	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	other	_	O	O	_	_	_	_	_
42	subunit	_	O	O	_	_	_	_	_
43	of	_	O	O	_	_	_	_	_
44	this	_	O	O	_	_	_	_	_
45	complex	_	O	O	_	_	_	_	_
46	,	_	O	O	_	_	_	_	_
47	GPIIIa	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	,	_	O	O	_	_	_	_	_
49	is	_	O	O	_	_	_	_	_
50	expressed	_	O	O	_	_	_	_	_
51	in	_	O	O	_	_	_	_	_
52	other	_	O	O	_	_	_	_	_
53	cells	_	O	O	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Two	_	O	O	_	_	_	_	_
2	domains	_	O	O	_	_	_	_	_
3	centered	_	O	O	_	_	_	_	_
4	at	_	O	O	_	_	_	_	_
5	positions	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	345	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	540	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	respectively	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	bind	_	O	O	_	_	_	_	_
15	proteins	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	are	_	O	O	_	_	_	_	_
18	present	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	megakaryocytic	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	nonrelated	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	as	_	O	O	_	_	_	_	_
26	well	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	An	_	O	O	_	_	_	_	_
2	unidentified	_	O	O	_	_	_	_	_
3	Ets	_	O	O	_	_	_	_	_
4	family	_	O	O	_	_	_	_	_
5	protein	_	O	O	_	_	_	_	_
6	binds	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	EBS	_	O	O	_	_	_	_	_
10	overlapping	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	consensus	_	O	O	_	_	_	_	_
13	GAS	_	O	O	_	_	_	_	_
14	motif	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	appears	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	negatively	_	O	O	_	_	_	_	_
19	regulate	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	promoter	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	induced	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	promoter	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	requires	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	complex	_	O	O	_	_	_	_	_
18	upstream	_	O	O	_	_	_	_	_
19	element	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	which	_	O	O	_	_	_	_	_
22	appears	_	O	O	_	_	_	_	_
23	to	_	O	O	_	_	_	_	_
24	contain	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	sites	_	O	O	_	_	_	_	_
27	for	_	O	O	_	_	_	_	_
28	both	_	O	O	_	_	_	_	_
29	positive	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	negative	_	O	O	_	_	_	_	_
32	regulatory	_	O	O	_	_	_	_	_
33	factors	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_


1	tuberculosis	_	O	O	_	_	_	_	_
2	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	levels	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	PBMC	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	monocytes	_	O	O	_	_	_	_	_
14	from	_	O	O	_	_	_	_	_
15	healthy	_	O	O	_	_	_	_	_
16	subjects	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	from	_	O	O	_	_	_	_	_
19	patients	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	nontuberculous	_	O	O	_	_	_	_	_
22	pulmonary	_	O	O	_	_	_	_	_
23	conditions	_	O	O	_	_	_	_	_
24	were	_	O	O	_	_	_	_	_
25	intact	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Further	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	by	_	O	O	_	_	_	_	_
4	electrophoretic	_	O	O	_	_	_	_	_
5	mobility	_	O	O	_	_	_	_	_
6	shift	_	O	O	_	_	_	_	_
7	assay	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	was	_	O	O	_	_	_	_	_
14	activated	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	monocytes	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	tuberculous	_	O	O	_	_	_	_	_
19	patients	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	which	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	responsive	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	activation	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	NF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	was	_	O	O	_	_	_	_	_
23	up	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	regulated	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	PBMC	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	monocytes	_	O	O	_	_	_	_	_
30	from	_	O	O	_	_	_	_	_
31	patients	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	but	_	O	O	_	_	_	_	_
34	not	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	mononuclear	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	from	_	O	O	_	_	_	_	_
39	healthy	_	O	O	_	_	_	_	_
40	subjects	_	O	O	_	_	_	_	_
41	or	_	O	O	_	_	_	_	_
42	those	_	O	O	_	_	_	_	_
43	with	_	O	O	_	_	_	_	_
44	nontuberculous	_	O	O	_	_	_	_	_
45	lung	_	O	O	_	_	_	_	_
46	diseases	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_


1	On	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	basis	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	these	_	O	O	_	_	_	_	_
6	observations	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	it	_	O	O	_	_	_	_	_
9	has	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	proposed	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	reactivation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	latent	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	harbored	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	chronically	_	O	O	_	_	_	_	_
22	infected	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	lymphocytes	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	monocytes	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	macrophages	_	O	O	_	_	_	_	_
30	plays	_	O	O	_	_	_	_	_
31	an	_	O	O	_	_	_	_	_
32	important	_	O	O	_	_	_	_	_
33	role	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	pathogenesis	_	O	O	_	_	_	_	_
37	of	_	O	O	_	_	_	_	_
38	AIDS	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Northern	_	O	O	_	_	_	_	_
2	blot	_	O	O	_	_	_	_	_
3	analyses	_	O	O	_	_	_	_	_
4	performed	_	O	O	_	_	_	_	_
5	on	_	O	O	_	_	_	_	_
6	rat	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	mouse	_	O	O	_	_	_	_	_
9	tissues	_	O	O	_	_	_	_	_
10	have	_	O	O	_	_	_	_	_
11	detected	_	O	O	_	_	_	_	_
12	ubiquitously	_	O	O	_	_	_	_	_
13	expressed	_	O	O	_	_	_	_	_
14	Pan	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	transcripts	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	but	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	abundance	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	distribution	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	form	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	Pan	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	proteins	_	O	O	_	_	_	_	_
28	have	_	O	O	_	_	_	_	_
29	not	_	O	O	_	_	_	_	_
30	been	_	O	O	_	_	_	_	_
31	clearly	_	O	O	_	_	_	_	_
32	defined	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	promoter	_	O	O	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	Epstein	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	Barr	_	O	O	_	_	_	_	_
10	virus	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	transformed	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	lymphocytes	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	controlled	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	nuclear	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	chi	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	regulation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	has	_	O	O	_	_	_	_	_
13	been	_	O	O	_	_	_	_	_
14	investigated	_	O	O	_	_	_	_	_
15	mainly	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	lymphocytes	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	predominant	_	O	O	_	_	_	_	_
22	producers	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	promoter	_	O	O	_	_	_	_	_
6	bearing	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	defective	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	chi	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	site	_	O	O	_	_	_	_	_
14	was	_	O	O	_	_	_	_	_
15	completely	_	O	O	_	_	_	_	_
16	inactive	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	EBV	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	transformed	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	while	_	O	O	_	_	_	_	_
25	it	_	O	O	_	_	_	_	_
26	still	_	O	O	_	_	_	_	_
27	had	_	O	O	_	_	_	_	_
28	activity	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	Jurkat	_	O	O	_	_	_	_	_
31	T	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	through	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	deletion	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	human	_	O	O	_	_	_	_	_
10	UDG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	promoter	_	O	O	_	_	_	_	_
12	sequences	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	F	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	activates	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	UDG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	promoter	_	O	O	_	_	_	_	_
26	through	_	O	O	_	_	_	_	_
27	several	_	O	O	_	_	_	_	_
28	E	_	O	O	_	_	_	_	_
29	2	_	O	O	_	_	_	_	_
30	F	_	O	O	_	_	_	_	_
31	sites	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	earlier	_	O	O	_	_	_	_	_
4	found	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	Jurkat	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	kinase	_	O	O	_	_	_	_	_
13	C	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	PKC	_	O	O	_	_	_	_	_
16	)	_	O	O	_	_	_	_	_
17	enhances	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	cyclic	_	O	O	_	_	_	_	_
20	adenosine	_	O	O	_	_	_	_	_
21	monophosphate	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	cAMP	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	accumulation	_	O	O	_	_	_	_	_
26	induced	_	O	O	_	_	_	_	_
27	by	_	O	O	_	_	_	_	_
28	adenosine	_	O	O	_	_	_	_	_
29	receptor	_	O	O	_	_	_	_	_
30	stimulation	_	O	O	_	_	_	_	_
31	or	_	O	O	_	_	_	_	_
32	activation	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	Gs	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	Human	_	O	O	_	_	_	_	_
2	immunodeficiency	_	O	O	_	_	_	_	_
3	virus	_	O	O	_	_	_	_	_
4	type	_	O	O	_	_	_	_	_
5	1	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	HIV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	replicates	_	O	O	_	_	_	_	_
12	more	_	O	O	_	_	_	_	_
13	efficiently	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	vitro	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	differentiated	_	O	O	_	_	_	_	_
18	macrophages	_	O	O	_	_	_	_	_
19	than	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	freshly	_	O	O	_	_	_	_	_
22	isolated	_	O	O	_	_	_	_	_
23	monocytes	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	transcriptional	_	O	O	_	_	_	_	_
6	trans	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	activator	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	Human	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	leukemia	_	O	O	_	_	_	_	_
16	virus	_	O	O	_	_	_	_	_
17	type	_	O	O	_	_	_	_	_
18	I	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	HTLV	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	I	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	induces	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	expression	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	many	_	O	O	_	_	_	_	_
30	cellular	_	O	O	_	_	_	_	_
31	genes	_	O	O	_	_	_	_	_
32	through	_	O	O	_	_	_	_	_
33	interaction	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	at	_	O	O	_	_	_	_	_
36	least	_	O	O	_	_	_	_	_
37	three	_	O	O	_	_	_	_	_
38	distinct	_	O	O	_	_	_	_	_
39	cellular	_	O	O	_	_	_	_	_
40	transcription	_	O	O	_	_	_	_	_
41	factors	_	O	O	_	_	_	_	_
42	;	_	O	O	_	_	_	_	_
43	CREB	_	O	O	_	_	_	_	_
44	/	_	O	O	_	_	_	_	_
45	ATF	_	O	O	_	_	_	_	_
46	,	_	O	O	_	_	_	_	_
47	NF	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	kappaB	_	O	O	_	_	_	_	_
50	,	_	O	O	_	_	_	_	_
51	and	_	O	O	_	_	_	_	_
52	SRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	first	_	O	O	_	_	_	_	_
5	demonstration	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	lithium	_	O	O	_	_	_	_	_
8	can	_	O	O	_	_	_	_	_
9	alter	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	Tcf	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	responsive	_	O	O	_	_	_	_	_
16	genes	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	points	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	difference	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	regulation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	Wnt	_	O	O	_	_	_	_	_
27	signaling	_	O	O	_	_	_	_	_
28	between	_	O	O	_	_	_	_	_
29	fibroblasts	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	lymphocytes	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Glucocorticoids	_	O	O	_	_	_	_	_
2	(	_	O	O	_	_	_	_	_
3	GC	_	O	O	_	_	_	_	_
4	)	_	O	O	_	_	_	_	_
5	have	_	O	O	_	_	_	_	_
6	long	_	O	O	_	_	_	_	_
7	been	_	O	O	_	_	_	_	_
8	used	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	most	_	O	O	_	_	_	_	_
12	effective	_	O	O	_	_	_	_	_
13	agents	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	treatment	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	allergic	_	O	O	_	_	_	_	_
19	diseases	_	O	O	_	_	_	_	_
20	accompanied	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	eosinophilia	_	O	O	_	_	_	_	_
23	such	_	O	O	_	_	_	_	_
24	as	_	O	O	_	_	_	_	_
25	chronic	_	O	O	_	_	_	_	_
26	asthma	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	atopic	_	O	O	_	_	_	_	_
29	dermatitis	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	development	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	chronic	_	O	O	_	_	_	_	_
5	eosinophilic	_	O	O	_	_	_	_	_
6	inflammation	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	dependent	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	)	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	selective	_	O	O	_	_	_	_	_
21	eosinophil	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	activating	_	O	O	_	_	_	_	_
24	factor	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	produced	_	O	O	_	_	_	_	_
27	by	_	O	O	_	_	_	_	_
28	helper	_	O	O	_	_	_	_	_
29	T	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Electrophoretic	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	assay	_	O	O	_	_	_	_	_
5	analysis	_	O	O	_	_	_	_	_
6	suggested	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	AP	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappaB	_	O	O	_	_	_	_	_
15	are	_	O	O	_	_	_	_	_
16	among	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	possible	_	O	O	_	_	_	_	_
19	targets	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	GC	_	O	O	_	_	_	_	_
22	actions	_	O	O	_	_	_	_	_
23	on	_	O	O	_	_	_	_	_
24	TCR	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	stimulated	_	O	O	_	_	_	_	_
27	T	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Forced	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	E	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	F	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	could	_	O	O	_	_	_	_	_
9	induce	_	O	O	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	all	_	O	O	_	_	_	_	_
13	members	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	endogenous	_	O	O	_	_	_	_	_
17	MCM	_	O	O	_	_	_	_	_
18	genes	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	rat	_	O	O	_	_	_	_	_
21	embryonal	_	O	O	_	_	_	_	_
22	fibroblast	_	O	O	_	_	_	_	_
23	REF	_	O	O	_	_	_	_	_
24	52	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	first	_	O	O	_	_	_	_	_
3	product	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	ascorbate	_	O	O	_	_	_	_	_
6	oxidation	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	ascorbate	_	O	O	_	_	_	_	_
10	free	_	O	O	_	_	_	_	_
11	radical	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	AFR	_	O	O	_	_	_	_	_
14	)	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	acts	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	biological	_	O	O	_	_	_	_	_
19	systems	_	O	O	_	_	_	_	_
20	mainly	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	an	_	O	O	_	_	_	_	_
23	oxidant	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	through	_	O	O	_	_	_	_	_
27	its	_	O	O	_	_	_	_	_
28	role	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	plasma	_	O	O	_	_	_	_	_
32	membrane	_	O	O	_	_	_	_	_
33	redox	_	O	O	_	_	_	_	_
34	system	_	O	O	_	_	_	_	_
35	exerts	_	O	O	_	_	_	_	_
36	different	_	O	O	_	_	_	_	_
37	effects	_	O	O	_	_	_	_	_
38	on	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	cell	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Numerous	_	O	O	_	_	_	_	_
2	cellular	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	biochemical	_	O	O	_	_	_	_	_
5	abnormalities	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	immune	_	O	O	_	_	_	_	_
8	regulation	_	O	O	_	_	_	_	_
9	have	_	O	O	_	_	_	_	_
10	been	_	O	O	_	_	_	_	_
11	described	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	patients	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	systemic	_	O	O	_	_	_	_	_
16	lupus	_	O	O	_	_	_	_	_
17	erythematosus	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	SLE	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	including	_	O	O	_	_	_	_	_
23	surface	_	O	O	_	_	_	_	_
24	Ag	_	O	O	_	_	_	_	_
25	receptor	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	initiated	_	O	O	_	_	_	_	_
28	signaling	_	O	O	_	_	_	_	_
29	events	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	lymphokine	_	O	O	_	_	_	_	_
32	production	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	measured	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappa	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	activity	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	nuclear	_	O	O	_	_	_	_	_
12	extracts	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	gel	_	O	O	_	_	_	_	_
15	shift	_	O	O	_	_	_	_	_
16	analysis	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Also	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	NF	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	kappa	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	activity	_	O	O	_	_	_	_	_
8	remained	_	O	O	_	_	_	_	_
9	absent	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	follow	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	up	_	O	O	_	_	_	_	_
14	studies	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Finally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	immunoblot	_	O	O	_	_	_	_	_
4	analysis	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	nuclear	_	O	O	_	_	_	_	_
7	extracts	_	O	O	_	_	_	_	_
8	showed	_	O	O	_	_	_	_	_
9	decreased	_	O	O	_	_	_	_	_
10	or	_	O	O	_	_	_	_	_
11	absent	_	O	O	_	_	_	_	_
12	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	protein	_	O	O	_	_	_	_	_
15	levels	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	inducible	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cell	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	specific	_	O	O	_	_	_	_	_
8	enhancers	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	murine	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	Interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	Il	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	contain	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	kB	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	like	_	O	O	_	_	_	_	_
26	sequence	_	O	O	_	_	_	_	_
27	GGGATTTCACC	_	O	O	_	_	_	_	_
28	as	_	O	O	_	_	_	_	_
29	an	_	O	O	_	_	_	_	_
30	essential	_	O	O	_	_	_	_	_
31	cis	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	acting	_	O	O	_	_	_	_	_
34	enhancer	_	O	O	_	_	_	_	_
35	motif	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	vitro	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cell	_	O	O	_	_	_	_	_
5	differentiation	_	O	O	_	_	_	_	_
6	.	_	O	O	_	_	_	_	_

1	Calcineurin	_	O	O	_	_	_	_	_
2	activates	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	from	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	synergy	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	either	_	O	O	_	_	_	_	_
14	protein	_	O	O	_	_	_	_	_
15	kinase	_	O	O	_	_	_	_	_
16	C	_	O	O	_	_	_	_	_
17	or	_	O	O	_	_	_	_	_
18	NF	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	kappa	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	AP	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	T	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	Both	_	O	O	_	_	_	_	_
2	constitutively	_	O	O	_	_	_	_	_
3	active	_	O	O	_	_	_	_	_
4	forms	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	CN	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	protein	_	O	O	_	_	_	_	_
9	kinase	_	O	O	_	_	_	_	_
10	C	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	PKC	_	O	O	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	synergistically	_	O	O	_	_	_	_	_
15	activated	_	O	O	_	_	_	_	_
16	transcription	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	promoter	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_




1	Click	_	O	O	_	_	_	_	_
2	here	_	O	O	_	_	_	_	_
3	for	_	O	O	_	_	_	_	_
4	additional	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	file	_	O	O	_	_	_	_	_
7	.	_	O	O	_	_	_	_	_



1	Effect	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	on	_	O	O	_	_	_	_	_
7	Already	_	O	O	_	_	_	_	_
8	Existing	_	O	O	_	_	_	_	_
9	Natural	_	O	O	_	_	_	_	_
10	or	_	O	O	_	_	_	_	_
11	Inducible	_	O	O	_	_	_	_	_
12	Treg	_	O	O	_	_	_	_	_
13	Cells	_	O	O	_	_	_	_	_


1	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	espression	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	assessed	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	real	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	time	_	O	O	_	_	_	_	_
10	PCR	_	O	O	_	_	_	_	_
11	analysis	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	resting	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	re	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	stimulated	_	O	O	_	_	_	_	_
21	with	_	O	O	_	_	_	_	_
22	plate	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	bound	_	O	O	_	_	_	_	_
25	anti	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	/	_	O	O	_	_	_	_	_
30	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	with	_	O	O	_	_	_	_	_
34	or	_	O	O	_	_	_	_	_
35	without	_	O	O	_	_	_	_	_
36	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	plus	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	during	_	O	O	_	_	_	_	_
45	3	_	O	O	_	_	_	_	_
46	d	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	in	_	O	O	_	_	_	_	_
49	the	_	O	O	_	_	_	_	_
50	presence	_	O	O	_	_	_	_	_
51	(	_	O	O	_	_	_	_	_
52	black	_	O	O	_	_	_	_	_
53	bar	_	O	O	_	_	_	_	_
54	)	_	O	O	_	_	_	_	_
55	or	_	O	O	_	_	_	_	_
56	absence	_	O	O	_	_	_	_	_
57	(	_	O	O	_	_	_	_	_
58	white	_	O	O	_	_	_	_	_
59	bar	_	O	O	_	_	_	_	_
60	)	_	O	O	_	_	_	_	_
61	of	_	O	O	_	_	_	_	_
62	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
63	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
64	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
65	(	_	O	O	_	_	_	_	_
66	100	_	O	O	_	_	_	_	_
67	ng	_	O	O	_	_	_	_	_
68	/	_	O	O	_	_	_	_	_
69	ml	_	O	O	_	_	_	_	_
70	)	_	O	O	_	_	_	_	_
71	.	_	O	O	_	_	_	_	_

1	Addition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	rIL	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	2	_	O	O	_	_	_	_	_
6	fully	_	O	O	_	_	_	_	_
7	restored	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	proliferative	_	O	O	_	_	_	_	_
10	response	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	partially	_	O	O	_	_	_	_	_
13	restored	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	production	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	but	_	O	O	_	_	_	_	_
26	not	_	O	O	_	_	_	_	_
27	that	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	other	_	O	O	_	_	_	_	_
30	cytokines	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	+	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	stimulated	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	PMA	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	ionomycin	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	2	_	O	O	_	_	_	_	_
14	h	_	O	O	_	_	_	_	_
15	at	_	O	O	_	_	_	_	_
16	37	_	O	O	_	_	_	_	_
17	degreesC	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	alveolar	_	O	O	_	_	_	_	_
3	macrophages	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	markedly	_	O	O	_	_	_	_	_
6	deficient	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	REF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	AP	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	DNA	_	O	O	_	_	_	_	_
16	binding	_	O	O	_	_	_	_	_
17	activity	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	1998	_	O	O	_	_	_	_	_
3	)	_	O	O	_	_	_	_	_
4	Am	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	why	_	O	O	_	_	_	_	_
4	alveolar	_	O	O	_	_	_	_	_
5	macrophages	_	O	O	_	_	_	_	_
6	do	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	express	_	O	O	_	_	_	_	_
9	AP	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	we	_	O	O	_	_	_	_	_
17	first	_	O	O	_	_	_	_	_
18	showed	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	there	_	O	O	_	_	_	_	_
21	was	_	O	O	_	_	_	_	_
22	not	_	O	O	_	_	_	_	_
23	a	_	O	O	_	_	_	_	_
24	decrease	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	expression	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	FOS	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	JUN	_	O	O	_	_	_	_	_
32	proteins	_	O	O	_	_	_	_	_
33	that	_	O	O	_	_	_	_	_
34	make	_	O	O	_	_	_	_	_
35	up	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	AP	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	complex	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	vitro	_	O	O	_	_	_	_	_
6	differentiation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	monocytes	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	macrophage	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	like	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	resulted	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	decreased	_	O	O	_	_	_	_	_
18	amounts	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	REF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	MZF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	activates	_	O	O	_	_	_	_	_
8	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	reporter	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	hematopoietic	_	O	O	_	_	_	_	_
15	cell	_	O	O	_	_	_	_	_
16	lines	_	O	O	_	_	_	_	_
17	K	_	O	O	_	_	_	_	_
18	562	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	Jurkat	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	therefore	_	O	O	_	_	_	_	_
3	compared	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	turnover	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	mature	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	HeLa	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	proteins	_	O	O	_	_	_	_	_
3	display	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	high	_	O	O	_	_	_	_	_
6	turnover	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	although	_	O	O	_	_	_	_	_
11	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	considerably	_	O	O	_	_	_	_	_
17	more	_	O	O	_	_	_	_	_
18	stable	_	O	O	_	_	_	_	_
19	than	_	O	O	_	_	_	_	_
20	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	investigated	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	processes	_	O	O	_	_	_	_	_
7	involved	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	persistent	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappa	_	O	O	_	_	_	_	_
15	B	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	failed	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	markedly	_	O	O	_	_	_	_	_
8	affect	_	O	O	_	_	_	_	_
9	transcriptional	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	Gal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	BD	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	c	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	has	_	O	O	_	_	_	_	_
25	also	_	O	O	_	_	_	_	_
26	been	_	O	O	_	_	_	_	_
27	demonstrated	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	bind	_	O	O	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	HTLV	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	I	_	O	O	_	_	_	_	_
35	LTR	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	Gal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	BD	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	Tax	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	(	_	O	O	_	_	_	_	_
45	see	_	O	O	_	_	_	_	_
46	Figure	_	O	O	_	_	_	_	_
47	5	_	O	O	_	_	_	_	_
48	)	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_


1	Regulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	cell	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	type	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	specific	_	O	O	_	_	_	_	_
8	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	chain	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	gene	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	:	_	O	O	_	_	_	_	_
18	potential	_	O	O	_	_	_	_	_
19	role	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	physical	_	O	O	_	_	_	_	_
22	interactions	_	O	O	_	_	_	_	_
23	between	_	O	O	_	_	_	_	_
24	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	HMG	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	I	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	Y	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	NF	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	kappa	_	O	O	_	_	_	_	_
39	B	_	O	O	_	_	_	_	_
40	family	_	O	O	_	_	_	_	_
41	proteins	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	provide	_	O	O	_	_	_	_	_
4	significant	_	O	O	_	_	_	_	_
5	new	_	O	O	_	_	_	_	_
6	insights	_	O	O	_	_	_	_	_
7	into	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	protein	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	protein	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	DNA	_	O	O	_	_	_	_	_
16	interactions	_	O	O	_	_	_	_	_
17	that	_	O	O	_	_	_	_	_
18	regulate	_	O	O	_	_	_	_	_
19	cell	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	type	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	specific	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	inducible	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	gene	_	O	O	_	_	_	_	_
32	expression	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	also	_	O	O	_	_	_	_	_
35	have	_	O	O	_	_	_	_	_
36	implications	_	O	O	_	_	_	_	_
37	for	_	O	O	_	_	_	_	_
38	other	_	O	O	_	_	_	_	_
39	genes	_	O	O	_	_	_	_	_
40	regulated	_	O	O	_	_	_	_	_
41	by	_	O	O	_	_	_	_	_
42	Elf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	and	_	O	O	_	_	_	_	_
46	NF	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	kappa	_	O	O	_	_	_	_	_
49	B	_	O	O	_	_	_	_	_
50	family	_	O	O	_	_	_	_	_
51	proteins	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	DNA	_	O	O	_	_	_	_	_
2	(	_	O	O	_	_	_	_	_
3	0	_	O	O	_	_	_	_	_
4	.	_	O	O	_	_	_	_	_
5	8	_	O	O	_	_	_	_	_
6	microg	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	was	_	O	O	_	_	_	_	_
9	digested	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	40	_	O	O	_	_	_	_	_
12	U	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	respective	_	O	O	_	_	_	_	_
15	enzyme	_	O	O	_	_	_	_	_
16	for	_	O	O	_	_	_	_	_
17	6	_	O	O	_	_	_	_	_
18	h	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	ensure	_	O	O	_	_	_	_	_
23	complete	_	O	O	_	_	_	_	_
24	cleavage	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	additional	_	O	O	_	_	_	_	_
27	20	_	O	O	_	_	_	_	_
28	U	_	O	O	_	_	_	_	_
29	for	_	O	O	_	_	_	_	_
30	16	_	O	O	_	_	_	_	_
31	h	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	When	_	O	O	_	_	_	_	_
2	DNA	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	methylated	_	O	O	_	_	_	_	_
5	at	_	O	O	_	_	_	_	_
6	specific	_	O	O	_	_	_	_	_
7	sites	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	sensitive	_	O	O	_	_	_	_	_
11	enzymes	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	not	_	O	O	_	_	_	_	_
14	able	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	digest	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	DNA	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	amplification	_	O	O	_	_	_	_	_
21	took	_	O	O	_	_	_	_	_
22	place	_	O	O	_	_	_	_	_
23	;	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	case	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	no	_	O	O	_	_	_	_	_
28	methylation	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	DNA	_	O	O	_	_	_	_	_
31	was	_	O	O	_	_	_	_	_
32	digested	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	no	_	O	O	_	_	_	_	_
35	product	_	O	O	_	_	_	_	_
36	was	_	O	O	_	_	_	_	_
37	generated	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	clinical	_	O	O	_	_	_	_	_
3	benefits	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	salicylates	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	treatment	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	several	_	O	O	_	_	_	_	_
11	diseases	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	including	_	O	O	_	_	_	_	_
14	atherosclerosis	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	rheumatoid	_	O	O	_	_	_	_	_
17	arthritis	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	may	_	O	O	_	_	_	_	_
20	be	_	O	O	_	_	_	_	_
21	related	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	their	_	O	O	_	_	_	_	_
24	ability	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	reduce	_	O	O	_	_	_	_	_
27	monocyte	_	O	O	_	_	_	_	_
28	gene	_	O	O	_	_	_	_	_
29	expression	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_


1	tuberculosis	_	O	O	_	_	_	_	_
2	infection	_	O	O	_	_	_	_	_
3	may	_	O	O	_	_	_	_	_
4	play	_	O	O	_	_	_	_	_
5	an	_	O	O	_	_	_	_	_
6	important	_	O	O	_	_	_	_	_
7	immunomodulatory	_	O	O	_	_	_	_	_
8	role	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	host	_	O	O	_	_	_	_	_
12	response	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_



1	We	_	O	O	_	_	_	_	_
2	report	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	structure	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	regulation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	gene	_	O	O	_	_	_	_	_
10	represented	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	clone	_	O	O	_	_	_	_	_
13	pAT	_	O	O	_	_	_	_	_
14	133	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	which	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	upon	_	O	O	_	_	_	_	_
20	transition	_	O	O	_	_	_	_	_
21	from	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	resting	_	O	O	_	_	_	_	_
24	state	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	G	_	O	O	_	_	_	_	_
27	0	_	O	O	_	_	_	_	_
28	)	_	O	O	_	_	_	_	_
29	through	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	early	_	O	O	_	_	_	_	_
32	phase	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	cell	_	O	O	_	_	_	_	_
36	cycle	_	O	O	_	_	_	_	_
37	(	_	O	O	_	_	_	_	_
38	G	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	histiocytic	_	O	O	_	_	_	_	_
4	U	_	O	O	_	_	_	_	_
5	937	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	mRNA	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	clone	_	O	O	_	_	_	_	_
10	pAT	_	O	O	_	_	_	_	_
11	133	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	constitutively	_	O	O	_	_	_	_	_
14	expressed	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	whereas	_	O	O	_	_	_	_	_
17	mRNA	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	pAT	_	O	O	_	_	_	_	_
20	225	_	O	O	_	_	_	_	_
21	/	_	O	O	_	_	_	_	_
22	EGR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	was	_	O	O	_	_	_	_	_
25	induced	_	O	O	_	_	_	_	_
26	upon	_	O	O	_	_	_	_	_
27	induction	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	terminal	_	O	O	_	_	_	_	_
30	differentiation	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	After	_	O	O	_	_	_	_	_
2	5	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	day	_	O	O	_	_	_	_	_
5	anti	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	CD	_	O	O	_	_	_	_	_
8	3	_	O	O	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	levels	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	56	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	lck	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	59	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	fyn	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	protein	_	O	O	_	_	_	_	_
26	tyrosine	_	O	O	_	_	_	_	_
27	kinase	_	O	O	_	_	_	_	_
28	activity	_	O	O	_	_	_	_	_
29	increased	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Stimulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	antigen	_	O	O	_	_	_	_	_
7	results	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	activation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	several	_	O	O	_	_	_	_	_
12	kinases	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	including	_	O	O	_	_	_	_	_
15	protein	_	O	O	_	_	_	_	_
16	kinase	_	O	O	_	_	_	_	_
17	C	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	PKC	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	may	_	O	O	_	_	_	_	_
24	mediate	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	later	_	O	O	_	_	_	_	_
27	induction	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	activation	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	related	_	O	O	_	_	_	_	_
32	genes	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	show	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	phorbol	_	O	O	_	_	_	_	_
6	ester	_	O	O	_	_	_	_	_
7	treatment	_	O	O	_	_	_	_	_
8	also	_	O	O	_	_	_	_	_
9	abolishes	_	O	O	_	_	_	_	_
10	induction	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	chloramphenicol	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	acetyltransferase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	Ar	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	5	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	transfected	_	O	O	_	_	_	_	_
21	with	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	plasmid	_	O	O	_	_	_	_	_
24	containing	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	linked	_	O	O	_	_	_	_	_
31	to	_	O	O	_	_	_	_	_
32	this	_	O	O	_	_	_	_	_
33	reporter	_	O	O	_	_	_	_	_
34	gene	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	29	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	controlled	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	complex	_	O	O	_	_	_	_	_
14	interplay	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	positive	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	negative	_	O	O	_	_	_	_	_
19	regulatory	_	O	O	_	_	_	_	_
20	elements	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	activates	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	targeting	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	inhibitory	_	O	O	_	_	_	_	_
13	molecule	_	O	O	_	_	_	_	_
14	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	increased	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	NF	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	kappa	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	dependent	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	genes	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	including	_	O	O	_	_	_	_	_
17	those	_	O	O	_	_	_	_	_
18	encoding	_	O	O	_	_	_	_	_
19	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	activates	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	lines	_	O	O	_	_	_	_	_
18	by	_	O	O	_	_	_	_	_
19	targeting	_	O	O	_	_	_	_	_
20	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_


1	Members	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	protein	_	O	O	_	_	_	_	_
5	family	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	characterized	_	O	O	_	_	_	_	_
8	by	_	O	O	_	_	_	_	_
9	three	_	O	O	_	_	_	_	_
10	zinc	_	O	O	_	_	_	_	_
11	fingers	_	O	O	_	_	_	_	_
12	highly	_	O	O	_	_	_	_	_
13	homologous	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	those	_	O	O	_	_	_	_	_
16	found	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	interact	_	O	O	_	_	_	_	_
24	with	_	O	O	_	_	_	_	_
25	these	_	O	O	_	_	_	_	_
26	motifs	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Testing	_	O	O	_	_	_	_	_
2	their	_	O	O	_	_	_	_	_
3	activity	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	transgenic	_	O	O	_	_	_	_	_
6	mice	_	O	O	_	_	_	_	_
7	shows	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	EKLF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	direct	_	O	O	_	_	_	_	_
13	activator	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	5	_	O	O	_	_	_	_	_
16	'	_	O	O	_	_	_	_	_
17	HS	_	O	O	_	_	_	_	_
18	3	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	those	_	O	O	_	_	_	_	_
3	experiments	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	concentrations	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	used	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	low	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	as	_	O	O	_	_	_	_	_
17	we	_	O	O	_	_	_	_	_
18	also	_	O	O	_	_	_	_	_
19	observed	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	at	_	O	O	_	_	_	_	_
25	low	_	O	O	_	_	_	_	_
26	concentration	_	O	O	_	_	_	_	_
27	slightly	_	O	O	_	_	_	_	_
28	enhanced	_	O	O	_	_	_	_	_
29	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	expression	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	it	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	shown	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	ChIP	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	binds	_	O	O	_	_	_	_	_
12	this	_	O	O	_	_	_	_	_
13	element	_	O	O	_	_	_	_	_
14	also	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	intact	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	known	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	can	_	O	O	_	_	_	_	_
8	induce	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	chromatin	_	O	O	_	_	_	_	_
12	remodeling	_	O	O	_	_	_	_	_
13	[	_	O	O	_	_	_	_	_
14	56	_	O	O	_	_	_	_	_
15	]	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	directly	_	O	O	_	_	_	_	_
19	transactivating	_	O	O	_	_	_	_	_
20	promoters	_	O	O	_	_	_	_	_
21	[	_	O	O	_	_	_	_	_
22	36	_	O	O	_	_	_	_	_
23	]	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	or	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	as	_	O	O	_	_	_	_	_
28	shown	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	current	_	O	O	_	_	_	_	_
32	study	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	acts	_	O	O	_	_	_	_	_
35	as	_	O	O	_	_	_	_	_
36	a	_	O	O	_	_	_	_	_
37	repressor	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	gene	_	O	O	_	_	_	_	_
40	expression	_	O	O	_	_	_	_	_
41	[	_	O	O	_	_	_	_	_
42	21	_	O	O	_	_	_	_	_
43	,	_	O	O	_	_	_	_	_
44	57	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	59	_	O	O	_	_	_	_	_
47	]	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	Protease	_	O	O	_	_	_	_	_
2	treatment	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	nuclear	_	O	O	_	_	_	_	_
5	extracts	_	O	O	_	_	_	_	_
6	distinguishes	_	O	O	_	_	_	_	_
7	between	_	O	O	_	_	_	_	_
8	class	_	O	O	_	_	_	_	_
9	II	_	O	O	_	_	_	_	_
10	MHC	_	O	O	_	_	_	_	_
11	X	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	box	_	O	O	_	_	_	_	_
14	DNA	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	binding	_	O	O	_	_	_	_	_
17	proteins	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	wild	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	type	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	class	_	O	O	_	_	_	_	_
24	II	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	deficient	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	different	_	O	O	_	_	_	_	_
6	X	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	box	_	O	O	_	_	_	_	_
9	activities	_	O	O	_	_	_	_	_
10	represented	_	O	O	_	_	_	_	_
11	distinct	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	binding	_	O	O	_	_	_	_	_
14	proteins	_	O	O	_	_	_	_	_
15	or	_	O	O	_	_	_	_	_
16	multimeric	_	O	O	_	_	_	_	_
17	forms	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	same	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	s	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	protease	_	O	O	_	_	_	_	_
27	treatment	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	crude	_	O	O	_	_	_	_	_
31	nuclear	_	O	O	_	_	_	_	_
32	extracts	_	O	O	_	_	_	_	_
33	followed	_	O	O	_	_	_	_	_
34	by	_	O	O	_	_	_	_	_
35	DNA	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	binding	_	O	O	_	_	_	_	_
38	assays	_	O	O	_	_	_	_	_
39	were	_	O	O	_	_	_	_	_
40	carried	_	O	O	_	_	_	_	_
41	out	_	O	O	_	_	_	_	_
42	and	_	O	O	_	_	_	_	_
43	demonstrated	_	O	O	_	_	_	_	_
44	that	_	O	O	_	_	_	_	_
45	B	_	O	O	_	_	_	_	_
46	cell	_	O	O	_	_	_	_	_
47	extracts	_	O	O	_	_	_	_	_
48	contain	_	O	O	_	_	_	_	_
49	at	_	O	O	_	_	_	_	_
50	least	_	O	O	_	_	_	_	_
51	two	_	O	O	_	_	_	_	_
52	X	_	O	O	_	_	_	_	_
53	1	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	specific	_	O	O	_	_	_	_	_
56	factors	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_

1	Proteins	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	ATF	_	O	O	_	_	_	_	_
5	/	_	O	O	_	_	_	_	_
6	CREB	_	O	O	_	_	_	_	_
7	class	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	transcription	_	O	O	_	_	_	_	_
10	factors	_	O	O	_	_	_	_	_
11	stimulate	_	O	O	_	_	_	_	_
12	gene	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	several	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	growth	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	related	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	through	_	O	O	_	_	_	_	_
22	protein	_	O	O	_	_	_	_	_
23	kinase	_	O	O	_	_	_	_	_
24	A	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	related	_	O	O	_	_	_	_	_
27	cAMP	_	O	O	_	_	_	_	_
28	response	_	O	O	_	_	_	_	_
29	elements	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Primers	_	O	O	_	_	_	_	_
2	used	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	Vkappacon	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	Jkappa	_	O	O	_	_	_	_	_
7	5	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	degrees	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	have	_	O	O	_	_	_	_	_
13	been	_	O	O	_	_	_	_	_
14	described	_	O	O	_	_	_	_	_
15	previously	_	O	O	_	_	_	_	_
16	[	_	O	O	_	_	_	_	_
17	74	_	O	O	_	_	_	_	_
18	]	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	PCR	_	O	O	_	_	_	_	_
2	conditions	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	94	_	O	O	_	_	_	_	_
5	degreesC	_	O	O	_	_	_	_	_
6	for	_	O	O	_	_	_	_	_
7	2	_	O	O	_	_	_	_	_
8	min	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	40	_	O	O	_	_	_	_	_
11	cycles	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	94	_	O	O	_	_	_	_	_
14	degreesC	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	30	_	O	O	_	_	_	_	_
17	s	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	63	_	O	O	_	_	_	_	_
20	degreesC	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	90	_	O	O	_	_	_	_	_
23	s	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	72	_	O	O	_	_	_	_	_
27	degreesC	_	O	O	_	_	_	_	_
28	for	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	min	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	followed	_	O	O	_	_	_	_	_
33	by	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	cycle	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	72	_	O	O	_	_	_	_	_
38	degreesC	_	O	O	_	_	_	_	_
39	for	_	O	O	_	_	_	_	_
40	5	_	O	O	_	_	_	_	_
41	min	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_


1	Determination	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	cell	_	O	O	_	_	_	_	_
4	death	_	O	O	_	_	_	_	_

1	At	_	O	O	_	_	_	_	_
2	least	_	O	O	_	_	_	_	_
3	1	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	000	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	per	_	O	O	_	_	_	_	_
8	sample	_	O	O	_	_	_	_	_
9	were	_	O	O	_	_	_	_	_
10	run	_	O	O	_	_	_	_	_
11	on	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	BD	_	O	O	_	_	_	_	_
14	FACSCalibur	_	O	O	_	_	_	_	_
15	flow	_	O	O	_	_	_	_	_
16	cytometer	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	results	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	cascade	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	subsequent	_	O	O	_	_	_	_	_
14	proliferation	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	differentiation	_	O	O	_	_	_	_	_
17	into	_	O	O	_	_	_	_	_
18	effector	_	O	O	_	_	_	_	_
19	phenotypes	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_


1	(	_	O	O	_	_	_	_	_
2	ABSTRACT	_	O	O	_	_	_	_	_
3	TRUNCATED	_	O	O	_	_	_	_	_
4	AT	_	O	O	_	_	_	_	_
5	400	_	O	O	_	_	_	_	_
6	WORDS	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_

1	From	_	O	O	_	_	_	_	_
2	nuclear	_	O	O	_	_	_	_	_
3	runoff	_	O	O	_	_	_	_	_
4	experiments	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	we	_	O	O	_	_	_	_	_
7	found	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	one	_	O	O	_	_	_	_	_
10	subunit	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	particular	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	isoform	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	Mr	_	O	O	_	_	_	_	_
20	=	_	O	O	_	_	_	_	_
21	56	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	000	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	was	_	O	O	_	_	_	_	_
27	amplified	_	O	O	_	_	_	_	_
28	primarily	_	O	O	_	_	_	_	_
29	by	_	O	O	_	_	_	_	_
30	transcriptional	_	O	O	_	_	_	_	_
31	means	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	transfected	_	O	O	_	_	_	_	_
3	promoter	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	luciferase	_	O	O	_	_	_	_	_
6	reporter	_	O	O	_	_	_	_	_
7	plasmids	_	O	O	_	_	_	_	_
8	into	_	O	O	_	_	_	_	_
9	THP	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	1	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	define	_	O	O	_	_	_	_	_
15	sequences	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	mediate	_	O	O	_	_	_	_	_
18	transcriptional	_	O	O	_	_	_	_	_
19	control	_	O	O	_	_	_	_	_
20	during	_	O	O	_	_	_	_	_
21	monocyte	_	O	O	_	_	_	_	_
22	differentiation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	found	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	sequences	_	O	O	_	_	_	_	_
5	downstream	_	O	O	_	_	_	_	_
6	from	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	transcriptional	_	O	O	_	_	_	_	_
9	start	_	O	O	_	_	_	_	_
10	site	_	O	O	_	_	_	_	_
11	were	_	O	O	_	_	_	_	_
12	sufficient	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	confer	_	O	O	_	_	_	_	_
15	increased	_	O	O	_	_	_	_	_
16	expression	_	O	O	_	_	_	_	_
17	during	_	O	O	_	_	_	_	_
18	THP	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	differentiation	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	upregulation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	kappa	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	binding	_	O	O	_	_	_	_	_
11	activity	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	regulated	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	triggering	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	selected	_	O	O	_	_	_	_	_
19	epitopes	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	HLA	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	DR	_	O	O	_	_	_	_	_
24	antigens	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	vitro	_	O	O	_	_	_	_	_
3	studies	_	O	O	_	_	_	_	_
4	on	_	O	O	_	_	_	_	_
5	hematopoietic	_	O	O	_	_	_	_	_
6	control	_	O	O	_	_	_	_	_
7	mechanisms	_	O	O	_	_	_	_	_
8	have	_	O	O	_	_	_	_	_
9	been	_	O	O	_	_	_	_	_
10	hampered	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	heterogeneity	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	analyzed	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	populations	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	ie	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	lack	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	lineage	_	O	O	_	_	_	_	_
25	specificity	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	developmental	_	O	O	_	_	_	_	_
28	stage	_	O	O	_	_	_	_	_
29	homogeneity	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	progenitor	_	O	O	_	_	_	_	_
32	/	_	O	O	_	_	_	_	_
33	precursor	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	growing	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	culture	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	early	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	intermediate	_	O	O	_	_	_	_	_
5	stages	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	erythroid	_	O	O	_	_	_	_	_
8	differentiation	_	O	O	_	_	_	_	_
9	we	_	O	O	_	_	_	_	_
10	monitored	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	induction	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	36	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	Tal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	EKLF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	NF	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	E	_	O	O	_	_	_	_	_
25	2	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	that	_	O	O	_	_	_	_	_
32	preceeded	_	O	O	_	_	_	_	_
33	expression	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	EpoR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	cloned	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	mouse	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	GATA	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	1	_	O	O	_	_	_	_	_
11	genes	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	region	_	O	O	_	_	_	_	_
3	upstream	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	first	_	O	O	_	_	_	_	_
7	exon	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	highly	_	O	O	_	_	_	_	_
11	conserved	_	O	O	_	_	_	_	_
12	between	_	O	O	_	_	_	_	_
13	mouse	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	man	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	acts	_	O	O	_	_	_	_	_
18	as	_	O	O	_	_	_	_	_
19	an	_	O	O	_	_	_	_	_
20	erythroid	_	O	O	_	_	_	_	_
21	specific	_	O	O	_	_	_	_	_
22	enhancer	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	transient	_	O	O	_	_	_	_	_
25	assays	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	if	_	O	O	_	_	_	_	_
28	linked	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	or	_	O	O	_	_	_	_	_
35	to	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	SV	_	O	O	_	_	_	_	_
38	40	_	O	O	_	_	_	_	_
39	promoter	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_


1	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Antagonizes	_	O	O	_	_	_	_	_
4	CREB	_	O	O	_	_	_	_	_
5	Transcriptional	_	O	O	_	_	_	_	_
6	Activation	_	O	O	_	_	_	_	_
7	by	_	O	O	_	_	_	_	_
8	Disrupting	_	O	O	_	_	_	_	_
9	Coactivator	_	O	O	_	_	_	_	_
10	Recruitment	_	O	O	_	_	_	_	_


1	Concanavalin	_	O	O	_	_	_	_	_
2	A	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	activated	_	O	O	_	_	_	_	_
5	cycling	_	O	O	_	_	_	_	_
6	T	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	blasts	_	O	O	_	_	_	_	_
9	from	_	O	O	_	_	_	_	_
10	mice	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	are	_	O	O	_	_	_	_	_
13	transgenic	_	O	O	_	_	_	_	_
14	for	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	dominant	_	O	O	_	_	_	_	_
17	IkappaB	_	O	O	_	_	_	_	_
18	molecule	_	O	O	_	_	_	_	_
19	have	_	O	O	_	_	_	_	_
20	increased	_	O	O	_	_	_	_	_
21	sensitivity	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	Fas	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	mediated	_	O	O	_	_	_	_	_
26	apoptosis	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	associated	_	O	O	_	_	_	_	_
29	with	_	O	O	_	_	_	_	_
30	a	_	O	O	_	_	_	_	_
31	down	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	regulation	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	NF	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	kappaB	_	O	O	_	_	_	_	_
38	complexes	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	nucleus	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	immunodeficiency	_	O	O	_	_	_	_	_
3	virus	_	O	O	_	_	_	_	_
4	type	_	O	O	_	_	_	_	_
5	1	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	HIV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	HIV	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	2	_	O	O	_	_	_	_	_
15	are	_	O	O	_	_	_	_	_
16	structurally	_	O	O	_	_	_	_	_
17	related	_	O	O	_	_	_	_	_
18	retroviruses	_	O	O	_	_	_	_	_
19	which	_	O	O	_	_	_	_	_
20	both	_	O	O	_	_	_	_	_
21	cause	_	O	O	_	_	_	_	_
22	AIDS	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	humans	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	analysed	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	effect	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	mitogenic	_	O	O	_	_	_	_	_
8	lectins	_	O	O	_	_	_	_	_
9	on	_	O	O	_	_	_	_	_
10	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	protein	_	O	O	_	_	_	_	_
18	levels	_	O	O	_	_	_	_	_
19	as	_	O	O	_	_	_	_	_
20	well	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	on	_	O	O	_	_	_	_	_
23	activator	_	O	O	_	_	_	_	_
24	protein	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	1	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	AP	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	binding	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	enhancer	_	O	O	_	_	_	_	_
35	activity	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	Jurkat	_	O	O	_	_	_	_	_
38	T	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	cells	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	THP	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	1	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	Fc	_	O	O	_	_	_	_	_
8	gamma	_	O	O	_	_	_	_	_
9	R	_	O	O	_	_	_	_	_
10	cross	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	linking	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	which	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	known	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	bind	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	regulatory	_	O	O	_	_	_	_	_
27	region	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	long	_	O	O	_	_	_	_	_
31	terminal	_	O	O	_	_	_	_	_
32	repeat	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	LTR	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	HIV	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	1	_	O	O	_	_	_	_	_
40	and	_	O	O	_	_	_	_	_
41	to	_	O	O	_	_	_	_	_
42	activate	_	O	O	_	_	_	_	_
43	HIV	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	1	_	O	O	_	_	_	_	_
46	transcription	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappa	_	O	O	_	_	_	_	_
4	B	_	O	O	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	stably	_	O	O	_	_	_	_	_
10	expressing	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	human	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	lymphotropic	_	O	O	_	_	_	_	_
19	virus	_	O	O	_	_	_	_	_
20	type	_	O	O	_	_	_	_	_
21	I	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Nonetheless	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	both	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	endogenous	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	transfected	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	was	_	O	O	_	_	_	_	_
12	inducible	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	PMA	_	O	O	_	_	_	_	_
15	treatment	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	individual	_	O	O	_	_	_	_	_
4	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	+	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	results	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	differential	_	O	O	_	_	_	_	_
12	lymphokine	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	:	_	O	O	_	_	_	_	_
15	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	is	_	O	O	_	_	_	_	_
23	preferentially	_	O	O	_	_	_	_	_
24	produced	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	T	_	O	O	_	_	_	_	_
27	helper	_	O	O	_	_	_	_	_
28	type	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	TH	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	which	_	O	O	_	_	_	_	_
37	are	_	O	O	_	_	_	_	_
38	involved	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	cell	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	mediated	_	O	O	_	_	_	_	_
43	immune	_	O	O	_	_	_	_	_
44	responses	_	O	O	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	whereas	_	O	O	_	_	_	_	_
47	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
48	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
50	is	_	O	O	_	_	_	_	_
51	synthesized	_	O	O	_	_	_	_	_
52	by	_	O	O	_	_	_	_	_
53	TH	_	O	O	_	_	_	_	_
54	2	_	O	O	_	_	_	_	_
55	cells	_	O	O	_	_	_	_	_
56	,	_	O	O	_	_	_	_	_
57	which	_	O	O	_	_	_	_	_
58	are	_	O	O	_	_	_	_	_
59	essential	_	O	O	_	_	_	_	_
60	for	_	O	O	_	_	_	_	_
61	humoral	_	O	O	_	_	_	_	_
62	immunity	_	O	O	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	compared	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	VD	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	their	_	O	O	_	_	_	_	_
8	antiproliferative	_	O	O	_	_	_	_	_
9	effect	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	up	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	30	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	fold	_	O	O	_	_	_	_	_
16	higher	_	O	O	_	_	_	_	_
17	on	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	peripheral	_	O	O	_	_	_	_	_
20	blood	_	O	O	_	_	_	_	_
21	mononuclear	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	even	_	O	O	_	_	_	_	_
25	up	_	O	O	_	_	_	_	_
26	to	_	O	O	_	_	_	_	_
27	300	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	fold	_	O	O	_	_	_	_	_
30	higher	_	O	O	_	_	_	_	_
31	on	_	O	O	_	_	_	_	_
32	human	_	O	O	_	_	_	_	_
33	breast	_	O	O	_	_	_	_	_
34	cancer	_	O	O	_	_	_	_	_
35	MCF	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	7	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	95	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	vav	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	TCR	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	mediated	_	O	O	_	_	_	_	_
11	signaling	_	O	O	_	_	_	_	_
12	processes	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	unclear	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	factors	_	O	O	_	_	_	_	_
5	bound	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	novel	_	O	O	_	_	_	_	_
9	dyad	_	O	O	_	_	_	_	_
10	symmetrical	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	method	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	based	_	O	O	_	_	_	_	_
5	on	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	coamplification	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	VDR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	cDNA	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	an	_	O	O	_	_	_	_	_
13	internal	_	O	O	_	_	_	_	_
14	standard	_	O	O	_	_	_	_	_
15	consisting	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	known	_	O	O	_	_	_	_	_
18	concentrations	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	VDR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	CDNA	_	O	O	_	_	_	_	_
24	mutated	_	O	O	_	_	_	_	_
25	at	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	BglII	_	O	O	_	_	_	_	_
28	restriction	_	O	O	_	_	_	_	_
29	site	_	O	O	_	_	_	_	_
30	;	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	interassay	_	O	O	_	_	_	_	_
33	coefficient	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	variation	_	O	O	_	_	_	_	_
36	is	_	O	O	_	_	_	_	_
37	11	_	O	O	_	_	_	_	_
38	%.	_	O	O	_	_	_	_	_

1	Transcription	_	O	O	_	_	_	_	_
2	factor	_	O	O	_	_	_	_	_
3	binding	_	O	O	_	_	_	_	_
4	sites	_	O	O	_	_	_	_	_
5	downstream	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	human	_	O	O	_	_	_	_	_
9	immunodeficiency	_	O	O	_	_	_	_	_
10	virus	_	O	O	_	_	_	_	_
11	type	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	start	_	O	O	_	_	_	_	_
15	site	_	O	O	_	_	_	_	_
16	are	_	O	O	_	_	_	_	_
17	important	_	O	O	_	_	_	_	_
18	for	_	O	O	_	_	_	_	_
19	virus	_	O	O	_	_	_	_	_
20	infectivity	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	mobility	_	O	O	_	_	_	_	_
3	shift	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	sequence	_	O	O	_	_	_	_	_
6	specificity	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	AT	_	O	O	_	_	_	_	_
11	were	_	O	O	_	_	_	_	_
12	similar	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	those	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	P	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	only	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	small	_	O	O	_	_	_	_	_
24	amount	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	P	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	was	_	O	O	_	_	_	_	_
29	detected	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	NF	_	O	O	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	P	_	O	O	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	crude	_	O	O	_	_	_	_	_
37	nuclear	_	O	O	_	_	_	_	_
38	extracts	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	component	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	s	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	NF	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	AT	_	O	O	_	_	_	_	_
14	has	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	potential	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	reconstitute	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	P	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	whereas	_	O	O	_	_	_	_	_
24	NF	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	kappa	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	alone	_	O	O	_	_	_	_	_
29	cannot	_	O	O	_	_	_	_	_
30	account	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	P	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	crude	_	O	O	_	_	_	_	_
38	extracts	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Unlike	_	O	O	_	_	_	_	_
2	NF	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	AT	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	NF	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	P	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	does	_	O	O	_	_	_	_	_
11	not	_	O	O	_	_	_	_	_
12	contain	_	O	O	_	_	_	_	_
13	AP	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	as	_	O	O	_	_	_	_	_
16	its	_	O	O	_	_	_	_	_
17	DNA	_	O	O	_	_	_	_	_
18	binding	_	O	O	_	_	_	_	_
19	component	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	TINUR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	belongs	_	O	O	_	_	_	_	_
3	to	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	NGFI	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	/	_	O	O	_	_	_	_	_
9	nur	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	77	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	family	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	steroid	_	O	O	_	_	_	_	_
15	receptor	_	O	O	_	_	_	_	_
16	superfamily	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	an	_	O	O	_	_	_	_	_
20	orphan	_	O	O	_	_	_	_	_
21	receptor	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	expressed	_	O	O	_	_	_	_	_
5	p	_	O	O	_	_	_	_	_
6	40	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	35	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	mRNA	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	phorbol	_	O	O	_	_	_	_	_
14	myristate	_	O	O	_	_	_	_	_
15	acetate	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	PMA	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	stimulation	_	O	O	_	_	_	_	_
20	strongly	_	O	O	_	_	_	_	_
21	enhanced	_	O	O	_	_	_	_	_
22	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	p	_	O	O	_	_	_	_	_
26	70	_	O	O	_	_	_	_	_
27	production	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	eukaryotic	_	O	O	_	_	_	_	_
3	transcription	_	O	O	_	_	_	_	_
4	factor	_	O	O	_	_	_	_	_
5	NF	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	involved	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	inducible	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	various	_	O	O	_	_	_	_	_
17	inflammatory	_	O	O	_	_	_	_	_
18	genes	_	O	O	_	_	_	_	_
19	as	_	O	O	_	_	_	_	_
20	well	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	HIV	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	replication	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	increase	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	observed	_	O	O	_	_	_	_	_
8	only	_	O	O	_	_	_	_	_
9	when	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	promoter	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	511	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	to	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	+	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	176	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	luciferase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	construct	_	O	O	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	cotransfected	_	O	O	_	_	_	_	_
25	with	_	O	O	_	_	_	_	_
26	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	expression	_	O	O	_	_	_	_	_
32	vectors	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	Fig	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	abrogated	_	O	O	_	_	_	_	_
5	when	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	Runx	_	O	O	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	sites	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	promoter	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	511	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	+	_	O	O	_	_	_	_	_
20	176	_	O	O	_	_	_	_	_
21	)	_	O	O	_	_	_	_	_
22	luciferase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	construct	_	O	O	_	_	_	_	_
24	were	_	O	O	_	_	_	_	_
25	mutated	_	O	O	_	_	_	_	_
26	(	_	O	O	_	_	_	_	_
27	Fig	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	activation	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	inhibited	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	known	_	O	O	_	_	_	_	_
7	inhibitors	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappa	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	or	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	simultaneous	_	O	O	_	_	_	_	_
16	treatment	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	surfactant	_	O	O	_	_	_	_	_
22	lipids	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	results	_	O	O	_	_	_	_	_
6	demonstrated	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	repressive	_	O	O	_	_	_	_	_
9	role	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	induced	_	O	O	_	_	_	_	_
16	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	in	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	generation	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	iTreg	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Concomitant	_	O	O	_	_	_	_	_
2	downregulation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	IgH	_	O	O	_	_	_	_	_
5	3	_	O	O	_	_	_	_	_
6	'	_	O	O	_	_	_	_	_
7	enhancer	_	O	O	_	_	_	_	_
8	activity	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	plasmacytoma	_	O	O	_	_	_	_	_
17	x	_	O	O	_	_	_	_	_
18	fibroblast	_	O	O	_	_	_	_	_
19	environment	_	O	O	_	_	_	_	_
20	:	_	O	O	_	_	_	_	_
21	implications	_	O	O	_	_	_	_	_
22	for	_	O	O	_	_	_	_	_
23	dysregulation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	translocated	_	O	O	_	_	_	_	_
26	c	_	O	O	_	_	_	_	_
27	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Using	_	O	O	_	_	_	_	_
2	ATL	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	16	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	which	_	O	O	_	_	_	_	_
8	express	_	O	O	_	_	_	_	_
9	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	mRNA	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	we	_	O	O	_	_	_	_	_
15	have	_	O	O	_	_	_	_	_
16	identified	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	region	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	within	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	human	_	O	O	_	_	_	_	_
23	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	gene	_	O	O	_	_	_	_	_
27	promoter	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	that	_	O	O	_	_	_	_	_
30	regulates	_	O	O	_	_	_	_	_
31	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	gene	_	O	O	_	_	_	_	_
35	transcription	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	using	_	O	O	_	_	_	_	_
4	ATL	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	16	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	nuclear	_	O	O	_	_	_	_	_
9	extract	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	we	_	O	O	_	_	_	_	_
12	demonstrated	_	O	O	_	_	_	_	_
13	that	_	O	O	_	_	_	_	_
14	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	only	_	O	O	_	_	_	_	_
20	GATA	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	binding	_	O	O	_	_	_	_	_
23	protein	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	forms	_	O	O	_	_	_	_	_
26	specific	_	O	O	_	_	_	_	_
27	DNA	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	protein	_	O	O	_	_	_	_	_
30	complex	_	O	O	_	_	_	_	_
31	with	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	70	_	O	O	_	_	_	_	_
35	GATA	_	O	O	_	_	_	_	_
36	site	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Similar	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	obtained	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	treated	_	O	O	_	_	_	_	_
9	with	_	O	O	_	_	_	_	_
10	anti	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	IgM	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	L	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	26	_	O	O	_	_	_	_	_
19	%	_	O	O	_	_	_	_	_
20	mean	_	O	O	_	_	_	_	_
21	reduction	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	n	_	O	O	_	_	_	_	_
24	=	_	O	O	_	_	_	_	_
25	6	_	O	O	_	_	_	_	_
26	;	_	O	O	_	_	_	_	_
27	p	_	O	O	_	_	_	_	_
28	<	_	O	O	_	_	_	_	_
29	/	_	O	O	_	_	_	_	_
30	=	_	O	O	_	_	_	_	_
31	0	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_
33	023	_	O	O	_	_	_	_	_
34	)	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	gene	_	O	O	_	_	_	_	_
6	displays	_	O	O	_	_	_	_	_
7	both	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	specific	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	inducible	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	:	_	O	O	_	_	_	_	_
15	it	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	only	_	O	O	_	_	_	_	_
18	expressed	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	+	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	after	_	O	O	_	_	_	_	_
26	antigenic	_	O	O	_	_	_	_	_
27	or	_	O	O	_	_	_	_	_
28	mitogenic	_	O	O	_	_	_	_	_
29	stimulation	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	high	_	O	O	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	WT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	has	_	O	O	_	_	_	_	_
8	been	_	O	O	_	_	_	_	_
9	detected	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	a	_	O	O	_	_	_	_	_
12	range	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	acute	_	O	O	_	_	_	_	_
15	leukemias	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	WT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	downregulated	_	O	O	_	_	_	_	_
22	during	_	O	O	_	_	_	_	_
23	induced	_	O	O	_	_	_	_	_
24	differentiation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	some	_	O	O	_	_	_	_	_
27	leukemic	_	O	O	_	_	_	_	_
28	cell	_	O	O	_	_	_	_	_
29	lines	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	when	_	O	O	_	_	_	_	_
4	combined	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	unstimulated	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	or	_	O	O	_	_	_	_	_
9	T	_	O	O	_	_	_	_	_
10	cell	_	O	O	_	_	_	_	_
11	extracts	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	full	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	length	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	but	_	O	O	_	_	_	_	_
18	not	_	O	O	_	_	_	_	_
19	truncated	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	Jun	_	O	O	_	_	_	_	_
22	/	_	O	O	_	_	_	_	_
23	Fos	_	O	O	_	_	_	_	_
24	heterodimers	_	O	O	_	_	_	_	_
25	were	_	O	O	_	_	_	_	_
26	able	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	form	_	O	O	_	_	_	_	_
29	an	_	O	O	_	_	_	_	_
30	NFAT	_	O	O	_	_	_	_	_
31	complex	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	indicating	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	presence	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	a	_	O	O	_	_	_	_	_
38	constitutively	_	O	O	_	_	_	_	_
39	expressed	_	O	O	_	_	_	_	_
40	nuclear	_	O	O	_	_	_	_	_
41	factor	_	O	O	_	_	_	_	_
42	(	_	O	O	_	_	_	_	_
43	s	_	O	O	_	_	_	_	_
44	)	_	O	O	_	_	_	_	_
45	in	_	O	O	_	_	_	_	_
46	B	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	T	_	O	O	_	_	_	_	_
49	cells	_	O	O	_	_	_	_	_
50	necessary	_	O	O	_	_	_	_	_
51	for	_	O	O	_	_	_	_	_
52	the	_	O	O	_	_	_	_	_
53	formation	_	O	O	_	_	_	_	_
54	of	_	O	O	_	_	_	_	_
55	the	_	O	O	_	_	_	_	_
56	NFAT	_	O	O	_	_	_	_	_
57	complex	_	O	O	_	_	_	_	_
58	in	_	O	O	_	_	_	_	_
59	both	_	O	O	_	_	_	_	_
60	cell	_	O	O	_	_	_	_	_
61	types	_	O	O	_	_	_	_	_
62	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	viral	_	O	O	_	_	_	_	_
3	encoded	_	O	O	_	_	_	_	_
4	protein	_	O	O	_	_	_	_	_
5	tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	thought	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	play	_	O	O	_	_	_	_	_
11	an	_	O	O	_	_	_	_	_
12	important	_	O	O	_	_	_	_	_
13	role	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	oncogenesis	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Infection	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	monocytes	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	influenza	_	O	O	_	_	_	_	_
7	A	_	O	O	_	_	_	_	_
8	virus	_	O	O	_	_	_	_	_
9	induces	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	broad	_	O	O	_	_	_	_	_
12	range	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	proinflammatory	_	O	O	_	_	_	_	_
15	cytokines	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	mononuclear	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	attracting	_	O	O	_	_	_	_	_
20	chemokines	_	O	O	_	_	_	_	_
21	before	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	infected	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	undergo	_	O	O	_	_	_	_	_
26	apoptosis	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	study	_	O	O	_	_	_	_	_
3	transcriptional	_	O	O	_	_	_	_	_
4	regulation	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	normal	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	we	_	O	O	_	_	_	_	_
12	have	_	O	O	_	_	_	_	_
13	optimized	_	O	O	_	_	_	_	_
14	conditions	_	O	O	_	_	_	_	_
15	for	_	O	O	_	_	_	_	_
16	transient	_	O	O	_	_	_	_	_
17	transfection	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	primary	_	O	O	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	phytohemagglutinin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	or	_	O	O	_	_	_	_	_
8	antibodies	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	CD	_	O	O	_	_	_	_	_
11	3	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	costimulation	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	provided	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	pairs	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	CD	_	O	O	_	_	_	_	_
21	2	_	O	O	_	_	_	_	_
22	antibodies	_	O	O	_	_	_	_	_
23	or	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	7	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	positive	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	or	_	O	O	_	_	_	_	_
33	B	_	O	O	_	_	_	_	_
34	7	_	O	O	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	negative	_	O	O	_	_	_	_	_
37	(	_	O	O	_	_	_	_	_
38	endothelial	_	O	O	_	_	_	_	_
39	)	_	O	O	_	_	_	_	_
40	accessory	_	O	O	_	_	_	_	_
41	cells	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	are	_	O	O	_	_	_	_	_
44	mediated	_	O	O	_	_	_	_	_
45	through	_	O	O	_	_	_	_	_
46	the	_	O	O	_	_	_	_	_
47	same	_	O	O	_	_	_	_	_
48	cis	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	elements	_	O	O	_	_	_	_	_
51	.	_	O	O	_	_	_	_	_

1	Experimental	_	O	O	_	_	_	_	_
2	setup	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	A	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	results	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	mouse	_	O	O	_	_	_	_	_
11	suppression	_	O	O	_	_	_	_	_
12	assay	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	FACS	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	purified	_	O	O	_	_	_	_	_
20	naive	_	O	O	_	_	_	_	_
21	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	+	_	O	O	_	_	_	_	_
24	8	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	T	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	from	_	O	O	_	_	_	_	_
29	CbfbF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	/	_	O	O	_	_	_	_	_
31	F	_	O	O	_	_	_	_	_
32	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	cre	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	(	_	O	O	_	_	_	_	_
37	left	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	control	_	O	O	_	_	_	_	_
41	CbfbF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	/	_	O	O	_	_	_	_	_
43	+	_	O	O	_	_	_	_	_
44	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	cre	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	mice	_	O	O	_	_	_	_	_
49	(	_	O	O	_	_	_	_	_
50	Cd	_	BPROTEIN	BPROTEIN	_	_	_	_	_
51	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
53	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	;	_	O	O	_	_	_	_	_
55	right	_	O	O	_	_	_	_	_
56	)	_	O	O	_	_	_	_	_
57	were	_	O	O	_	_	_	_	_
58	activated	_	O	O	_	_	_	_	_
59	in	_	O	O	_	_	_	_	_
60	vitro	_	O	O	_	_	_	_	_
61	with	_	O	O	_	_	_	_	_
62	anti	_	O	O	_	_	_	_	_
63	-	_	O	O	_	_	_	_	_
64	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
65	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
66	/	_	O	O	_	_	_	_	_
67	28	_	BPROTEIN	BPROTEIN	_	_	_	_	_
68	mAb	_	O	O	_	_	_	_	_
69	,	_	O	O	_	_	_	_	_
70	50	_	O	O	_	_	_	_	_
71	U	_	O	O	_	_	_	_	_
72	/	_	O	O	_	_	_	_	_
73	ml	_	O	O	_	_	_	_	_
74	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
75	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
76	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
77	,	_	O	O	_	_	_	_	_
78	and	_	O	O	_	_	_	_	_
79	2	_	O	O	_	_	_	_	_
80	.	_	O	O	_	_	_	_	_
81	5	_	O	O	_	_	_	_	_
82	ng	_	O	O	_	_	_	_	_
83	/	_	O	O	_	_	_	_	_
84	ml	_	O	O	_	_	_	_	_
85	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
86	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
87	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
88	.	_	O	O	_	_	_	_	_

1	If	_	O	O	_	_	_	_	_
2	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	functions	_	O	O	_	_	_	_	_
5	as	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	repressor	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	dependent	_	O	O	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	then	_	O	O	_	_	_	_	_
18	we	_	O	O	_	_	_	_	_
19	hypothesized	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	overexpression	_	O	O	_	_	_	_	_
24	could	_	O	O	_	_	_	_	_
25	selectively	_	O	O	_	_	_	_	_
26	down	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	regulate	_	O	O	_	_	_	_	_
29	transcription	_	O	O	_	_	_	_	_
30	from	_	O	O	_	_	_	_	_
31	promoters	_	O	O	_	_	_	_	_
32	previously	_	O	O	_	_	_	_	_
33	shown	_	O	O	_	_	_	_	_
34	to	_	O	O	_	_	_	_	_
35	be	_	O	O	_	_	_	_	_
36	responsive	_	O	O	_	_	_	_	_
37	to	_	O	O	_	_	_	_	_
38	NF	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	kappaB	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	NF	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	kappaB	_	O	O	_	_	_	_	_
4	plays	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	crucial	_	O	O	_	_	_	_	_
7	role	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	regulating	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	directed	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	HIV	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	LTR	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	+	_	O	O	_	_	_	_	_
23	T	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	[	_	O	O	_	_	_	_	_
26	21	_	O	O	_	_	_	_	_
27	]	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Calcium	_	O	O	_	_	_	_	_
2	/	_	O	O	_	_	_	_	_
3	calmodulin	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	dependent	_	O	O	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	kinase	_	O	O	_	_	_	_	_
8	II	_	O	O	_	_	_	_	_
9	downregulates	_	O	O	_	_	_	_	_
10	both	_	O	O	_	_	_	_	_
11	calcineurin	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	protein	_	O	O	_	_	_	_	_
14	kinase	_	O	O	_	_	_	_	_
15	C	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	mediated	_	O	O	_	_	_	_	_
18	pathways	_	O	O	_	_	_	_	_
19	for	_	O	O	_	_	_	_	_
20	cytokine	_	O	O	_	_	_	_	_
21	gene	_	O	O	_	_	_	_	_
22	transcription	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	human	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Recent	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	have	_	O	O	_	_	_	_	_
4	identified	_	O	O	_	_	_	_	_
5	calcineurin	_	O	O	_	_	_	_	_
6	as	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	key	_	O	O	_	_	_	_	_
9	enzyme	_	O	O	_	_	_	_	_
10	for	_	O	O	_	_	_	_	_
11	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	promoter	_	O	O	_	_	_	_	_
22	activation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	used	_	O	O	_	_	_	_	_
4	mutants	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	these	_	O	O	_	_	_	_	_
7	kinases	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	phosphatases	_	O	O	_	_	_	_	_
10	(	_	O	O	_	_	_	_	_
11	gamma	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	*	_	O	O	_	_	_	_	_
14	CaM	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	K	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	delta	_	O	O	_	_	_	_	_
19	CaM	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	AI	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	respectively	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	explore	_	O	O	_	_	_	_	_
27	their	_	O	O	_	_	_	_	_
28	relative	_	O	O	_	_	_	_	_
29	role	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	cytokine	_	O	O	_	_	_	_	_
32	gene	_	O	O	_	_	_	_	_
33	transcription	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	their	_	O	O	_	_	_	_	_
36	interactions	_	O	O	_	_	_	_	_
37	with	_	O	O	_	_	_	_	_
38	PKC	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	dependent	_	O	O	_	_	_	_	_
41	signaling	_	O	O	_	_	_	_	_
42	systems	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	shown	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	A	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	immunoblotting	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	purified	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	+	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	immunohistochemistry	_	O	O	_	_	_	_	_
25	staining	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	spleen	_	O	O	_	_	_	_	_
28	tissue	_	O	O	_	_	_	_	_
29	from	_	O	O	_	_	_	_	_
30	wild	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	type	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	WT	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	and	_	O	O	_	_	_	_	_
37	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	transgenic	_	O	O	_	_	_	_	_
40	mice	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Lymphocytes	_	O	O	_	_	_	_	_
2	from	_	O	O	_	_	_	_	_
3	CML	_	O	O	_	_	_	_	_
4	patients	_	O	O	_	_	_	_	_
5	lack	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	47	_	O	O	_	_	_	_	_
8	kDa	_	O	O	_	_	_	_	_
9	factor	_	O	O	_	_	_	_	_
10	having	_	O	O	_	_	_	_	_
11	affinity	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	a	_	O	O	_	_	_	_	_
14	genomic	_	O	O	_	_	_	_	_
15	sterol	_	O	O	_	_	_	_	_
16	regulatory	_	O	O	_	_	_	_	_
17	sequence	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_


1	Based	_	O	O	_	_	_	_	_
2	upon	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	results	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	propose	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	this	_	O	O	_	_	_	_	_
9	factor	_	O	O	_	_	_	_	_
10	may	_	O	O	_	_	_	_	_
11	have	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	role	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	pathophysiology	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	chronic	_	O	O	_	_	_	_	_
18	myeloid	_	O	O	_	_	_	_	_
19	leukaemia	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	novel	_	O	O	_	_	_	_	_
3	member	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	tumor	_	O	O	_	_	_	_	_
7	necrosis	_	O	O	_	_	_	_	_
8	factor	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	TNF	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	receptor	_	O	O	_	_	_	_	_
13	family	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	designated	_	O	O	_	_	_	_	_
16	TRAMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	has	_	O	O	_	_	_	_	_
19	been	_	O	O	_	_	_	_	_
20	identified	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	TRAMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	does	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	appear	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	interact	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	any	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	known	_	O	O	_	_	_	_	_
15	apoptosis	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	inducing	_	O	O	_	_	_	_	_
18	ligands	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	TNF	_	O	O	_	_	_	_	_
22	family	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Moreover	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	further	_	O	O	_	_	_	_	_
5	investigated	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	physiologic	_	O	O	_	_	_	_	_
8	relevance	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	these	_	O	O	_	_	_	_	_
11	observations	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	Finally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	soluble	_	O	O	_	_	_	_	_
4	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	sCD	_	O	O	_	_	_	_	_
8	4	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	prevented	_	O	O	_	_	_	_	_
11	virus	_	O	O	_	_	_	_	_
12	reactivation	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	D	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	/	_	O	O	_	_	_	_	_
17	CDR	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	loop	_	O	O	_	_	_	_	_
21	ligands	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Phosphoinositide	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	PI	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	activated	_	O	O	_	_	_	_	_
13	by	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	diverse	_	O	O	_	_	_	_	_
16	set	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	receptors	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	determine	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	function	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	including	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	T	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	cell	_	O	O	_	_	_	_	_
31	antigen	_	O	O	_	_	_	_	_
32	receptor	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	TCR	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	costimulatory	_	O	O	_	_	_	_	_
39	receptor	_	O	O	_	_	_	_	_
40	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	negative	_	O	O	_	_	_	_	_
45	regulators	_	O	O	_	_	_	_	_
46	of	_	O	O	_	_	_	_	_
47	T	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	cell	_	O	O	_	_	_	_	_
50	activation	_	O	O	_	_	_	_	_
51	such	_	O	O	_	_	_	_	_
52	as	_	O	O	_	_	_	_	_
53	CTLA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
54	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
55	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	.	_	O	O	_	_	_	_	_

1	RESULTS	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	Certain	_	O	O	_	_	_	_	_
4	aspects	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	TCR	_	O	O	_	_	_	_	_
7	responses	_	O	O	_	_	_	_	_
8	such	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	induction	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	transcriptional	_	O	O	_	_	_	_	_
14	activity	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	AP	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	serum	_	O	O	_	_	_	_	_
20	response	_	O	O	_	_	_	_	_
21	factor	_	O	O	_	_	_	_	_
22	were	_	O	O	_	_	_	_	_
23	not	_	O	O	_	_	_	_	_
24	affected	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	expression	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	mutant	_	O	O	_	_	_	_	_
30	forms	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	PI	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_


1	A	_	O	O	_	_	_	_	_
2	TBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	mutant	_	O	O	_	_	_	_	_
4	defective	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	interaction	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	TBP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	associated	_	O	O	_	_	_	_	_
11	factor	_	O	O	_	_	_	_	_
12	TAFII	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	250	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	also	_	O	O	_	_	_	_	_
15	failed	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	mediate	_	O	O	_	_	_	_	_
18	transactivation	_	O	O	_	_	_	_	_
19	through	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	CIITA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	activation	_	O	O	_	_	_	_	_
23	domain	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_


1	Defective	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	gene	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	associated	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	impaired	_	O	O	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	FosB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	JunB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	anergic	_	O	O	_	_	_	_	_
25	T	_	O	O	_	_	_	_	_
26	helper	_	O	O	_	_	_	_	_
27	1	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Upon	_	O	O	_	_	_	_	_
2	functional	_	O	O	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	granulocytes	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	4	_	O	O	_	_	_	_	_
8	beta	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	phorbol	_	O	O	_	_	_	_	_
11	12	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	myristate	_	O	O	_	_	_	_	_
14	13	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	acetate	_	O	O	_	_	_	_	_
17	(	_	O	O	_	_	_	_	_
18	PMA	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	levels	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	jun	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	jun	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	D	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	transcripts	_	O	O	_	_	_	_	_
34	were	_	O	O	_	_	_	_	_
35	increased	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	becoming	_	O	O	_	_	_	_	_
4	increasingly	_	O	O	_	_	_	_	_
5	apparent	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	chronic	_	O	O	_	_	_	_	_
9	gut	_	O	O	_	_	_	_	_
10	inflammation	_	O	O	_	_	_	_	_
11	observed	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	idiopathic	_	O	O	_	_	_	_	_
15	inflammatory	_	O	O	_	_	_	_	_
16	bowel	_	O	O	_	_	_	_	_
17	diseases	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	e	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_
21	g	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	ulcerative	_	O	O	_	_	_	_	_
2	colitis	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	Crohn	_	O	O	_	_	_	_	_
5	'	_	O	O	_	_	_	_	_
6	s	_	O	O	_	_	_	_	_
7	disease	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	associated	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	enhanced	_	O	O	_	_	_	_	_
13	production	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	leukocyte	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	derived	_	O	O	_	_	_	_	_
18	oxidants	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Oxidants	_	O	O	_	_	_	_	_
2	such	_	O	O	_	_	_	_	_
3	as	_	O	O	_	_	_	_	_
4	hydrogen	_	O	O	_	_	_	_	_
5	peroxide	_	O	O	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	known	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	activate	_	O	O	_	_	_	_	_
10	certain	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	factors	_	O	O	_	_	_	_	_
13	such	_	O	O	_	_	_	_	_
14	as	_	O	O	_	_	_	_	_
15	nuclear	_	O	O	_	_	_	_	_
16	transcription	_	O	O	_	_	_	_	_
17	factor	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	beta	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	studied	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	regulation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	AP	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	activity	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	human	_	O	O	_	_	_	_	_
13	peripheral	_	O	O	_	_	_	_	_
14	blood	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	lymphocytes	_	O	O	_	_	_	_	_
17	stimulated	_	O	O	_	_	_	_	_
18	through	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	activation	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	inducer	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	(	_	O	O	_	_	_	_	_
24	AIM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	/	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	69	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	activation	_	O	O	_	_	_	_	_
30	pathway	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_


1	Activated	_	O	O	_	_	_	_	_
2	ras	_	O	O	_	_	_	_	_
3	expression	_	O	O	_	_	_	_	_
4	also	_	O	O	_	_	_	_	_
5	replaced	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	requirement	_	O	O	_	_	_	_	_
8	for	_	O	O	_	_	_	_	_
9	PKC	_	O	O	_	_	_	_	_
10	stimulation	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	NF	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	AT	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	genes	_	O	O	_	_	_	_	_
17	is	_	O	O	_	_	_	_	_
18	regulated	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	heat	_	O	O	_	_	_	_	_
21	shock	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	human	_	O	O	_	_	_	_	_
24	lymphoid	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	unique	_	O	O	_	_	_	_	_
5	DNA	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	protein	_	O	O	_	_	_	_	_
8	complex	_	O	O	_	_	_	_	_
9	was	_	O	O	_	_	_	_	_
10	detected	_	O	O	_	_	_	_	_
11	when	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	promoter	_	O	O	_	_	_	_	_
14	central	_	O	O	_	_	_	_	_
15	21	_	O	O	_	_	_	_	_
16	bp	_	O	O	_	_	_	_	_
17	repeat	_	O	O	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	reacted	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	nuclear	_	O	O	_	_	_	_	_
22	extracts	_	O	O	_	_	_	_	_
23	derived	_	O	O	_	_	_	_	_
24	from	_	O	O	_	_	_	_	_
25	either	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	U	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	373	_	O	O	_	_	_	_	_
30	MG	_	O	O	_	_	_	_	_
31	glioblastoma	_	O	O	_	_	_	_	_
32	cell	_	O	O	_	_	_	_	_
33	line	_	O	O	_	_	_	_	_
34	or	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	THP	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	1	_	O	O	_	_	_	_	_
39	mature	_	O	O	_	_	_	_	_
40	monocytic	_	O	O	_	_	_	_	_
41	cell	_	O	O	_	_	_	_	_
42	line	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_



1	A	_	O	O	_	_	_	_	_
2	possible	_	O	O	_	_	_	_	_
3	signaling	_	O	O	_	_	_	_	_
4	role	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	Syk	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	tyrosine	_	O	O	_	_	_	_	_
9	kinase	_	O	O	_	_	_	_	_
10	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	cytoplasmic	_	O	O	_	_	_	_	_
4	tyrosine	_	O	O	_	_	_	_	_
5	kinases	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	an	_	O	O	_	_	_	_	_
8	important	_	O	O	_	_	_	_	_
9	aspect	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	signal	_	O	O	_	_	_	_	_
12	transduction	_	O	O	_	_	_	_	_
13	mediated	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	integrins	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	neutrophils	_	O	O	_	_	_	_	_
3	can	_	O	O	_	_	_	_	_
4	be	_	O	O	_	_	_	_	_
5	induced	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	actively	_	O	O	_	_	_	_	_
8	transcribe	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	number	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	early	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	response	_	O	O	_	_	_	_	_
15	genes	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	particular	_	O	O	_	_	_	_	_
19	those	_	O	O	_	_	_	_	_
20	encoding	_	O	O	_	_	_	_	_
21	cytokines	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	chemokines	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	high	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	affinity	_	O	O	_	_	_	_	_
30	surface	_	O	O	_	_	_	_	_
31	receptor	_	O	O	_	_	_	_	_
32	for	_	O	O	_	_	_	_	_
33	IgG	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	FcgammaRI	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	little	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	known	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	date	_	O	O	_	_	_	_	_
7	about	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	regulation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	gene	_	O	O	_	_	_	_	_
12	transcription	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	neutrophils	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	several	_	O	O	_	_	_	_	_
17	indications	_	O	O	_	_	_	_	_
18	point	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	role	_	O	O	_	_	_	_	_
22	for	_	O	O	_	_	_	_	_
23	distinct	_	O	O	_	_	_	_	_
24	transcription	_	O	O	_	_	_	_	_
25	factors	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	such	_	O	O	_	_	_	_	_
28	as	_	O	O	_	_	_	_	_
29	members	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	NF	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	kappaB	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	STAT	_	O	O	_	_	_	_	_
37	families	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	Freshly	_	O	O	_	_	_	_	_
2	isolated	_	O	O	_	_	_	_	_
3	monocytes	_	O	O	_	_	_	_	_
4	treated	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	protein	_	O	O	_	_	_	_	_
8	phosphatase	_	O	O	_	_	_	_	_
9	inhibitor	_	O	O	_	_	_	_	_
10	okadaic	_	O	O	_	_	_	_	_
11	acid	_	O	O	_	_	_	_	_
12	secreted	_	O	O	_	_	_	_	_
13	high	_	O	O	_	_	_	_	_
14	levels	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	protein	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	which	_	O	O	_	_	_	_	_
22	coincided	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	enhanced	_	O	O	_	_	_	_	_
25	binding	_	O	O	_	_	_	_	_
26	activity	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	NF	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	kappa	_	O	O	_	_	_	_	_
31	B	_	O	O	_	_	_	_	_
32	as	_	O	O	_	_	_	_	_
33	well	_	O	O	_	_	_	_	_
34	as	_	O	O	_	_	_	_	_
35	with	_	O	O	_	_	_	_	_
36	phosphorylation	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	activation	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	ERK	_	O	O	_	_	_	_	_
42	1	_	O	O	_	_	_	_	_
43	/	_	O	O	_	_	_	_	_
44	2	_	O	O	_	_	_	_	_
45	and	_	O	O	_	_	_	_	_
46	JNK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
47	proteins	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_


1	CsA	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	found	_	O	O	_	_	_	_	_
4	not	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	inhibit	_	O	O	_	_	_	_	_
7	lck	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	gene	_	O	O	_	_	_	_	_
9	expression	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	nor	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	activity	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	lck	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	product	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	An	_	O	O	_	_	_	_	_
2	enhancer	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	blocking	_	O	O	_	_	_	_	_
5	element	_	O	O	_	_	_	_	_
6	between	_	O	O	_	_	_	_	_
7	alpha	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	delta	_	O	O	_	_	_	_	_
10	gene	_	O	O	_	_	_	_	_
11	segments	_	O	O	_	_	_	_	_
12	within	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	human	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	receptor	_	O	O	_	_	_	_	_
18	alpha	_	O	O	_	_	_	_	_
19	/	_	O	O	_	_	_	_	_
20	delta	_	O	O	_	_	_	_	_
21	locus	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_


1	Using	_	O	O	_	_	_	_	_
2	electrophoretic	_	O	O	_	_	_	_	_
3	mobility	_	O	O	_	_	_	_	_
4	shift	_	O	O	_	_	_	_	_
5	assays	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	we	_	O	O	_	_	_	_	_
8	have	_	O	O	_	_	_	_	_
9	studied	_	O	O	_	_	_	_	_
10	these	_	O	O	_	_	_	_	_
11	transcription	_	O	O	_	_	_	_	_
12	factors	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	primary	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	blood	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	verify	_	O	O	_	_	_	_	_
22	their	_	O	O	_	_	_	_	_
23	presence	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	a	_	O	O	_	_	_	_	_
26	physiologic	_	O	O	_	_	_	_	_
27	setting	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	identify	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	signals	_	O	O	_	_	_	_	_
33	that	_	O	O	_	_	_	_	_
34	stimulate	_	O	O	_	_	_	_	_
35	factor	_	O	O	_	_	_	_	_
36	activity	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	using	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	reverse	_	O	O	_	_	_	_	_
5	transcription	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	PCR	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	based	_	O	O	_	_	_	_	_
10	approach	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	set	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	primers	_	O	O	_	_	_	_	_
16	specific	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	DNA	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	binding	_	O	O	_	_	_	_	_
22	domains	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	highly	_	O	O	_	_	_	_	_
25	homologous	_	O	O	_	_	_	_	_
26	members	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	C	_	O	O	_	_	_	_	_
30	/	_	O	O	_	_	_	_	_
31	EBP	_	O	O	_	_	_	_	_
32	family	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	transcriptional	_	O	O	_	_	_	_	_
35	regulators	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	we	_	O	O	_	_	_	_	_
38	have	_	O	O	_	_	_	_	_
39	cloned	_	O	O	_	_	_	_	_
40	a	_	O	O	_	_	_	_	_
41	novel	_	O	O	_	_	_	_	_
42	human	_	O	O	_	_	_	_	_
43	gene	_	O	O	_	_	_	_	_
44	encoding	_	O	O	_	_	_	_	_
45	a	_	O	O	_	_	_	_	_
46	member	_	O	O	_	_	_	_	_
47	of	_	O	O	_	_	_	_	_
48	the	_	O	O	_	_	_	_	_
49	C	_	O	O	_	_	_	_	_
50	/	_	O	O	_	_	_	_	_
51	EBP	_	O	O	_	_	_	_	_
52	gene	_	O	O	_	_	_	_	_
53	family	_	O	O	_	_	_	_	_
54	,	_	O	O	_	_	_	_	_
55	identified	_	O	O	_	_	_	_	_
56	as	_	O	O	_	_	_	_	_
57	the	_	O	O	_	_	_	_	_
58	human	_	O	O	_	_	_	_	_
59	homolog	_	O	O	_	_	_	_	_
60	of	_	O	O	_	_	_	_	_
61	CRP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
62	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
63	,	_	O	O	_	_	_	_	_
64	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
65	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
66	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
67	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
68	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
69	.	_	O	O	_	_	_	_	_

1	Western	_	O	O	_	_	_	_	_
2	blot	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	immunoprecipitation	_	O	O	_	_	_	_	_
5	studies	_	O	O	_	_	_	_	_
6	using	_	O	O	_	_	_	_	_
7	rabbit	_	O	O	_	_	_	_	_
8	anti	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	antibodies	_	O	O	_	_	_	_	_
16	raised	_	O	O	_	_	_	_	_
17	against	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	N	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	terminal	_	O	O	_	_	_	_	_
22	portion	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	amino	_	O	O	_	_	_	_	_
31	acids	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	115	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	showed	_	O	O	_	_	_	_	_
37	that	_	O	O	_	_	_	_	_
38	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	is	_	O	O	_	_	_	_	_
44	a	_	O	O	_	_	_	_	_
45	32	_	O	O	_	_	_	_	_
46	-	_	O	O	_	_	_	_	_
47	kDa	_	O	O	_	_	_	_	_
48	nuclear	_	O	O	_	_	_	_	_
49	phosphoprotein	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	Cotransfection	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	sense	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	antisense	_	O	O	_	_	_	_	_
12	expression	_	O	O	_	_	_	_	_
13	constructs	_	O	O	_	_	_	_	_
14	together	_	O	O	_	_	_	_	_
15	with	_	O	O	_	_	_	_	_
16	chloramphenicol	_	O	O	_	_	_	_	_
17	acetyltransferase	_	O	O	_	_	_	_	_
18	reporter	_	O	O	_	_	_	_	_
19	vectors	_	O	O	_	_	_	_	_
20	containing	_	O	O	_	_	_	_	_
21	myeloid	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	specific	_	O	O	_	_	_	_	_
26	c	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	mim	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	human	_	O	O	_	_	_	_	_
31	myeloperoxidase	_	O	O	_	_	_	_	_
32	promoters	_	O	O	_	_	_	_	_
33	suggested	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	role	_	O	O	_	_	_	_	_
36	for	_	O	O	_	_	_	_	_
37	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	transcription	_	O	O	_	_	_	_	_
43	factor	_	O	O	_	_	_	_	_
44	in	_	O	O	_	_	_	_	_
45	the	_	O	O	_	_	_	_	_
46	regulation	_	O	O	_	_	_	_	_
47	of	_	O	O	_	_	_	_	_
48	a	_	O	O	_	_	_	_	_
49	subset	_	O	O	_	_	_	_	_
50	of	_	O	O	_	_	_	_	_
51	myeloid	_	O	O	_	_	_	_	_
52	-	_	O	O	_	_	_	_	_
53	cell	_	O	O	_	_	_	_	_
54	-	_	O	O	_	_	_	_	_
55	specific	_	O	O	_	_	_	_	_
56	genes	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_

1	Intercellular	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	adhesion	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	molecule	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	ICAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	is	_	O	O	_	_	_	_	_
11	an	_	O	O	_	_	_	_	_
12	important	_	O	O	_	_	_	_	_
13	molecule	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	promotion	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	polymorphonuclear	_	O	O	_	_	_	_	_
18	neutrophil	_	O	O	_	_	_	_	_
19	transendothelial	_	O	O	_	_	_	_	_
20	migration	_	O	O	_	_	_	_	_
21	during	_	O	O	_	_	_	_	_
22	inflammation	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Human	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	express	_	O	O	_	_	_	_	_
5	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	receptors	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	nuclear	_	O	O	_	_	_	_	_
3	factor	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	activated	_	O	O	_	_	_	_	_
6	T	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	NFAT	_	O	O	_	_	_	_	_
10	)	_	O	O	_	_	_	_	_
11	group	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factors	_	O	O	_	_	_	_	_
15	is	_	O	O	_	_	_	_	_
16	retained	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	cytoplasm	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	quiescent	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Transcriptional	_	O	O	_	_	_	_	_
2	targeting	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	retroviral	_	O	O	_	_	_	_	_
5	vectors	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	erythroblastic	_	O	O	_	_	_	_	_
9	progeny	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	transduced	_	O	O	_	_	_	_	_
12	hematopoietic	_	O	O	_	_	_	_	_
13	stem	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	biological	_	O	O	_	_	_	_	_
7	effect	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	PNU	_	O	O	_	_	_	_	_
10	156804	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	vitro	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	indistinguishable	_	O	O	_	_	_	_	_
15	from	_	O	O	_	_	_	_	_
16	UP	_	O	O	_	_	_	_	_
17	:	_	O	O	_	_	_	_	_
18	PNU	_	O	O	_	_	_	_	_
19	156804	_	O	O	_	_	_	_	_
20	blocks	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	proliferation	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	mid	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	late	_	O	O	_	_	_	_	_
29	G	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	as	_	O	O	_	_	_	_	_
33	determined	_	O	O	_	_	_	_	_
34	by	_	O	O	_	_	_	_	_
35	cell	_	O	O	_	_	_	_	_
36	cycle	_	O	O	_	_	_	_	_
37	analysis	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	expression	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	cyclins	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	cyclin	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	dependent	_	O	O	_	_	_	_	_
47	kinases	_	O	O	_	_	_	_	_
48	and	_	O	O	_	_	_	_	_
49	retinoblastoma	_	O	O	_	_	_	_	_
50	phosphorylation	_	O	O	_	_	_	_	_
51	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	we	_	O	O	_	_	_	_	_
5	show	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	PNU	_	O	O	_	_	_	_	_
8	156804	_	O	O	_	_	_	_	_
9	does	_	O	O	_	_	_	_	_
10	not	_	O	O	_	_	_	_	_
11	block	_	O	O	_	_	_	_	_
12	significantly	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	induction	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	either	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	or	_	O	O	_	_	_	_	_
21	IL	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	2	_	O	O	_	_	_	_	_
24	R	_	O	O	_	_	_	_	_
25	alpha	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	gamma	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	chains	_	O	O	_	_	_	_	_
31	but	_	O	O	_	_	_	_	_
32	inhibits	_	O	O	_	_	_	_	_
33	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	dependent	_	O	O	_	_	_	_	_
38	T	_	O	O	_	_	_	_	_
39	cell	_	O	O	_	_	_	_	_
40	proliferation	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	show	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	PNU	_	O	O	_	_	_	_	_
5	156804	_	O	O	_	_	_	_	_
6	does	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	inhibit	_	O	O	_	_	_	_	_
9	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	myc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mRNA	_	O	O	_	_	_	_	_
17	induction	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Part	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	this	_	O	O	_	_	_	_	_
4	process	_	O	O	_	_	_	_	_
5	involves	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	prevention	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	development	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	Th	_	O	O	_	_	_	_	_
13	1	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	which	_	O	O	_	_	_	_	_
17	are	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	primary	_	O	O	_	_	_	_	_
20	source	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	IFNgamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	)	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	a	_	O	O	_	_	_	_	_
29	potent	_	O	O	_	_	_	_	_
30	activator	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	monocytes	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	an	_	O	O	_	_	_	_	_
35	inhibitor	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	Th	_	O	O	_	_	_	_	_
38	2	_	O	O	_	_	_	_	_
39	proliferation	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Hepatocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	nuclear	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	HNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	homeodomain	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	containing	_	O	O	_	_	_	_	_
18	protein	_	O	O	_	_	_	_	_
19	that	_	O	O	_	_	_	_	_
20	functions	_	O	O	_	_	_	_	_
21	as	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	dimer	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	DCoH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	regulates	_	O	O	_	_	_	_	_
7	formation	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	transcriptionally	_	O	O	_	_	_	_	_
10	active	_	O	O	_	_	_	_	_
11	tetrameric	_	O	O	_	_	_	_	_
12	complexes	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	may	_	O	O	_	_	_	_	_
15	contribute	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	developmental	_	O	O	_	_	_	_	_
19	specificity	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	complex	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	chickens	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	estrogens	_	O	O	_	_	_	_	_
5	stimulate	_	O	O	_	_	_	_	_
6	outgrowth	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	bone	_	O	O	_	_	_	_	_
9	marrow	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	derived	_	O	O	_	_	_	_	_
12	erythroid	_	O	O	_	_	_	_	_
13	progenitor	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	delay	_	O	O	_	_	_	_	_
17	their	_	O	O	_	_	_	_	_
18	maturation	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	ER	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	bind	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	each	_	O	O	_	_	_	_	_
9	other	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	vitro	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	absence	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	DNA	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	coimmunoprecipitation	_	O	O	_	_	_	_	_
3	experiments	_	O	O	_	_	_	_	_
4	using	_	O	O	_	_	_	_	_
5	transfected	_	O	O	_	_	_	_	_
6	COS	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	ER	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	associate	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	ligand	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	dependent	_	O	O	_	_	_	_	_
20	manner	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	(	_	O	O	_	_	_	_	_
2	ABSTRACT	_	O	O	_	_	_	_	_
3	TRUNCATED	_	O	O	_	_	_	_	_
4	AT	_	O	O	_	_	_	_	_
5	250	_	O	O	_	_	_	_	_
6	WORDS	_	O	O	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_


1	High	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	cytokine	_	O	O	_	_	_	_	_
5	gene	_	O	O	_	_	_	_	_
6	expression	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	also	_	O	O	_	_	_	_	_
11	required	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	TCR	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	costimulatory	_	O	O	_	_	_	_	_
16	signals	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Costimulatory	_	O	O	_	_	_	_	_
2	signals	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	such	_	O	O	_	_	_	_	_
5	as	_	O	O	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	cell	_	O	O	_	_	_	_	_
12	surface	_	O	O	_	_	_	_	_
13	molecule	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	cells	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	lead	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	activation	_	O	O	_	_	_	_	_
21	through	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	distinct	_	O	O	_	_	_	_	_
24	region	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	granulocyte	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	macrophage	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	colony	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	stimulating	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	promoter	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	region	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	termed	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	CK	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	1	_	O	O	_	_	_	_	_
9	or	_	O	O	_	_	_	_	_
10	CD	_	O	O	_	_	_	_	_
11	28	_	O	O	_	_	_	_	_
12	RE	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	appears	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	bind	_	O	O	_	_	_	_	_
17	specific	_	O	O	_	_	_	_	_
18	members	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	NF	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	kappa	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	family	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	transcription	_	O	O	_	_	_	_	_
28	factors	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	CK	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	1	_	O	O	_	_	_	_	_
5	/	_	O	O	_	_	_	_	_
6	CD	_	O	O	_	_	_	_	_
7	28	_	O	O	_	_	_	_	_
8	RE	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	shows	_	O	O	_	_	_	_	_
14	a	_	O	O	_	_	_	_	_
15	high	_	O	O	_	_	_	_	_
16	degree	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	similarity	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	CD	_	O	O	_	_	_	_	_
25	28	_	O	O	_	_	_	_	_
26	RE	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	gene	_	O	O	_	_	_	_	_
33	also	_	O	O	_	_	_	_	_
34	contains	_	O	O	_	_	_	_	_
35	a	_	O	O	_	_	_	_	_
36	related	_	O	O	_	_	_	_	_
37	region	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	There	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	no	_	O	O	_	_	_	_	_
4	difference	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	induction	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	when	_	O	O	_	_	_	_	_
12	endogenous	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	were	_	O	O	_	_	_	_	_
21	neutralized	_	O	O	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	Fig	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	found	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	interferon	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	alpha	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	IFN	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	alpha	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	inhibited	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	deprivation	_	O	O	_	_	_	_	_
26	apoptosis	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	Th	_	O	O	_	_	_	_	_
29	0	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	Th	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	and	_	O	O	_	_	_	_	_
35	Th	_	O	O	_	_	_	_	_
36	2	_	O	O	_	_	_	_	_
37	clones	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	OFT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	appeared	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	have	_	O	O	_	_	_	_	_
9	approximately	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	same	_	O	O	_	_	_	_	_
12	transactivation	_	O	O	_	_	_	_	_
13	ability	_	O	O	_	_	_	_	_
14	as	_	O	O	_	_	_	_	_
15	OTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	when	_	O	O	_	_	_	_	_
19	normalized	_	O	O	_	_	_	_	_
20	for	_	O	O	_	_	_	_	_
21	binding	_	O	O	_	_	_	_	_
22	activity	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Invariably	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	coding	_	O	O	_	_	_	_	_
8	region	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	intact	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	but	_	O	O	_	_	_	_	_
13	its	_	O	O	_	_	_	_	_
14	5	_	O	O	_	_	_	_	_
15	'	_	O	O	_	_	_	_	_
16	untranslated	_	O	O	_	_	_	_	_
17	region	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	replaced	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	sequences	_	O	O	_	_	_	_	_
22	from	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	translocation	_	O	O	_	_	_	_	_
25	partner	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Although	_	O	O	_	_	_	_	_
2	polyclonal	_	O	O	_	_	_	_	_
3	activation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	B	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	vitro	_	O	O	_	_	_	_	_
9	invariably	_	O	O	_	_	_	_	_
10	decreased	_	O	O	_	_	_	_	_
11	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	MRNA	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	activated	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	cells	_	O	O	_	_	_	_	_
20	from	_	O	O	_	_	_	_	_
21	human	_	O	O	_	_	_	_	_
22	germinal	_	O	O	_	_	_	_	_
23	centers	_	O	O	_	_	_	_	_
24	expressed	_	O	O	_	_	_	_	_
25	BCL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	mRNA	_	O	O	_	_	_	_	_
29	at	_	O	O	_	_	_	_	_
30	levels	_	O	O	_	_	_	_	_
31	comparable	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	levels	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	resting	_	O	O	_	_	_	_	_
37	B	_	O	O	_	_	_	_	_
38	cells	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_


1	Here	_	O	O	_	_	_	_	_
2	it	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	shown	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	glucocorticoids	_	O	O	_	_	_	_	_
7	are	_	O	O	_	_	_	_	_
8	potent	_	O	O	_	_	_	_	_
9	inhibitors	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	nuclear	_	O	O	_	_	_	_	_
12	factor	_	O	O	_	_	_	_	_
13	kappa	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	mice	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	cultured	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	inhibition	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	mediated	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	induction	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	inhibitory	_	O	O	_	_	_	_	_
14	protein	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	which	_	O	O	_	_	_	_	_
17	traps	_	O	O	_	_	_	_	_
18	activated	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	kappa	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	inactive	_	O	O	_	_	_	_	_
25	cytoplasmic	_	O	O	_	_	_	_	_
26	complexes	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_


1	A	_	O	O	_	_	_	_	_
2	switch	_	O	O	_	_	_	_	_
3	from	_	O	O	_	_	_	_	_
4	human	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	fetal	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	adult	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	occurs	_	O	O	_	_	_	_	_
19	within	_	O	O	_	_	_	_	_
20	erythroid	_	O	O	_	_	_	_	_
21	precursor	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	adult	_	O	O	_	_	_	_	_
26	lineage	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	findings	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	compatible	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	competitive	_	O	O	_	_	_	_	_
8	model	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	switching	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	which	_	O	O	_	_	_	_	_
13	EKLF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	mediates	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	adult	_	O	O	_	_	_	_	_
17	stage	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	specific	_	O	O	_	_	_	_	_
20	interaction	_	O	O	_	_	_	_	_
21	between	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	gene	_	O	O	_	_	_	_	_
27	promoter	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	locus	_	O	O	_	_	_	_	_
31	control	_	O	O	_	_	_	_	_
32	region	_	O	O	_	_	_	_	_
33	that	_	O	O	_	_	_	_	_
34	excludes	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	gamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	gene	_	O	O	_	_	_	_	_
40	.	_	O	O	_	_	_	_	_

1	Together	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	vivo	_	O	O	_	_	_	_	_
6	studies	_	O	O	_	_	_	_	_
7	define	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	critical	_	O	O	_	_	_	_	_
10	signal	_	O	O	_	_	_	_	_
11	response	_	O	O	_	_	_	_	_
12	domain	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	coordinately	_	O	O	_	_	_	_	_
20	controls	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	biologic	_	O	O	_	_	_	_	_
23	activities	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	NF	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	kappa	_	O	O	_	_	_	_	_
33	B	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	response	_	O	O	_	_	_	_	_
36	to	_	O	O	_	_	_	_	_
37	viral	_	O	O	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	immune	_	O	O	_	_	_	_	_
40	stimuli	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Naive	_	O	O	_	_	_	_	_
2	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	+	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	cells	_	O	O	_	_	_	_	_
7	differentiate	_	O	O	_	_	_	_	_
8	into	_	O	O	_	_	_	_	_
9	effector	_	O	O	_	_	_	_	_
10	CTLs	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	ability	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	lyse	_	O	O	_	_	_	_	_
16	antigen	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	bearing	_	O	O	_	_	_	_	_
19	target	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	exocytosis	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	lytic	_	O	O	_	_	_	_	_
25	granules	_	O	O	_	_	_	_	_
26	containing	_	O	O	_	_	_	_	_
27	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	granzymes	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	produce	_	O	O	_	_	_	_	_
34	inflammatory	_	O	O	_	_	_	_	_
35	cytokines	_	O	O	_	_	_	_	_
36	such	_	O	O	_	_	_	_	_
37	as	_	O	O	_	_	_	_	_
38	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
39	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	upon	_	O	O	_	_	_	_	_
44	restimulation	_	O	O	_	_	_	_	_
45	through	_	O	O	_	_	_	_	_
46	the	_	O	O	_	_	_	_	_
47	TCR	_	O	O	_	_	_	_	_
48	(	_	O	O	_	_	_	_	_
49	1	_	O	O	_	_	_	_	_
50	,	_	O	O	_	_	_	_	_
51	2	_	O	O	_	_	_	_	_
52	)	_	O	O	_	_	_	_	_
53	.	_	O	O	_	_	_	_	_

1	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	required	_	O	O	_	_	_	_	_
5	for	_	O	O	_	_	_	_	_
6	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	expression	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	both	_	O	O	_	_	_	_	_
13	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	bind	_	O	O	_	_	_	_	_
18	at	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	Prf	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	locus	_	O	O	_	_	_	_	_
23	;	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	contrast	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	expression	_	O	O	_	_	_	_	_
29	is	_	O	O	_	_	_	_	_
30	unaffected	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	T	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	bet	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	-	_	O	O	_	_	_	_	_
36	deficient	_	O	O	_	_	_	_	_
37	cells	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	we	_	O	O	_	_	_	_	_
4	found	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	had	_	O	O	_	_	_	_	_
10	an	_	O	O	_	_	_	_	_
11	antiproliferative	_	O	O	_	_	_	_	_
12	effect	_	O	O	_	_	_	_	_
13	both	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	naive	_	O	O	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	+	_	O	O	_	_	_	_	_
20	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	memory	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	19	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	+	_	O	O	_	_	_	_	_
32	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	+	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	stimulated	_	O	O	_	_	_	_	_
37	with	_	O	O	_	_	_	_	_
38	anti	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	IgM	_	O	O	_	_	_	_	_
41	alone	_	O	O	_	_	_	_	_
42	or	_	O	O	_	_	_	_	_
43	the	_	O	O	_	_	_	_	_
44	combined	_	O	O	_	_	_	_	_
45	action	_	O	O	_	_	_	_	_
46	of	_	O	O	_	_	_	_	_
47	anti	_	O	O	_	_	_	_	_
48	-	_	O	O	_	_	_	_	_
49	IgM	_	O	O	_	_	_	_	_
50	and	_	O	O	_	_	_	_	_
51	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
52	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
53	L	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	.	_	O	O	_	_	_	_	_

1	Additionally	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	BMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	induced	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	death	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	activated	_	O	O	_	_	_	_	_
11	memory	_	O	O	_	_	_	_	_
12	B	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_

1	Since	_	O	O	_	_	_	_	_
2	expression	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	viruses	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	large	_	O	O	_	_	_	_	_
9	part	_	O	O	_	_	_	_	_
10	regulated	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	sequence	_	O	O	_	_	_	_	_
14	elements	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	their	_	O	O	_	_	_	_	_
17	long	_	O	O	_	_	_	_	_
18	terminal	_	O	O	_	_	_	_	_
19	repeats	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	LTRs	_	O	O	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	this	_	O	O	_	_	_	_	_
25	study	_	O	O	_	_	_	_	_
26	was	_	O	O	_	_	_	_	_
27	directed	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	an	_	O	O	_	_	_	_	_
30	analysis	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	regulatory	_	O	O	_	_	_	_	_
34	elements	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	HIV	_	O	O	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	2	_	O	O	_	_	_	_	_
40	LTR	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	enhancers	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	part	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	identical	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	enhancer	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	cis	_	O	O	_	_	_	_	_
3	element	_	O	O	_	_	_	_	_
4	binds	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	complex	_	O	O	_	_	_	_	_
8	referred	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	as	_	O	O	_	_	_	_	_
11	HRF	_	O	O	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	heme	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	responsive	_	O	O	_	_	_	_	_
16	factor	_	O	O	_	_	_	_	_
17	)	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	which	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	greatly	_	O	O	_	_	_	_	_
22	enhanced	_	O	O	_	_	_	_	_
23	both	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	heme	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	treated	_	O	O	_	_	_	_	_
28	FLCs	_	O	O	_	_	_	_	_
29	and	_	O	O	_	_	_	_	_
30	during	_	O	O	_	_	_	_	_
31	monocyte	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	macrophage	_	O	O	_	_	_	_	_
36	differentiation	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Antisense	_	O	O	_	_	_	_	_
2	phosphorothioate	_	O	O	_	_	_	_	_
3	oligonucleotides	_	O	O	_	_	_	_	_
4	to	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	subunits	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	NF	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	kappa	_	O	O	_	_	_	_	_
17	B	_	O	O	_	_	_	_	_
18	complex	_	O	O	_	_	_	_	_
19	were	_	O	O	_	_	_	_	_
20	used	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	define	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	physiologic	_	O	O	_	_	_	_	_
25	role	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	this	_	O	O	_	_	_	_	_
28	transcription	_	O	O	_	_	_	_	_
29	factor	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	resting	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	stimulated	_	O	O	_	_	_	_	_
34	granulocytes	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Interferon	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	alpha	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	IFN	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	alpha	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	pleiotropic	_	O	O	_	_	_	_	_
12	cytokine	_	O	O	_	_	_	_	_
13	that	_	O	O	_	_	_	_	_
14	has	_	O	O	_	_	_	_	_
15	antiviral	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	antiproliferative	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	immunoregulatory	_	O	O	_	_	_	_	_
21	functions	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	IL	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	12	_	O	O	_	_	_	_	_
4	induced	_	O	O	_	_	_	_	_
5	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	15	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	induced	_	O	O	_	_	_	_	_
16	STAT	_	O	O	_	_	_	_	_
17	5	_	O	O	_	_	_	_	_
18	binding	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	GAS	_	O	O	_	_	_	_	_
22	elements	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Pertussis	_	O	O	_	_	_	_	_
2	toxin	_	O	O	_	_	_	_	_
3	treatment	_	O	O	_	_	_	_	_
4	markedly	_	O	O	_	_	_	_	_
5	decreased	_	O	O	_	_	_	_	_
6	kappaB	_	O	O	_	_	_	_	_
7	binding	_	O	O	_	_	_	_	_
8	activities	_	O	O	_	_	_	_	_
9	induced	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	both	_	O	O	_	_	_	_	_
12	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	a	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	a	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	whereas	_	O	O	_	_	_	_	_
21	cholera	_	O	O	_	_	_	_	_
22	toxin	_	O	O	_	_	_	_	_
23	displayed	_	O	O	_	_	_	_	_
24	no	_	O	O	_	_	_	_	_
25	inhibitory	_	O	O	_	_	_	_	_
26	effect	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Analysis	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	RelA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	mRNA	_	O	O	_	_	_	_	_
9	revealed	_	O	O	_	_	_	_	_
10	that	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	stability	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	RelA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	(	_	O	O	_	_	_	_	_
16	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	mRNA	_	O	O	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	significantly	_	O	O	_	_	_	_	_
22	higher	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	MDMs	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	compared	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	monocytes	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	MDMs	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	an	_	O	O	_	_	_	_	_
5	upregulation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	synthesis	_	O	O	_	_	_	_	_
12	as	_	O	O	_	_	_	_	_
13	well	_	O	O	_	_	_	_	_
14	as	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	appearance	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	a	_	O	O	_	_	_	_	_
19	novel	_	O	O	_	_	_	_	_
20	M	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	r	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	40	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	000	_	O	O	_	_	_	_	_
27	form	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	were	_	O	O	_	_	_	_	_
34	also	_	O	O	_	_	_	_	_
35	observed	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	the	_	O	O	_	_	_	_	_
2	cells	_	O	O	_	_	_	_	_
3	are	_	O	O	_	_	_	_	_
4	tolerant	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	protein	_	O	O	_	_	_	_	_
3	tyrosine	_	O	O	_	_	_	_	_
4	kinase	_	O	O	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	v	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	abl	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	oncogene	_	O	O	_	_	_	_	_
12	has	_	O	O	_	_	_	_	_
13	been	_	O	O	_	_	_	_	_
14	demonstrated	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	subvert	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	normal	_	O	O	_	_	_	_	_
19	second	_	O	O	_	_	_	_	_
20	messenger	_	O	O	_	_	_	_	_
21	systems	_	O	O	_	_	_	_	_
22	used	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	lymphoid	_	O	O	_	_	_	_	_
25	cells	_	O	O	_	_	_	_	_
26	for	_	O	O	_	_	_	_	_
27	growth	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	differentiation	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Utilizing	_	O	O	_	_	_	_	_
2	a	_	O	O	_	_	_	_	_
3	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	activation	_	O	O	_	_	_	_	_
7	site	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	like	_	O	O	_	_	_	_	_
10	DNA	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	element	_	O	O	_	_	_	_	_
13	located	_	O	O	_	_	_	_	_
14	upstream	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	I	_	O	O	_	_	_	_	_
18	epsilon	_	O	O	_	_	_	_	_
19	exon	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	we	_	O	O	_	_	_	_	_
22	demonstrated	_	O	O	_	_	_	_	_
23	by	_	O	O	_	_	_	_	_
24	gel	_	O	O	_	_	_	_	_
25	mobility	_	O	O	_	_	_	_	_
26	shift	_	O	O	_	_	_	_	_
27	assays	_	O	O	_	_	_	_	_
28	that	_	O	O	_	_	_	_	_
29	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	induced	_	O	O	_	_	_	_	_
33	a	_	O	O	_	_	_	_	_
34	binding	_	O	O	_	_	_	_	_
35	activity	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	cytosol	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	nucleus	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	BL	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	2	_	O	O	_	_	_	_	_
45	cells	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	factor	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	designated	_	O	O	_	_	_	_	_
5	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	NAF	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	induced	_	O	O	_	_	_	_	_
15	nuclear	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	activating	_	O	O	_	_	_	_	_
18	factors	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	was	_	O	O	_	_	_	_	_
22	identified	_	O	O	_	_	_	_	_
23	as	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	tyrosine	_	O	O	_	_	_	_	_
26	phosphoprotein	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	which	_	O	O	_	_	_	_	_
29	translocates	_	O	O	_	_	_	_	_
30	from	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	cytosol	_	O	O	_	_	_	_	_
33	to	_	O	O	_	_	_	_	_
34	the	_	O	O	_	_	_	_	_
35	nucleus	_	O	O	_	_	_	_	_
36	upon	_	O	O	_	_	_	_	_
37	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
38	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
40	treatment	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	Enhancement	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	IFNA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	synthesis	_	O	O	_	_	_	_	_
5	observed	_	O	O	_	_	_	_	_
6	upon	_	O	O	_	_	_	_	_
7	HIV	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	infection	_	O	O	_	_	_	_	_
11	resulted	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	significant	_	O	O	_	_	_	_	_
14	inhibition	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	HIV	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	replication	_	O	O	_	_	_	_	_
20	for	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	period	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	at	_	O	O	_	_	_	_	_
25	least	_	O	O	_	_	_	_	_
26	30	_	O	O	_	_	_	_	_
27	days	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Alpha	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	lipoic	_	O	O	_	_	_	_	_
4	acid	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	potent	_	O	O	_	_	_	_	_
8	inhibitor	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	NF	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	kappa	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	human	_	O	O	_	_	_	_	_
17	T	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Expressed	_	O	O	_	_	_	_	_
2	in	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	cytoplasm	_	O	O	_	_	_	_	_
5	or	_	O	O	_	_	_	_	_
6	on	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	cell	_	O	O	_	_	_	_	_
9	surface	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	chimera	_	O	O	_	_	_	_	_
13	inhibited	_	O	O	_	_	_	_	_
14	or	_	O	O	_	_	_	_	_
15	activated	_	O	O	_	_	_	_	_
16	early	_	O	O	_	_	_	_	_
17	signaling	_	O	O	_	_	_	_	_
18	events	_	O	O	_	_	_	_	_
19	from	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	cell	_	O	O	_	_	_	_	_
23	antigen	_	O	O	_	_	_	_	_
24	receptor	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	contrast	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	most	_	O	O	_	_	_	_	_
10	LPS	_	O	O	_	_	_	_	_
11	effects	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	AP	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	but	_	O	O	_	_	_	_	_
18	not	_	O	O	_	_	_	_	_
19	nuclear	_	O	O	_	_	_	_	_
20	factor	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kappaB	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	mediates	_	O	O	_	_	_	_	_
25	LPS	_	O	O	_	_	_	_	_
26	induction	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	collagenase	_	O	O	_	_	_	_	_
29	transcription	_	O	O	_	_	_	_	_
30	in	_	O	O	_	_	_	_	_
31	macrophagelike	_	O	O	_	_	_	_	_
32	cells	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Three	_	O	O	_	_	_	_	_
2	interacting	_	O	O	_	_	_	_	_
3	proteins	_	O	O	_	_	_	_	_
4	have	_	O	O	_	_	_	_	_
5	recently	_	O	O	_	_	_	_	_
6	been	_	O	O	_	_	_	_	_
7	shown	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	contribute	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	subset	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	restricted	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	gene	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Understanding	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	cis	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	transacting	_	O	O	_	_	_	_	_
7	factors	_	O	O	_	_	_	_	_
8	that	_	O	O	_	_	_	_	_
9	regulate	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	tissue	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	specific	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	PECAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	should	_	O	O	_	_	_	_	_
20	increase	_	O	O	_	_	_	_	_
21	our	_	O	O	_	_	_	_	_
22	understanding	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	mechanisms	_	O	O	_	_	_	_	_
26	by	_	O	O	_	_	_	_	_
27	which	_	O	O	_	_	_	_	_
28	vascular	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	specific	_	O	O	_	_	_	_	_
31	gene	_	O	O	_	_	_	_	_
32	expression	_	O	O	_	_	_	_	_
33	is	_	O	O	_	_	_	_	_
34	achieved	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	induction	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	STAT	_	O	O	_	_	_	_	_
5	activity	_	O	O	_	_	_	_	_
6	was	_	O	O	_	_	_	_	_
7	inhibited	_	O	O	_	_	_	_	_
8	completely	_	O	O	_	_	_	_	_
9	by	_	O	O	_	_	_	_	_
10	pretreatment	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	either	_	O	O	_	_	_	_	_
13	cycloheximide	_	O	O	_	_	_	_	_
14	or	_	O	O	_	_	_	_	_
15	cyclosporin	_	O	O	_	_	_	_	_
16	A	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	thus	_	O	O	_	_	_	_	_
19	indicating	_	O	O	_	_	_	_	_
20	that	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	induction	_	O	O	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	due	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	secondary	_	O	O	_	_	_	_	_
28	factor	_	O	O	_	_	_	_	_
29	produced	_	O	O	_	_	_	_	_
30	by	_	O	O	_	_	_	_	_
31	the	_	O	O	_	_	_	_	_
32	activated	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Upon	_	O	O	_	_	_	_	_
2	stimulation	_	O	O	_	_	_	_	_
3	by	_	O	O	_	_	_	_	_
4	various	_	O	O	_	_	_	_	_
5	agents	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	I	_	O	O	_	_	_	_	_
8	kappaB	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	proteolyzed	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappaB	_	O	O	_	_	_	_	_
15	translocates	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	nucleus	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	where	_	O	O	_	_	_	_	_
21	it	_	O	O	_	_	_	_	_
22	activates	_	O	O	_	_	_	_	_
23	its	_	O	O	_	_	_	_	_
24	target	_	O	O	_	_	_	_	_
25	genes	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	demonstrate	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	upon	_	O	O	_	_	_	_	_
5	stimulation	_	O	O	_	_	_	_	_
6	by	_	O	O	_	_	_	_	_
7	lipopolysaccharide	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	Taxol	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	phorbol	_	O	O	_	_	_	_	_
12	myristate	_	O	O	_	_	_	_	_
13	acetate	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	interleukin	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	1	_	O	O	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	or	_	O	O	_	_	_	_	_
20	double	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	stranded	_	O	O	_	_	_	_	_
23	RNA	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	is	_	O	O	_	_	_	_	_
29	not	_	O	O	_	_	_	_	_
30	degraded	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	as	_	O	O	_	_	_	_	_
33	a	_	O	O	_	_	_	_	_
34	result	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	an	_	O	O	_	_	_	_	_
37	absence	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	induced	_	O	O	_	_	_	_	_
40	phosphorylation	_	O	O	_	_	_	_	_
41	on	_	O	O	_	_	_	_	_
42	serines	_	O	O	_	_	_	_	_
43	32	_	O	O	_	_	_	_	_
44	and	_	O	O	_	_	_	_	_
45	36	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	Analysis	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	redox	_	O	O	_	_	_	_	_
5	status	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_
9	3	_	O	O	_	_	_	_	_
10	E	_	O	O	_	_	_	_	_
11	2	_	O	O	_	_	_	_	_
12	does	_	O	O	_	_	_	_	_
13	not	_	O	O	_	_	_	_	_
14	reveal	_	O	O	_	_	_	_	_
15	any	_	O	O	_	_	_	_	_
16	difference	_	O	O	_	_	_	_	_
17	from	_	O	O	_	_	_	_	_
18	wild	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	type	_	O	O	_	_	_	_	_
21	70	_	O	O	_	_	_	_	_
22	Z	_	O	O	_	_	_	_	_
23	/	_	O	O	_	_	_	_	_
24	3	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	Whole	_	O	O	_	_	_	_	_
2	cell	_	O	O	_	_	_	_	_
3	lysates	_	O	O	_	_	_	_	_
4	were	_	O	O	_	_	_	_	_
5	prepared	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	radioimmunoprecipitation	_	O	O	_	_	_	_	_
8	assay	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	RIPA	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	buffer	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	20	_	O	O	_	_	_	_	_
15	mM	_	O	O	_	_	_	_	_
16	Tris	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	HCl	_	O	O	_	_	_	_	_
19	[	_	O	O	_	_	_	_	_
20	pH	_	O	O	_	_	_	_	_
21	7	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_
23	5	_	O	O	_	_	_	_	_
24	]	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	150	_	O	O	_	_	_	_	_
27	mM	_	O	O	_	_	_	_	_
28	NaCl	_	O	O	_	_	_	_	_
29	,	_	O	O	_	_	_	_	_
30	1	_	O	O	_	_	_	_	_
31	mM	_	O	O	_	_	_	_	_
32	EDTA	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	1	_	O	O	_	_	_	_	_
35	%	_	O	O	_	_	_	_	_
36	NP	_	O	O	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	40	_	O	O	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	0	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_
42	1	_	O	O	_	_	_	_	_
43	%	_	O	O	_	_	_	_	_
44	SDS	_	O	O	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	0	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_
48	1	_	O	O	_	_	_	_	_
49	%	_	O	O	_	_	_	_	_
50	sodium	_	O	O	_	_	_	_	_
51	deoxycholate	_	O	O	_	_	_	_	_
52	)	_	O	O	_	_	_	_	_
53	supplemented	_	O	O	_	_	_	_	_
54	with	_	O	O	_	_	_	_	_
55	2	_	O	O	_	_	_	_	_
56	mM	_	O	O	_	_	_	_	_
57	phenylmethylsulfonyl	_	O	O	_	_	_	_	_
58	fluoride	_	O	O	_	_	_	_	_
59	,	_	O	O	_	_	_	_	_
60	1	_	O	O	_	_	_	_	_
61	mM	_	O	O	_	_	_	_	_
62	Na	_	O	O	_	_	_	_	_
63	3	_	O	O	_	_	_	_	_
64	VO	_	O	O	_	_	_	_	_
65	4	_	O	O	_	_	_	_	_
66	,	_	O	O	_	_	_	_	_
67	and	_	O	O	_	_	_	_	_
68	1	_	O	O	_	_	_	_	_
69	:	_	O	O	_	_	_	_	_
70	100	_	O	O	_	_	_	_	_
71	protease	_	O	O	_	_	_	_	_
72	/	_	O	O	_	_	_	_	_
73	phosphatase	_	O	O	_	_	_	_	_
74	inhibitor	_	O	O	_	_	_	_	_
75	cocktails	_	O	O	_	_	_	_	_
76	(	_	O	O	_	_	_	_	_
77	Sigma	_	O	O	_	_	_	_	_
78	)	_	O	O	_	_	_	_	_
79	.	_	O	O	_	_	_	_	_

1	Lysates	_	O	O	_	_	_	_	_
2	were	_	O	O	_	_	_	_	_
3	boiled	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	presence	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_
10	5	_	O	O	_	_	_	_	_
11	%	_	O	O	_	_	_	_	_
12	beta	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	mecaptoethanol	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	separated	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	denaturing	_	O	O	_	_	_	_	_
19	SDS	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	PAGE	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	transferred	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	0	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_
28	45	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	mum	_	O	O	_	_	_	_	_
31	Optitran	_	O	O	_	_	_	_	_
32	membranes	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	Schleicher	_	O	O	_	_	_	_	_
35	&	_	O	O	_	_	_	_	_
36	Schuell	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	a	_	O	O	_	_	_	_	_
40	Bio	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	Rad	_	O	O	_	_	_	_	_
43	transfer	_	O	O	_	_	_	_	_
44	unit	_	O	O	_	_	_	_	_
45	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	suggest	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	third	_	O	O	_	_	_	_	_
10	component	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	necessary	_	O	O	_	_	_	_	_
13	for	_	O	O	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	activation	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	that	_	O	O	_	_	_	_	_
18	this	_	O	O	_	_	_	_	_
19	third	_	O	O	_	_	_	_	_
20	component	_	O	O	_	_	_	_	_
21	may	_	O	O	_	_	_	_	_
22	vary	_	O	O	_	_	_	_	_
23	with	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	type	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	All	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	motifs	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	essential	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	collectively	_	O	O	_	_	_	_	_
8	control	_	O	O	_	_	_	_	_
9	transcriptional	_	O	O	_	_	_	_	_
10	activity	_	O	O	_	_	_	_	_
11	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	+	_	O	O	_	_	_	_	_
4	Tcells	_	O	O	_	_	_	_	_
5	producing	_	O	O	_	_	_	_	_
6	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	)	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	)	_	O	O	_	_	_	_	_
23	are	_	O	O	_	_	_	_	_
24	reported	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	chronic	_	O	O	_	_	_	_	_
27	infections	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	showed	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	development	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	producing	_	O	O	_	_	_	_	_
11	Th	_	O	O	_	_	_	_	_
12	1	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	required	_	O	O	_	_	_	_	_
15	high	_	O	O	_	_	_	_	_
16	Tcell	_	O	O	_	_	_	_	_
17	receptor	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	TCR	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	ligation	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	sustained	_	O	O	_	_	_	_	_
24	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	ERK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	MAP	_	O	O	_	_	_	_	_
30	kinases	_	O	O	_	_	_	_	_
31	phosphorylation	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	-	_	O	O	_	_	_	_	_
38	induced	_	O	O	_	_	_	_	_
39	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	transcription	_	O	O	_	_	_	_	_
42	factor	_	O	O	_	_	_	_	_
43	activation	_	O	O	_	_	_	_	_
44	.	_	O	O	_	_	_	_	_

1	Protein	_	O	O	_	_	_	_	_
2	kinase	_	O	O	_	_	_	_	_
3	D	_	O	O	_	_	_	_	_
4	serine	_	O	O	_	_	_	_	_
5	kinases	_	O	O	_	_	_	_	_
6	have	_	O	O	_	_	_	_	_
7	been	_	O	O	_	_	_	_	_
8	proposed	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	regulate	_	O	O	_	_	_	_	_
11	diverse	_	O	O	_	_	_	_	_
12	cellular	_	O	O	_	_	_	_	_
13	functions	_	O	O	_	_	_	_	_
14	including	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	phosphorylation	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	nuclear	_	O	O	_	_	_	_	_
19	localisation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	class	_	O	O	_	_	_	_	_
22	II	_	O	O	_	_	_	_	_
23	HDACs	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	phosphorylation	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	HSP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	27	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Taken	_	O	O	_	_	_	_	_
2	together	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	these	_	O	O	_	_	_	_	_
5	data	_	O	O	_	_	_	_	_
6	indicate	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	loss	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	expression	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	PKD	_	O	O	_	_	_	_	_
13	family	_	O	O	_	_	_	_	_
14	members	_	O	O	_	_	_	_	_
15	does	_	O	O	_	_	_	_	_
16	not	_	O	O	_	_	_	_	_
17	globally	_	O	O	_	_	_	_	_
18	impact	_	O	O	_	_	_	_	_
19	on	_	O	O	_	_	_	_	_
20	early	_	O	O	_	_	_	_	_
21	BCR	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	regulated	_	O	O	_	_	_	_	_
24	signalling	_	O	O	_	_	_	_	_
25	pathways	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_




1	Human	_	O	O	_	_	_	_	_
2	lysosomal	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	acid	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	lipase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	(	_	O	O	_	_	_	_	_
6	LAL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	)	_	O	O	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	hydrolase	_	O	O	_	_	_	_	_
11	required	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	cleavage	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	cholesteryl	_	O	O	_	_	_	_	_
17	esters	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	triglycerides	_	O	O	_	_	_	_	_
20	derived	_	O	O	_	_	_	_	_
21	from	_	O	O	_	_	_	_	_
22	plasma	_	O	O	_	_	_	_	_
23	lipoproteins	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	human	_	O	O	_	_	_	_	_
3	monocytic	_	O	O	_	_	_	_	_
4	leukemia	_	O	O	_	_	_	_	_
5	cell	_	O	O	_	_	_	_	_
6	line	_	O	O	_	_	_	_	_
7	THP	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	differentiates	_	O	O	_	_	_	_	_
11	into	_	O	O	_	_	_	_	_
12	macrophage	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	like	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	when	_	O	O	_	_	_	_	_
17	treated	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	phorbol	_	O	O	_	_	_	_	_
20	esters	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Co	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	transfections	_	O	O	_	_	_	_	_
4	with	_	O	O	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	plasmids	_	O	O	_	_	_	_	_
7	for	_	O	O	_	_	_	_	_
8	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	AP	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	2	_	O	O	_	_	_	_	_
14	further	_	O	O	_	_	_	_	_
15	emphasized	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	important	_	O	O	_	_	_	_	_
18	role	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	these	_	O	O	_	_	_	_	_
21	transcription	_	O	O	_	_	_	_	_
22	factors	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	both	_	O	O	_	_	_	_	_
25	basal	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	PMA	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	enhanced	_	O	O	_	_	_	_	_
30	LAL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	expression	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Introduction	_	O	O	_	_	_	_	_

1	PKD	_	O	O	_	_	_	_	_
2	enzymes	_	O	O	_	_	_	_	_
3	have	_	O	O	_	_	_	_	_
4	been	_	O	O	_	_	_	_	_
5	proposed	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	regulate	_	O	O	_	_	_	_	_
8	numerous	_	O	O	_	_	_	_	_
9	cellular	_	O	O	_	_	_	_	_
10	functions	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	including	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	proliferation	_	O	O	_	_	_	_	_
15	[	_	O	O	_	_	_	_	_
16	13	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	16	_	O	O	_	_	_	_	_
19	]	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	anti	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	apoptotic	_	O	O	_	_	_	_	_
24	signals	_	O	O	_	_	_	_	_
25	[	_	O	O	_	_	_	_	_
26	17	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	18	_	O	O	_	_	_	_	_
29	]	_	O	O	_	_	_	_	_
30	and	_	O	O	_	_	_	_	_
31	thymocyte	_	O	O	_	_	_	_	_
32	development	_	O	O	_	_	_	_	_
33	[	_	O	O	_	_	_	_	_
34	19	_	O	O	_	_	_	_	_
35	]	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	investigate	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	biological	_	O	O	_	_	_	_	_
5	role	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	PKDs	_	O	O	_	_	_	_	_
8	we	_	O	O	_	_	_	_	_
9	have	_	O	O	_	_	_	_	_
10	generated	_	O	O	_	_	_	_	_
11	DT	_	O	O	_	_	_	_	_
12	40	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	lines	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	lack	_	O	O	_	_	_	_	_
18	expression	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	one	_	O	O	_	_	_	_	_
21	or	_	O	O	_	_	_	_	_
22	more	_	O	O	_	_	_	_	_
23	members	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	PKD	_	O	O	_	_	_	_	_
27	family	_	O	O	_	_	_	_	_
28	[	_	O	O	_	_	_	_	_
29	1	_	O	O	_	_	_	_	_
30	]	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	allowing	_	O	O	_	_	_	_	_
33	us	_	O	O	_	_	_	_	_
34	to	_	O	O	_	_	_	_	_
35	investigate	_	O	O	_	_	_	_	_
36	the	_	O	O	_	_	_	_	_
37	function	_	O	O	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	s	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	PKD	_	O	O	_	_	_	_	_
43	isoforms	_	O	O	_	_	_	_	_
44	following	_	O	O	_	_	_	_	_
45	B	_	O	O	_	_	_	_	_
46	cell	_	O	O	_	_	_	_	_
47	antigen	_	O	O	_	_	_	_	_
48	receptor	_	O	O	_	_	_	_	_
49	(	_	O	O	_	_	_	_	_
50	BCR	_	O	O	_	_	_	_	_
51	)	_	O	O	_	_	_	_	_
52	stimulation	_	O	O	_	_	_	_	_
53	,	_	O	O	_	_	_	_	_
54	as	_	O	O	_	_	_	_	_
55	well	_	O	O	_	_	_	_	_
56	addressing	_	O	O	_	_	_	_	_
57	the	_	O	O	_	_	_	_	_
58	issue	_	O	O	_	_	_	_	_
59	of	_	O	O	_	_	_	_	_
60	functional	_	O	O	_	_	_	_	_
61	redundancy	_	O	O	_	_	_	_	_
62	between	_	O	O	_	_	_	_	_
63	the	_	O	O	_	_	_	_	_
64	different	_	O	O	_	_	_	_	_
65	PKD	_	O	O	_	_	_	_	_
66	family	_	O	O	_	_	_	_	_
67	members	_	O	O	_	_	_	_	_
68	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	PKD	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	null	_	O	O	_	_	_	_	_
6	DT	_	O	O	_	_	_	_	_
7	40	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	are	_	O	O	_	_	_	_	_
11	viable	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	proliferate	_	O	O	_	_	_	_	_
14	normally	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Together	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	findings	_	O	O	_	_	_	_	_
5	reveal	_	O	O	_	_	_	_	_
6	that	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	lymphocytes	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	PKD	_	O	O	_	_	_	_	_
12	kinases	_	O	O	_	_	_	_	_
13	are	_	O	O	_	_	_	_	_
14	not	_	O	O	_	_	_	_	_
15	critical	_	O	O	_	_	_	_	_
16	regulators	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	many	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	cellular	_	O	O	_	_	_	_	_
22	processes	_	O	O	_	_	_	_	_
23	previously	_	O	O	_	_	_	_	_
24	ascribed	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	them	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	other	_	O	O	_	_	_	_	_
29	cellular	_	O	O	_	_	_	_	_
30	systems	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_





1	TNFRI	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	has	_	O	O	_	_	_	_	_
3	been	_	O	O	_	_	_	_	_
4	recently	_	O	O	_	_	_	_	_
5	shown	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	activate	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	kappaB	_	O	O	_	_	_	_	_
11	through	_	O	O	_	_	_	_	_
12	association	_	O	O	_	_	_	_	_
13	with	_	O	O	_	_	_	_	_
14	TRADD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	RIP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	TRAF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	;	_	O	O	_	_	_	_	_
22	activation	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	inducing	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	kinase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	NIK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	;	_	O	O	_	_	_	_	_
35	activation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	IkappaB	_	O	O	_	_	_	_	_
39	alpha	_	O	O	_	_	_	_	_
40	kinases	_	O	O	_	_	_	_	_
41	(	_	O	O	_	_	_	_	_
42	IKKalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	IKKbeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	)	_	O	O	_	_	_	_	_
46	;	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	phosphorylation	_	O	O	_	_	_	_	_
49	of	_	O	O	_	_	_	_	_
50	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
51	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	Dominant	_	O	O	_	_	_	_	_
2	negative	_	O	O	_	_	_	_	_
3	mutants	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	NIK	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	IKKalpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	or	_	O	O	_	_	_	_	_
10	IKKbeta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	substantially	_	O	O	_	_	_	_	_
12	inhibited	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappaB	_	O	O	_	_	_	_	_
16	activation	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	or	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	each	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	its	_	O	O	_	_	_	_	_
25	effector	_	O	O	_	_	_	_	_
26	sites	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Stimulation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	lymphocytes	_	O	O	_	_	_	_	_
5	through	_	O	O	_	_	_	_	_
6	their	_	O	O	_	_	_	_	_
7	antigen	_	O	O	_	_	_	_	_
8	receptor	_	O	O	_	_	_	_	_
9	leads	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	appearance	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	several	_	O	O	_	_	_	_	_
15	transcription	_	O	O	_	_	_	_	_
16	factors	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	including	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	AT	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappa	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	which	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	involved	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	regulating	_	O	O	_	_	_	_	_
33	genes	_	O	O	_	_	_	_	_
34	required	_	O	O	_	_	_	_	_
35	for	_	O	O	_	_	_	_	_
36	immunologic	_	O	O	_	_	_	_	_
37	activation	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_

1	Consistent	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	findings	_	O	O	_	_	_	_	_
4	obtained	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	transient	_	O	O	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	assays	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	we	_	O	O	_	_	_	_	_
11	observed	_	O	O	_	_	_	_	_
12	marked	_	O	O	_	_	_	_	_
13	accumulation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	transcription	_	O	O	_	_	_	_	_
17	factor	_	O	O	_	_	_	_	_
18	NF	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	kappa	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	nucleus	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	Namalwa	_	O	O	_	_	_	_	_
27	B	_	O	O	_	_	_	_	_
28	lymphoid	_	O	O	_	_	_	_	_
29	cells	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	which	_	O	O	_	_	_	_	_
32	constitutively	_	O	O	_	_	_	_	_
33	express	_	O	O	_	_	_	_	_
34	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	Consequently	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	one	_	O	O	_	_	_	_	_
4	function	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	Tax	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	infected	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	HTLV	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	I	_	O	O	_	_	_	_	_
14	might	_	O	O	_	_	_	_	_
15	involve	_	O	O	_	_	_	_	_
16	cell	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	type	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	specific	_	O	O	_	_	_	_	_
21	suppression	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	as	_	O	O	_	_	_	_	_
24	opposed	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	distinct	_	O	O	_	_	_	_	_
30	signal	_	O	O	_	_	_	_	_
31	pathways	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Several	_	O	O	_	_	_	_	_
2	DNA	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	binding	_	O	O	_	_	_	_	_
5	proteins	_	O	O	_	_	_	_	_
6	are	_	O	O	_	_	_	_	_
7	known	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	bind	_	O	O	_	_	_	_	_
10	this	_	O	O	_	_	_	_	_
11	sequence	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	best	_	O	O	_	_	_	_	_
3	characterized	_	O	O	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	specific	_	O	O	_	_	_	_	_
10	OTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	ubiquitous	_	O	O	_	_	_	_	_
16	OTF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	is	_	O	O	_	_	_	_	_
3	located	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	nucleus	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	mature	_	O	O	_	_	_	_	_
9	B	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	but	_	O	O	_	_	_	_	_
13	is	_	O	O	_	_	_	_	_
14	present	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	other	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	types	_	O	O	_	_	_	_	_
19	as	_	O	O	_	_	_	_	_
20	an	_	O	O	_	_	_	_	_
21	inactive	_	O	O	_	_	_	_	_
22	cytoplasmic	_	O	O	_	_	_	_	_
23	complex	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	cloning	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	complementary	_	O	O	_	_	_	_	_
6	DNA	_	O	O	_	_	_	_	_
7	for	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	50	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	K	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	subunit	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	helped	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	identify	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	exclusively	_	O	O	_	_	_	_	_
17	cytoplasmic	_	O	O	_	_	_	_	_
18	105	_	O	O	_	_	_	_	_
19	K	_	O	O	_	_	_	_	_
20	precursor	_	O	O	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	V	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_
28	B	_	O	O	_	_	_	_	_
29	.,	_	O	O	_	_	_	_	_
30	P	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_
32	K	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	show	_	O	O	_	_	_	_	_
3	here	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	HIV	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	1	_	O	O	_	_	_	_	_
9	protease	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	can	_	O	O	_	_	_	_	_
11	process	_	O	O	_	_	_	_	_
12	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	increases	_	O	O	_	_	_	_	_
16	levels	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	active	_	O	O	_	_	_	_	_
19	nuclear	_	O	O	_	_	_	_	_
20	NF	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kappa	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	complex	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	ability	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	BHRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	inhibit	_	O	O	_	_	_	_	_
8	apoptosis	_	O	O	_	_	_	_	_
9	is	_	O	O	_	_	_	_	_
10	dependent	_	O	O	_	_	_	_	_
11	on	_	O	O	_	_	_	_	_
12	stimulus	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	type	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	ability	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	BHRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	protect	_	O	O	_	_	_	_	_
8	MCF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	Fas	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	from	_	O	O	_	_	_	_	_
13	apoptosis	_	O	O	_	_	_	_	_
14	induced	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	various	_	O	O	_	_	_	_	_
17	stimuli	_	O	O	_	_	_	_	_
18	was	_	O	O	_	_	_	_	_
19	identical	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	that	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	Bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	Bcl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	xL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	36	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	cell	_	O	O	_	_	_	_	_
6	surface	_	O	O	_	_	_	_	_
7	glycoprotein	_	O	O	_	_	_	_	_
8	composed	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	a	_	O	O	_	_	_	_	_
11	single	_	O	O	_	_	_	_	_
12	polypeptide	_	O	O	_	_	_	_	_
13	chain	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	which	_	O	O	_	_	_	_	_
16	interacts	_	O	O	_	_	_	_	_
17	with	_	O	O	_	_	_	_	_
18	thrombospondin	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	collagens	_	O	O	_	_	_	_	_
21	type	_	O	O	_	_	_	_	_
22	I	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	IV	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	oxidized	_	O	O	_	_	_	_	_
27	low	_	O	O	_	_	_	_	_
28	density	_	O	O	_	_	_	_	_
29	lipoprotein	_	O	O	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	fatty	_	O	O	_	_	_	_	_
32	acids	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	anionic	_	O	O	_	_	_	_	_
35	phospholipids	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	erythrocytes	_	O	O	_	_	_	_	_
39	parasitized	_	O	O	_	_	_	_	_
40	with	_	O	O	_	_	_	_	_
41	Plasmodium	_	O	O	_	_	_	_	_
42	falciparum	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	involvement	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	members	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	PEBP	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	/	_	O	O	_	_	_	_	_
10	CBF	_	O	O	_	_	_	_	_
11	family	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	chromosome	_	O	O	_	_	_	_	_
14	translocations	_	O	O	_	_	_	_	_
15	associated	_	O	O	_	_	_	_	_
16	with	_	O	O	_	_	_	_	_
17	acute	_	O	O	_	_	_	_	_
18	myeloid	_	O	O	_	_	_	_	_
19	leukemia	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	transcriptional	_	O	O	_	_	_	_	_
25	regulation	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	myeloid	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	specific	_	O	O	_	_	_	_	_
31	genes	_	O	O	_	_	_	_	_
32	encoding	_	O	O	_	_	_	_	_
33	for	_	O	O	_	_	_	_	_
34	myeloperoxidase	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	elastase	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	and	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	colony	_	O	O	_	_	_	_	_
41	-	_	O	O	_	_	_	_	_
42	stimulating	_	O	O	_	_	_	_	_
43	factor	_	O	O	_	_	_	_	_
44	receptor	_	O	O	_	_	_	_	_
45	,	_	O	O	_	_	_	_	_
46	highlights	_	O	O	_	_	_	_	_
47	the	_	O	O	_	_	_	_	_
48	relevance	_	O	O	_	_	_	_	_
49	of	_	O	O	_	_	_	_	_
50	the	_	O	O	_	_	_	_	_
51	regulation	_	O	O	_	_	_	_	_
52	of	_	O	O	_	_	_	_	_
53	the	_	O	O	_	_	_	_	_
54	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
55	36	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	gene	_	O	O	_	_	_	_	_
57	promoter	_	O	O	_	_	_	_	_
58	in	_	O	O	_	_	_	_	_
59	monocytic	_	O	O	_	_	_	_	_
60	cells	_	O	O	_	_	_	_	_
61	by	_	O	O	_	_	_	_	_
62	members	_	O	O	_	_	_	_	_
63	of	_	O	O	_	_	_	_	_
64	the	_	O	O	_	_	_	_	_
65	PEBP	_	O	O	_	_	_	_	_
66	2	_	O	O	_	_	_	_	_
67	/	_	O	O	_	_	_	_	_
68	CBF	_	O	O	_	_	_	_	_
69	family	_	O	O	_	_	_	_	_
70	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	demonstrate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	incubation	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	human	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	with	_	O	O	_	_	_	_	_
11	low	_	O	O	_	_	_	_	_
12	concentrations	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	approximately	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	5	_	O	O	_	_	_	_	_
18	nM	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	calyculin	_	O	O	_	_	_	_	_
22	A	_	O	O	_	_	_	_	_
23	or	_	O	O	_	_	_	_	_
24	okadaic	_	O	O	_	_	_	_	_
25	acid	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	potent	_	O	O	_	_	_	_	_
28	inhibitors	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	protein	_	O	O	_	_	_	_	_
31	phosphatase	_	O	O	_	_	_	_	_
32	type	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	PP	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	1	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	type	_	O	O	_	_	_	_	_
41	2	_	O	O	_	_	_	_	_
42	A	_	O	O	_	_	_	_	_
43	(	_	O	O	_	_	_	_	_
44	PP	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	2	_	O	O	_	_	_	_	_
47	A	_	O	O	_	_	_	_	_
48	)	_	O	O	_	_	_	_	_
49	,	_	O	O	_	_	_	_	_
50	induces	_	O	O	_	_	_	_	_
51	the	_	O	O	_	_	_	_	_
52	phosphorylation	_	O	O	_	_	_	_	_
53	of	_	O	O	_	_	_	_	_
54	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
55	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
56	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	even	_	O	O	_	_	_	_	_
59	in	_	O	O	_	_	_	_	_
60	the	_	O	O	_	_	_	_	_
61	absence	_	O	O	_	_	_	_	_
62	of	_	O	O	_	_	_	_	_
63	any	_	O	O	_	_	_	_	_
64	cellular	_	O	O	_	_	_	_	_
65	stimulus	_	O	O	_	_	_	_	_
66	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	induction	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	phosphorylation	_	O	O	_	_	_	_	_
10	by	_	O	O	_	_	_	_	_
11	both	_	O	O	_	_	_	_	_
12	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	phosphatase	_	O	O	_	_	_	_	_
18	inhibitors	_	O	O	_	_	_	_	_
19	is	_	O	O	_	_	_	_	_
20	associated	_	O	O	_	_	_	_	_
21	with	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	subsequent	_	O	O	_	_	_	_	_
24	degradation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	studies	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	specific	_	O	O	_	_	_	_	_
6	tyrosine	_	O	O	_	_	_	_	_
7	phosphorylation	_	O	O	_	_	_	_	_
8	following	_	O	O	_	_	_	_	_
9	PTK	_	O	O	_	_	_	_	_
10	activation	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	involved	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	mobilization	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	nuclear	_	O	O	_	_	_	_	_
22	factor	_	O	O	_	_	_	_	_
23	kappa	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	,	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	VCAM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	mRNA	_	O	O	_	_	_	_	_
31	expression	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_


1	T	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	lymphocytes	_	O	O	_	_	_	_	_
4	from	_	O	O	_	_	_	_	_
5	individuals	_	O	O	_	_	_	_	_
6	with	_	O	O	_	_	_	_	_
7	filarial	_	O	O	_	_	_	_	_
8	inflammatory	_	O	O	_	_	_	_	_
9	disease	_	O	O	_	_	_	_	_
10	have	_	O	O	_	_	_	_	_
11	increased	_	O	O	_	_	_	_	_
12	transendothelial	_	O	O	_	_	_	_	_
13	migration	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	vitro	_	O	O	_	_	_	_	_
16	.	_	O	O	_	_	_	_	_

1	TAL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	LIM	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	only	_	O	O	_	_	_	_	_
7	proteins	_	O	O	_	_	_	_	_
8	synergistically	_	O	O	_	_	_	_	_
9	induce	_	O	O	_	_	_	_	_
10	retinaldehyde	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	dehydrogenase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	acute	_	O	O	_	_	_	_	_
19	lymphoblastic	_	O	O	_	_	_	_	_
20	leukemia	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	acting	_	O	O	_	_	_	_	_
23	as	_	O	O	_	_	_	_	_
24	cofactors	_	O	O	_	_	_	_	_
25	for	_	O	O	_	_	_	_	_
26	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	understand	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	molecular	_	O	O	_	_	_	_	_
5	mechanisms	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	functional	_	O	O	_	_	_	_	_
8	synergy	_	O	O	_	_	_	_	_
9	between	_	O	O	_	_	_	_	_
10	TAL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	LMO	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	tumorigenesis	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	transcriptional	_	O	O	_	_	_	_	_
18	regulation	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	we	_	O	O	_	_	_	_	_
21	tried	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	identify	_	O	O	_	_	_	_	_
24	downstream	_	O	O	_	_	_	_	_
25	target	_	O	O	_	_	_	_	_
26	genes	_	O	O	_	_	_	_	_
27	regulated	_	O	O	_	_	_	_	_
28	by	_	O	O	_	_	_	_	_
29	TAL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	and	_	O	O	_	_	_	_	_
32	LMO	_	O	O	_	_	_	_	_
33	by	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	subtractive	_	O	O	_	_	_	_	_
36	PCR	_	O	O	_	_	_	_	_
37	method	_	O	O	_	_	_	_	_
38	.	_	O	O	_	_	_	_	_


1	This	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	factor	_	O	O	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	composed	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	products	_	O	O	_	_	_	_	_
8	from	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	fos	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	jun	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	proto	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	oncogene	_	O	O	_	_	_	_	_
16	family	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	believed	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	be	_	O	O	_	_	_	_	_
22	important	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	regulating	_	O	O	_	_	_	_	_
25	cell	_	O	O	_	_	_	_	_
26	growth	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	proliferation	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Intriguingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	methylation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	promoter	_	O	O	_	_	_	_	_
10	significantly	_	O	O	_	_	_	_	_
11	decreased	_	O	O	_	_	_	_	_
12	promoter	_	O	O	_	_	_	_	_
13	activity	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	positive	_	O	O	_	_	_	_	_
20	SD	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	1	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	by	_	O	O	_	_	_	_	_
25	85	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_
27	0	_	O	O	_	_	_	_	_
28	%	_	O	O	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	Figure	_	O	O	_	_	_	_	_
31	5	_	O	O	_	_	_	_	_
32	B	_	O	O	_	_	_	_	_
33	)	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	ZEB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	vertebrate	_	O	O	_	_	_	_	_
5	homolog	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	Zfh	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	1	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	binds	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	subset	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	E	_	O	O	_	_	_	_	_
16	boxes	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	blocks	_	O	O	_	_	_	_	_
19	myogenesis	_	O	O	_	_	_	_	_
20	through	_	O	O	_	_	_	_	_
21	transcriptional	_	O	O	_	_	_	_	_
22	repression	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	muscle	_	O	O	_	_	_	_	_
25	genes	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	specific	_	O	O	_	_	_	_	_
5	members	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	NF	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	kappa	_	O	O	_	_	_	_	_
11	B	_	O	O	_	_	_	_	_
12	family	_	O	O	_	_	_	_	_
13	contribute	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	this	_	O	O	_	_	_	_	_
16	effect	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	we	_	O	O	_	_	_	_	_
19	have	_	O	O	_	_	_	_	_
20	examined	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	abilities	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	different	_	O	O	_	_	_	_	_
25	NF	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	kappa	_	O	O	_	_	_	_	_
28	B	_	O	O	_	_	_	_	_
29	subunits	_	O	O	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	act	_	O	O	_	_	_	_	_
32	with	_	O	O	_	_	_	_	_
33	Tat	_	BPROTEIN	BPROTEIN	_	_	_	_	_
34	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	I	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	to	_	O	O	_	_	_	_	_
37	stimulate	_	O	O	_	_	_	_	_
38	transcription	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	HIV	_	O	O	_	_	_	_	_
41	in	_	O	O	_	_	_	_	_
42	Jurkat	_	O	O	_	_	_	_	_
43	T	_	O	O	_	_	_	_	_
44	-	_	O	O	_	_	_	_	_
45	leukemia	_	O	O	_	_	_	_	_
46	cells	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	Efficient	_	O	O	_	_	_	_	_
2	transcription	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	replication	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	simian	_	O	O	_	_	_	_	_
7	immunodeficiency	_	O	O	_	_	_	_	_
8	virus	_	O	O	_	_	_	_	_
9	in	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	absence	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	NF	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	kappaB	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	binding	_	O	O	_	_	_	_	_
20	elements	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	All	_	O	O	_	_	_	_	_
2	mutants	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	including	_	O	O	_	_	_	_	_
5	one	_	O	O	_	_	_	_	_
6	extensively	_	O	O	_	_	_	_	_
7	mutagenized	_	O	O	_	_	_	_	_
8	strain	_	O	O	_	_	_	_	_
9	entirely	_	O	O	_	_	_	_	_
10	missing	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	NF	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	kappaB	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	four	_	O	O	_	_	_	_	_
17	Spl	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	binding	_	O	O	_	_	_	_	_
19	elements	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	replicated	_	O	O	_	_	_	_	_
22	with	_	O	O	_	_	_	_	_
23	wild	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	type	_	O	O	_	_	_	_	_
26	kinetics	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	a	_	O	O	_	_	_	_	_
30	wild	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	type	_	O	O	_	_	_	_	_
33	level	_	O	O	_	_	_	_	_
34	in	_	O	O	_	_	_	_	_
35	peripheral	_	O	O	_	_	_	_	_
36	blood	_	O	O	_	_	_	_	_
37	mononuclear	_	O	O	_	_	_	_	_
38	cell	_	O	O	_	_	_	_	_
39	cultures	_	O	O	_	_	_	_	_
40	in	_	O	O	_	_	_	_	_
41	50	_	O	O	_	_	_	_	_
42	to	_	O	O	_	_	_	_	_
43	100	_	O	O	_	_	_	_	_
44	%	_	O	O	_	_	_	_	_
45	of	_	O	O	_	_	_	_	_
46	the	_	O	O	_	_	_	_	_
47	experiments	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	One	_	O	O	_	_	_	_	_
2	group	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	mutants	_	O	O	_	_	_	_	_
5	replicated	_	O	O	_	_	_	_	_
6	very	_	O	O	_	_	_	_	_
7	similarly	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	SIVmac	_	O	O	_	_	_	_	_
10	239	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	kinetics	_	O	O	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	yield	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	CEMxl	_	O	O	_	_	_	_	_
17	74	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	2	_	O	O	_	_	_	_	_
21	xNFKappaB	_	O	O	_	_	_	_	_
22	>	_	O	O	_	_	_	_	_
23	or	_	O	O	_	_	_	_	_
24	=	_	O	O	_	_	_	_	_
25	SlVmac	_	O	O	_	_	_	_	_
26	239	_	O	O	_	_	_	_	_
27	approximately	_	O	O	_	_	_	_	_
28	deltaNFkappaB	_	O	O	_	_	_	_	_
29	approximately	_	O	O	_	_	_	_	_
30	deltaSpl	_	O	O	_	_	_	_	_
31	234	_	O	O	_	_	_	_	_
32	approximately	_	O	O	_	_	_	_	_
33	substNFkappaB	_	O	O	_	_	_	_	_
34	approximately	_	O	O	_	_	_	_	_
35	substSpl	_	O	O	_	_	_	_	_
36	2	_	O	O	_	_	_	_	_
37	approximately	_	O	O	_	_	_	_	_
38	substSp	_	O	O	_	_	_	_	_
39	23	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	,	_	O	O	_	_	_	_	_
42	while	_	O	O	_	_	_	_	_
43	a	_	O	O	_	_	_	_	_
44	second	_	O	O	_	_	_	_	_
45	group	_	O	O	_	_	_	_	_
46	replicated	_	O	O	_	_	_	_	_
47	with	_	O	O	_	_	_	_	_
48	delayed	_	O	O	_	_	_	_	_
49	or	_	O	O	_	_	_	_	_
50	slightly	_	O	O	_	_	_	_	_
51	delayed	_	O	O	_	_	_	_	_
52	kinetics	_	O	O	_	_	_	_	_
53	in	_	O	O	_	_	_	_	_
54	CEMxl	_	O	O	_	_	_	_	_
55	74	_	O	O	_	_	_	_	_
56	cells	_	O	O	_	_	_	_	_
57	(	_	O	O	_	_	_	_	_
58	SIVmac	_	O	O	_	_	_	_	_
59	239	_	O	O	_	_	_	_	_
60	>	_	O	O	_	_	_	_	_
61	substSp	_	O	O	_	_	_	_	_
62	34	_	O	O	_	_	_	_	_
63	>	_	O	O	_	_	_	_	_
64	deltaNFkappaBdeltaSpl	_	O	O	_	_	_	_	_
65	234	_	O	O	_	_	_	_	_
66	approximately	_	O	O	_	_	_	_	_
67	deltaNFkappaBdeltaSp	_	O	O	_	_	_	_	_
68	1	_	O	O	_	_	_	_	_
69	>	_	O	O	_	_	_	_	_
70	substSpl	_	O	O	_	_	_	_	_
71	234	_	O	O	_	_	_	_	_
72	)	_	O	O	_	_	_	_	_
73	.	_	O	O	_	_	_	_	_

1	Therefore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	surprisingly	_	O	O	_	_	_	_	_
5	high	_	O	O	_	_	_	_	_
6	replicative	_	O	O	_	_	_	_	_
7	capacity	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	NF	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	kappaB	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	site	_	O	O	_	_	_	_	_
17	mutants	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	SIVmac	_	O	O	_	_	_	_	_
20	is	_	O	O	_	_	_	_	_
21	due	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	unique	_	O	O	_	_	_	_	_
24	features	_	O	O	_	_	_	_	_
25	or	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	enhancer	_	O	O	_	_	_	_	_
28	/	_	O	O	_	_	_	_	_
29	promoter	_	O	O	_	_	_	_	_
30	region	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Mice	_	O	O	_	_	_	_	_
2	lacking	_	O	O	_	_	_	_	_
3	Rel	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	are	_	O	O	_	_	_	_	_
5	defective	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	mitogenic	_	O	O	_	_	_	_	_
8	activation	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	B	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	lymphocytes	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	display	_	O	O	_	_	_	_	_
16	impaired	_	O	O	_	_	_	_	_
17	humoral	_	O	O	_	_	_	_	_
18	immunity	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	macrophages	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	slight	_	O	O	_	_	_	_	_
6	enhancement	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	production	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	seen	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	whereas	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	was	_	O	O	_	_	_	_	_
21	not	_	O	O	_	_	_	_	_
22	detected	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Targeted	_	O	O	_	_	_	_	_
2	degradation	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	but	_	O	O	_	_	_	_	_
9	not	_	O	O	_	_	_	_	_
10	v	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	Fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	by	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	phosphorylation	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	dependent	_	O	O	_	_	_	_	_
19	signal	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	Jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Tobacco	_	O	O	_	_	_	_	_
2	smoke	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	TS	_	O	O	_	_	_	_	_
5	)	_	O	O	_	_	_	_	_
6	exposure	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	major	_	O	O	_	_	_	_	_
10	risk	_	O	O	_	_	_	_	_
11	factor	_	O	O	_	_	_	_	_
12	for	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	disease	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	macrophages	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	healthy	_	O	O	_	_	_	_	_
20	smokers	_	O	O	_	_	_	_	_
21	have	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	depressed	_	O	O	_	_	_	_	_
24	capacity	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	release	_	O	O	_	_	_	_	_
27	cytokines	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	including	_	O	O	_	_	_	_	_
30	tumor	_	O	O	_	_	_	_	_
31	necrosis	_	O	O	_	_	_	_	_
32	factor	_	O	O	_	_	_	_	_
33	(	_	O	O	_	_	_	_	_
34	TNF	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	alpha	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	TPCK	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	TLCK	_	O	O	_	_	_	_	_
5	inhibited	_	O	O	_	_	_	_	_
6	LPS	_	O	O	_	_	_	_	_
7	induction	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	mRNA	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	promoter	_	O	O	_	_	_	_	_
17	activity	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	dose	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	dependent	_	O	O	_	_	_	_	_
23	manner	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Thymocytes	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	activated	_	O	O	_	_	_	_	_
4	peripheral	_	O	O	_	_	_	_	_
5	T	_	O	O	_	_	_	_	_
6	lymphocytes	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	or	_	O	O	_	_	_	_	_
9	an	_	O	O	_	_	_	_	_
10	activated	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	cell	_	O	O	_	_	_	_	_
14	clone	_	O	O	_	_	_	_	_
15	were	_	O	O	_	_	_	_	_
16	used	_	O	O	_	_	_	_	_
17	as	_	O	O	_	_	_	_	_
18	human	_	O	O	_	_	_	_	_
19	partners	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	respectively	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	three	_	O	O	_	_	_	_	_
25	independent	_	O	O	_	_	_	_	_
26	fusions	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	As	_	O	O	_	_	_	_	_
2	shown	_	O	O	_	_	_	_	_
3	in	_	O	O	_	_	_	_	_
4	Fig	_	O	O	_	_	_	_	_
5	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	PKD	_	O	O	_	_	_	_	_
4	kinases	_	O	O	_	_	_	_	_
5	do	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	play	_	O	O	_	_	_	_	_
8	an	_	O	O	_	_	_	_	_
9	essential	_	O	O	_	_	_	_	_
10	role	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	regulating	_	O	O	_	_	_	_	_
13	B	_	O	O	_	_	_	_	_
14	cell	_	O	O	_	_	_	_	_
15	survival	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	response	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	range	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	different	_	O	O	_	_	_	_	_
23	stress	_	O	O	_	_	_	_	_
24	stimuli	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	the	_	O	O	_	_	_	_	_
3	present	_	O	O	_	_	_	_	_
4	study	_	O	O	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	we	_	O	O	_	_	_	_	_
7	expanded	_	O	O	_	_	_	_	_
8	upon	_	O	O	_	_	_	_	_
9	these	_	O	O	_	_	_	_	_
10	observations	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	defining	_	O	O	_	_	_	_	_
13	additional	_	O	O	_	_	_	_	_
14	requirements	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	mediated	_	O	O	_	_	_	_	_
20	repression	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	NF	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	kappaB	_	O	O	_	_	_	_	_
25	activation	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	investigated	_	O	O	_	_	_	_	_
29	whether	_	O	O	_	_	_	_	_
30	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	could	_	O	O	_	_	_	_	_
33	target	_	O	O	_	_	_	_	_
34	additional	_	O	O	_	_	_	_	_
35	signaling	_	O	O	_	_	_	_	_
36	pathways	_	O	O	_	_	_	_	_
37	by	_	O	O	_	_	_	_	_
38	examining	_	O	O	_	_	_	_	_
39	transcriptional	_	O	O	_	_	_	_	_
40	activation	_	O	O	_	_	_	_	_
41	of	_	O	O	_	_	_	_	_
42	NF	_	O	O	_	_	_	_	_
43	-	_	O	O	_	_	_	_	_
44	kappaB	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	dependent	_	O	O	_	_	_	_	_
47	and	_	O	O	_	_	_	_	_
48	NF	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	kappaB	_	O	O	_	_	_	_	_
51	-	_	O	O	_	_	_	_	_
52	independent	_	O	O	_	_	_	_	_
53	retroviral	_	O	O	_	_	_	_	_
54	pathogens	_	O	O	_	_	_	_	_
55	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	characterization	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	molecular	_	O	O	_	_	_	_	_
6	targets	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	mechanism	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	s	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	utilized	_	O	O	_	_	_	_	_
17	by	_	O	O	_	_	_	_	_
18	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	support	_	O	O	_	_	_	_	_
22	Treg	_	O	O	_	_	_	_	_
23	development	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	function	_	O	O	_	_	_	_	_
26	will	_	O	O	_	_	_	_	_
27	aid	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	our	_	O	O	_	_	_	_	_
30	understanding	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	role	_	O	O	_	_	_	_	_
34	Tregs	_	O	O	_	_	_	_	_
35	play	_	O	O	_	_	_	_	_
36	in	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	pathogenesis	_	O	O	_	_	_	_	_
39	of	_	O	O	_	_	_	_	_
40	human	_	O	O	_	_	_	_	_
41	autoimmune	_	O	O	_	_	_	_	_
42	disease	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	Fourteen	_	O	O	_	_	_	_	_
2	percent	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	isolated	_	O	O	_	_	_	_	_
5	fragments	_	O	O	_	_	_	_	_
6	belong	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	already	_	O	O	_	_	_	_	_
9	known	_	O	O	_	_	_	_	_
10	genes	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	certainly	_	O	O	_	_	_	_	_
13	are	_	O	O	_	_	_	_	_
14	cytokines	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	transduction	_	O	O	_	_	_	_	_
17	/	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	factors	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Many	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	viral	_	O	O	_	_	_	_	_
5	proteins	_	O	O	_	_	_	_	_
6	expressed	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	transformed	_	O	O	_	_	_	_	_
9	cells	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	including	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	EBV	_	O	O	_	_	_	_	_
14	nuclear	_	O	O	_	_	_	_	_
15	antigens	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	latent	_	O	O	_	_	_	_	_
18	membrane	_	O	O	_	_	_	_	_
19	proteins	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	have	_	O	O	_	_	_	_	_
22	profound	_	O	O	_	_	_	_	_
23	effects	_	O	O	_	_	_	_	_
24	on	_	O	O	_	_	_	_	_
25	cell	_	O	O	_	_	_	_	_
26	growth	_	O	O	_	_	_	_	_
27	regulation	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	are	_	O	O	_	_	_	_	_
30	required	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	EBV	_	O	O	_	_	_	_	_
33	latent	_	O	O	_	_	_	_	_
34	infection	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	B	_	O	O	_	_	_	_	_
37	cell	_	O	O	_	_	_	_	_
38	transformation	_	O	O	_	_	_	_	_
39	[	_	O	O	_	_	_	_	_
40	1	_	O	O	_	_	_	_	_
41	]	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	controls	_	O	O	_	_	_	_	_
4	multiple	_	O	O	_	_	_	_	_
5	aspects	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	CTL	_	O	O	_	_	_	_	_
9	differentiation	_	O	O	_	_	_	_	_
10	program	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	part	_	O	O	_	_	_	_	_
14	through	_	O	O	_	_	_	_	_
15	induction	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_

1	Compared	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	WT	_	O	O	_	_	_	_	_
4	T	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	mRNA	_	O	O	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	were	_	O	O	_	_	_	_	_
13	essentially	_	O	O	_	_	_	_	_
14	undetectable	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	/	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	T	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	at	_	O	O	_	_	_	_	_
24	day	_	O	O	_	_	_	_	_
25	6	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	culture	_	O	O	_	_	_	_	_
28	(	_	O	O	_	_	_	_	_
29	Fig	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_


1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	controlled	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	expression	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	CTL	_	O	O	_	_	_	_	_
11	effector	_	O	O	_	_	_	_	_
12	genes	_	O	O	_	_	_	_	_
13	through	_	O	O	_	_	_	_	_
14	its	_	O	O	_	_	_	_	_
15	induction	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	,	_	O	O	_	_	_	_	_
19	we	_	O	O	_	_	_	_	_
20	retrovirally	_	O	O	_	_	_	_	_
21	expressed	_	O	O	_	_	_	_	_
22	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	Eo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	VP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	16	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	+	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	from	_	O	O	_	_	_	_	_
36	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	-	_	O	O	_	_	_	_	_
39	/	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	mice	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Reconstitution	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	/	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	+	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	with	_	O	O	_	_	_	_	_
14	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	restored	_	O	O	_	_	_	_	_
17	expression	_	O	O	_	_	_	_	_
18	of	_	O	O	_	_	_	_	_
19	Eomes	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	well	_	O	O	_	_	_	_	_
22	as	_	O	O	_	_	_	_	_
23	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	granzyme	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	(	_	O	O	_	_	_	_	_
33	Fig	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Notably	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	Eo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	VP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	16	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	did	_	O	O	_	_	_	_	_
8	not	_	O	O	_	_	_	_	_
9	up	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	regulate	_	O	O	_	_	_	_	_
12	perforin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	expression	_	O	O	_	_	_	_	_
14	when	_	O	O	_	_	_	_	_
15	expressed	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	/	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	even	_	O	O	_	_	_	_	_
25	though	_	O	O	_	_	_	_	_
26	it	_	O	O	_	_	_	_	_
27	restored	_	O	O	_	_	_	_	_
28	the	_	O	O	_	_	_	_	_
29	capacity	_	O	O	_	_	_	_	_
30	to	_	O	O	_	_	_	_	_
31	induce	_	O	O	_	_	_	_	_
32	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
35	expression	_	O	O	_	_	_	_	_
36	upon	_	O	O	_	_	_	_	_
37	TCR	_	O	O	_	_	_	_	_
38	restimulation	_	O	O	_	_	_	_	_
39	(	_	O	O	_	_	_	_	_
40	Fig	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_

1	4	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	A	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	B	_	O	O	_	_	_	_	_
6	)	_	O	O	_	_	_	_	_
7	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	in	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	absence	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	percentage	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	expressing	_	O	O	_	_	_	_	_
16	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	was	_	O	O	_	_	_	_	_
20	dramatically	_	O	O	_	_	_	_	_
21	diminished	_	O	O	_	_	_	_	_
22	as	_	O	O	_	_	_	_	_
23	expected	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	resulted	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	an	_	O	O	_	_	_	_	_
28	increase	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	percentage	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	cells	_	O	O	_	_	_	_	_
34	expressing	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	but	_	O	O	_	_	_	_	_
40	not	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	(	_	O	O	_	_	_	_	_
45	Figure	_	O	O	_	_	_	_	_
46	2	_	O	O	_	_	_	_	_
47	A	_	O	O	_	_	_	_	_
48	)	_	O	O	_	_	_	_	_
49	,	_	O	O	_	_	_	_	_
50	suggesting	_	O	O	_	_	_	_	_
51	that	_	O	O	_	_	_	_	_
52	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
53	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	contributes	_	O	O	_	_	_	_	_
55	to	_	O	O	_	_	_	_	_
56	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
57	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
59	expression	_	O	O	_	_	_	_	_
60	by	_	O	O	_	_	_	_	_
61	Th	_	O	O	_	_	_	_	_
62	1	_	O	O	_	_	_	_	_
63	cells	_	O	O	_	_	_	_	_
64	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	expression	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	associated	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	an	_	O	O	_	_	_	_	_
10	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	induced	_	O	O	_	_	_	_	_
15	Th	_	O	O	_	_	_	_	_
16	2	_	O	O	_	_	_	_	_
17	cell	_	O	O	_	_	_	_	_
18	phenotype	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	we	_	O	O	_	_	_	_	_
21	investigated	_	O	O	_	_	_	_	_
22	whether	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	differentiation	_	O	O	_	_	_	_	_
25	of	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	producing	_	O	O	_	_	_	_	_
32	Th	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	depended	_	O	O	_	_	_	_	_
36	on	_	O	O	_	_	_	_	_
37	signaling	_	O	O	_	_	_	_	_
38	through	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
41	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	receptor	_	O	O	_	_	_	_	_
44	via	_	O	O	_	_	_	_	_
45	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	activation	_	O	O	_	_	_	_	_
48	(	_	O	O	_	_	_	_	_
49	Glimcher	_	O	O	_	_	_	_	_
50	and	_	O	O	_	_	_	_	_
51	Murphy	_	O	O	_	_	_	_	_
52	,	_	O	O	_	_	_	_	_
53	2000	_	O	O	_	_	_	_	_
54	;	_	O	O	_	_	_	_	_
55	Murphy	_	O	O	_	_	_	_	_
56	etal	_	O	O	_	_	_	_	_
57	.,	_	O	O	_	_	_	_	_
58	2000	_	O	O	_	_	_	_	_
59	)	_	O	O	_	_	_	_	_
60	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	investigate	_	O	O	_	_	_	_	_
3	whether	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	inability	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	deficient	_	O	O	_	_	_	_	_
11	Tcells	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	produce	_	O	O	_	_	_	_	_
14	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	10	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	might	_	O	O	_	_	_	_	_
18	be	_	O	O	_	_	_	_	_
19	due	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	absence	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	as	_	O	O	_	_	_	_	_
29	suggested	_	O	O	_	_	_	_	_
30	before	_	O	O	_	_	_	_	_
31	(	_	O	O	_	_	_	_	_
32	Shaw	_	O	O	_	_	_	_	_
33	etal	_	O	O	_	_	_	_	_
34	.,	_	O	O	_	_	_	_	_
35	2006	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	we	_	O	O	_	_	_	_	_
39	differentiated	_	O	O	_	_	_	_	_
40	DO	_	O	O	_	_	_	_	_
41	11	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_
43	10	_	O	O	_	_	_	_	_
44	or	_	O	O	_	_	_	_	_
45	DO	_	O	O	_	_	_	_	_
46	11	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_
48	10	_	O	O	_	_	_	_	_
49	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
50	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
51	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
52	-	_	O	O	_	_	_	_	_
53	deficient	_	O	O	_	_	_	_	_
54	naive	_	O	O	_	_	_	_	_
55	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
56	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	+	_	O	O	_	_	_	_	_
58	Tcells	_	O	O	_	_	_	_	_
59	in	_	O	O	_	_	_	_	_
60	the	_	O	O	_	_	_	_	_
61	presence	_	O	O	_	_	_	_	_
62	of	_	O	O	_	_	_	_	_
63	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
64	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
65	12	_	IPROTEIN	IPROTEIN	_	_	_	_	_
66	and	_	O	O	_	_	_	_	_
67	increasing	_	O	O	_	_	_	_	_
68	doses	_	O	O	_	_	_	_	_
69	of	_	O	O	_	_	_	_	_
70	OVA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
71	.	_	O	O	_	_	_	_	_


1	A	_	O	O	_	_	_	_	_
2	novel	_	O	O	_	_	_	_	_
3	mitogen	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	inducible	_	O	O	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	product	_	O	O	_	_	_	_	_
8	related	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	/	_	O	O	_	_	_	_	_
13	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	105	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	kappa	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	participates	_	O	O	_	_	_	_	_
21	in	_	O	O	_	_	_	_	_
22	transactivation	_	O	O	_	_	_	_	_
23	through	_	O	O	_	_	_	_	_
24	a	_	O	O	_	_	_	_	_
25	kappa	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	site	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Here	_	O	O	_	_	_	_	_
2	we	_	O	O	_	_	_	_	_
3	report	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	the	_	O	O	_	_	_	_	_
6	formation	_	O	O	_	_	_	_	_
7	of	_	O	O	_	_	_	_	_
8	two	_	O	O	_	_	_	_	_
9	distinct	_	O	O	_	_	_	_	_
10	mitogen	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	inducible	_	O	O	_	_	_	_	_
13	DNA	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	binding	_	O	O	_	_	_	_	_
16	complexes	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	complex	_	O	O	_	_	_	_	_
22	within	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	HIV	_	O	O	_	_	_	_	_
25	enhancer	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	NFAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	complex	_	O	O	_	_	_	_	_
32	within	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
35	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
36	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	enhancer	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	is	_	O	O	_	_	_	_	_
40	inhibited	_	O	O	_	_	_	_	_
41	in	_	O	O	_	_	_	_	_
42	the	_	O	O	_	_	_	_	_
43	presence	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	CsA	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	kappa	_	O	O	_	_	_	_	_
3	B	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	binding	_	O	O	_	_	_	_	_
6	activity	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	HIV	_	O	O	_	_	_	_	_
10	enhancer	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	inhibited	_	O	O	_	_	_	_	_
13	only	_	O	O	_	_	_	_	_
14	if	_	O	O	_	_	_	_	_
15	it	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	activated	_	O	O	_	_	_	_	_
18	via	_	O	O	_	_	_	_	_
19	the	_	O	O	_	_	_	_	_
20	mitogen	_	O	O	_	_	_	_	_
21	phytohemagglutinin	_	O	O	_	_	_	_	_
22	whereas	_	O	O	_	_	_	_	_
23	phorbol	_	O	O	_	_	_	_	_
24	myristate	_	O	O	_	_	_	_	_
25	acetate	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	mediated	_	O	O	_	_	_	_	_
28	activation	_	O	O	_	_	_	_	_
29	is	_	O	O	_	_	_	_	_
30	completely	_	O	O	_	_	_	_	_
31	insensitive	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	drug	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	determine	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	mechanisms	_	O	O	_	_	_	_	_
5	responsible	_	O	O	_	_	_	_	_
6	for	_	O	O	_	_	_	_	_
7	these	_	O	O	_	_	_	_	_
8	differences	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	we	_	O	O	_	_	_	_	_
11	turned	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	human	_	O	O	_	_	_	_	_
14	U	_	O	O	_	_	_	_	_
15	937	_	O	O	_	_	_	_	_
16	promonocytic	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Activation	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	PPARgamma	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	may	_	O	O	_	_	_	_	_
5	play	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	role	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	induction	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	differentiation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	macrophages	_	O	O	_	_	_	_	_
15	to	_	O	O	_	_	_	_	_
16	foam	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	are	_	O	O	_	_	_	_	_
20	associated	_	O	O	_	_	_	_	_
21	with	_	O	O	_	_	_	_	_
22	atherosclerotic	_	O	O	_	_	_	_	_
23	lesions	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	Effects	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	overexpression	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	IL	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	1	_	O	O	_	_	_	_	_
8	receptor	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	associated	_	O	O	_	_	_	_	_
11	kinase	_	O	O	_	_	_	_	_
12	on	_	O	O	_	_	_	_	_
13	NFkappaB	_	O	O	_	_	_	_	_
14	activation	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	production	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	stress	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	activated	_	O	O	_	_	_	_	_
24	protein	_	O	O	_	_	_	_	_
25	kinases	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	murine	_	O	O	_	_	_	_	_
29	T	_	O	O	_	_	_	_	_
30	cell	_	O	O	_	_	_	_	_
31	line	_	O	O	_	_	_	_	_
32	EL	_	O	O	_	_	_	_	_
33	4	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	generated	_	O	O	_	_	_	_	_
3	permanent	_	O	O	_	_	_	_	_
4	clones	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	murine	_	O	O	_	_	_	_	_
8	T	_	O	O	_	_	_	_	_
9	cell	_	O	O	_	_	_	_	_
10	line	_	O	O	_	_	_	_	_
11	EL	_	O	O	_	_	_	_	_
12	4	_	O	O	_	_	_	_	_
13	6	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_
15	1	_	O	O	_	_	_	_	_
16	overexpressing	_	O	O	_	_	_	_	_
17	human	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	h	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	IRAK	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	evaluate	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	role	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	this	_	O	O	_	_	_	_	_
28	kinase	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	IL	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	1	_	O	O	_	_	_	_	_
33	signaling	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	has	_	O	O	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	been	_	O	O	_	_	_	_	_
7	shown	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	repress	_	O	O	_	_	_	_	_
10	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	promoter	_	O	O	_	_	_	_	_
13	activity	_	O	O	_	_	_	_	_
14	.	_	O	O	_	_	_	_	_


1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	demonstrated	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	Th	_	O	O	_	_	_	_	_
6	2	_	O	O	_	_	_	_	_
7	cells	_	O	O	_	_	_	_	_
8	have	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	limited	_	O	O	_	_	_	_	_
11	capacity	_	O	O	_	_	_	_	_
12	to	_	O	O	_	_	_	_	_
13	express	_	O	O	_	_	_	_	_
14	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	(	_	O	O	_	_	_	_	_
17	Figure	_	O	O	_	_	_	_	_
18	1	_	O	O	_	_	_	_	_
19	B	_	O	O	_	_	_	_	_
20	)	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Naturally	_	O	O	_	_	_	_	_
2	occurring	_	O	O	_	_	_	_	_
3	Th	_	O	O	_	_	_	_	_
4	2	_	O	O	_	_	_	_	_
5	cells	_	O	O	_	_	_	_	_
6	such	_	O	O	_	_	_	_	_
7	as	_	O	O	_	_	_	_	_
8	CRTH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	+	_	O	O	_	_	_	_	_
11	T	_	O	O	_	_	_	_	_
12	cells	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	T	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	isolated	_	O	O	_	_	_	_	_
17	according	_	O	O	_	_	_	_	_
18	to	_	O	O	_	_	_	_	_
19	their	_	O	O	_	_	_	_	_
20	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	secretion	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	or	_	O	O	_	_	_	_	_
26	an	_	O	O	_	_	_	_	_
27	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	producing	_	O	O	_	_	_	_	_
32	T	_	O	O	_	_	_	_	_
33	cell	_	O	O	_	_	_	_	_
34	clone	_	O	O	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	BR	_	O	O	_	_	_	_	_
37	8	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	were	_	O	O	_	_	_	_	_
40	also	_	O	O	_	_	_	_	_
41	lacking	_	O	O	_	_	_	_	_
42	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	expression	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	Figure	_	O	O	_	_	_	_	_
47	2	_	O	O	_	_	_	_	_
48	B	_	O	O	_	_	_	_	_
49	)	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	45	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	RO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	+	_	O	O	_	_	_	_	_
8	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	25	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	+	_	O	O	_	_	_	_	_
11	cells	_	O	O	_	_	_	_	_
12	abundantly	_	O	O	_	_	_	_	_
13	expressed	_	O	O	_	_	_	_	_
14	FOXP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	while	_	O	O	_	_	_	_	_
18	lacking	_	O	O	_	_	_	_	_
19	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	(	_	O	O	_	_	_	_	_
23	Figure	_	O	O	_	_	_	_	_
24	3	_	O	O	_	_	_	_	_
25	A	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	right	_	O	O	_	_	_	_	_
28	panel	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	used	_	O	O	_	_	_	_	_
3	oligonucleotide	_	O	O	_	_	_	_	_
4	probes	_	O	O	_	_	_	_	_
5	from	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	casein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	IRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	gene	_	O	O	_	_	_	_	_
15	promoters	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	ISRE	_	O	O	_	_	_	_	_
19	probe	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	detect	_	O	O	_	_	_	_	_
22	STAT	_	O	O	_	_	_	_	_
23	proteins	_	O	O	_	_	_	_	_
24	in	_	O	O	_	_	_	_	_
25	nuclear	_	O	O	_	_	_	_	_
26	extracts	_	O	O	_	_	_	_	_
27	from	_	O	O	_	_	_	_	_
28	acute	_	O	O	_	_	_	_	_
29	leukemia	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	bandshift	_	O	O	_	_	_	_	_
33	assays	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	proto	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	oncogene	_	O	O	_	_	_	_	_
5	c	_	O	O	_	_	_	_	_
6	-	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	an	_	O	O	_	_	_	_	_
10	immediate	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	early	_	O	O	_	_	_	_	_
13	gene	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	one	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	first	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	transcribed	_	O	O	_	_	_	_	_
22	after	_	O	O	_	_	_	_	_
23	stimulation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	most	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	with	_	O	O	_	_	_	_	_
28	a	_	O	O	_	_	_	_	_
29	variety	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	ligands	_	O	O	_	_	_	_	_
32	.	_	O	O	_	_	_	_	_

1	Spi	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	an	_	O	O	_	_	_	_	_
6	Ets	_	O	O	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	factor	_	O	O	_	_	_	_	_
9	related	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	oncoprotein	_	O	O	_	_	_	_	_
13	Spi	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	/	_	O	O	_	_	_	_	_
17	PU	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	highly	_	O	O	_	_	_	_	_
22	expressed	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	lymphoid	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	DeltaSpi	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	product	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	not	_	O	O	_	_	_	_	_
7	able	_	O	O	_	_	_	_	_
8	to	_	O	O	_	_	_	_	_
9	bind	_	O	O	_	_	_	_	_
10	DNA	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	recovered	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	cytoplasmic	_	O	O	_	_	_	_	_
16	cellular	_	O	O	_	_	_	_	_
17	extracts	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	65	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	6790	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	6799	_	O	O	_	_	_	_	_
6	,	_	O	O	_	_	_	_	_
7	1991	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	.	_	O	O	_	_	_	_	_

1	Site	_	O	O	_	_	_	_	_
2	B	_	O	O	_	_	_	_	_
3	(	_	O	O	_	_	_	_	_
4	nt	_	O	O	_	_	_	_	_
5	4519	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	4545	_	O	O	_	_	_	_	_
8	)	_	O	O	_	_	_	_	_
9	specifically	_	O	O	_	_	_	_	_
10	bound	_	O	O	_	_	_	_	_
11	four	_	O	O	_	_	_	_	_
12	distinct	_	O	O	_	_	_	_	_
13	nuclear	_	O	O	_	_	_	_	_
14	protein	_	O	O	_	_	_	_	_
15	complexes	_	O	O	_	_	_	_	_
16	:	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	ubiquitous	_	O	O	_	_	_	_	_
19	factor	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	a	_	O	O	_	_	_	_	_
22	T	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	specific	_	O	O	_	_	_	_	_
27	factor	_	O	O	_	_	_	_	_
28	,	_	O	O	_	_	_	_	_
29	a	_	O	O	_	_	_	_	_
30	B	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	cell	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	specific	_	O	O	_	_	_	_	_
35	factor	_	O	O	_	_	_	_	_
36	,	_	O	O	_	_	_	_	_
37	and	_	O	O	_	_	_	_	_
38	the	_	O	O	_	_	_	_	_
39	monocyte	_	O	O	_	_	_	_	_
40	/	_	O	O	_	_	_	_	_
41	macrophage	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	B	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	cell	_	O	O	_	_	_	_	_
47	-	_	O	O	_	_	_	_	_
48	specific	_	O	O	_	_	_	_	_
49	transcription	_	O	O	_	_	_	_	_
50	factor	_	O	O	_	_	_	_	_
51	PU	_	BPROTEIN	BPROTEIN	_	_	_	_	_
52	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
53	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
54	/	_	O	O	_	_	_	_	_
55	Spi	_	BPROTEIN	BPROTEIN	_	_	_	_	_
56	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
57	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
58	.	_	O	O	_	_	_	_	_

1	A	_	O	O	_	_	_	_	_
2	GC	_	O	O	_	_	_	_	_
3	box	_	O	O	_	_	_	_	_
4	containing	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	binding	_	O	O	_	_	_	_	_
7	site	_	O	O	_	_	_	_	_
8	for	_	O	O	_	_	_	_	_
9	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	was	_	O	O	_	_	_	_	_
12	identified	_	O	O	_	_	_	_	_
13	(	_	O	O	_	_	_	_	_
14	nt	_	O	O	_	_	_	_	_
15	4623	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	4631	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	purified	_	O	O	_	_	_	_	_
3	homodimer	_	O	O	_	_	_	_	_
4	(	_	O	O	_	_	_	_	_
5	two	_	O	O	_	_	_	_	_
6	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	s	_	O	O	_	_	_	_	_
9	)	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	DNA	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	binding	_	O	O	_	_	_	_	_
15	subunit	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	NF	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	kappa	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	binds	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	B	_	O	O	_	_	_	_	_
24	2	_	O	O	_	_	_	_	_
25	site	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	proenkephalin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	relatively	_	O	O	_	_	_	_	_
29	better	_	O	O	_	_	_	_	_
30	than	_	O	O	_	_	_	_	_
31	does	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	heterotetramer	_	O	O	_	_	_	_	_
34	(	_	O	O	_	_	_	_	_
35	two	_	O	O	_	_	_	_	_
36	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	65	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	s	_	O	O	_	_	_	_	_
39	plus	_	O	O	_	_	_	_	_
40	two	_	O	O	_	_	_	_	_
41	p	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	50	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	s	_	O	O	_	_	_	_	_
44	)	_	O	O	_	_	_	_	_
45	form	_	O	O	_	_	_	_	_
46	of	_	O	O	_	_	_	_	_
47	the	_	O	O	_	_	_	_	_
48	factor	_	O	O	_	_	_	_	_
49	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	as	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	kappa	_	O	O	_	_	_	_	_
7	B	_	O	O	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	ubiquitous	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	transcriptional	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	through	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	B	_	O	O	_	_	_	_	_
17	2	_	O	O	_	_	_	_	_
18	site	_	O	O	_	_	_	_	_
19	is	_	O	O	_	_	_	_	_
20	T	_	O	O	_	_	_	_	_
21	cell	_	O	O	_	_	_	_	_
22	specific	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	yet	_	O	O	_	_	_	_	_
25	another	_	O	O	_	_	_	_	_
26	T	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	cell	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	specific	_	O	O	_	_	_	_	_
31	factor	_	O	O	_	_	_	_	_
32	which	_	O	O	_	_	_	_	_
33	synergizes	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	NF	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	kappa	_	O	O	_	_	_	_	_
38	B	_	O	O	_	_	_	_	_
39	should	_	O	O	_	_	_	_	_
40	be	_	O	O	_	_	_	_	_
41	considered	_	O	O	_	_	_	_	_
42	.	_	O	O	_	_	_	_	_

1	Possible	_	O	O	_	_	_	_	_
2	role	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	nuclear	_	O	O	_	_	_	_	_
5	factor	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	kappa	_	O	O	_	_	_	_	_
8	B	_	O	O	_	_	_	_	_
9	activity	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	germline	_	O	O	_	_	_	_	_
12	C	_	O	O	_	_	_	_	_
13	epsilon	_	O	O	_	_	_	_	_
14	transcription	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	a	_	O	O	_	_	_	_	_
17	human	_	O	O	_	_	_	_	_
18	Burkitt	_	O	O	_	_	_	_	_
19	lymphoma	_	O	O	_	_	_	_	_
20	B	_	O	O	_	_	_	_	_
21	cell	_	O	O	_	_	_	_	_
22	line	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Both	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	anti	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	mAb	_	O	O	_	_	_	_	_
11	induced	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	phosphatidylinositol	_	O	O	_	_	_	_	_
15	3	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	kinase	_	O	O	_	_	_	_	_
18	(	_	O	O	_	_	_	_	_
19	PI	_	O	O	_	_	_	_	_
20	3	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	kinase	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	translocation	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	a	_	O	O	_	_	_	_	_
28	zeta	_	O	O	_	_	_	_	_
29	isoform	_	O	O	_	_	_	_	_
30	of	_	O	O	_	_	_	_	_
31	protein	_	O	O	_	_	_	_	_
32	kinase	_	O	O	_	_	_	_	_
33	C	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	and	_	O	O	_	_	_	_	_
36	nuclear	_	O	O	_	_	_	_	_
37	expression	_	O	O	_	_	_	_	_
38	of	_	O	O	_	_	_	_	_
39	NF	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	kappa	_	O	O	_	_	_	_	_
42	B	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	NAC	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	also	_	O	O	_	_	_	_	_
4	effective	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	diminishing	_	O	O	_	_	_	_	_
7	germline	_	O	O	_	_	_	_	_
8	C	_	O	O	_	_	_	_	_
9	epsilon	_	O	O	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	its	_	O	O	_	_	_	_	_
14	potency	_	O	O	_	_	_	_	_
15	was	_	O	O	_	_	_	_	_
16	higher	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	cultures	_	O	O	_	_	_	_	_
19	costimulated	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	anti	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	40	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	mAb	_	O	O	_	_	_	_	_
30	than	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	those	_	O	O	_	_	_	_	_
33	stimulated	_	O	O	_	_	_	_	_
34	with	_	O	O	_	_	_	_	_
35	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	alone	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	Currently	_	O	O	_	_	_	_	_
2	available	_	O	O	_	_	_	_	_
3	data	_	O	O	_	_	_	_	_
4	indicate	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	erythroid	_	O	O	_	_	_	_	_
7	and	_	O	O	_	_	_	_	_
8	megakaryocytic	_	O	O	_	_	_	_	_
9	differentiation	_	O	O	_	_	_	_	_
10	pathways	_	O	O	_	_	_	_	_
11	are	_	O	O	_	_	_	_	_
12	closely	_	O	O	_	_	_	_	_
13	related	_	O	O	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	each	_	O	O	_	_	_	_	_
16	other	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	there	_	O	O	_	_	_	_	_
20	may	_	O	O	_	_	_	_	_
21	exist	_	O	O	_	_	_	_	_
22	progenitor	_	O	O	_	_	_	_	_
23	cells	_	O	O	_	_	_	_	_
24	common	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	those	_	O	O	_	_	_	_	_
27	two	_	O	O	_	_	_	_	_
28	lineages	_	O	O	_	_	_	_	_
29	may	_	O	O	_	_	_	_	_
30	exist	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	We	_	O	O	_	_	_	_	_
2	have	_	O	O	_	_	_	_	_
3	isolated	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	novel	_	O	O	_	_	_	_	_
6	cDNA	_	O	O	_	_	_	_	_
7	clone	_	O	O	_	_	_	_	_
8	encoding	_	O	O	_	_	_	_	_
9	interferon	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	IFN	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	consensus	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	sequence	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	binding	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	protein	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	in	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	adult	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	T	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	leukemia	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	cell	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	line	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	or	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	activated	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	T	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	cells	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	ICSAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	)	_	O	O	_	_	_	_	_
33	;	_	O	O	_	_	_	_	_
34	this	_	O	O	_	_	_	_	_
35	protein	_	O	O	_	_	_	_	_
36	is	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	human	_	O	O	_	_	_	_	_
39	homolog	_	O	O	_	_	_	_	_
40	of	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	recently	_	O	O	_	_	_	_	_
43	cloned	_	O	O	_	_	_	_	_
44	Pip	_	BPROTEIN	BPROTEIN	_	_	_	_	_
45	/	_	O	O	_	_	_	_	_
46	LSIRF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_


1	In	_	O	O	_	_	_	_	_
2	this	_	O	O	_	_	_	_	_
3	paper	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	we	_	O	O	_	_	_	_	_
6	report	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	cross	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	linking	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	28	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	but	_	O	O	_	_	_	_	_
16	not	_	O	O	_	_	_	_	_
17	CD	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	LFA	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	1	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	or	_	O	O	_	_	_	_	_
28	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	)	_	O	O	_	_	_	_	_
31	leads	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	an	_	O	O	_	_	_	_	_
34	elevation	_	O	O	_	_	_	_	_
35	of	_	O	O	_	_	_	_	_
36	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
37	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
39	mRNA	_	O	O	_	_	_	_	_
40	,	_	O	O	_	_	_	_	_
41	with	_	O	O	_	_	_	_	_
42	only	_	O	O	_	_	_	_	_
43	minimal	_	O	O	_	_	_	_	_
44	activation	_	O	O	_	_	_	_	_
45	of	_	O	O	_	_	_	_	_
46	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
47	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	fos	_	IPROTEIN	IPROTEIN	_	_	_	_	_
49	expression	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_

1	Binding	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	type	_	O	O	_	_	_	_	_
4	I	_	O	O	_	_	_	_	_
5	interferon	_	O	O	_	_	_	_	_
6	(	_	O	O	_	_	_	_	_
7	IFN	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	alpha	_	O	O	_	_	_	_	_
10	/	_	O	O	_	_	_	_	_
11	beta	_	O	O	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	to	_	O	O	_	_	_	_	_
14	specific	_	O	O	_	_	_	_	_
15	receptors	_	O	O	_	_	_	_	_
16	results	_	O	O	_	_	_	_	_
17	in	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	rapid	_	O	O	_	_	_	_	_
20	transcriptional	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	independent	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	protein	_	O	O	_	_	_	_	_
26	synthesis	_	O	O	_	_	_	_	_
27	,	_	O	O	_	_	_	_	_
28	of	_	O	O	_	_	_	_	_
29	IFN	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	alpha	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	stimulated	_	O	O	_	_	_	_	_
34	genes	_	O	O	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	ISGs	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	in	_	O	O	_	_	_	_	_
39	human	_	O	O	_	_	_	_	_
40	fibroblasts	_	O	O	_	_	_	_	_
41	and	_	O	O	_	_	_	_	_
42	HeLa	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	Daudi	_	O	O	_	_	_	_	_
45	cell	_	O	O	_	_	_	_	_
46	lines	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	U	_	O	O	_	_	_	_	_
2	937	_	O	O	_	_	_	_	_
3	cells	_	O	O	_	_	_	_	_
4	express	_	O	O	_	_	_	_	_
5	both	_	O	O	_	_	_	_	_
6	type	_	O	O	_	_	_	_	_
7	I	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	type	_	O	O	_	_	_	_	_
10	II	_	O	O	_	_	_	_	_
11	IFN	_	O	O	_	_	_	_	_
12	receptors	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	but	_	O	O	_	_	_	_	_
15	only	_	O	O	_	_	_	_	_
16	IFN	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	alpha	_	O	O	_	_	_	_	_
19	is	_	O	O	_	_	_	_	_
20	capable	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	inducing	_	O	O	_	_	_	_	_
23	antiviral	_	O	O	_	_	_	_	_
24	protection	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	these	_	O	O	_	_	_	_	_
27	cells	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	T	_	O	O	_	_	_	_	_
2	lymphocytes	_	O	O	_	_	_	_	_
3	from	_	O	O	_	_	_	_	_
4	patients	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	renal	_	O	O	_	_	_	_	_
7	cell	_	O	O	_	_	_	_	_
8	carcinoma	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	RCC	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	show	_	O	O	_	_	_	_	_
13	reduced	_	O	O	_	_	_	_	_
14	immune	_	O	O	_	_	_	_	_
15	function	_	O	O	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	impaired	_	O	O	_	_	_	_	_
18	activation	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	transcription	_	O	O	_	_	_	_	_
22	factor	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	NF	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	kappaB	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	RCC	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	S	_	O	O	_	_	_	_	_
4	did	_	O	O	_	_	_	_	_
5	not	_	O	O	_	_	_	_	_
6	alter	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	cytoplasmic	_	O	O	_	_	_	_	_
9	levels	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	RelA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	but	_	O	O	_	_	_	_	_
18	did	_	O	O	_	_	_	_	_
19	suppress	_	O	O	_	_	_	_	_
20	their	_	O	O	_	_	_	_	_
21	nuclear	_	O	O	_	_	_	_	_
22	localization	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	inhibited	_	O	O	_	_	_	_	_
25	the	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	RelA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	/	_	O	O	_	_	_	_	_
30	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	kappaB	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	binding	_	O	O	_	_	_	_	_
35	complexes	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_



1	Some	_	O	O	_	_	_	_	_
2	antioxidants	_	O	O	_	_	_	_	_
3	inhibit	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	co	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	ordinate	_	O	O	_	_	_	_	_
10	fashion	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	production	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
22	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	by	_	O	O	_	_	_	_	_
30	human	_	O	O	_	_	_	_	_
31	peripheral	_	O	O	_	_	_	_	_
32	blood	_	O	O	_	_	_	_	_
33	mononuclear	_	O	O	_	_	_	_	_
34	cells	_	O	O	_	_	_	_	_
35	.	_	O	O	_	_	_	_	_


1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	cytokine	_	O	O	_	_	_	_	_
4	production	_	O	O	_	_	_	_	_
5	was	_	O	O	_	_	_	_	_
6	gene	_	O	O	_	_	_	_	_
7	selective	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	not	_	O	O	_	_	_	_	_
10	due	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	general	_	O	O	_	_	_	_	_
13	effects	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	protein	_	O	O	_	_	_	_	_
16	synthesis	_	O	O	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Nuclear	_	O	O	_	_	_	_	_
2	run	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	on	_	O	O	_	_	_	_	_
5	experiments	_	O	O	_	_	_	_	_
6	showed	_	O	O	_	_	_	_	_
7	that	_	O	O	_	_	_	_	_
8	THP	_	O	O	_	_	_	_	_
9	inhibited	_	O	O	_	_	_	_	_
10	transcription	_	O	O	_	_	_	_	_
11	of	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	gene	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	Thus	_	O	O	_	_	_	_	_
2	antioxidants	_	O	O	_	_	_	_	_
3	vary	_	O	O	_	_	_	_	_
4	widely	_	O	O	_	_	_	_	_
5	in	_	O	O	_	_	_	_	_
6	potency	_	O	O	_	_	_	_	_
7	as	_	O	O	_	_	_	_	_
8	inhibitors	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	activation	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	transcription	_	O	O	_	_	_	_	_
14	factors	_	O	O	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	transcription	_	O	O	_	_	_	_	_
19	of	_	O	O	_	_	_	_	_
20	genes	_	O	O	_	_	_	_	_
21	for	_	O	O	_	_	_	_	_
22	pro	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	inflammatory	_	O	O	_	_	_	_	_
25	cytokines	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Two	_	O	O	_	_	_	_	_
2	distinct	_	O	O	_	_	_	_	_
3	signal	_	O	O	_	_	_	_	_
4	transmission	_	O	O	_	_	_	_	_
5	pathways	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	lymphocytes	_	O	O	_	_	_	_	_
9	are	_	O	O	_	_	_	_	_
10	inhibited	_	O	O	_	_	_	_	_
11	by	_	O	O	_	_	_	_	_
12	complexes	_	O	O	_	_	_	_	_
13	formed	_	O	O	_	_	_	_	_
14	between	_	O	O	_	_	_	_	_
15	an	_	O	O	_	_	_	_	_
16	immunophilin	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	either	_	O	O	_	_	_	_	_
19	FK	_	O	O	_	_	_	_	_
20	506	_	O	O	_	_	_	_	_
21	or	_	O	O	_	_	_	_	_
22	rapamycin	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_

1	Remarkably	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	these	_	O	O	_	_	_	_	_
4	two	_	O	O	_	_	_	_	_
5	drugs	_	O	O	_	_	_	_	_
6	inhibit	_	O	O	_	_	_	_	_
7	each	_	O	O	_	_	_	_	_
8	other	_	O	O	_	_	_	_	_
9	'	_	O	O	_	_	_	_	_
10	s	_	O	O	_	_	_	_	_
11	actions	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	raising	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	possibility	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	both	_	O	O	_	_	_	_	_
18	act	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	means	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	a	_	O	O	_	_	_	_	_
23	common	_	O	O	_	_	_	_	_
24	immunophilin	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	immunosuppressant	_	O	O	_	_	_	_	_
27	binding	_	O	O	_	_	_	_	_
28	protein	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	an	_	O	O	_	_	_	_	_
4	excess	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	rapamycin	_	O	O	_	_	_	_	_
7	is	_	O	O	_	_	_	_	_
8	needed	_	O	O	_	_	_	_	_
9	to	_	O	O	_	_	_	_	_
10	revert	_	O	O	_	_	_	_	_
11	FK	_	O	O	_	_	_	_	_
12	506	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	mediated	_	O	O	_	_	_	_	_
15	inhibition	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	production	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	apoptosis	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	and	_	O	O	_	_	_	_	_
25	transcriptional	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	of	_	O	O	_	_	_	_	_
28	NF	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	AT	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	a	_	O	O	_	_	_	_	_
33	T	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	cell	_	O	O	_	_	_	_	_
36	-	_	O	O	_	_	_	_	_
37	specific	_	O	O	_	_	_	_	_
38	transcription	_	O	O	_	_	_	_	_
39	factor	_	O	O	_	_	_	_	_
40	necessary	_	O	O	_	_	_	_	_
41	for	_	O	O	_	_	_	_	_
42	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
43	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
44	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
45	gene	_	O	O	_	_	_	_	_
46	activation	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_


1	These	_	O	O	_	_	_	_	_
2	LTRs	_	O	O	_	_	_	_	_
3	differ	_	O	O	_	_	_	_	_
4	by	_	O	O	_	_	_	_	_
5	five	_	O	O	_	_	_	_	_
6	point	_	O	O	_	_	_	_	_
7	mutations	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	a	_	O	O	_	_	_	_	_
10	22	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	bp	_	O	O	_	_	_	_	_
13	duplication	_	O	O	_	_	_	_	_
14	in	_	O	O	_	_	_	_	_
15	SIVsmmPBj	_	O	O	_	_	_	_	_
16	14	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	which	_	O	O	_	_	_	_	_
19	includes	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	nuclear	_	O	O	_	_	_	_	_
22	factor	_	O	O	_	_	_	_	_
23	kappa	_	O	O	_	_	_	_	_
24	B	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	NF	_	O	O	_	_	_	_	_
27	kappa	_	O	O	_	_	_	_	_
28	B	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	site	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_

1	Strict	_	O	O	_	_	_	_	_
2	dependence	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	HS	_	O	O	_	_	_	_	_
5	I	_	O	O	_	_	_	_	_
6	activity	_	O	O	_	_	_	_	_
7	on	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	GATA	_	O	O	_	_	_	_	_
10	site	_	O	O	_	_	_	_	_
11	implies	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	assembly	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	protein	_	O	O	_	_	_	_	_
17	complex	_	O	O	_	_	_	_	_
18	containing	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	GATA	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	factor	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	presumably	_	O	O	_	_	_	_	_
25	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	or	_	O	O	_	_	_	_	_
29	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	is	_	O	O	_	_	_	_	_
34	critical	_	O	O	_	_	_	_	_
35	to	_	O	O	_	_	_	_	_
36	activating	_	O	O	_	_	_	_	_
37	or	_	O	O	_	_	_	_	_
38	maintaining	_	O	O	_	_	_	_	_
39	its	_	O	O	_	_	_	_	_
40	function	_	O	O	_	_	_	_	_
41	.	_	O	O	_	_	_	_	_


1	hLH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	mapped	_	O	O	_	_	_	_	_
6	to	_	O	O	_	_	_	_	_
7	chromosome	_	O	O	_	_	_	_	_
8	9	_	O	O	_	_	_	_	_
9	Q	_	O	O	_	_	_	_	_
10	33	_	O	O	_	_	_	_	_
11	-	_	O	O	_	_	_	_	_
12	34	_	O	O	_	_	_	_	_
13	.	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	same	_	O	O	_	_	_	_	_
19	region	_	O	O	_	_	_	_	_
20	as	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	reciprocal	_	O	O	_	_	_	_	_
23	translocation	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	creates	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	BCR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	ABL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	chimera	_	O	O	_	_	_	_	_
31	of	_	O	O	_	_	_	_	_
32	the	_	O	O	_	_	_	_	_
33	Philadelphia	_	O	O	_	_	_	_	_
34	chromosome	_	O	O	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	Ph	_	O	O	_	_	_	_	_
37	'	_	O	O	_	_	_	_	_
38	)	_	O	O	_	_	_	_	_
39	,	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	hallmark	_	O	O	_	_	_	_	_
42	of	_	O	O	_	_	_	_	_
43	CML	_	O	O	_	_	_	_	_
44	;	_	O	O	_	_	_	_	_
45	hLH	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
47	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
48	was	_	O	O	_	_	_	_	_
49	retained	_	O	O	_	_	_	_	_
50	on	_	O	O	_	_	_	_	_
51	the	_	O	O	_	_	_	_	_
52	derivative	_	O	O	_	_	_	_	_
53	9	_	O	O	_	_	_	_	_
54	chromosome	_	O	O	_	_	_	_	_
55	and	_	O	O	_	_	_	_	_
56	is	_	O	O	_	_	_	_	_
57	therefore	_	O	O	_	_	_	_	_
58	centromeric	_	O	O	_	_	_	_	_
59	of	_	O	O	_	_	_	_	_
60	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
61	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
62	ABL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
63	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	finding	_	O	O	_	_	_	_	_
3	that	_	O	O	_	_	_	_	_
4	dexamethasone	_	O	O	_	_	_	_	_
5	has	_	O	O	_	_	_	_	_
6	no	_	O	O	_	_	_	_	_
7	effect	_	O	O	_	_	_	_	_
8	on	_	O	O	_	_	_	_	_
9	TPA	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	induced	_	O	O	_	_	_	_	_
12	activation	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	PKC	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	suggests	_	O	O	_	_	_	_	_
16	that	_	O	O	_	_	_	_	_
17	this	_	O	O	_	_	_	_	_
18	glucocorticoid	_	O	O	_	_	_	_	_
19	inhibits	_	O	O	_	_	_	_	_
20	signals	_	O	O	_	_	_	_	_
21	downstream	_	O	O	_	_	_	_	_
22	or	_	O	O	_	_	_	_	_
23	parallel	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	this	_	O	O	_	_	_	_	_
26	enzyme	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	further	_	O	O	_	_	_	_	_
3	define	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	effects	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	dexamethasone	_	O	O	_	_	_	_	_
8	at	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	molecular	_	O	O	_	_	_	_	_
11	level	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	we	_	O	O	_	_	_	_	_
14	prepared	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	series	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	deleted	_	O	O	_	_	_	_	_
19	c	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	jun	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	promoter	_	O	O	_	_	_	_	_
23	fragments	_	O	O	_	_	_	_	_
24	linked	_	O	O	_	_	_	_	_
25	to	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	chloramphenicol	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	acetyltransferase	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	gene	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Increases	_	O	O	_	_	_	_	_
2	in	_	O	O	_	_	_	_	_
3	CAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
4	activity	_	O	O	_	_	_	_	_
5	during	_	O	O	_	_	_	_	_
6	transient	_	O	O	_	_	_	_	_
7	expression	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	these	_	O	O	_	_	_	_	_
10	constructs	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	TPA	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	treated	_	O	O	_	_	_	_	_
15	U	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	937	_	O	O	_	_	_	_	_
18	cells	_	O	O	_	_	_	_	_
19	could	_	O	O	_	_	_	_	_
20	be	_	O	O	_	_	_	_	_
21	assigned	_	O	O	_	_	_	_	_
22	to	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	region	_	O	O	_	_	_	_	_
25	(	_	O	O	_	_	_	_	_
26	-	_	O	O	_	_	_	_	_
27	97	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	-	_	O	O	_	_	_	_	_
30	20	_	O	O	_	_	_	_	_
31	)	_	O	O	_	_	_	_	_
32	of	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	promoter	_	O	O	_	_	_	_	_
35	that	_	O	O	_	_	_	_	_
36	contains	_	O	O	_	_	_	_	_
37	the	_	O	O	_	_	_	_	_
38	AP	_	O	O	_	_	_	_	_
39	-	_	O	O	_	_	_	_	_
40	1	_	O	O	_	_	_	_	_
41	binding	_	O	O	_	_	_	_	_
42	site	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	LPS	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	mediated	_	O	O	_	_	_	_	_
7	nuclear	_	O	O	_	_	_	_	_
8	binding	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	nuclear	_	O	O	_	_	_	_	_
11	factor	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	kappaB	_	O	O	_	_	_	_	_
14	/	_	O	O	_	_	_	_	_
15	Rel	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	specific	_	O	O	_	_	_	_	_
21	kappaB	_	O	O	_	_	_	_	_
22	site	_	O	O	_	_	_	_	_
23	was	_	O	O	_	_	_	_	_
24	inhibited	_	O	O	_	_	_	_	_
25	by	_	O	O	_	_	_	_	_
26	lysoPC	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	Preincubation	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	lysoPC	_	O	O	_	_	_	_	_
4	increased	_	O	O	_	_	_	_	_
5	monocytic	_	O	O	_	_	_	_	_
6	cAMP	_	O	O	_	_	_	_	_
7	levels	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_

1	Inhibition	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	adenylyl	_	O	O	_	_	_	_	_
4	cyclase	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	pretreatment	_	O	O	_	_	_	_	_
7	with	_	O	O	_	_	_	_	_
8	2	_	O	O	_	_	_	_	_
9	'	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	deoxy	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	3	_	O	O	_	_	_	_	_
14	'	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	adenosine	_	O	O	_	_	_	_	_
17	monophosphate	_	O	O	_	_	_	_	_
18	partially	_	O	O	_	_	_	_	_
19	reversed	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	inhibition	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	activity	_	O	O	_	_	_	_	_
25	promoted	_	O	O	_	_	_	_	_
26	by	_	O	O	_	_	_	_	_
27	lysoPC	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_

1	Furthermore	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	myricetin	_	O	O	_	_	_	_	_
4	was	_	O	O	_	_	_	_	_
5	also	_	O	O	_	_	_	_	_
6	found	_	O	O	_	_	_	_	_
7	to	_	O	O	_	_	_	_	_
8	inhibit	_	O	O	_	_	_	_	_
9	NFkappaB	_	O	O	_	_	_	_	_
10	activity	_	O	O	_	_	_	_	_
11	correlated	_	O	O	_	_	_	_	_
12	with	_	O	O	_	_	_	_	_
13	suppression	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	monocyte	_	O	O	_	_	_	_	_
16	adhesion	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	ECV	_	O	O	_	_	_	_	_
19	304	_	O	O	_	_	_	_	_
20	cells	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_


1	N	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	and	_	O	O	_	_	_	_	_
4	C	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	terminal	_	O	O	_	_	_	_	_
7	sequences	_	O	O	_	_	_	_	_
8	control	_	O	O	_	_	_	_	_
9	degradation	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	MAD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	/	_	O	O	_	_	_	_	_
14	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	response	_	O	O	_	_	_	_	_
20	to	_	O	O	_	_	_	_	_
21	inducers	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappa	_	O	O	_	_	_	_	_
26	B	_	O	O	_	_	_	_	_
27	activity	_	O	O	_	_	_	_	_
28	.	_	O	O	_	_	_	_	_


1	Using	_	O	O	_	_	_	_	_
2	anti	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	EBPbeta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	(	_	O	O	_	_	_	_	_
8	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	)	_	O	O	_	_	_	_	_
13	,	_	O	O	_	_	_	_	_
14	anti	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	EBPdelta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	(	_	O	O	_	_	_	_	_
20	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
21	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	IL	_	IPROTEIN	IPROTEIN	_	_	_	_	_
23	6	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	)	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	anti	_	O	O	_	_	_	_	_
28	-	_	O	O	_	_	_	_	_
29	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	ATc	_	IPROTEIN	IPROTEIN	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	anti	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	NF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	ATp	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	anti	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	Fos	_	O	O	_	_	_	_	_
42	,	_	O	O	_	_	_	_	_
43	and	_	O	O	_	_	_	_	_
44	anti	_	O	O	_	_	_	_	_
45	-	_	O	O	_	_	_	_	_
46	Jun	_	O	O	_	_	_	_	_
47	Abs	_	O	O	_	_	_	_	_
48	we	_	O	O	_	_	_	_	_
49	demonstrate	_	O	O	_	_	_	_	_
50	that	_	O	O	_	_	_	_	_
51	the	_	O	O	_	_	_	_	_
52	previously	_	O	O	_	_	_	_	_
53	identified	_	O	O	_	_	_	_	_
54	PRE	_	O	O	_	_	_	_	_
55	-	_	O	O	_	_	_	_	_
56	I	_	O	O	_	_	_	_	_
57	binding	_	O	O	_	_	_	_	_
58	factor	_	O	O	_	_	_	_	_
59	POS	_	O	O	_	_	_	_	_
60	-	_	O	O	_	_	_	_	_
61	1	_	O	O	_	_	_	_	_
62	is	_	O	O	_	_	_	_	_
63	composed	_	O	O	_	_	_	_	_
64	of	_	O	O	_	_	_	_	_
65	different	_	O	O	_	_	_	_	_
66	transcription	_	O	O	_	_	_	_	_
67	factors	_	O	O	_	_	_	_	_
68	in	_	O	O	_	_	_	_	_
69	different	_	O	O	_	_	_	_	_
70	Th	_	O	O	_	_	_	_	_
71	cell	_	O	O	_	_	_	_	_
72	subsets	_	O	O	_	_	_	_	_
73	.	_	O	O	_	_	_	_	_

1	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	Oct	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	can	_	O	O	_	_	_	_	_
9	bind	_	O	O	_	_	_	_	_
10	specifically	_	O	O	_	_	_	_	_
11	to	_	O	O	_	_	_	_	_
12	a	_	O	O	_	_	_	_	_
13	site	_	O	O	_	_	_	_	_
14	at	_	O	O	_	_	_	_	_
15	base	_	O	O	_	_	_	_	_
16	pair	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	55	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	vitro	_	O	O	_	_	_	_	_
21	,	_	O	O	_	_	_	_	_
22	and	_	O	O	_	_	_	_	_
23	this	_	O	O	_	_	_	_	_
24	site	_	O	O	_	_	_	_	_
25	is	_	O	O	_	_	_	_	_
26	specifically	_	O	O	_	_	_	_	_
27	protected	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	B	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	vivo	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	Administration	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	cytokines	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	antibodies	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	vivo	_	O	O	_	_	_	_	_
8	.	_	O	O	_	_	_	_	_

1	Macrophage	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	differentiation	_	O	O	_	_	_	_	_
4	of	_	O	O	_	_	_	_	_
5	NB	_	O	O	_	_	_	_	_
6	4	_	O	O	_	_	_	_	_
7	reduced	_	O	O	_	_	_	_	_
8	levels	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	mRNA	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	Nuclear	_	O	O	_	_	_	_	_
2	run	_	O	O	_	_	_	_	_
3	-	_	O	O	_	_	_	_	_
4	off	_	O	O	_	_	_	_	_
5	assays	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	half	_	O	O	_	_	_	_	_
8	-	_	O	O	_	_	_	_	_
9	life	_	O	O	_	_	_	_	_
10	studies	_	O	O	_	_	_	_	_
11	showed	_	O	O	_	_	_	_	_
12	that	_	O	O	_	_	_	_	_
13	accumulation	_	O	O	_	_	_	_	_
14	of	_	O	O	_	_	_	_	_
15	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	mRNA	_	O	O	_	_	_	_	_
20	by	_	O	O	_	_	_	_	_
21	9	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	cis	_	O	O	_	_	_	_	_
24	RA	_	O	O	_	_	_	_	_
25	was	_	O	O	_	_	_	_	_
26	due	_	O	O	_	_	_	_	_
27	to	_	O	O	_	_	_	_	_
28	enhanced	_	O	O	_	_	_	_	_
29	transcription	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	ATRA	_	O	O	_	_	_	_	_
2	also	_	O	O	_	_	_	_	_
3	induced	_	O	O	_	_	_	_	_
4	expression	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	C	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	/	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	EBP	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	epsilon	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	protein	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	NB	_	O	O	_	_	_	_	_
13	4	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	as	_	O	O	_	_	_	_	_
17	shown	_	O	O	_	_	_	_	_
18	by	_	O	O	_	_	_	_	_
19	Western	_	O	O	_	_	_	_	_
20	blotting	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	may	_	O	O	_	_	_	_	_
3	explain	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	at	_	O	O	_	_	_	_	_
6	least	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	part	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	increased	_	O	O	_	_	_	_	_
12	rate	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	HIV	_	O	O	_	_	_	_	_
15	transmission	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	women	_	O	O	_	_	_	_	_
18	with	_	O	O	_	_	_	_	_
19	BV	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	Cells	_	O	O	_	_	_	_	_
2	lines	_	O	O	_	_	_	_	_
3	were	_	O	O	_	_	_	_	_
4	incubated	_	O	O	_	_	_	_	_
5	at	_	O	O	_	_	_	_	_
6	37	_	O	O	_	_	_	_	_
7	degreesC	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	100	_	O	O	_	_	_	_	_
10	%	_	O	O	_	_	_	_	_
11	humidity	_	O	O	_	_	_	_	_
12	in	_	O	O	_	_	_	_	_
13	5	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	7	_	O	O	_	_	_	_	_
16	%	_	O	O	_	_	_	_	_
17	CO	_	O	O	_	_	_	_	_
18	2	_	O	O	_	_	_	_	_
19	and	_	O	O	_	_	_	_	_
20	passaged	_	O	O	_	_	_	_	_
21	using	_	O	O	_	_	_	_	_
22	standard	_	O	O	_	_	_	_	_
23	cell	_	O	O	_	_	_	_	_
24	culture	_	O	O	_	_	_	_	_
25	techniques	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Cyclosporin	_	O	O	_	_	_	_	_
2	A	_	O	O	_	_	_	_	_
3	inhibits	_	O	O	_	_	_	_	_
4	monocyte	_	O	O	_	_	_	_	_
5	tissue	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	activation	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	cardiac	_	O	O	_	_	_	_	_
10	transplant	_	O	O	_	_	_	_	_
11	recipients	_	O	O	_	_	_	_	_
12	.	_	O	O	_	_	_	_	_

1	BACKGROUND	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	Fibrin	_	O	O	_	_	_	_	_
4	deposition	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	thrombosis	_	O	O	_	_	_	_	_
7	have	_	O	O	_	_	_	_	_
8	been	_	O	O	_	_	_	_	_
9	implicated	_	O	O	_	_	_	_	_
10	in	_	O	O	_	_	_	_	_
11	both	_	O	O	_	_	_	_	_
12	allograft	_	O	O	_	_	_	_	_
13	rejection	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	vasculopathy	_	O	O	_	_	_	_	_
16	after	_	O	O	_	_	_	_	_
17	cardiac	_	O	O	_	_	_	_	_
18	transplantation	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	Because	_	O	O	_	_	_	_	_
2	monocytes	_	O	O	_	_	_	_	_
3	play	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	pivotal	_	O	O	_	_	_	_	_
6	role	_	O	O	_	_	_	_	_
7	in	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	pathophysiology	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	intravascular	_	O	O	_	_	_	_	_
12	coagulation	_	O	O	_	_	_	_	_
13	activation	_	O	O	_	_	_	_	_
14	through	_	O	O	_	_	_	_	_
15	their	_	O	O	_	_	_	_	_
16	ability	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	synthesize	_	O	O	_	_	_	_	_
19	tissue	_	BPROTEIN	BPROTEIN	_	_	_	_	_
20	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	(	_	O	O	_	_	_	_	_
22	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	,	_	O	O	_	_	_	_	_
25	we	_	O	O	_	_	_	_	_
26	asked	_	O	O	_	_	_	_	_
27	(	_	O	O	_	_	_	_	_
28	1	_	O	O	_	_	_	_	_
29	)	_	O	O	_	_	_	_	_
30	whether	_	O	O	_	_	_	_	_
31	monocyte	_	O	O	_	_	_	_	_
32	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
33	activation	_	O	O	_	_	_	_	_
34	occurs	_	O	O	_	_	_	_	_
35	in	_	O	O	_	_	_	_	_
36	cardiac	_	O	O	_	_	_	_	_
37	transplant	_	O	O	_	_	_	_	_
38	recipients	_	O	O	_	_	_	_	_
39	and	_	O	O	_	_	_	_	_
40	(	_	O	O	_	_	_	_	_
41	2	_	O	O	_	_	_	_	_
42	)	_	O	O	_	_	_	_	_
43	whether	_	O	O	_	_	_	_	_
44	monocyte	_	O	O	_	_	_	_	_
45	TF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
46	expression	_	O	O	_	_	_	_	_
47	is	_	O	O	_	_	_	_	_
48	affected	_	O	O	_	_	_	_	_
49	by	_	O	O	_	_	_	_	_
50	treatment	_	O	O	_	_	_	_	_
51	with	_	O	O	_	_	_	_	_
52	cyclosporin	_	O	O	_	_	_	_	_
53	A	_	O	O	_	_	_	_	_
54	(	_	O	O	_	_	_	_	_
55	CsA	_	O	O	_	_	_	_	_
56	)	_	O	O	_	_	_	_	_
57	.	_	O	O	_	_	_	_	_


1	We	_	O	O	_	_	_	_	_
2	examined	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	contribution	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	two	_	O	O	_	_	_	_	_
8	isoforms	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	STAT	_	O	O	_	_	_	_	_
11	5	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	A	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	and	_	O	O	_	_	_	_	_
17	STAT	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	5	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
28	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	induced	_	O	O	_	_	_	_	_
32	activation	_	O	O	_	_	_	_	_
33	of	_	O	O	_	_	_	_	_
34	human	_	O	O	_	_	_	_	_
35	peripheral	_	O	O	_	_	_	_	_
36	blood	_	O	O	_	_	_	_	_
37	T	_	O	O	_	_	_	_	_
38	lymphoblasts	_	O	O	_	_	_	_	_
39	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	kinetics	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	this	_	O	O	_	_	_	_	_
5	translocation	_	O	O	_	_	_	_	_
6	were	_	O	O	_	_	_	_	_
7	delayed	_	O	O	_	_	_	_	_
8	in	_	O	O	_	_	_	_	_
9	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	treated	_	O	O	_	_	_	_	_
14	as	_	O	O	_	_	_	_	_
15	compared	_	O	O	_	_	_	_	_
16	to	_	O	O	_	_	_	_	_
17	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
18	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	treated	_	O	O	_	_	_	_	_
22	cells	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_


1	RESULTS	_	O	O	_	_	_	_	_
2	:	_	O	O	_	_	_	_	_
3	With	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	exception	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	indomethacin	_	O	O	_	_	_	_	_
8	,	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	used	_	O	O	_	_	_	_	_
11	immunosuppressive	_	O	O	_	_	_	_	_
12	and	_	O	O	_	_	_	_	_
13	anti	_	O	O	_	_	_	_	_
14	-	_	O	O	_	_	_	_	_
15	inflammatory	_	O	O	_	_	_	_	_
16	agents	_	O	O	_	_	_	_	_
17	significantly	_	O	O	_	_	_	_	_
18	inhibited	_	O	O	_	_	_	_	_
19	T	_	O	O	_	_	_	_	_
20	cell	_	O	O	_	_	_	_	_
21	proliferation	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	response	_	O	O	_	_	_	_	_
24	to	_	O	O	_	_	_	_	_
25	influenza	_	O	O	_	_	_	_	_
26	virus	_	O	O	_	_	_	_	_
27	antigen	_	O	O	_	_	_	_	_
28	in	_	O	O	_	_	_	_	_
29	a	_	O	O	_	_	_	_	_
30	dose	_	O	O	_	_	_	_	_
31	-	_	O	O	_	_	_	_	_
32	dependent	_	O	O	_	_	_	_	_
33	manner	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Interestingly	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	CyA	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	indomethacin	_	O	O	_	_	_	_	_
6	did	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	suppress	_	O	O	_	_	_	_	_
9	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
16	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	induced	_	O	O	_	_	_	_	_
21	adhesion	_	O	O	_	_	_	_	_
22	molecule	_	O	O	_	_	_	_	_
23	expression	_	O	O	_	_	_	_	_
24	on	_	O	O	_	_	_	_	_
25	HUVECs	_	O	O	_	_	_	_	_
26	,	_	O	O	_	_	_	_	_
27	whereas	_	O	O	_	_	_	_	_
28	aspirin	_	O	O	_	_	_	_	_
29	had	_	O	O	_	_	_	_	_
30	an	_	O	O	_	_	_	_	_
31	inhibitory	_	O	O	_	_	_	_	_
32	effect	_	O	O	_	_	_	_	_
33	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	addition	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	aspirin	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	indomethacin	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	but	_	O	O	_	_	_	_	_
9	not	_	O	O	_	_	_	_	_
10	CyA	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	induced	_	O	O	_	_	_	_	_
13	Hsp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	70	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	in	_	O	O	_	_	_	_	_
17	HUVECs	_	O	O	_	_	_	_	_
18	that	_	O	O	_	_	_	_	_
19	correlated	_	O	O	_	_	_	_	_
20	with	_	O	O	_	_	_	_	_
21	induction	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	HSF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	activity	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	However	_	O	O	_	_	_	_	_
2	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
3	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	,	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	crucial	_	O	O	_	_	_	_	_
8	factor	_	O	O	_	_	_	_	_
9	for	_	O	O	_	_	_	_	_
10	thymopoiesis	_	O	O	_	_	_	_	_
11	that	_	O	O	_	_	_	_	_
12	is	_	O	O	_	_	_	_	_
13	secreted	_	O	O	_	_	_	_	_
14	mainly	_	O	O	_	_	_	_	_
15	by	_	O	O	_	_	_	_	_
16	TEC	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	is	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	necessary	_	O	O	_	_	_	_	_
21	cofactor	_	O	O	_	_	_	_	_
22	for	_	O	O	_	_	_	_	_
23	NF	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	kappaB	_	O	O	_	_	_	_	_
26	activation	_	O	O	_	_	_	_	_
27	elicited	_	O	O	_	_	_	_	_
28	by	_	O	O	_	_	_	_	_
29	TNF	_	O	O	_	_	_	_	_
30	or	_	O	O	_	_	_	_	_
31	IL	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	1	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_


1	It	_	O	O	_	_	_	_	_
2	was	_	O	O	_	_	_	_	_
3	shown	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	TGF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	beta	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	is	_	O	O	_	_	_	_	_
9	mandatory	_	O	O	_	_	_	_	_
10	for	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	maintenance	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	peripheral	_	O	O	_	_	_	_	_
15	T	_	O	O	_	_	_	_	_
16	reg	_	O	O	_	_	_	_	_
17	cells	_	O	O	_	_	_	_	_
18	and	_	O	O	_	_	_	_	_
19	their	_	O	O	_	_	_	_	_
20	expression	_	O	O	_	_	_	_	_
21	of	_	O	O	_	_	_	_	_
22	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
23	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
24	(	_	O	O	_	_	_	_	_
25	Marie	_	O	O	_	_	_	_	_
26	et	_	O	O	_	_	_	_	_
27	al	_	O	O	_	_	_	_	_
28	.,	_	O	O	_	_	_	_	_
29	2005	_	O	O	_	_	_	_	_
30	;	_	O	O	_	_	_	_	_
31	Rubtsov	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	Rudensky	_	O	O	_	_	_	_	_
34	,	_	O	O	_	_	_	_	_
35	2007	_	O	O	_	_	_	_	_
36	)	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	could	_	O	O	_	_	_	_	_
3	be	_	O	O	_	_	_	_	_
4	dependent	_	O	O	_	_	_	_	_
5	on	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	stage	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	cells	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	organ	_	O	O	_	_	_	_	_
13	from	_	O	O	_	_	_	_	_
14	which	_	O	O	_	_	_	_	_
15	they	_	O	O	_	_	_	_	_
16	were	_	O	O	_	_	_	_	_
17	isolated	_	O	O	_	_	_	_	_
18	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	both	_	O	O	_	_	_	_	_
3	human	_	O	O	_	_	_	_	_
4	and	_	O	O	_	_	_	_	_
5	mouse	_	O	O	_	_	_	_	_
6	systems	_	O	O	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	reduced	_	O	O	_	_	_	_	_
9	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	expression	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	associated	_	O	O	_	_	_	_	_
14	with	_	O	O	_	_	_	_	_
15	reduced	_	O	O	_	_	_	_	_
16	T	_	O	O	_	_	_	_	_
17	reg	_	O	O	_	_	_	_	_
18	cell	_	O	O	_	_	_	_	_
19	suppressive	_	O	O	_	_	_	_	_
20	activity	_	O	O	_	_	_	_	_
21	.	_	O	O	_	_	_	_	_

1	Runx	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	regulates	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	transitions	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	developing	_	O	O	_	_	_	_	_
8	thymocytes	_	O	O	_	_	_	_	_
9	from	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
12	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	double	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	negative	_	O	O	_	_	_	_	_
20	stage	_	O	O	_	_	_	_	_
21	to	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
24	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
25	+	_	O	O	_	_	_	_	_
26	CD	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	8	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	+	_	O	O	_	_	_	_	_
29	double	_	O	O	_	_	_	_	_
30	-	_	O	O	_	_	_	_	_
31	positive	_	O	O	_	_	_	_	_
32	stage	_	O	O	_	_	_	_	_
33	and	_	O	O	_	_	_	_	_
34	from	_	O	O	_	_	_	_	_
35	the	_	O	O	_	_	_	_	_
36	DP	_	O	O	_	_	_	_	_
37	stage	_	O	O	_	_	_	_	_
38	to	_	O	O	_	_	_	_	_
39	the	_	O	O	_	_	_	_	_
40	mature	_	O	O	_	_	_	_	_
41	single	_	O	O	_	_	_	_	_
42	-	_	O	O	_	_	_	_	_
43	positive	_	O	O	_	_	_	_	_
44	stage	_	O	O	_	_	_	_	_
45	(	_	O	O	_	_	_	_	_
46	Egawa	_	O	O	_	_	_	_	_
47	et	_	O	O	_	_	_	_	_
48	al	_	O	O	_	_	_	_	_
49	.,	_	O	O	_	_	_	_	_
50	2007	_	O	O	_	_	_	_	_
51	)	_	O	O	_	_	_	_	_
52	.	_	O	O	_	_	_	_	_

1	RUNX	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	interacts	_	O	O	_	_	_	_	_
4	physically	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	Foxp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	protein	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	it	_	O	O	_	_	_	_	_
12	was	_	O	O	_	_	_	_	_
13	demonstrated	_	O	O	_	_	_	_	_
14	that	_	O	O	_	_	_	_	_
15	this	_	O	O	_	_	_	_	_
16	interaction	_	O	O	_	_	_	_	_
17	might	_	O	O	_	_	_	_	_
18	be	_	O	O	_	_	_	_	_
19	responsible	_	O	O	_	_	_	_	_
20	for	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	suppression	_	O	O	_	_	_	_	_
23	of	_	O	O	_	_	_	_	_
24	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	and	_	O	O	_	_	_	_	_
28	IFN	_	BPROTEIN	BPROTEIN	_	_	_	_	_
29	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
30	gamma	_	IPROTEIN	IPROTEIN	_	_	_	_	_
31	production	_	O	O	_	_	_	_	_
32	and	_	O	O	_	_	_	_	_
33	up	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	regulation	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	T	_	O	O	_	_	_	_	_
38	reg	_	O	O	_	_	_	_	_
39	cell	_	O	O	_	_	_	_	_
40	-	_	O	O	_	_	_	_	_
41	associated	_	O	O	_	_	_	_	_
42	molecules	_	O	O	_	_	_	_	_
43	(	_	O	O	_	_	_	_	_
44	Ono	_	O	O	_	_	_	_	_
45	et	_	O	O	_	_	_	_	_
46	al	_	O	O	_	_	_	_	_
47	.,	_	O	O	_	_	_	_	_
48	2007	_	O	O	_	_	_	_	_
49	)	_	O	O	_	_	_	_	_
50	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	two	_	O	O	_	_	_	_	_
3	G	_	O	O	_	_	_	_	_
4	-	_	O	O	_	_	_	_	_
5	to	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	T	_	O	O	_	_	_	_	_
8	substitutions	_	O	O	_	_	_	_	_
9	introduced	_	O	O	_	_	_	_	_
10	into	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	GC	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	box	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	180	_	O	O	_	_	_	_	_
18	bp	_	O	O	_	_	_	_	_
19	fragment	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	180	_	O	O	_	_	_	_	_
22	mut	_	O	O	_	_	_	_	_
23	)	_	O	O	_	_	_	_	_
24	are	_	O	O	_	_	_	_	_
25	specified	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	Peripheral	_	O	O	_	_	_	_	_
2	blood	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	provided	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	Blood	_	O	O	_	_	_	_	_
8	Bank	_	O	O	_	_	_	_	_
9	at	_	O	O	_	_	_	_	_
10	Buskerud	_	O	O	_	_	_	_	_
11	Regional	_	O	O	_	_	_	_	_
12	Hospital	_	O	O	_	_	_	_	_
13	with	_	O	O	_	_	_	_	_
14	formal	_	O	O	_	_	_	_	_
15	agreement	_	O	O	_	_	_	_	_
16	by	_	O	O	_	_	_	_	_
17	the	_	O	O	_	_	_	_	_
18	patients	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	approval	_	O	O	_	_	_	_	_
22	by	_	O	O	_	_	_	_	_
23	the	_	O	O	_	_	_	_	_
24	regional	_	O	O	_	_	_	_	_
25	ethics	_	O	O	_	_	_	_	_
26	committee	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	UT	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	7	_	O	O	_	_	_	_	_
4	Epo	_	O	O	_	_	_	_	_
5	and	_	O	O	_	_	_	_	_
6	UT	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	7	_	O	O	_	_	_	_	_
9	expressed	_	O	O	_	_	_	_	_
10	similar	_	O	O	_	_	_	_	_
11	levels	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	mRNA	_	O	O	_	_	_	_	_
17	and	_	O	O	_	_	_	_	_
18	binding	_	O	O	_	_	_	_	_
19	activity	_	O	O	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	comparison	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	UT	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	7	_	O	O	_	_	_	_	_
7	Epo	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	expressed	_	O	O	_	_	_	_	_
10	alpha	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	and	_	O	O	_	_	_	_	_
14	higher	_	O	O	_	_	_	_	_
15	levels	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	gamma	_	O	O	_	_	_	_	_
18	-	_	O	O	_	_	_	_	_
19	globin	_	O	O	_	_	_	_	_
20	(	_	O	O	_	_	_	_	_
21	5	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	fold	_	O	O	_	_	_	_	_
24	)	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	beta	_	BPROTEIN	BPROTEIN	_	_	_	_	_
27	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
28	globin	_	IPROTEIN	IPROTEIN	_	_	_	_	_
29	(	_	O	O	_	_	_	_	_
30	from	_	O	O	_	_	_	_	_
31	barely	_	O	O	_	_	_	_	_
32	to	_	O	O	_	_	_	_	_
33	clearly	_	O	O	_	_	_	_	_
34	detectable	_	O	O	_	_	_	_	_
35	)	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_

1	The	_	O	O	_	_	_	_	_
2	levels	_	O	O	_	_	_	_	_
3	of	_	O	O	_	_	_	_	_
4	GATA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	,	_	O	O	_	_	_	_	_
8	Epo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
9	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	R	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	globin	_	O	O	_	_	_	_	_
13	mRNA	_	O	O	_	_	_	_	_
14	expressed	_	O	O	_	_	_	_	_
15	were	_	O	O	_	_	_	_	_
16	not	_	O	O	_	_	_	_	_
17	affected	_	O	O	_	_	_	_	_
18	by	_	O	O	_	_	_	_	_
19	a	_	O	O	_	_	_	_	_
20	24	_	O	O	_	_	_	_	_
21	-	_	O	O	_	_	_	_	_
22	hour	_	O	O	_	_	_	_	_
23	incubation	_	O	O	_	_	_	_	_
24	of	_	O	O	_	_	_	_	_
25	either	_	O	O	_	_	_	_	_
26	cell	_	O	O	_	_	_	_	_
27	line	_	O	O	_	_	_	_	_
28	with	_	O	O	_	_	_	_	_
29	Epo	_	BPROTEIN	BPROTEIN	_	_	_	_	_
30	,	_	O	O	_	_	_	_	_
31	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
32	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
33	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
34	or	_	O	O	_	_	_	_	_
35	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
36	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
37	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
38	(	_	O	O	_	_	_	_	_
39	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
40	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
41	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
42	)	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_



1	AM	_	O	O	_	_	_	_	_
2	580	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	a	_	O	O	_	_	_	_	_
5	stable	_	O	O	_	_	_	_	_
6	benzoic	_	O	O	_	_	_	_	_
7	derivative	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	retinoic	_	O	O	_	_	_	_	_
10	acid	_	O	O	_	_	_	_	_
11	,	_	O	O	_	_	_	_	_
12	has	_	O	O	_	_	_	_	_
13	powerful	_	O	O	_	_	_	_	_
14	and	_	O	O	_	_	_	_	_
15	selective	_	O	O	_	_	_	_	_
16	cyto	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	differentiating	_	O	O	_	_	_	_	_
19	effects	_	O	O	_	_	_	_	_
20	on	_	O	O	_	_	_	_	_
21	acute	_	O	O	_	_	_	_	_
22	promyelocytic	_	O	O	_	_	_	_	_
23	leukemia	_	O	O	_	_	_	_	_
24	cells	_	O	O	_	_	_	_	_
25	.	_	O	O	_	_	_	_	_

1	By	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	AM	_	O	O	_	_	_	_	_
5	580	_	O	O	_	_	_	_	_
6	is	_	O	O	_	_	_	_	_
7	not	_	O	O	_	_	_	_	_
8	effective	_	O	O	_	_	_	_	_
9	as	_	O	O	_	_	_	_	_
10	ATRA	_	O	O	_	_	_	_	_
11	in	_	O	O	_	_	_	_	_
12	modulating	_	O	O	_	_	_	_	_
13	the	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	these	_	O	O	_	_	_	_	_
17	differentiation	_	O	O	_	_	_	_	_
18	markers	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	the	_	O	O	_	_	_	_	_
21	HL	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	60	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	line	_	O	O	_	_	_	_	_
26	and	_	O	O	_	_	_	_	_
27	in	_	O	O	_	_	_	_	_
28	freshly	_	O	O	_	_	_	_	_
29	isolated	_	O	O	_	_	_	_	_
30	granulocytes	_	O	O	_	_	_	_	_
31	obtained	_	O	O	_	_	_	_	_
32	from	_	O	O	_	_	_	_	_
33	the	_	O	O	_	_	_	_	_
34	peripheral	_	O	O	_	_	_	_	_
35	blood	_	O	O	_	_	_	_	_
36	of	_	O	O	_	_	_	_	_
37	chronic	_	O	O	_	_	_	_	_
38	myelogenous	_	O	O	_	_	_	_	_
39	leukemia	_	O	O	_	_	_	_	_
40	patients	_	O	O	_	_	_	_	_
41	during	_	O	O	_	_	_	_	_
42	the	_	O	O	_	_	_	_	_
43	stable	_	O	O	_	_	_	_	_
44	phase	_	O	O	_	_	_	_	_
45	of	_	O	O	_	_	_	_	_
46	the	_	O	O	_	_	_	_	_
47	disease	_	O	O	_	_	_	_	_
48	.	_	O	O	_	_	_	_	_

1	Binding	_	O	O	_	_	_	_	_
2	experiments	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	using	_	O	O	_	_	_	_	_
5	COS	_	O	O	_	_	_	_	_
6	-	_	O	O	_	_	_	_	_
7	7	_	O	O	_	_	_	_	_
8	cells	_	O	O	_	_	_	_	_
9	transiently	_	O	O	_	_	_	_	_
10	transfected	_	O	O	_	_	_	_	_
11	with	_	O	O	_	_	_	_	_
12	PML	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	RAR	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	and	_	O	O	_	_	_	_	_
16	the	_	O	O	_	_	_	_	_
17	normal	_	O	O	_	_	_	_	_
18	RAR	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	show	_	O	O	_	_	_	_	_
22	that	_	O	O	_	_	_	_	_
23	AM	_	O	O	_	_	_	_	_
24	580	_	O	O	_	_	_	_	_
25	has	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	lower	_	O	O	_	_	_	_	_
28	affinity	_	O	O	_	_	_	_	_
29	than	_	O	O	_	_	_	_	_
30	ATRA	_	O	O	_	_	_	_	_
31	for	_	O	O	_	_	_	_	_
32	both	_	O	O	_	_	_	_	_
33	receptors	_	O	O	_	_	_	_	_
34	.	_	O	O	_	_	_	_	_

1	Abstract	_	O	O	_	_	_	_	_

1	To	_	O	O	_	_	_	_	_
2	investigate	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	importance	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	protein	_	O	O	_	_	_	_	_
7	kinase	_	O	O	_	_	_	_	_
8	D	_	O	O	_	_	_	_	_
9	(	_	O	O	_	_	_	_	_
10	PKD	_	O	O	_	_	_	_	_
11	)	_	O	O	_	_	_	_	_
12	enzymes	_	O	O	_	_	_	_	_
13	we	_	O	O	_	_	_	_	_
14	generated	_	O	O	_	_	_	_	_
15	a	_	O	O	_	_	_	_	_
16	PKD	_	O	O	_	_	_	_	_
17	-	_	O	O	_	_	_	_	_
18	null	_	O	O	_	_	_	_	_
19	DT	_	O	O	_	_	_	_	_
20	40	_	O	O	_	_	_	_	_
21	B	_	O	O	_	_	_	_	_
22	-	_	O	O	_	_	_	_	_
23	lymphocyte	_	O	O	_	_	_	_	_
24	cell	_	O	O	_	_	_	_	_
25	line	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_


1	LMP	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	Activates	_	O	O	_	_	_	_	_
4	Akt	_	BPROTEIN	BPROTEIN	_	_	_	_	_
5	Signaling	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	Deregulates	_	O	O	_	_	_	_	_
8	the	_	O	O	_	_	_	_	_
9	Rb	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	Cell	_	O	O	_	_	_	_	_
11	Cycle	_	O	O	_	_	_	_	_
12	Pathway	_	O	O	_	_	_	_	_




1	Thus	_	O	O	_	_	_	_	_
2	,	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	dioxin	_	O	O	_	_	_	_	_
5	receptor	_	O	O	_	_	_	_	_
6	system	_	O	O	_	_	_	_	_
7	provides	_	O	O	_	_	_	_	_
8	a	_	O	O	_	_	_	_	_
9	complex	_	O	O	_	_	_	_	_
10	and	_	O	O	_	_	_	_	_
11	interesting	_	O	O	_	_	_	_	_
12	model	_	O	O	_	_	_	_	_
13	of	_	O	O	_	_	_	_	_
14	the	_	O	O	_	_	_	_	_
15	regulation	_	O	O	_	_	_	_	_
16	of	_	O	O	_	_	_	_	_
17	transcription	_	O	O	_	_	_	_	_
18	factors	_	O	O	_	_	_	_	_
19	by	_	O	O	_	_	_	_	_
20	hsp	_	O	O	_	_	_	_	_
21	90	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	More	_	O	O	_	_	_	_	_
2	than	_	O	O	_	_	_	_	_
3	50	_	O	O	_	_	_	_	_
4	%	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	TPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	treated	_	O	O	_	_	_	_	_
9	UT	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	7	_	O	O	_	_	_	_	_
12	/	_	O	O	_	_	_	_	_
13	GMT	_	O	O	_	_	_	_	_
14	cells	_	O	O	_	_	_	_	_
15	positively	_	O	O	_	_	_	_	_
16	stained	_	O	O	_	_	_	_	_
17	for	_	O	O	_	_	_	_	_
18	Hb	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	TPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	induced	_	O	O	_	_	_	_	_
3	tyrosine	_	O	O	_	_	_	_	_
4	phosphorylation	_	O	O	_	_	_	_	_
5	of	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	TPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	but	_	O	O	_	_	_	_	_
10	not	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	erythropoietin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	EPO	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
16	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
17	.	_	O	O	_	_	_	_	_

1	Isoelectric	_	O	O	_	_	_	_	_
2	focusing	_	O	O	_	_	_	_	_
3	demonstrated	_	O	O	_	_	_	_	_
4	that	_	O	O	_	_	_	_	_
5	TPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
6	induced	_	O	O	_	_	_	_	_
7	fetal	_	O	O	_	_	_	_	_
8	and	_	O	O	_	_	_	_	_
9	adult	_	O	O	_	_	_	_	_
10	Hb	_	O	O	_	_	_	_	_
11	synthesis	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	whereas	_	O	O	_	_	_	_	_
14	EPO	_	BPROTEIN	BPROTEIN	_	_	_	_	_
15	induced	_	O	O	_	_	_	_	_
16	embryonic	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	fetal	_	O	O	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	adult	_	O	O	_	_	_	_	_
22	Hb	_	O	O	_	_	_	_	_
23	synthesis	_	O	O	_	_	_	_	_
24	.	_	O	O	_	_	_	_	_

1	PU	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	.	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	is	_	O	O	_	_	_	_	_
5	a	_	O	O	_	_	_	_	_
6	hematopoietic	_	O	O	_	_	_	_	_
7	transcription	_	O	O	_	_	_	_	_
8	factor	_	O	O	_	_	_	_	_
9	belonging	_	O	O	_	_	_	_	_
10	to	_	O	O	_	_	_	_	_
11	the	_	O	O	_	_	_	_	_
12	Ets	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	family	_	O	O	_	_	_	_	_
15	.	_	O	O	_	_	_	_	_

1	It	_	O	O	_	_	_	_	_
2	binds	_	O	O	_	_	_	_	_
3	the	_	O	O	_	_	_	_	_
4	so	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	called	_	O	O	_	_	_	_	_
7	Pu	_	O	O	_	_	_	_	_
8	box	_	O	O	_	_	_	_	_
9	,	_	O	O	_	_	_	_	_
10	an	_	O	O	_	_	_	_	_
11	important	_	O	O	_	_	_	_	_
12	tissue	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	specific	_	O	O	_	_	_	_	_
15	regulatory	_	O	O	_	_	_	_	_
16	DNA	_	O	O	_	_	_	_	_
17	element	_	O	O	_	_	_	_	_
18	present	_	O	O	_	_	_	_	_
19	in	_	O	O	_	_	_	_	_
20	a	_	O	O	_	_	_	_	_
21	number	_	O	O	_	_	_	_	_
22	of	_	O	O	_	_	_	_	_
23	genes	_	O	O	_	_	_	_	_
24	expressed	_	O	O	_	_	_	_	_
25	in	_	O	O	_	_	_	_	_
26	these	_	O	O	_	_	_	_	_
27	cell	_	O	O	_	_	_	_	_
28	lineages	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_



1	Among	_	O	O	_	_	_	_	_
2	these	_	O	O	_	_	_	_	_
3	target	_	O	O	_	_	_	_	_
4	genes	_	O	O	_	_	_	_	_
5	is	_	O	O	_	_	_	_	_
6	the	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	encoding	_	O	O	_	_	_	_	_
9	interleukin	_	BPROTEIN	BPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	(	_	O	O	_	_	_	_	_
13	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
14	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	a	_	O	O	_	_	_	_	_
18	cytokine	_	O	O	_	_	_	_	_
19	facilitating	_	O	O	_	_	_	_	_
20	progression	_	O	O	_	_	_	_	_
21	through	_	O	O	_	_	_	_	_
22	the	_	O	O	_	_	_	_	_
23	G	_	O	O	_	_	_	_	_
24	1	_	O	O	_	_	_	_	_
25	phase	_	O	O	_	_	_	_	_
26	of	_	O	O	_	_	_	_	_
27	the	_	O	O	_	_	_	_	_
28	cell	_	O	O	_	_	_	_	_
29	cycle	_	O	O	_	_	_	_	_
30	.	_	O	O	_	_	_	_	_

1	Using	_	O	O	_	_	_	_	_
2	a	_	O	O	_	_	_	_	_
3	sensitive	_	O	O	_	_	_	_	_
4	,	_	O	O	_	_	_	_	_
5	reverse	_	O	O	_	_	_	_	_
6	transcription	_	O	O	_	_	_	_	_
7	-	_	O	O	_	_	_	_	_
8	polymerase	_	O	O	_	_	_	_	_
9	chain	_	O	O	_	_	_	_	_
10	reaction	_	O	O	_	_	_	_	_
11	(	_	O	O	_	_	_	_	_
12	RT	_	O	O	_	_	_	_	_
13	-	_	O	O	_	_	_	_	_
14	PCR	_	O	O	_	_	_	_	_
15	)	_	O	O	_	_	_	_	_
16	assay	_	O	O	_	_	_	_	_
17	,	_	O	O	_	_	_	_	_
18	G	_	BPROTEIN	BPROTEIN	_	_	_	_	_
19	0	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	S	_	IPROTEIN	IPROTEIN	_	_	_	_	_
21	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
22	mRNA	_	O	O	_	_	_	_	_
23	levels	_	O	O	_	_	_	_	_
24	were	_	O	O	_	_	_	_	_
25	assayed	_	O	O	_	_	_	_	_
26	in	_	O	O	_	_	_	_	_
27	cultured	_	O	O	_	_	_	_	_
28	blood	_	O	O	_	_	_	_	_
29	mononuclear	_	O	O	_	_	_	_	_
30	cells	_	O	O	_	_	_	_	_
31	.	_	O	O	_	_	_	_	_


1	The	_	O	O	_	_	_	_	_
2	class	_	O	O	_	_	_	_	_
3	II	_	O	O	_	_	_	_	_
4	major	_	O	O	_	_	_	_	_
5	histocompatibility	_	O	O	_	_	_	_	_
6	complex	_	O	O	_	_	_	_	_
7	gene	_	O	O	_	_	_	_	_
8	HLA	_	O	O	_	_	_	_	_
9	-	_	O	O	_	_	_	_	_
10	DRA	_	O	O	_	_	_	_	_
11	is	_	O	O	_	_	_	_	_
12	expressed	_	O	O	_	_	_	_	_
13	in	_	O	O	_	_	_	_	_
14	B	_	O	O	_	_	_	_	_
15	cells	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	activated	_	O	O	_	_	_	_	_
18	T	_	O	O	_	_	_	_	_
19	lymphocytes	_	O	O	_	_	_	_	_
20	,	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	in	_	O	O	_	_	_	_	_
23	antigen	_	O	O	_	_	_	_	_
24	-	_	O	O	_	_	_	_	_
25	presenting	_	O	O	_	_	_	_	_
26	cells	_	O	O	_	_	_	_	_
27	.	_	O	O	_	_	_	_	_

1	In	_	O	O	_	_	_	_	_
2	contrast	_	O	O	_	_	_	_	_
3	,	_	O	O	_	_	_	_	_
4	the	_	O	O	_	_	_	_	_
5	binding	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	the	_	O	O	_	_	_	_	_
8	nuclear	_	O	O	_	_	_	_	_
9	factor	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	activated	_	O	O	_	_	_	_	_
12	T	_	O	O	_	_	_	_	_
13	cells	_	O	O	_	_	_	_	_
14	(	_	O	O	_	_	_	_	_
15	NF	_	O	O	_	_	_	_	_
16	-	_	O	O	_	_	_	_	_
17	AT	_	O	O	_	_	_	_	_
18	)	_	O	O	_	_	_	_	_
19	to	_	O	O	_	_	_	_	_
20	its	_	O	O	_	_	_	_	_
21	response	_	O	O	_	_	_	_	_
22	element	_	O	O	_	_	_	_	_
23	in	_	O	O	_	_	_	_	_
24	the	_	O	O	_	_	_	_	_
25	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
26	2	_	IPROTEIN	IPROTEIN	_	_	_	_	_
27	enhancer	_	O	O	_	_	_	_	_
28	and	_	O	O	_	_	_	_	_
29	to	_	O	O	_	_	_	_	_
30	an	_	O	O	_	_	_	_	_
31	NF	_	O	O	_	_	_	_	_
32	-	_	O	O	_	_	_	_	_
33	AT	_	O	O	_	_	_	_	_
34	-	_	O	O	_	_	_	_	_
35	like	_	O	O	_	_	_	_	_
36	response	_	O	O	_	_	_	_	_
37	element	_	O	O	_	_	_	_	_
38	present	_	O	O	_	_	_	_	_
39	in	_	O	O	_	_	_	_	_
40	the	_	O	O	_	_	_	_	_
41	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
42	4	_	IPROTEIN	IPROTEIN	_	_	_	_	_
43	enhancer	_	O	O	_	_	_	_	_
44	was	_	O	O	_	_	_	_	_
45	abnormal	_	O	O	_	_	_	_	_
46	.	_	O	O	_	_	_	_	_

1	Starting	_	O	O	_	_	_	_	_
2	with	_	O	O	_	_	_	_	_
3	a	_	O	O	_	_	_	_	_
4	replication	_	O	O	_	_	_	_	_
5	-	_	O	O	_	_	_	_	_
6	incompetent	_	O	O	_	_	_	_	_
7	molecular	_	O	O	_	_	_	_	_
8	clone	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	human	_	O	O	_	_	_	_	_
11	immunodeficiency	_	O	O	_	_	_	_	_
12	virus	_	O	O	_	_	_	_	_
13	type	_	O	O	_	_	_	_	_
14	1	_	O	O	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	lacking	_	O	O	_	_	_	_	_
17	all	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	NF	_	O	O	_	_	_	_	_
20	-	_	O	O	_	_	_	_	_
21	kappa	_	O	O	_	_	_	_	_
22	B	_	O	O	_	_	_	_	_
23	and	_	O	O	_	_	_	_	_
24	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
25	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
26	binding	_	O	O	_	_	_	_	_
27	sites	_	O	O	_	_	_	_	_
28	present	_	O	O	_	_	_	_	_
29	in	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	native	_	O	O	_	_	_	_	_
32	long	_	O	O	_	_	_	_	_
33	terminal	_	O	O	_	_	_	_	_
34	repeat	_	O	O	_	_	_	_	_
35	(	_	O	O	_	_	_	_	_
36	LTR	_	O	O	_	_	_	_	_
37	)	_	O	O	_	_	_	_	_
38	,	_	O	O	_	_	_	_	_
39	proviruses	_	O	O	_	_	_	_	_
40	containing	_	O	O	_	_	_	_	_
41	reconstructed	_	O	O	_	_	_	_	_
42	LTRs	_	O	O	_	_	_	_	_
43	with	_	O	O	_	_	_	_	_
44	individual	_	O	O	_	_	_	_	_
45	or	_	O	O	_	_	_	_	_
46	combinations	_	O	O	_	_	_	_	_
47	of	_	O	O	_	_	_	_	_
48	NF	_	O	O	_	_	_	_	_
49	-	_	O	O	_	_	_	_	_
50	kappa	_	O	O	_	_	_	_	_
51	B	_	O	O	_	_	_	_	_
52	and	_	O	O	_	_	_	_	_
53	Sp	_	BPROTEIN	BPROTEIN	_	_	_	_	_
54	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
55	elements	_	O	O	_	_	_	_	_
56	were	_	O	O	_	_	_	_	_
57	generated	_	O	O	_	_	_	_	_
58	and	_	O	O	_	_	_	_	_
59	evaluated	_	O	O	_	_	_	_	_
60	for	_	O	O	_	_	_	_	_
61	their	_	O	O	_	_	_	_	_
62	capacity	_	O	O	_	_	_	_	_
63	to	_	O	O	_	_	_	_	_
64	produce	_	O	O	_	_	_	_	_
65	virus	_	O	O	_	_	_	_	_
66	progeny	_	O	O	_	_	_	_	_
67	following	_	O	O	_	_	_	_	_
68	transfection	_	O	O	_	_	_	_	_
69	-	_	O	O	_	_	_	_	_
70	cocultivation	_	O	O	_	_	_	_	_
71	.	_	O	O	_	_	_	_	_

1	Our	_	O	O	_	_	_	_	_
2	results	_	O	O	_	_	_	_	_
3	indicate	_	O	O	_	_	_	_	_
4	distinct	_	O	O	_	_	_	_	_
5	effects	_	O	O	_	_	_	_	_
6	of	_	O	O	_	_	_	_	_
7	B	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	7	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	and	_	O	O	_	_	_	_	_
10	LFA	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	3	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	costimulation	_	O	O	_	_	_	_	_
14	on	_	O	O	_	_	_	_	_
15	the	_	O	O	_	_	_	_	_
16	activity	_	O	O	_	_	_	_	_
17	of	_	O	O	_	_	_	_	_
18	AP	_	O	O	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	1	_	O	O	_	_	_	_	_
21	and	_	O	O	_	_	_	_	_
22	NF	_	O	O	_	_	_	_	_
23	-	_	O	O	_	_	_	_	_
24	kappa	_	O	O	_	_	_	_	_
25	B	_	O	O	_	_	_	_	_
26	.	_	O	O	_	_	_	_	_

1	Cupric	_	O	O	_	_	_	_	_
2	ion	_	O	O	_	_	_	_	_
3	blocks	_	O	O	_	_	_	_	_
4	NF	_	O	O	_	_	_	_	_
5	kappa	_	O	O	_	_	_	_	_
6	B	_	O	O	_	_	_	_	_
7	activation	_	O	O	_	_	_	_	_
8	through	_	O	O	_	_	_	_	_
9	inhibiting	_	O	O	_	_	_	_	_
10	the	_	O	O	_	_	_	_	_
11	signal	_	O	O	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	phosphorylation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
20	.	_	O	O	_	_	_	_	_


1	Various	_	O	O	_	_	_	_	_
2	extracellular	_	O	O	_	_	_	_	_
3	signals	_	O	O	_	_	_	_	_
4	induce	_	O	O	_	_	_	_	_
5	phosphorylation	_	O	O	_	_	_	_	_
6	and	_	O	O	_	_	_	_	_
7	rapid	_	O	O	_	_	_	_	_
8	degradation	_	O	O	_	_	_	_	_
9	of	_	O	O	_	_	_	_	_
10	I	_	BPROTEIN	BPROTEIN	_	_	_	_	_
11	kappa	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	B	_	IPROTEIN	IPROTEIN	_	_	_	_	_
13	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	to	_	O	O	_	_	_	_	_
15	release	_	O	O	_	_	_	_	_
16	NF	_	O	O	_	_	_	_	_
17	kappa	_	O	O	_	_	_	_	_
18	B	_	O	O	_	_	_	_	_
19	.	_	O	O	_	_	_	_	_

1	This	_	O	O	_	_	_	_	_
2	gene	_	O	O	_	_	_	_	_
3	is	_	O	O	_	_	_	_	_
4	yet	_	O	O	_	_	_	_	_
5	another	_	O	O	_	_	_	_	_
6	in	_	O	O	_	_	_	_	_
7	a	_	O	O	_	_	_	_	_
8	growing	_	O	O	_	_	_	_	_
9	list	_	O	O	_	_	_	_	_
10	of	_	O	O	_	_	_	_	_
11	important	_	O	O	_	_	_	_	_
12	regulatory	_	O	O	_	_	_	_	_
13	molecules	_	O	O	_	_	_	_	_
14	whose	_	O	O	_	_	_	_	_
15	expression	_	O	O	_	_	_	_	_
16	is	_	O	O	_	_	_	_	_
17	transcriptionally	_	O	O	_	_	_	_	_
18	induced	_	O	O	_	_	_	_	_
19	upon	_	O	O	_	_	_	_	_
20	cellular	_	O	O	_	_	_	_	_
21	activation	_	O	O	_	_	_	_	_
22	.	_	O	O	_	_	_	_	_

1	Protein	_	O	O	_	_	_	_	_
2	concentration	_	O	O	_	_	_	_	_
3	was	_	O	O	_	_	_	_	_
4	determined	_	O	O	_	_	_	_	_
5	by	_	O	O	_	_	_	_	_
6	Lowry	_	O	O	_	_	_	_	_
7	assay	_	O	O	_	_	_	_	_
8	(	_	O	O	_	_	_	_	_
9	Bio	_	O	O	_	_	_	_	_
10	-	_	O	O	_	_	_	_	_
11	Rad	_	O	O	_	_	_	_	_
12	,	_	O	O	_	_	_	_	_
13	Hercules	_	O	O	_	_	_	_	_
14	,	_	O	O	_	_	_	_	_
15	California	_	O	O	_	_	_	_	_
16	,	_	O	O	_	_	_	_	_
17	United	_	O	O	_	_	_	_	_
18	States	_	O	O	_	_	_	_	_
19	)	_	O	O	_	_	_	_	_
20	and	_	O	O	_	_	_	_	_
21	colorimetric	_	O	O	_	_	_	_	_
22	reactions	_	O	O	_	_	_	_	_
23	were	_	O	O	_	_	_	_	_
24	read	_	O	O	_	_	_	_	_
25	using	_	O	O	_	_	_	_	_
26	a	_	O	O	_	_	_	_	_
27	VersaMax	_	O	O	_	_	_	_	_
28	microplate	_	O	O	_	_	_	_	_
29	reader	_	O	O	_	_	_	_	_
30	(	_	O	O	_	_	_	_	_
31	Molecular	_	O	O	_	_	_	_	_
32	Devices	_	O	O	_	_	_	_	_
33	,	_	O	O	_	_	_	_	_
34	Sunnyvale	_	O	O	_	_	_	_	_
35	,	_	O	O	_	_	_	_	_
36	California	_	O	O	_	_	_	_	_
37	,	_	O	O	_	_	_	_	_
38	United	_	O	O	_	_	_	_	_
39	States	_	O	O	_	_	_	_	_
40	)	_	O	O	_	_	_	_	_
41	at	_	O	O	_	_	_	_	_
42	an	_	O	O	_	_	_	_	_
43	absorbance	_	O	O	_	_	_	_	_
44	of	_	O	O	_	_	_	_	_
45	750	_	O	O	_	_	_	_	_
46	nm	_	O	O	_	_	_	_	_
47	.	_	O	O	_	_	_	_	_

1	IL	_	BPROTEIN	BPROTEIN	_	_	_	_	_
2	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
3	1	_	IPROTEIN	IPROTEIN	_	_	_	_	_
4	receptor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
5	antagonist	_	IPROTEIN	IPROTEIN	_	_	_	_	_
6	(	_	IPROTEIN	IPROTEIN	_	_	_	_	_
7	ra	_	IPROTEIN	IPROTEIN	_	_	_	_	_
8	)	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	inhibited	_	O	O	_	_	_	_	_
10	LPS	_	O	O	_	_	_	_	_
11	enhancement	_	O	O	_	_	_	_	_
12	of	_	O	O	_	_	_	_	_
13	HIV	_	O	O	_	_	_	_	_
14	expression	_	O	O	_	_	_	_	_
15	in	_	O	O	_	_	_	_	_
16	GM	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	CSF	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	-	_	O	O	_	_	_	_	_
20	stimulated	_	O	O	_	_	_	_	_
21	cells	_	O	O	_	_	_	_	_
22	,	_	O	O	_	_	_	_	_
23	suggesting	_	O	O	_	_	_	_	_
24	that	_	O	O	_	_	_	_	_
25	endogenous	_	O	O	_	_	_	_	_
26	IL	_	O	O	_	_	_	_	_
27	-	_	O	O	_	_	_	_	_
28	1	_	O	O	_	_	_	_	_
29	was	_	O	O	_	_	_	_	_
30	involved	_	O	O	_	_	_	_	_
31	in	_	O	O	_	_	_	_	_
32	LPS	_	O	O	_	_	_	_	_
33	-	_	O	O	_	_	_	_	_
34	mediated	_	O	O	_	_	_	_	_
35	viral	_	O	O	_	_	_	_	_
36	production	_	O	O	_	_	_	_	_
37	.	_	O	O	_	_	_	_	_

1	Anti	_	O	O	_	_	_	_	_
2	-	_	O	O	_	_	_	_	_
3	rheumatic	_	O	O	_	_	_	_	_
4	compound	_	O	O	_	_	_	_	_
5	aurothioglucose	_	O	O	_	_	_	_	_
6	inhibits	_	O	O	_	_	_	_	_
7	tumor	_	BPROTEIN	BPROTEIN	_	_	_	_	_
8	necrosis	_	IPROTEIN	IPROTEIN	_	_	_	_	_
9	factor	_	IPROTEIN	IPROTEIN	_	_	_	_	_
10	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
11	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
12	-	_	O	O	_	_	_	_	_
13	induced	_	O	O	_	_	_	_	_
14	HIV	_	O	O	_	_	_	_	_
15	-	_	O	O	_	_	_	_	_
16	1	_	O	O	_	_	_	_	_
17	replication	_	O	O	_	_	_	_	_
18	in	_	O	O	_	_	_	_	_
19	latently	_	O	O	_	_	_	_	_
20	infected	_	O	O	_	_	_	_	_
21	OM	_	O	O	_	_	_	_	_
22	10	_	O	O	_	_	_	_	_
23	.	_	O	O	_	_	_	_	_
24	1	_	O	O	_	_	_	_	_
25	and	_	O	O	_	_	_	_	_
26	Ach	_	O	O	_	_	_	_	_
27	2	_	O	O	_	_	_	_	_
28	cells	_	O	O	_	_	_	_	_
29	.	_	O	O	_	_	_	_	_

1	Treatment	_	O	O	_	_	_	_	_
2	of	_	O	O	_	_	_	_	_
3	T	_	O	O	_	_	_	_	_
4	cells	_	O	O	_	_	_	_	_
5	with	_	O	O	_	_	_	_	_
6	a	_	O	O	_	_	_	_	_
7	variety	_	O	O	_	_	_	_	_
8	of	_	O	O	_	_	_	_	_
9	stimuli	_	O	O	_	_	_	_	_
10	,	_	O	O	_	_	_	_	_
11	including	_	O	O	_	_	_	_	_
12	TNF	_	BPROTEIN	BPROTEIN	_	_	_	_	_
13	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
14	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
15	,	_	O	O	_	_	_	_	_
16	leads	_	O	O	_	_	_	_	_
17	to	_	O	O	_	_	_	_	_
18	the	_	O	O	_	_	_	_	_
19	translocation	_	O	O	_	_	_	_	_
20	of	_	O	O	_	_	_	_	_
21	the	_	O	O	_	_	_	_	_
22	active	_	O	O	_	_	_	_	_
23	p	_	O	O	_	_	_	_	_
24	65	_	O	O	_	_	_	_	_
25	-	_	O	O	_	_	_	_	_
26	50	_	O	O	_	_	_	_	_
27	heterodimer	_	O	O	_	_	_	_	_
28	to	_	O	O	_	_	_	_	_
29	the	_	O	O	_	_	_	_	_
30	nucleus	_	O	O	_	_	_	_	_
31	,	_	O	O	_	_	_	_	_
32	albeit	_	O	O	_	_	_	_	_
33	at	_	O	O	_	_	_	_	_
34	a	_	O	O	_	_	_	_	_
35	lower	_	O	O	_	_	_	_	_
36	level	_	O	O	_	_	_	_	_
37	in	_	O	O	_	_	_	_	_
38	T	_	O	O	_	_	_	_	_
39	cells	_	O	O	_	_	_	_	_
40	from	_	O	O	_	_	_	_	_
41	the	_	O	O	_	_	_	_	_
42	elderly	_	O	O	_	_	_	_	_
43	.	_	O	O	_	_	_	_	_

1	These	_	O	O	_	_	_	_	_
2	data	_	O	O	_	_	_	_	_
3	collectively	_	O	O	_	_	_	_	_
4	suggest	_	O	O	_	_	_	_	_
5	that	_	O	O	_	_	_	_	_
6	PAO	_	O	O	_	_	_	_	_
7	interferes	_	O	O	_	_	_	_	_
8	with	_	O	O	_	_	_	_	_
9	the	_	O	O	_	_	_	_	_
10	phosphorylation	_	O	O	_	_	_	_	_
11	and	_	O	O	_	_	_	_	_
12	the	_	O	O	_	_	_	_	_
13	regulated	_	O	O	_	_	_	_	_
14	degradation	_	O	O	_	_	_	_	_
15	of	_	O	O	_	_	_	_	_
16	IkappaB	_	BPROTEIN	BPROTEIN	_	_	_	_	_
17	-	_	IPROTEIN	IPROTEIN	_	_	_	_	_
18	alpha	_	IPROTEIN	IPROTEIN	_	_	_	_	_
19	,	_	O	O	_	_	_	_	_
20	induced	_	O	O	_	_	_	_	_
21	by	_	O	O	_	_	_	_	_
22	TNF	_	O	O	_	_	_	_	_
23	,	_	O	O	_	_	_	_	_
24	without	_	O	O	_	_	_	_	_
25	affecting	_	O	O	_	_	_	_	_
26	the	_	O	O	_	_	_	_	_
27	chymotryptic	_	O	O	_	_	_	_	_
28	activity	_	O	O	_	_	_	_	_
29	of	_	O	O	_	_	_	_	_
30	the	_	O	O	_	_	_	_	_
31	proteasome	_	O	O	_	_	_	_	_
32	,	_	O	O	_	_	_	_	_
33	independent	_	O	O	_	_	_	_	_
34	of	_	O	O	_	_	_	_	_
35	age	_	O	O	_	_	_	_	_
36	.	_	O	O	_	_	_	_	_



